pathway_name,pathway_source,num_overlapping_genes,overlapping_genes,num_all_pathway_genes,P_genes,Q_genes,num_overlapping_metabolites,overlapping_metabolites,num_all_pathway_metabolites,P_metabolites,Q_metabolites,P_joint,Q_joint
Cell Cycle,Reactome,135,KNTC1;NUP50;BRIP1;RNF168;CENPN;INCENP;CENPE;CENPF;PDS5B;SMC1A;SPC25;CKAP5;CDC23;BARD1;NUDC;OIP5;MCM3;MCM5;MCM6;NUF2;HMMR;MCM10;BUB1;RUVBL2;NCAPG2;BANF1;RCC2;CKS1B;SPDL1;NUP205;BLM;AURKA;DSN1;HIST1H2AK;POLE;NUP133;HIST1H2AC;HIST1H2AB;HIST1H2BG;NCAPG;HIST1H2BH;HIST1H3C;HIST1H3I;NDC80;HIST1H4D;HIST1H4F;ANAPC1;NUP37;CDC16;NUP210;MAD1L1;BUB1B;NCAPD2;NUP62;CDT1;PLK1;RHNO1;KIF2C;HSP90AB1;FOXM1;HIST1H3F;NUP188;FZR1;NCAPD3;ZWILCH;RANGAP1;SET;CENPT;NUP107;RBBP4;WEE1;RBL1;POLA1;POLD1;ANAPC15;UBE2C;CDC20;NUP88;TOPBP1;SMC4;BIRC5;E2F1;NSL1;E2F4;NUP214;NEK2;ODF2;SMC2;RFC5;NHP2;NCAPH;CDCA8;CCNA2;CCNB1;PPP1CC;KIF20A;SPC24;LIG1;HIST1H2BF;HDAC1;PPP2R5D;NDC1;BABAM1;CCNB2;CDC7;TPX2;MASTL;MCM2;EXO1;H2AFX;H2AFZ;TMPO;HIST1H2BB;CDK5RAP2;CEP152;CDK1;ZW10;BUB3;CDC25A;CDC25C;ESPL1;RPA1;SKA1;PCNT;CDCA5;PMF1;PLK4;STAG3;TOP2A;MAD2L1;CDK2;BORA;CDK4;AURKB;CDK6,563 (564),4.53e-74,2.08e-70,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,31 (33),5.62e-05,0.00233,4.57e-76,1.16e-72
Cell Cycle_ Mitotic,Reactome,123,KNTC1;NUP50;CENPN;INCENP;CENPE;CENPF;PDS5B;SMC1A;SPC25;CKAP5;CDC23;NUDC;MCM2;MCM3;MCM5;MCM6;NUF2;HMMR;MCM10;BUB1;NCAPG2;BANF1;RCC2;SPDL1;NUP205;AURKA;DSN1;HIST1H2AK;CKS1B;NUP133;HIST1H2AC;NEK2;HIST1H2BG;NCAPG;HIST1H2BH;HIST1H3C;HIST1H3I;NDC80;HIST1H4D;HIST1H4F;ANAPC1;NUP37;CDC16;NUP210;MAD1L1;BUB1B;NCAPD2;NUP62;CDT1;PLK1;CDC7;KIF2C;HSP90AB1;FOXM1;HIST1H3F;NUP188;NCAPD3;ZWILCH;RANGAP1;SET;CENPT;NUP107;RBBP4;WEE1;RBL1;POLA1;POLD1;POLE;UBE2C;CDC20;NUP88;SMC4;BIRC5;E2F1;NSL1;ANAPC15;E2F4;CDK2;NUP214;FZR1;ODF2;SMC2;RFC5;NCAPH;CDCA8;CCNA2;CCNB1;PPP1CC;KIF20A;SPC24;LIG1;HIST1H2BF;PPP2R5D;NDC1;CCNB2;TPX2;MASTL;H2AFX;H2AFZ;TMPO;HIST1H2BB;CDK5RAP2;HIST1H2AB;CEP152;CDK1;ZW10;BUB3;CDC25A;CDC25C;ESPL1;RPA1;SKA1;AURKB;CDCA5;PMF1;PLK4;TOP2A;MAD2L1;HDAC1;BORA;CDK4;PCNT;CDK6,480 (481),1.12e-70,2.57e-67,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,30 (30),4.92e-05,0.00212,9.48e-73,1.2e-69
M Phase,Reactome,89,PDS5B;NUP50;CENPN;INCENP;CENPE;CENPF;KNTC1;SMC1A;SPC25;CKAP5;CDC23;NUDC;NUF2;MAD1L1;NCAPG2;BANF1;RCC2;SPDL1;NUP205;DSN1;HIST1H2AK;MASTL;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H3C;HIST1H3I;NDC80;HIST1H4D;HIST1H4F;ANAPC1;NUP37;CDC16;NUP210;BUB1;BUB1B;NCAPD2;PLK1;KIF2C;HIST1H3F;CDK1;NCAPD3;ZWILCH;RANGAP1;SET;CENPT;NUP107;ANAPC15;UBE2C;ZW10;NUP88;SMC4;BIRC5;NSL1;NUP214;NEK2;ODF2;SMC2;NCAPH;CDCA8;CCNB1;PPP1CC;KIF20A;SPC24;NCAPG;PPP2R5D;NDC1;CCNB2;NUP133;H2AFX;H2AFZ;TMPO;HIST1H2BB;CDK5RAP2;CEP152;NUP188;CDC20;BUB3;ESPL1;SKA1;PCNT;CDCA5;PMF1;PLK4;MAD2L1;NUP62;AURKB,339 (340),2.36e-51,3.61e-48,1,HMDB00538,18 (18),0.125,0.306,3.53e-50,2.97e-47
Cell Cycle Checkpoints,Reactome,73,SPC24;BUB1B;BUB1;KNTC1;CCNB1;ZWILCH;INCENP;HIST1H2BG;BRIP1;HIST1H2BF;PPP2R5D;EXO1;RHNO1;BABAM1;CENPN;NUP107;NDC80;CENPE;CENPF;HIST1H4D;HIST1H4F;ANAPC1;CCNB2;NUP37;CDC16;ANAPC15;RNF168;BLM;UBE2C;MAD1L1;RANGAP1;SPC25;CKAP5;NUP133;CDC23;BARD1;H2AFX;RFC5;MCM3;HIST1H2BB;MCM2;BIRC5;CDC20;MCM5;MCM6;NSL1;PLK1;NUF2;CDK1;SKA1;MCM10;ZW10;BUB3;CDC25A;CDC25C;RPA1;NUDC;CDCA8;KIF2C;PMF1;DSN1;CENPT;CDC7;RCC2;MAD2L1;WEE1;HIST1H2BH;CDK2;CCNA2;SPDL1;AURKB;PPP1CC;TOPBP1,249 (250),1.18e-45,1.36e-42,1,HMDB00538,3 (3),0.0219,0.134,2.81e-45,1.78e-42
Mitotic Prometaphase,Reactome,54,SPC24;NDC80;BUB1;PDS5B;CCNB1;ZWILCH;PPP2R5D;NCAPG;CENPT;CENPN;NUP107;INCENP;CENPE;CENPF;KNTC1;CCNB2;NUP37;SMC1A;MAD1L1;RANGAP1;SPC25;NCAPD2;CKAP5;NUP133;SMC4;ZW10;CDK5RAP2;BIRC5;NSL1;CEP152;NUF2;CDK1;SKA1;NEK2;ODF2;CDC20;BUB3;SMC2;PLK1;NCAPH;NUDC;CDCA8;KIF2C;CDCA5;PMF1;DSN1;PLK4;BUB1B;RCC2;MAD2L1;SPDL1;AURKB;PPP1CC;PCNT,186 (186),1.46e-33,1.06e-30,1,HMDB00538,6 (6),0.0434,0.161,5.06e-33,2.56e-30
Resolution of Sister Chromatid Cohesion,Reactome,43,SPC24;BUB1;KNTC1;CCNB1;ZWILCH;PPP2R5D;CENPT;CENPN;NUP107;INCENP;CENPE;CENPF;PDS5B;CCNB2;NUP37;SMC1A;MAD1L1;RANGAP1;SPC25;CKAP5;NUP133;CDC20;BIRC5;NSL1;NDC80;NUF2;CDK1;ZW10;BUB3;PLK1;SKA1;NUDC;CDCA8;KIF2C;CDCA5;PMF1;DSN1;BUB1B;RCC2;MAD2L1;SPDL1;AURKB;PPP1CC,109 (109),2.9e-33,1.66e-30,1,HMDB00538,6 (6),0.0434,0.161,9.96e-33,4.2e-30
Mitotic Anaphase,Reactome,48,SPC24;BUB1;PDS5B;ZWILCH;PPP2R5D;CENPT;CENPN;NUP107;INCENP;CENPE;CENPF;ANAPC1;KNTC1;NUP37;CDC16;ANAPC15;SMC1A;UBE2C;MAD1L1;RANGAP1;SPC25;CKAP5;NUP133;CDC20;TMPO;BIRC5;NSL1;NDC80;NUF2;BUB1B;ZW10;BUB3;PLK1;ESPL1;SKA1;NUDC;CDCA8;KIF2C;CDCA5;PMF1;DSN1;BANF1;RCC2;MAD2L1;CDC23;SPDL1;AURKB;PPP1CC,140 (140),1.11e-33,1.01e-30,0,,4 (4),1,1,8.5e-32,3.07e-29
Mitotic Metaphase and Anaphase,Reactome,48,SPC24;BUB1;PDS5B;ZWILCH;PPP2R5D;CENPT;CENPN;NUP107;INCENP;CENPE;CENPF;ANAPC1;KNTC1;NUP37;CDC16;ANAPC15;SMC1A;UBE2C;MAD1L1;RANGAP1;SPC25;CKAP5;NUP133;CDC20;TMPO;BIRC5;NSL1;NDC80;NUF2;BUB1B;ZW10;BUB3;PLK1;ESPL1;SKA1;NUDC;CDCA8;KIF2C;CDCA5;PMF1;DSN1;BANF1;RCC2;MAD2L1;CDC23;SPDL1;AURKB;PPP1CC,141 (141),1.62e-33,1.06e-30,0,,4 (4),1,1,1.24e-31,3.92e-29
Separation of Sister Chromatids,Reactome,46,SPC24;BUB1;PDS5B;ZWILCH;PPP2R5D;CENPT;CENPN;NUP107;INCENP;CENPE;CENPF;ANAPC1;KNTC1;NUP37;CDC16;ANAPC15;SMC1A;UBE2C;MAD1L1;RANGAP1;SPC25;CKAP5;NUP133;CDC20;BIRC5;NSL1;NDC80;NUF2;ZW10;BUB3;PLK1;ESPL1;SKA1;NUDC;CDCA8;KIF2C;CDCA5;PMF1;DSN1;BUB1B;RCC2;MAD2L1;CDC23;SPDL1;AURKB;PPP1CC,129 (129),3.4e-33,1.73e-30,0,,2 (2),1,1,2.58e-31,7.24e-29
Mitotic Spindle Checkpoint,Reactome,42,SPC24;BUB1;KNTC1;ZWILCH;PPP2R5D;CENPT;CENPN;NUP107;NDC80;CENPE;CENPF;ANAPC1;NUP37;CDC16;ANAPC15;UBE2C;MAD1L1;RANGAP1;SPC25;CKAP5;NUP133;CDC20;BIRC5;NSL1;INCENP;NUF2;ZW10;BUB3;PLK1;SKA1;NUDC;CDCA8;KIF2C;PMF1;DSN1;BUB1B;RCC2;MAD2L1;CDC23;SPDL1;AURKB;PPP1CC,113 (113),3.03e-31,1.39e-28,0,,0 (0),1,1,3.03e-31,1.39e-28
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Reactome,37,SPC24;BUB1;KNTC1;ZWILCH;PPP2R5D;CENPT;CENPN;NUP107;INCENP;CENPE;CENPF;NUP37;MAD1L1;RANGAP1;SPC25;CKAP5;NUP133;ZW10;BIRC5;NSL1;NDC80;NUF2;CDC20;BUB3;PLK1;SKA1;NUDC;CDCA8;KIF2C;PMF1;DSN1;BUB1B;RCC2;MAD2L1;SPDL1;AURKB;PPP1CC,96 (96),2.58e-28,9.88e-26,0,,0 (0),1,1,2.58e-28,9.88e-26
Amplification of signal from the kinetochores,Reactome,37,SPC24;BUB1;KNTC1;ZWILCH;PPP2R5D;CENPT;CENPN;NUP107;INCENP;CENPE;CENPF;NUP37;MAD1L1;RANGAP1;SPC25;CKAP5;NUP133;ZW10;BIRC5;NSL1;NDC80;NUF2;CDC20;BUB3;PLK1;SKA1;NUDC;CDCA8;KIF2C;PMF1;DSN1;BUB1B;RCC2;MAD2L1;SPDL1;AURKB;PPP1CC,96 (96),2.58e-28,9.88e-26,0,,0 (0),1,1,2.58e-28,9.88e-26
Retinoblastoma Gene in Cancer,Wikipathways,34,MSH6;HDAC1;RBBP4;WEE1;ANLN;CCNB2;POLA1;POLE;SMC1A;H2AFZ;SUV39H1;BARD1;CDC25A;MCM3;HMGB1;HMGB2;E2F1;MCM6;CDT1;STMN1;CDK1;CCNA2;SMC2;RFC5;CCNB1;RPA1;TTK;PLK4;CDC7;TOP2A;CDK2;DNMT1;CDK4;CDK6,89 (89),5.95e-26,2.1e-23,0,,0 (0),1,1,5.95e-26,2.1e-23
RHO GTPases Activate Formins,Reactome,37,SPC24;BUB1;KNTC1;ZWILCH;PPP2R5D;CENPT;CENPN;NUP107;INCENP;CENPE;CENPF;NUP37;MAD1L1;RANGAP1;SPC25;CKAP5;NUP133;CDC20;BIRC5;NSL1;NDC80;NUF2;ZW10;BUB3;PLK1;SKA1;NUDC;CDCA8;KIF2C;PMF1;DSN1;BUB1B;RCC2;MAD2L1;SPDL1;AURKB;PPP1CC,123 (123),7.16e-24,2.19e-21,1,HMDB00538,7 (7),0.0505,0.173,2.07e-23,5.24e-21
RHO GTPase Effectors,Reactome,56,SPC24;NDC80;BUB1;KNTC1;HIST1H3F;HIST1H2AK;HIST1H2AC;ZWILCH;CENPT;HIST1H2BG;KIF2C;HIST1H2BF;PPP2R5D;HIST1H2BH;CENPN;HIST1H3C;PRC1;NUP107;INCENP;CENPE;CENPF;HIST1H4D;HIST1H4F;NUP37;ZW10;RANGAP1;SPC25;CKAP5;NUP133;H2AFX;H2AFZ;KIF14;HIST1H2BB;BIRC5;HIST1H3I;NSL1;MAD1L1;PLK1;NUF2;HIST1H2AB;BUB1B;CDC20;BUB3;CDC25C;SKA1;NUDC;CDCA8;CIT;PMF1;DSN1;IQGAP3;RCC2;MAD2L1;SPDL1;AURKB;PPP1CC,300 (301),3.97e-24,1.3e-21,1,HMDB00538,24 (27),0.163,0.38,3.67e-23,8.44e-21
Cell cycle - Homo sapiens (human),KEGG,35,TGFB1;CDK1;FZR1;CDK2;WEE1;ANAPC1;RBL1;CDC16;SMC1A;BUB1;BUB1B;MAD2L1;MCM2;MCM3;E2F1;MCM5;MCM6;E2F4;CDC25C;CDC23;HDAC2;CDC20;BUB3;CDC25A;PLK1;ESPL1;TTK;CCNB2;CDK6;CDK4;MAD1L1;HDAC1;CCNA2;CCNB1;CDC7,124 (124),1.29e-21,3.7e-19,0,,0 (0),1,1,1.29e-21,3.7e-19
Mitotic Prophase,Reactome,37,HIST1H3F;HIST1H2AK;NUP188;MASTL;NCAPD3;HIST1H2AB;SET;HIST1H2BG;HIST1H2BF;HIST1H2BH;NDC1;HIST1H3C;NUP107;HIST1H4D;HIST1H4F;CCNB2;HIST1H2AC;NUP37;NUP210;NUP50;NUP88;NUP133;SMC4;H2AFX;H2AFZ;TMPO;HIST1H2BB;HIST1H3I;NUP62;NUP214;CDK1;SMC2;PLK1;NCAPG2;BANF1;CCNB1;NUP205,143 (144),2.41e-21,6.52e-19,1,HMDB00538,16 (16),0.112,0.28,1.37e-20,2.88e-18
Cell Cycle,Wikipathways,33,TGFB1;BUB1;CCNB1;FZR1;HDAC1;RBL1;CDK2;WEE1;ANAPC1;CCNB2;CDC16;SMC1A;MAD1L1;MCM2;MCM3;E2F1;MCM5;MCM6;E2F4;CDC25C;CDK1;CCNA2;CDC20;BUB3;CDC25A;PLK1;ESPL1;TTK;CDC7;CDC23;HDAC2;CDK4;CDK6,120 (120),4.68e-20,1.19e-17,0,,0 (0),1,1,4.68e-20,1.19e-17
Signaling by Rho GTPases,Reactome,61,SPC24;BUB3;ZW10;BUB1;KNTC1;HIST1H3F;HIST1H2AK;HIST1H2AC;ZWILCH;RANGAP1;HIST1H2BG;KIF2C;HIST1H2BF;PPP2R5D;HIST1H2BH;IQGAP3;CENPT;CENPN;HIST1H3C;NUP107;NDC80;CENPE;CENPF;HIST1H4D;HIST1H4F;H2AFZ;AURKB;NUP37;ECT2;MAD1L1;BUB1B;CKAP5;NUP133;H2AFX;RACGAP1;KIF14;HIST1H2BB;BIRC5;HIST1H3I;NSL1;PLK1;NUF2;OCRL;INCENP;HIST1H2AB;CDC20;PLEKHG2;PRC1;ARHGAP11A;CDC25C;SKA1;NUDC;CDCA8;CIT;PMF1;DSN1;SPC25;RCC2;MAD2L1;SPDL1;PPP1CC,430 (435),8.27e-20,2e-17,1,HMDB00538,24 (27),0.163,0.38,6.32e-19,1.23e-16
S Phase,Reactome,26,PDS5B;LIG1;CKS1B;FZR1;WEE1;ANAPC1;POLE;POLA1;POLD1;CDC16;ANAPC15;SMC1A;UBE2C;RFC5;MCM2;MCM3;MCM5;MCM6;CDT1;CDK2;CDC25A;RPA1;CDCA5;CDC23;CCNA2;CDK4,103 (103),4.52e-15,7.98e-13,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,17 (17),4.53e-06,0.000461,9.48e-19,1.71e-16
PLK1 signaling events,PID,21,KIF20A;SPC24;PRC1;PLK1;AURKA;ECT2;WEE1;CCNB1;CENPE;FZR1;ODF2;INCENP;NDC80;CDK1;NUDC;BORA;BUB1;CDC20;BUB1B;TPX2;CDC25C,44 (44),6.11e-19,1.4e-16,0,,1 (1),1,1,2.62e-17,4.42e-15
G2/M Checkpoints,Reactome,30,BLM;HIST1H2BG;BRIP1;HIST1H2BF;HIST1H2BH;EXO1;BABAM1;HIST1H4D;HIST1H4F;CCNB2;RNF168;TOPBP1;BARD1;H2AFX;RFC5;HIST1H2BB;MCM2;MCM3;MCM5;MCM6;CDK1;MCM10;CDC25A;CDC25C;RPA1;RHNO1;WEE1;CDK2;CCNB1;CDC7,119 (120),3.51e-17,7.32e-15,1,HMDB00538,3 (3),0.0219,0.134,3.29e-17,5.19e-15
DNA Replication,Reactome,21,RFC5;MCM2;RPA1;ANAPC1;ANAPC15;MCM3;UBE2C;POLA1;MCM6;POLD1;CDC16;POLE;LIG1;CDT1;MCM5;CDC23;CDK2;CCNA2;FZR1;MCM10;CDC7,80 (80),8.78e-13,1.09e-10,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,14 (14),1.93e-06,0.000275,7.1e-17,1.06e-14
Aurora B signaling,PID,20,KIF20A;SMC2;INCENP;NDC80;NCAPH;AURKA;CDCA8;NSUN2;KIF2C;RACGAP1;CBX5;SMC4;STMN1;NCAPG;PPP2R5D;BIRC5;BUB1;AURKB;PPP1CC;NCAPD2,41 (41),2.44e-18,5.34e-16,0,,2 (2),1,1,1.01e-16,1.43e-14
Chromosome Maintenance,Reactome,23,LIG1;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;CENPT;HIST1H2BH;CENPN;RBBP4;HIST1H4F;POLA1;POLD1;POLE;HIST1H2AK;H2AFX;H2AFZ;HIST1H2BB;OIP5;RFC5;NHP2;RPA1;RUVBL2;HIST1H4D,111 (112),1.49e-11,1.49e-09,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,13 (15),1.39e-06,0.000214,8.13e-16,1.08e-13
Synthesis of DNA,Reactome,19,RFC5;MCM2;RPA1;ANAPC1;POLE;MCM3;UBE2C;MCM5;FZR1;POLD1;CDC16;ANAPC15;CDT1;POLA1;CDC23;CDK2;CCNA2;MCM6;LIG1,75 (75),2.15e-11,2.06e-09,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,13 (13),1.39e-06,0.000214,1.16e-15,1.47e-13
APC/C-mediated degradation of cell cycle proteins,Reactome,18,BUB3;PLK1;AURKA;ANAPC1;CCNB1;UBE2C;NEK2;CDC16;ANAPC15;CDK2;MAD2L1;CDK1;CDC23;CCNA2;FZR1;AURKB;BUB1B;CDC20,41 (41),1.32e-15,2.43e-13,1,HMDB00538,4 (4),0.0292,0.138,1.5e-15,1.72e-13
Regulation of mitotic cell cycle,Reactome,18,BUB3;PLK1;AURKA;ANAPC1;CCNB1;UBE2C;NEK2;CDC16;ANAPC15;CDK2;MAD2L1;CDK1;CDC23;CCNA2;FZR1;AURKB;BUB1B;CDC20,41 (41),1.32e-15,2.43e-13,1,HMDB00538,4 (4),0.0292,0.138,1.5e-15,1.72e-13
Influenza Infection,Reactome,18,TGFB1;NUP107;NUP50;RAN;KPNB1;NUP133;GTF2F1;NUP62;CANX;NUP214;NUP188;NUP210;NDC1;NUP37;KPNA1;NUP205;KPNA2;NUP88,63 (63),7.92e-12,8.45e-10,3,HMDB00285;HMDB00538;HMDB00082,6 (9),6.56e-06,0.000498,2e-15,2.2e-13
Telomere Maintenance,Reactome,19,RFC5;NHP2;RPA1;H2AFX;H2AFZ;HIST1H4D;HIST1H4F;LIG1;POLA1;HIST1H2AB;POLD1;RUVBL2;POLE;HIST1H2BG;HIST1H2AC;HIST1H2AK;HIST1H2BF;HIST1H2BH;HIST1H2BB,83 (84),1.45e-10,9.96e-09,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,13 (14),1.39e-06,0.000214,7.48e-15,7.88e-13
Gene expression (Transcription),Reactome,103,SMARCB1;NUP50;SETD1A;BRIP1;NUP37;PHF19;NOC2L;INTS1;BARD1;E2F7;NCBP1;NUP62;SSRP1;CDC7;BLM;AURKA;HIST1H2AK;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H3C;HIST1H3I;INTS2;CSTF2;EHMT2;HIST1H4D;HIST1H4F;H2AFZ;SRSF4;SUV39H1;NUP210;MLH1;FIP1L1;DGCR8;TAF1;CPSF2;TAF9;TET3;DEK;RHNO1;RBBP4;DNMT1;DDX39B;RAD51;HSPD1;FANCD2;HIST1H3F;NUP188;RAN;MYBBP1A;HDAC6;IPO8;NUP107;MED24;INTS7;RBL1;NUP88;TOPBP1;HIPK2;BIRC5;E2F1;E2F4;CDK2;PIWIL2;NUP214;RFC5;ATAD2;TFAM;E2F8;CCNA2;CCNB1;NUP205;TGFB1;SRRT;NCOR2;LRPPRC;GTF2F1;INTS5;NDC1;GTF3A;TRIM28;CBX5;FANCI;TPX2;NUP133;EXO1;SMARCA4;H2AFX;SMARCC1;UHRF1;HIST1H2BB;CDK1;HDAC2;CDC25C;RPA1;SNRPE;HDAC1;MYB;CDK4;AURKB;CDK6,1364 (1373),1.18e-12,1.42e-10,4,HMDB03337;HMDB00538;HMDB00285;HMDB00082,45 (66),0.00025,0.0086,1.08e-14,1.08e-12
Influenza Life Cycle,Reactome,16,NUP107;NUP50;RAN;KPNB1;NUP133;GTF2F1;NUP62;CANX;NUP214;NUP188;NUP210;NDC1;NUP37;KPNA1;NUP205;NUP88,53 (53),4.61e-11,3.71e-09,3,HMDB00285;HMDB00538;HMDB00082,6 (9),6.56e-06,0.000498,1.11e-14,1.08e-12
Transcriptional regulation by small RNAs,Reactome,27,HIST1H3F;NUP50;RAN;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;HIST1H2BH;NDC1;IPO8;HIST1H3C;NUP107;HIST1H4D;HIST1H4F;NUP37;NUP210;HIST1H2AK;NUP88;NUP133;H2AFX;H2AFZ;HIST1H2BB;HIST1H3I;NUP62;NUP214;NUP188;NUP205,106 (107),1.04e-15,2.07e-13,0,,1 (3),1,1,3.69e-14,3.46e-12
Cellular responses to stress,Reactome,46,NUP88;HIST1H3I;HIST1H3F;HIST1H2AK;UBE2C;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;HIST1H2BH;NDC1;HDAC6;HIST1H3C;NUP107;EHMT2;HIST1H4D;HIST1H4F;ANAPC1;NUP37;CDC16;ANAPC15;EGLN1;NUP210;NUP50;HIST1H1D;HIST1H1E;NUP133;H2AFX;H2AFZ;HIST1H2BB;E2F1;CDK2;NUP62;NUP214;NUP188;FZR1;RPA1;CDK6;FKBP4;RBBP4;STIP1;CDC23;CCNA2;CDK4;NUP205;HSP90AB1,344 (345),3.61e-14,5.72e-12,2,HMDB03337;HMDB00538,39 (48),0.0323,0.149,4.12e-14,3.72e-12
Mitotic G1-G1/S phases,Reactome,25,CKS1B;HDAC1;RBBP4;WEE1;RBL1;POLA1;POLE;MCM2;MCM3;E2F1;MCM5;MCM6;E2F4;CDT1;CDK1;MCM10;CDC25A;CCNB1;RPA1;CDC7;TOP2A;CDK2;CCNA2;CDK4;CDK6,104 (104),5.21e-14,7.97e-12,1,HMDB00538,4 (4),0.0292,0.138,5.33e-14,4.65e-12
Condensation of Prophase Chromosomes,Reactome,22,HIST1H3F;HIST1H2AK;NCAPD3;HIST1H2AB;SET;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H3C;HIST1H3I;HIST1H4D;HIST1H4F;SMC4;H2AFX;H2AFZ;HIST1H2BB;HIST1H2AC;CDK1;SMC2;PLK1;NCAPG2;CCNB1,76 (77),2.69e-14,4.4e-12,1,HMDB00538,10 (10),0.0714,0.205,6.69e-14,5.64e-12
Senescence-Associated Secretory Phenotype (SASP),Reactome,25,HIST1H3F;HIST1H2AK;HIST1H2AC;FZR1;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H3C;HIST1H3I;EHMT2;HIST1H4D;HIST1H4F;ANAPC1;CDC16;ANAPC15;UBE2C;H2AFX;H2AFZ;HIST1H2BB;CDK2;HIST1H2AB;CDC23;CCNA2;CDK4;CDK6,111 (112),2.58e-13,3.7e-11,1,HMDB00538,4 (4),0.0292,0.138,2.52e-13,2.01e-11
Gene Silencing by RNA,Reactome,29,HIST1H3F;NUP50;DGCR8;RAN;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;HIST1H2BH;NDC1;IPO8;HIST1H3C;NUP107;HIST1H4D;HIST1H4F;NUP37;NUP210;HIST1H2AK;NUP88;NUP133;H2AFX;H2AFZ;HIST1H2BB;HIST1H3I;NUP62;NUP214;NUP188;PIWIL2;NUP205,133 (134),7.58e-15,1.29e-12,0,,5 (8),1,1,2.54e-13,2.01e-11
Homology Directed Repair,Reactome,28,RAD51;BLM;RAD51AP1;EME1;HIST1H2BG;BRIP1;HIST1H2BF;HIST1H2BH;EXO1;BABAM1;HIST1H4D;HIST1H4F;POLD1;POLE;RNF168;TOPBP1;BARD1;H2AFX;RFC5;HIST1H2BB;TIMELESS;POLQ;RPA1;GEN1;RHNO1;PALB2;CDK2;CCNA2,139 (141),1.84e-13,2.73e-11,1,HMDB00538,8 (10),0.0575,0.186,3.51e-13,2.69e-11
Regulation of APC/C activators between G1/S and early anaphase,Reactome,15,BUB3;PLK1;ANAPC1;UBE2C;FZR1;CDC16;ANAPC15;MAD2L1;CDK1;CDC23;CDK2;CCNA2;CCNB1;BUB1B;CDC20,36 (36),8.32e-13,1.06e-10,1,HMDB00538,2 (2),0.0147,0.119,4.03e-13,3e-11
HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA),Reactome,27,RAD51;BLM;RAD51AP1;EME1;HIST1H2BG;BRIP1;HIST1H2BF;HIST1H2BH;EXO1;BABAM1;HIST1H4D;HIST1H4F;POLD1;POLE;RNF168;TOPBP1;BARD1;H2AFX;HIST1H2BB;TIMELESS;RFC5;RPA1;GEN1;RHNO1;PALB2;CDK2;CCNA2,133 (135),4.12e-13,5.73e-11,1,HMDB00538,8 (10),0.0575,0.186,7.67e-13,5.54e-11
Viral Messenger RNA Synthesis,Reactome,12,NUP107;NUP50;NUP133;NUP37;GTF2F1;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,42 (42),2.55e-08,1.04e-06,3,HMDB00285;HMDB00538;HMDB00082,4 (5),1.32e-06,0.000214,1.08e-12,7.58e-11
DNA Double-Strand Break Repair,Reactome,30,RAD51;BLM;RAD51AP1;EME1;HIST1H2BG;BRIP1;HIST1H2BF;HIST1H2BH;EXO1;BABAM1;HIST1H4D;HIST1H4F;POLD1;POLE;RNF168;PAXIP1;TOPBP1;BARD1;H2AFX;RFC5;HIST1H2BB;TIMELESS;POLQ;RPA1;GEN1;RHNO1;PALB2;CDK2;CCNA2;KPNA2,167 (169),5.89e-13,7.95e-11,1,HMDB00538,12 (14),0.0851,0.228,1.59e-12,1.08e-10
Influenza Viral RNA Transcription and Replication,Reactome,12,NUP107;NUP50;NUP133;NUP37;GTF2F1;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,44 (44),4.54e-08,1.74e-06,3,HMDB00285;HMDB00538;HMDB00082,4 (5),1.32e-06,0.000214,1.89e-12,1.26e-10
Epigenetic regulation of gene expression,Reactome,25,HIST1H3F;HIST1H2AK;HIST1H2AC;HIST1H2AB;MYBBP1A;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H3C;HIST1H3I;PHF19;EHMT2;RBBP4;HIST1H4F;SUV39H1;H2AFX;H2AFZ;UHRF1;HIST1H2BB;HDAC2;TET3;DEK;HIST1H4D;HDAC1;DNMT1,150 (151),2.78e-10,1.72e-08,3,HMDB00285;HMDB00538;HMDB00082,18 (24),0.000253,0.00865,2.2e-12,1.43e-10
Nuclear Pore Complex (NPC) Disassembly,Reactome,14,NUP107;NUP50;NUP188;CCNB2;NUP37;NUP133;NUP62;NUP214;CDK1;NUP210;NDC1;CCNB1;NUP205;NUP88,34 (34),5.94e-12,6.49e-10,1,HMDB00538,2 (2),0.0147,0.119,2.71e-12,1.71e-10
Nuclear Envelope Breakdown,Reactome,17,NUP107;PLK1;TMPO;NUP50;NUP188;CCNB2;NUP37;BANF1;NUP133;NUP62;NUP214;CDK1;NUP210;NDC1;CCNB1;NUP205;NUP88,51 (51),1.84e-12,2.16e-10,1,HMDB00538,7 (7),0.0505,0.173,2.88e-12,1.77e-10
SUMOylation,Reactome,25,BLM;NUP50;HDAC1;NDC1;RNF168;NUP107;HIST1H4D;HIST1H4F;CBX5;NUP37;SMC1A;NUP210;NUP88;NUP133;UBA2;SUMO3;NUP214;NUP188;HDAC2;SMC5;RPA1;TOP2A;NUP62;NSMCE1;NUP205,126 (126),5.3e-12,5.93e-10,1,HMDB00538,3 (3),0.0219,0.134,3.58e-12,2.16e-10
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,Reactome,14,BUB3;PLK1;ANAPC1;UBE2C;NEK2;CDC16;ANAPC15;MAD2L1;CDK1;CDC23;CCNA2;CCNB1;BUB1B;CDC20,32 (32),2.16e-12,2.47e-10,0,,0 (0),1,1,2.16e-12,2.47e-10
DNA Repair,Reactome,42,RAD51;BLM;FANCD2;LIG1;RAD51AP1;EME1;HIST1H2BG;BRIP1;HIST1H2BF;MLH1;EXO1;BABAM1;HIST1H4D;HIST1H4F;FANCI;POLD1;POLE;RNF168;PAXIP1;TOPBP1;BARD1;H2AFX;POLQ;MSH6;HIST1H2BB;PRPF19;TIMELESS;SUMO3;CHD1L;RFC5;RPA1;USP1;DDB1;GEN1;RHNO1;PALB2;HIST1H2BH;CDK2;CCNA2;RAD23B;KPNA2;REV1,317 (320),6.81e-13,8.94e-11,1,HMDB00538,38 (48),0.247,0.541,5.11e-12,3.01e-10
Metabolism of RNA,Reactome,55,DHX15;CPSF2;UTP6;PRPF31;NUP50;HEATR1;SF3A3;EXOSC9;GTF2F1;NDC1;CHERP;RPL36A;RPLP0;NOP56;NUP107;NUP37;DHX37;RPS5;SF3A1;SRSF4;CLNS1A;NUP210;EXOSC6;EIF4G1;NUP88;NUP133;CSTF2;FIP1L1;GEMIN5;PRPF19;NCBP1;RAN;RPSA;NUP62;NUP214;NUP188;UPF1;UTP3;SNRNP40;PTBP1;SRRT;RPL13A;NHP2;NSUN2;SNRPE;RPL4;SET;SF3B3;DDX39B;SNRPD1;RPL9;PPIL1;KHSRP;NUP205;EFTUD2,584 (586),1.92e-10,1.26e-08,3,HMDB00095;HMDB00538;HMDB00082,35 (72),0.00188,0.0443,1.07e-11,6.16e-10
Interactions of Vpr with host cellular proteins,Reactome,14,NUP107;SLC25A5;NUP50;NUP133;BANF1;NUP62;NUP214;NUP188;NUP210;NDC1;NUP37;KPNA1;NUP205;NUP88,35 (35),9.57e-12,9.98e-10,0,,0 (0),1,1,9.57e-12,9.98e-10
G2/M DNA damage checkpoint,Reactome,21,RFC5;CDC25C;BARD1;RPA1;H2AFX;BLM;HIST1H4D;HIST1H4F;HIST1H2BB;CDK1;RHNO1;HIST1H2BG;BABAM1;BRIP1;HIST1H2BF;HIST1H2BH;CCNB1;EXO1;WEE1;RNF168;TOPBP1,95 (96),3.15e-11,2.73e-09,1,HMDB00538,3 (3),0.0219,0.134,2.01e-11,1.13e-09
SUMO E3 ligases SUMOylate target proteins,Reactome,24,BLM;NUP50;HDAC1;NDC1;RNF168;NUP107;HIST1H4D;HIST1H4F;CBX5;NUP37;SMC1A;NUP210;NUP88;NUP133;SUMO3;NUP214;NUP188;HDAC2;SMC5;RPA1;TOP2A;NUP62;NSMCE1;NUP205,120 (120),1.19e-11,1.21e-09,0,,0 (0),1,1,1.19e-11,1.21e-09
G1/S Transition,Reactome,19,CDC25A;CCNB1;RPA1;WEE1;CKS1B;MCM3;E2F1;POLA1;MCM6;POLE;CDT1;MCM5;CDK1;CDK2;CCNA2;CDK4;MCM10;CDC7;MCM2,76 (76),2.77e-11,2.45e-09,1,HMDB00538,4 (4),0.0292,0.138,2.33e-11,1.28e-09
Transport of Ribonucleoproteins into the Host Nucleus,Reactome,13,NUP107;NUP50;NUP133;KPNB1;NUP62;NUP214;NUP188;NUP210;NDC1;NUP37;KPNA1;NUP205;NUP88,30 (30),1.56e-11,1.52e-09,0,,0 (0),1,1,1.56e-11,1.52e-09
Cellular responses to external stimuli,Reactome,46,NUP88;HIST1H3I;HIST1H3F;HIST1H2AK;UBE2C;HIST1H2AC;FZR1;HIST1H2BG;HIST1H2BF;HIST1H2BH;NDC1;HDAC6;HIST1H3C;NUP107;EHMT2;HIST1H4D;HIST1H4F;ANAPC1;NUP37;CDC16;ANAPC15;EGLN1;NUP210;NUP50;HIST1H1D;HIST1H1E;NUP133;H2AFX;H2AFZ;HIST1H2BB;E2F1;CDK2;NUP62;NUP214;NUP188;HIST1H2AB;RPA1;CDK6;FKBP4;RBBP4;STIP1;CDC23;CCNA2;CDK4;NUP205;HSP90AB1,413 (414),2.61e-11,2.35e-09,2,HMDB03337;HMDB00538,46 (57),0.0437,0.162,3.25e-11,1.73e-09
HIV Infection,Reactome,26,LIG1;RAN;RANGAP1;GTF2F1;AP2S1;NDC1;AP2A2;NUP107;KPNB1;SLC25A5;NUP37;NUP210;NUP50;NUP88;NUP133;NCBP1;NUP62;NUP214;NUP188;TAF1;SSRP1;TAF9;PPIA;BANF1;KPNA1;NUP205,195 (197),1.64e-08,7.25e-07,3,HMDB00285;HMDB00538;HMDB00082,12 (13),7.02e-05,0.0027,3.29e-11,1.73e-09
RNA Polymerase I Transcription,Reactome,18,HIST1H3C;HIST1H3I;H2AFX;EHMT2;RBBP4;HIST1H4F;HIST1H2BB;H2AFZ;HIST1H2AC;HIST1H2AB;HIST1H3F;HIST1H2BG;HIST1H2BF;HIST1H2BH;HDAC1;HDAC2;HIST1H4D;HIST1H2AK,113 (114),1.83e-07,5.79e-06,3,HMDB00285;HMDB00538;HMDB00082,6 (8),6.56e-06,0.000498,3.41e-11,1.76e-09
APC/C:Cdc20 mediated degradation of mitotic proteins,Reactome,13,BUB3;ANAPC1;UBE2C;NEK2;CDC16;ANAPC15;MAD2L1;CDK1;CDC23;CCNA2;CCNB1;BUB1B;CDC20,31 (31),2.6e-11,2.35e-09,0,,0 (0),1,1,2.6e-11,2.35e-09
Negative epigenetic regulation of rRNA expression,Reactome,18,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;SUV39H1;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HDAC1;DNMT1;HIST1H2AK;HDAC2,110 (111),1.2e-07,3.96e-06,3,HMDB00285;HMDB00538;HMDB00082,8 (12),1.82e-05,0.000873,6.08e-11,3.07e-09
DNA Replication,Wikipathways,13,RFC5;RPA1;MCM2;MCM3;MCM5;MCM6;POLD1;POLE;CDT1;POLA1;CDK2;MCM10;CDC7,42 (42),2.21e-09,1.1e-07,2,HMDB00285;HMDB00082,7 (7),0.00105,0.027,6.43e-11,3.16e-09
HIV Life Cycle,Reactome,22,NUP50;RAN;RANGAP1;GTF2F1;NDC1;NUP107;NUP37;NUP210;LIG1;NUP88;NUP133;NCBP1;NUP62;NUP214;NUP188;TAF1;SSRP1;TAF9;PPIA;BANF1;KPNA1;NUP205,154 (156),6.05e-08,2.22e-06,3,HMDB00285;HMDB00538;HMDB00082,10 (11),3.86e-05,0.0017,6.49e-11,3.16e-09
Vpr-mediated nuclear import of PICs,Reactome,13,NUP107;NUP50;NUP133;BANF1;NUP62;NUP214;NUP188;NUP210;NDC1;NUP37;KPNA1;NUP205;NUP88,32 (32),4.23e-11,3.47e-09,0,,0 (0),1,1,4.23e-11,3.47e-09
NoRC negatively regulates rRNA expression,Reactome,17,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HDAC1;DNMT1;HIST1H2AK;HDAC2,107 (108),4.17e-07,1.2e-05,3,HMDB00285;HMDB00538;HMDB00082,6 (9),6.56e-06,0.000498,7.55e-11,3.6e-09
Mitotic G2-G2/M phases,Reactome,25,FOXM1;AURKA;NEK2;CENPF;RBBP4;WEE1;CCNB2;ODF2;TPX2;CKAP5;CDK5RAP2;E2F1;PLK1;CDK1;HMMR;CCNA2;CDC25A;CDC25C;PLK4;CEP152;CDK2;BORA;CCNB1;PCNT;HSP90AB1,139 (139),5.07e-11,4.01e-09,1,HMDB00538,8 (8),0.0575,0.186,8.03e-11,3.76e-09
Cellular Senescence,Reactome,29,HIST1H3F;HIST1H2AK;HIST1H2AC;FZR1;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H3C;HIST1H3I;EHMT2;RBBP4;HIST1H4F;ANAPC1;CDC16;ANAPC15;UBE2C;HIST1H1D;HIST1H1E;H2AFX;H2AFZ;HIST1H2BB;E2F1;CDC23;HIST1H2AB;HIST1H4D;CDK2;CCNA2;CDK4;CDK6,188 (189),7.11e-11,5.35e-09,1,HMDB00538,9 (11),0.0645,0.198,1.24e-10,5.71e-09
Transport of Mature mRNA Derived from an Intronless Transcript,Reactome,14,NUP107;FIP1L1;NUP50;NUP133;NCBP1;NUP37;CPSF2;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,40 (40),8.06e-11,5.97e-09,0,,0 (0),1,1,8.06e-11,5.97e-09
Transport of Mature mRNAs Derived from Intronless Transcripts,Reactome,14,NUP107;FIP1L1;NUP50;NUP133;NCBP1;NUP37;CPSF2;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,41 (41),1.18e-10,8.48e-09,0,,0 (0),1,1,1.18e-10,8.48e-09
Processing of Capped Intron-Containing Pre-mRNA,Reactome,32,DHX15;PRPF31;NUP50;SNRNP40;GTF2F1;SF3A3;NDC1;CHERP;SF3B3;PTBP1;NUP107;NUP37;SF3A1;SRSF4;SRRT;NUP210;PPIL1;NUP88;NUP133;CSTF2;FIP1L1;PRPF19;NCBP1;NUP62;NUP214;NUP188;CPSF2;SNRPD1;SNRPE;DDX39B;NUP205;EFTUD2,240 (240),3.53e-10,2.13e-08,1,HMDB00538,3 (4),0.0219,0.134,2.06e-10,9.3e-09
RNA Polymerase I Chain Elongation,Reactome,14,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2AK;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H2BB,91 (92),6.46e-06,0.000145,3,HMDB00285;HMDB00538;HMDB00082,4 (5),1.32e-06,0.000214,2.26e-10,1e-08
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,Reactome,12,BUB3;ANAPC1;UBE2C;NEK2;CDC16;ANAPC15;MAD2L1;CDK1;CDC23;CCNA2;BUB1B;CDC20,29 (29),1.86e-10,1.26e-08,0,,0 (0),1,1,1.86e-10,1.26e-08
G2/M Transition,Reactome,24,FOXM1;AURKA;NEK2;CENPF;RBBP4;WEE1;CCNB2;ODF2;TPX2;CKAP5;CDK5RAP2;PLK1;CDK1;HMMR;CCNA2;CDC25A;CDC25C;PLK4;CEP152;CDK2;BORA;CCNB1;PCNT;HSP90AB1,137 (137),2.19e-10,1.4e-08,1,HMDB00538,8 (8),0.0575,0.186,3.29e-10,1.43e-08
SUMOylation of DNA damage response and repair proteins,Reactome,18,SMC5;NUP107;RPA1;BLM;NSMCE1;NUP50;SUMO3;NUP133;NUP37;SMC1A;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;RNF168;NUP88,76 (76),2.44e-10,1.54e-08,0,,0 (0),1,1,2.44e-10,1.54e-08
Extension of Telomeres,Reactome,8,RFC5;NHP2;RPA1;RUVBL2;LIG1;POLA1;POLD1;POLE,30 (30),1.01e-05,0.000212,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,13 (14),1.39e-06,0.000214,3.63e-10,1.56e-08
Chromatin organization,Reactome,35,HIST1H3F;HIST1H2AG;HIST1H2AK;SETD1A;NCOR2;HIST1H2AC;HIST1H2AB;RCOR1;HIST1H2BG;HIST1H2BF;HIST1H2BH;DOT1L;HIST1H3C;HIST1H3I;KDM2B;EHMT2;RBBP4;HIST1H4F;SUV39H1;SMARCA4;SMARCB1;SMARCC1;HIST1H2BB;HIST2H2AB;JADE1;KDM5D;TAF9;RUVBL2;UTY;HCFC1;HIST1H4D;HIST1H2AH;HDAC1;HDAC2;CDK4,272 (272),1.39e-10,9.7e-09,1,HMDB00538,15 (16),0.105,0.266,3.81e-10,1.58e-08
Chromatin modifying enzymes,Reactome,35,HIST1H3F;HIST1H2AG;HIST1H2AK;SETD1A;NCOR2;HIST1H2AC;HIST1H2AB;RCOR1;HIST1H2BG;HIST1H2BF;HIST1H2BH;DOT1L;HIST1H3C;HIST1H3I;KDM2B;EHMT2;RBBP4;HIST1H4F;SUV39H1;SMARCA4;SMARCB1;SMARCC1;HIST1H2BB;HIST2H2AB;JADE1;KDM5D;TAF9;RUVBL2;UTY;HCFC1;HIST1H4D;HIST1H2AH;HDAC1;HDAC2;CDK4,272 (272),1.39e-10,9.7e-09,1,HMDB00538,15 (16),0.105,0.266,3.81e-10,1.58e-08
Polo-like kinase mediated events,Reactome,9,FOXM1;CDC25C;CENPF;RBBP4;WEE1;CCNB2;CDC25A;PLK1;CCNB1,16 (16),1.18e-09,6.4e-08,1,HMDB00538,2 (2),0.0147,0.119,4.48e-10,1.83e-08
SUMOylation of DNA replication proteins,Reactome,13,NUP107;NUP210;NUP50;NUP133;NUP37;TOP2A;SUMO3;NUP214;NUP188;NUP62;NDC1;NUP205;NUP88,37 (37),3.65e-10,2.15e-08,0,,0 (0),1,1,3.65e-10,2.15e-08
ATR signaling pathway,PID,13,RAD51;CDC25A;PLK1;RPA1;TOPBP1;FANCD2;MCM2;TIMELESS;CDC25C;SMARCAL1;CDK2;CCNA2;RFC5,37 (37),3.65e-10,2.15e-08,0,,0 (0),1,1,3.65e-10,2.15e-08
Processing of DNA double-strand break ends,Reactome,20,RFC5;BARD1;RPA1;H2AFX;BLM;HIST1H4D;HIST1H4F;HIST1H2BB;RHNO1;TIMELESS;HIST1H2BG;BABAM1;BRIP1;HIST1H2BF;HIST1H2BH;CDK2;CCNA2;EXO1;RNF168;TOPBP1,98 (99),4.29e-10,2.46e-08,1,HMDB00538,7 (9),0.0505,0.173,5.54e-10,2.22e-08
Interactions of Rev with host cellular proteins,Reactome,14,NUP107;NUP50;RAN;NUP205;NUP133;RANGAP1;NUP62;NUP214;NUP188;NUP210;NDC1;NUP37;KPNB1;NUP88,37 (37),2.35e-11,2.2e-09,0,,3 (3),1,1,5.99e-10,2.34e-08
Metabolism of proteins,Reactome,117,MRPS31;CYC1;NUP50;CAND1;NUP37;GALNT1;RNF168;RPLP0;MRPL12;SPP1;RPS5;CTSC;TTLL5;UGGT1;PSME3;PSMC1;EIF3C;SRP72;PSMD2;PSMD3;PSMD5;PSMD7;NUP62;PSMD13;SMC5;DDB1;F10;B4GALT6;TUFM;NUP205;BLM;TUBA1B;HIST1H2AK;HIST1H2AC;HIST1H2AB;FARSA;FBXW8;HIST1H2BF;HIST1H2BH;HIST1H3C;HIST1H3I;HIST1H4D;HIST1H4F;RPL36A;NUP210;COPZ1;ECI2;NOS2;PIGO;HIST1H2AH;NSMCE1;RAD23B;HSPD1;GPLD1;HIST1H3F;HIST1H2AG;CDK1;FN1;NOP56;NUP107;TCP1;SMC1A;CANX;TUBA1C;UBE2C;USP24;NUP88;UBA2;CDC25A;BIRC5;CCT2;RPSA;NUP214;TARS2;PIGU;HIST1H2BG;ALG10B;CCNA2;MRPL2;TGFB1;CCNF;CCT6A;BARD1;NDC1;BABAM1;IGFBP4;IGFBP6;CBX5;VCAN;EIF4G1;EIF5A;NUP133;PSMD1;TRAPPC10;H2AFX;H2AFZ;HIST2H2AB;HIST1H2BB;SUMO3;PRKCSH;EIF3B;NUP188;EIF3D;GALNT6;EIF3I;CDC20;RPL13A;GFM1;RPA1;CTSG;RPL4;HCFC1;TOP2A;RPL9;HDAC1;HDAC2;DCAF7,1999 (2008),2.02e-07,6.27e-06,6,HMDB00285;HMDB01265;HMDB00082;HMDB00538;HMDB01176;HMDB00095,117 (269),0.000117,0.00438,6.02e-10,2.34e-08
SUMOylation of chromatin organization proteins,Reactome,17,NUP107;NUP210;HIST1H4D;HIST1H4F;NUP50;NUP188;CBX5;NUP133;NUP37;HDAC2;SUMO3;NUP214;HDAC1;NUP62;NDC1;NUP205;NUP88,70 (70),5.08e-10,2.84e-08,0,,0 (0),1,1,5.08e-10,2.84e-08
Regulation of sister chromatid separation at the metaphase-anaphase transition,Wikipathways,9,BUB3;BUB1;ESPL1;CENPE;SMC1A;MAD2L1;MAD1L1;BUB1B;CDC20,15 (15),5.36e-10,2.96e-08,0,,0 (0),1,1,5.36e-10,2.96e-08
snRNP Assembly,Reactome,16,NUP107;SNRPD1;GEMIN5;NUP50;SNRPE;NUP133;NCBP1;NUP37;CLNS1A;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,52 (52),3.33e-11,2.78e-09,0,,3 (4),1,1,8.37e-10,3.16e-08
Metabolism of non-coding RNA,Reactome,16,NUP107;SNRPD1;GEMIN5;NUP50;SNRPE;NUP133;NCBP1;NUP37;CLNS1A;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,52 (52),3.33e-11,2.78e-09,0,,3 (4),1,1,8.37e-10,3.16e-08
Infectious disease,Reactome,30,TGFB1;MET;LIG1;RAN;RANGAP1;GTF2F1;AP2S1;NDC1;AP2A2;NUP107;KPNB1;SLC25A5;NUP37;CANX;NUP210;NUP50;NUP88;NUP133;NCBP1;NUP62;NUP214;NUP188;TAF1;SSRP1;TAF9;PPIA;BANF1;KPNA1;NUP205;KPNA2,251 (253),1.71e-08,7.46e-07,3,HMDB00285;HMDB00538;HMDB00082,37 (55),0.00221,0.051,9.43e-10,3.51e-08
Condensation of Prometaphase Chromosomes,Reactome,8,SMC2;SMC4;NCAPH;NCAPG;CCNB2;CDK1;CCNB1;NCAPD2,12 (12),1.55e-09,8.15e-08,1,HMDB00538,4 (4),0.0292,0.138,1.12e-09,4.1e-08
Late Phase of HIV Life Cycle,Reactome,19,TAF9;NUP107;RAN;PPIA;NUP50;NUP133;NCBP1;NUP37;RANGAP1;GTF2F1;NUP62;NUP214;NUP188;TAF1;NUP210;NDC1;NUP205;SSRP1;NUP88,141 (143),1.21e-06,3.17e-05,3,HMDB00285;HMDB00538;HMDB00082,10 (10),3.86e-05,0.0017,1.16e-09,4.17e-08
Pyrimidine metabolism,EHMN,19,POLQ;NUP107;PAPD7;RFC5;NUP50;NUP133;POLA1;NUP37;POLD1;NT5C;POLE;NUP62;NUP214;NUP188;NUP210;NUP88;ENTPD5;DUT;NUP205,135 (136),6.13e-07,1.7e-05,5,HMDB00095;HMDB00285;HMDB00538;HMDB01176;HMDB00082,70 (77),0.000104,0.00395,1.55e-09,5.53e-08
RNA Polymerase II Transcription,Reactome,80,TGFB1;RAD51;CPSF2;TRIM28;AURKA;FANCD2;HIST1H3F;SRRT;HIST1H2AK;SETD1A;HSPD1;HIST1H2AC;CDK4;LRPPRC;GTF2F1;HIST1H2BG;INTS5;BRIP1;HIST1H2BF;BARD1;RHNO1;EXO1;HDAC6;HIST1H3C;HIST1H3I;INTS2;CSTF2;EHMT2;INTS7;HIST1H4F;NOC2L;CBX5;RBL1;FANCI;RBBP4;SRSF4;H2AFZ;BLM;INTS1;TPX2;TOPBP1;MLH1;SMARCA4;H2AFX;SMARCC1;FIP1L1;NCOR2;HIST1H2BB;CDK6;BIRC5;E2F1;NCBP1;E2F4;CDK2;CDK1;TAF1;HIPK2;HIST1H2AB;SSRP1;TAF9;RFC5;CDC25C;ATAD2;RPA1;DEK;MYB;SNRPE;SMARCB1;CCNA2;MED24;DDX39B;E2F7;HIST1H4D;E2F8;HIST1H2BH;HDAC1;HDAC2;CCNB1;AURKB;CDC7,1228 (1236),4.54e-07,1.29e-05,4,HMDB03337;HMDB00538;HMDB00285;HMDB00082,39 (52),0.000142,0.00514,1.57e-09,5.53e-08
Rev-mediated nuclear export of HIV RNA,Reactome,13,NUP107;NUP50;RAN;NUP37;NUP133;RANGAP1;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,33 (33),6.74e-11,5.2e-09,0,,3 (3),1,1,1.65e-09,5.67e-08
Host Interactions of HIV factors,Reactome,20,AP2A2;NUP107;RAN;SLC25A5;PPIA;NUP50;NUP188;NUP133;BANF1;RANGAP1;NUP205;NUP62;NUP214;AP2S1;NUP210;NDC1;NUP37;KPNA1;KPNB1;NUP88,89 (89),6.8e-11,5.2e-09,0,,5 (5),1,1,1.66e-09,5.67e-08
Transport of the SLBP independent Mature mRNA,Reactome,12,NUP107;NUP50;NUP133;NCBP1;NUP37;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,33 (33),1.11e-09,6.07e-08,0,,0 (0),1,1,1.11e-09,6.07e-08
Nuclear import of Rev protein,Reactome,13,NUP107;NUP50;RAN;NUP205;NUP133;NUP62;NUP214;NUP188;NUP210;NDC1;NUP37;KPNB1;NUP88,34 (34),1.05e-10,7.69e-09,0,,2 (2),1,1,2.53e-09,8.53e-08
Transport of the SLBP Dependant Mature mRNA,Reactome,12,NUP107;NUP50;NUP133;NCBP1;NUP37;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,34 (34),1.66e-09,8.65e-08,0,,0 (0),1,1,1.66e-09,8.65e-08
Lysine metabolism,EHMN,15,NUP107;OGDH;SUV39H1;NUP50;SETD1A;EHMT2;NUP37;NUP133;NUP62;NUP214;NUP188;NUP210;DOT1L;NUP205;NUP88,60 (60),3.47e-09,1.68e-07,2,HMDB00538;HMDB01325,39 (53),0.0323,0.149,2.68e-09,8.84e-08
Switching of origins to a post-replicative state,Reactome,13,ANAPC1;MCM2;MCM3;MCM5;FZR1;CDC16;ANAPC15;CDK2;CDT1;UBE2C;CDC23;CCNA2;MCM6,46 (46),7.67e-09,3.63e-07,1,HMDB00538,2 (2),0.0147,0.119,2.69e-09,8.84e-08
tRNA processing in the nucleus,Reactome,13,NUP107;CSTF2;NUP50;RAN;NUP37;NUP133;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,57 (57),1.27e-07,4.15e-06,2,HMDB00538;HMDB00082,7 (10),0.00105,0.027,3.16e-09,1.02e-07
G0 and Early G1,Reactome,10,CDC25A;RBBP4;RBL1;E2F1;TOP2A;E2F4;CDK2;CDK1;HDAC1;CCNA2,25 (25),9.45e-09,4.3e-07,1,HMDB00538,2 (2),0.0147,0.119,3.29e-09,1.05e-07
Cdc20:Phospho-APC/C mediated degradation of Cyclin A,Reactome,11,BUB3;ANAPC1;UBE2C;CDC16;ANAPC15;MAD2L1;CDK1;CDC23;CCNA2;BUB1B;CDC20,28 (28),2.12e-09,1.08e-07,0,,0 (0),1,1,2.12e-09,1.08e-07
FOXM1 transcription factor network,PID,13,FOXM1;PLK1;CENPF;CKS1B;BIRC5;CCNB2;NEK2;CDK1;CCNB1;CDK2;CCNA2;CDK4;AURKB,42 (42),2.21e-09,1.1e-07,0,,0 (0),1,1,2.21e-09,1.1e-07
Regulation of TP53 Activity through Phosphorylation,Reactome,18,TAF9;RFC5;BARD1;RPA1;AURKA;BLM;HIPK2;NOC2L;RHNO1;EXO1;BRIP1;TAF1;CDK2;CCNA2;AURKB;SSRP1;TPX2;TOPBP1,93 (93),7.88e-09,3.69e-07,1,HMDB00538,3 (3),0.0219,0.134,4.06e-09,1.28e-07
RNA transport - Homo sapiens (human),KEGG,27,NUP50;NUP188;RAN;RANGAP1;NDC1;NUP107;STRAP;TACC3;NUP37;CLNS1A;NUP210;EIF4G1;NUP88;NUP133;GEMIN5;NCBP1;NUP62;NUP214;EIF3B;EIF3C;UPF1;EIF3I;EIF3D;DDX39B;SUMO3;KPNB1;NUP205,171 (171),1.9e-10,1.26e-08,0,,2 (3),1,1,4.44e-09,1.38e-07
HDACs deacetylate histones,Reactome,20,HIST1H3C;HIST1H3I;HIST1H2AG;HIST1H2AH;RBBP4;HIST1H4F;HIST1H2BB;HIST2H2AB;HIST1H2AC;HIST1H2AB;HIST1H3F;RCOR1;HIST1H2BG;HIST1H2BF;HIST1H2BH;HDAC1;NCOR2;HIST1H4D;HIST1H2AK;HDAC2,94 (94),1.95e-10,1.26e-08,0,,2 (3),1,1,4.55e-09,1.4e-07
Factors involved in megakaryocyte development and platelet production,Reactome,22,KIF20A;DOCK1;HIST1H3F;RCOR1;HIST1H3C;HIST1H3I;CENPE;WEE1;CBX5;HDAC2;KIF16B;KIF15;RACGAP1;CDK2;HDAC1;KIF18B;KIF20B;KIF11;KIFC1;MYB;KIF22;KIF2C,131 (131),2.86e-09,1.39e-07,1,HMDB00538,10 (11),0.0714,0.205,4.75e-09,1.45e-07
Post-translational protein modification,Reactome,82,TGFB1;BLM;CCNF;GPLD1;SPP1;TUBA1B;NUP210;NUP50;NUP188;HIST1H2AC;HIST1H2AB;CDC25A;FBXW8;RNF168;HIST1H2BF;CAND1;HIST1H2BH;NDC1;GALNT1;BABAM1;FN1;NUP107;VCAN;HIST1H4D;HIST1H4F;CANX;CBX5;NUP37;PSMC1;HDAC2;CTSC;TTLL5;TUBA1C;HIST1H2AG;HIST2H2AB;UBE2C;PSME3;IGFBP4;HIST1H2AK;USP24;NUP88;EIF5A;NUP133;PSMD1;BARD1;TRAPPC10;UBA2;SMC1A;PSMD2;HIST1H2BB;UGGT1;BIRC5;PSMD3;PSMD5;PSMD7;SUMO3;NUP214;CDK1;PSMD13;PRKCSH;GALNT6;HIST1H2BG;CDC20;SMC5;HDAC1;COPZ1;RPA1;HIST1H2AH;NSMCE1;DDB1;HCFC1;F10;PIGO;TOP2A;B4GALT6;PIGU;ALG10B;NUP62;CCNA2;NUP205;DCAF7;RAD23B,1378 (1383),1.14e-05,0.000236,6,HMDB00285;HMDB01265;HMDB00082;HMDB00538;HMDB01176;HMDB00095,87 (176),2.14e-05,0.00102,5.67e-09,1.7e-07
Aminosugars metabolism,EHMN,11,NUP107;SLC38A1;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,51 (51),2.15e-06,5.43e-05,4,HMDB00285;HMDB00538;HMDB01176;HMDB00082,37 (43),0.000115,0.00434,5.72e-09,1.7e-07
Telomere C-strand (Lagging Strand) Synthesis,Reactome,6,RFC5;RPA1;LIG1;POLA1;POLD1;POLE,24 (24),0.000199,0.00343,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,13 (14),1.39e-06,0.000214,6.34e-09,1.86e-07
NEP/NS2 Interacts with the Cellular Export Machinery,Reactome,12,NUP107;NUP50;RAN;NUP37;NUP133;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,30 (30),3e-10,1.83e-08,0,,3 (3),1,1,6.87e-09,2e-07
Activation of the pre-replicative complex,Reactome,11,RPA1;MCM2;MCM3;POLA1;MCM6;POLE;CDT1;MCM5;CDK2;MCM10;CDC7,33 (33),1.61e-08,7.17e-07,1,HMDB00538,3 (3),0.0219,0.134,8.04e-09,2.31e-07
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,Reactome,18,HIST1H3C;HIST1H3I;H2AFX;EHMT2;HIST1H3F;HIST1H4F;HIST1H2BB;H2AFZ;HIST1H2AC;HIST1H2AB;RBBP4;HIST1H2BG;HDAC1;HIST1H2BH;HDAC2;HIST1H4D;HIST1H2BF;HIST1H2AK,78 (79),3.87e-10,2.25e-08,0,,2 (3),1,1,8.77e-09,2.49e-07
Export of Viral Ribonucleoproteins from Nucleus,Reactome,12,NUP107;NUP50;RAN;NUP37;NUP133;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,31 (31),4.73e-10,2.68e-08,0,,3 (3),1,1,1.06e-08,2.98e-07
Cyclin A/B1/B2 associated events during G2/M transition,Reactome,10,CDC25A;PLK1;FOXM1;WEE1;CCNB2;CDC25C;CDK1;CDK2;CCNA2;CCNB1,25 (25),9.45e-09,4.3e-07,1,HMDB00538,7 (7),0.0505,0.173,1.07e-08,2.98e-07
Glycolysis,Reactome,15,NUP107;TPI1;NUP50;NUP133;PGP;NUP37;NUP62;NUP214;NUP188;PPP2R5D;NUP210;NDC1;PFKL;NUP205;NUP88,70 (71),3.34e-08,1.31e-06,2,HMDB00094;HMDB00538,26 (32),0.015,0.121,1.12e-08,3.08e-07
RNA Polymerase I Promoter Opening,Reactome,14,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H2AK,64 (65),7.29e-08,2.52e-06,1,HMDB00538,1 (2),0.00737,0.119,1.2e-08,3.25e-07
Meiosis,Reactome,16,HIST1H3C;SMC1A;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;STAG3;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2AC;HIST1H2BF;HIST1H2BH;HIST1H2AK,77 (78),1.86e-08,7.96e-07,1,HMDB00538,4 (5),0.0292,0.138,1.21e-08,3.25e-07
HDR through Homologous Recombination (HRR),Reactome,15,RAD51;TOPBP1;BARD1;RPA1;RFC5;RAD51AP1;EME1;GEN1;RHNO1;PALB2;POLD1;POLE;BRIP1;BLM;EXO1,68 (69),2.2e-08,9.31e-07,1,HMDB00538,5 (6),0.0363,0.149,1.75e-08,4.67e-07
Activation of ATR in response to replication stress,Reactome,11,CDC25A;CDC25C;RPA1;RFC5;MCM2;MCM3;MCM5;MCM6;CDK2;MCM10;CDC7,37 (37),6.21e-08,2.23e-06,1,HMDB00538,2 (2),0.0147,0.119,1.99e-08,5.24e-07
Vitamin B5 - CoA biosynthesis from pantothenate,EHMN,10,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,31 (31),1.05e-07,3.49e-06,2,HMDB00538;HMDB00082,20 (21),0.00898,0.119,2.05e-08,5.34e-07
Transport of Mature Transcript to Cytoplasm,Reactome,16,NUP107;FIP1L1;NUP50;SRSF4;NUP133;NCBP1;DDX39B;CPSF2;NUP62;NUP214;NUP188;NUP210;NDC1;NUP37;NUP205;NUP88,82 (82),4.77e-08,1.81e-06,1,HMDB00538,3 (4),0.0219,0.134,2.27e-08,5.86e-07
APC-Cdc20 mediated degradation of Nek2A,Reactome,10,BUB3;ANAPC1;NEK2;CDC16;ANAPC15;MAD2L1;UBE2C;CDC23;BUB1B;CDC20,26 (26),1.49e-08,6.68e-07,0,,0 (0),1,1,1.49e-08,6.68e-07
DNA strand elongation,Reactome,9,RFC5;RPA1;LIG1;MCM2;MCM3;MCM5;MCM6;POLD1;POLA1,32 (32),1.7e-06,4.34e-05,2,HMDB00095;HMDB00538,6 (6),0.000753,0.0204,2.75e-08,6.99e-07
PRC2 methylates histones and DNA,Reactome,17,HIST1H3C;HIST1H3I;PHF19;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;RBBP4;HIST1H2BG;HIST1H2BF;HIST1H2BH;DNMT1;HIST1H4D;HIST1H2AK,74 (75),1.29e-09,6.87e-08,0,,2 (3),1,1,2.76e-08,6.99e-07
DNA Replication Pre-Initiation,Reactome,11,RPA1;MCM2;MCM3;POLA1;MCM6;POLE;CDT1;MCM5;CDK2;MCM10;CDC7,37 (37),6.21e-08,2.23e-06,1,HMDB00538,3 (3),0.0219,0.134,2.92e-08,7.23e-07
M/G1 Transition,Reactome,11,RPA1;MCM2;MCM3;POLA1;MCM6;POLE;CDT1;MCM5;CDK2;MCM10;CDC7,37 (37),6.21e-08,2.23e-06,1,HMDB00538,3 (3),0.0219,0.134,2.92e-08,7.23e-07
DNA methylation,Reactome,16,HIST1H3C;HIST1H3I;UHRF1;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;DNMT1;HIST1H2AK,66 (67),1.7e-09,8.75e-08,0,,3 (5),1,1,3.6e-08,8.83e-07
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,Reactome,10,PLK1;AURKA;ANAPC1;FZR1;CDC16;ANAPC15;UBE2C;CDC23;AURKB;CDC20,27 (27),2.28e-08,9.43e-07,0,,0 (0),1,1,2.28e-08,9.43e-07
Inactivation of APC/C via direct inhibition of the APC/C complex,Reactome,9,BUB3;ANAPC1;CDC16;ANAPC15;MAD2L1;UBE2C;CDC23;BUB1B;CDC20,21 (21),2.57e-08,1.04e-06,0,,0 (0),1,1,2.57e-08,1.04e-06
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,Reactome,9,BUB3;ANAPC1;CDC16;ANAPC15;MAD2L1;UBE2C;CDC23;BUB1B;CDC20,21 (21),2.57e-08,1.04e-06,0,,0 (0),1,1,2.57e-08,1.04e-06
RMTs methylate histone arginines,Reactome,15,HIST1H3C;HIST1H3I;SMARCA4;SMARCB1;SMARCC1;HIST1H3F;HIST1H4F;HIST1H2AK;HIST2H2AB;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2AH;HIST1H2AG;CDK4,74 (74),7.36e-08,2.52e-06,1,HMDB00538,4 (4),0.0292,0.138,4.5e-08,1.09e-06
Positive epigenetic regulation of rRNA expression,Reactome,20,HIST1H3C;HIST1H3I;H2AFX;EHMT2;RBBP4;HIST1H4F;HIST1H2BB;DEK;HIST1H2AC;HIST1H2AB;HIST1H3F;MYBBP1A;HIST1H2BG;H2AFZ;HIST1H2BF;HIST1H2BH;HDAC1;HDAC2;HIST1H4D;HIST1H2AK,108 (109),2.6e-09,1.29e-07,0,,4 (5),1,1,5.41e-08,1.3e-06
Regulation of TP53 Activity,Reactome,23,BLM;AURKA;HDAC1;BRIP1;BARD1;EXO1;EHMT2;RBBP4;NOC2L;SSRP1;TPX2;TOPBP1;HIPK2;CDK1;TAF1;CCNA2;TAF9;RFC5;RPA1;RHNO1;CDK2;HDAC2;AURKB,162 (162),3.41e-08,1.32e-06,1,HMDB00538,11 (13),0.0783,0.213,5.53e-08,1.32e-06
Transcriptional Regulation by TP53,Reactome,36,FANCD2;AURKA;BLM;HIPK2;LRPPRC;GTF2F1;BRIP1;MLH1;EXO1;EHMT2;RBBP4;NOC2L;RBL1;FANCI;HDAC2;TPX2;TOPBP1;BARD1;E2F7;BIRC5;E2F1;E2F4;CDK2;CDK1;TAF1;SSRP1;TAF9;RFC5;CDC25C;RPA1;RHNO1;E2F8;HDAC1;CCNA2;CCNB1;AURKB,371 (374),1.49e-07,4.83e-06,2,HMDB03337;HMDB00538,29 (37),0.0185,0.134,5.71e-08,1.35e-06
RNA Polymerase I Promoter Clearance,Reactome,18,HIST1H3C;HIST1H3I;H2AFX;EHMT2;RBBP4;HIST1H4F;HIST1H2BB;H2AFZ;HIST1H2AC;HIST1H2AB;HIST1H3F;HIST1H2BG;HIST1H2BF;HIST1H2BH;HDAC1;HDAC2;HIST1H4D;HIST1H2AK,111 (112),1.38e-07,4.5e-06,1,HMDB00538,3 (4),0.0219,0.134,6.26e-08,1.46e-06
DNA replication - Homo sapiens (human),KEGG,11,RFC5;RNASEH2B;LIG1;MCM2;MCM3;POLA1;MCM6;POLD1;POLE;MCM5;RPA1,36 (36),4.51e-08,1.74e-06,0,,0 (0),1,1,4.51e-08,1.74e-06
Homologous DNA Pairing and Strand Exchange,Reactome,11,RAD51;RFC5;EXO1;RPA1;TOPBP1;RAD51AP1;RHNO1;PALB2;BRIP1;BLM;BARD1,42 (42),2.62e-07,7.98e-06,1,HMDB00538,2 (2),0.0147,0.119,7.85e-08,1.82e-06
Gastric Cancer Network 1,Wikipathways,10,KIF15;NUP107;AURKA;ECT2;E2F7;CENPF;KIF20B;TOP2A;UBE2C;TPX2,29 (29),5.06e-08,1.87e-06,0,,0 (0),1,1,5.06e-08,1.87e-06
Mitotic G2-G2-M phases,Wikipathways,5,CDC25A;PLK1;CCNB1;CCNB2;CENPF,5 (5),7.1e-08,2.51e-06,1,HMDB00538,8 (8),0.0575,0.186,8.3e-08,1.91e-06
Regulation of Glucokinase by Glucokinase Regulatory Protein,Reactome,11,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,30 (30),5.03e-09,2.4e-07,0,,3 (4),1,1,1.01e-07,2.3e-06
G1 to S cell cycle control,Wikipathways,14,CDC25A;CCNB1;RPA1;WEE1;MCM2;MCM3;E2F1;MCM5;MCM6;POLE;CDK1;CDK2;CDK4;CDK6,64 (64),7.29e-08,2.52e-06,0,,0 (0),1,1,7.29e-08,2.52e-06
Phosphorylation of Emi1,Reactome,5,CCNB1;PLK1;CDK1;CDC20;FZR1,6 (6),4.13e-07,1.19e-05,1,HMDB00538,2 (2),0.0147,0.119,1.21e-07,2.73e-06
E2F transcription factor network,PID,15,CDC25A;TOPBP1;RBBP4;MCM3;TRIM28;CBX5;RBL1;POLA1;E2F1;E2F7;E2F4;HDAC1;CDK1;CDK2;CCNA2,75 (75),8.89e-08,3.02e-06,0,,0 (2),1,1,8.89e-08,3.02e-06
Aurora A signaling,PID,10,CKAP5;AURKA;TACC3;BIRC5;RAN;FZR1;PPP2R5D;DLGAP5;AURKB;TPX2,31 (31),1.05e-07,3.49e-06,0,,0 (0),1,1,1.05e-07,3.49e-06
Mitotic G1-G1-S phases,Wikipathways,8,CDC25A;RBL1;POLA1;E2F1;TOP2A;CDT1;CDK1;CCNA2,20 (20),3.02e-07,8.99e-06,1,HMDB00538,4 (4),0.0292,0.138,1.72e-07,3.85e-06
Transport of Mature mRNA derived from an Intron-Containing Transcript,Reactome,14,NUP107;NUP50;SRSF4;NUP133;NCBP1;DDX39B;NUP62;NUP214;NUP188;NUP210;NDC1;NUP37;NUP205;NUP88,73 (73),4.14e-07,1.19e-05,1,HMDB00538,3 (4),0.0219,0.134,1.77e-07,3.9e-06
Regulation of retinoblastoma protein,PID,15,SMARCA4;SMARCB1;RBBP4;DNMT1;SUV39H1;E2F1;MET;CTBP1;E2F4;CDK2;TAF1;HDAC1;CCNA2;CDK4;CDK6,64 (64),9.08e-09,4.21e-07,0,,1 (2),1,1,1.77e-07,3.9e-06
Pentose phosphate pathway,EHMN,10,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,29 (29),5.06e-08,1.87e-06,1,HMDB00538,29 (37),0.194,0.437,1.91e-07,4.16e-06
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,Reactome,14,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H2AK,68 (69),1.64e-07,5.25e-06,1,HMDB00538,10 (11),0.0714,0.205,2.25e-07,4.87e-06
DNA Mismatch Repair,Wikipathways,6,EXO1;RPA1;LIG1;MSH6;POLD1;MLH1,9 (9),2e-07,6.26e-06,0,,0 (0),1,1,2e-07,6.26e-06
Homologous recombination - Homo sapiens (human),KEGG,11,RAD51;BLM;BARD1;RPA1;TOPBP1;EME1;RAD54L;POLD1;PALB2;BRIP1;BABAM1,41 (41),2e-07,6.26e-06,0,,0 (0),1,1,2e-07,6.26e-06
RUNX1 regulates transcription of genes involved in differentiation of HSCs,Reactome,15,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;MYB;HIST1H2AK,86 (88),5.82e-07,1.64e-05,1,HMDB00538,4 (4),0.0292,0.138,3.21e-07,6.87e-06
Systemic lupus erythematosus - Homo sapiens (human),KEGG,21,HIST1H3C;HIST1H3I;SNRPD1;H2AFX;HIST1H2AH;HIST1H4D;HIST1H4F;HIST1H2AK;CTSG;HIST1H2AG;HIST1H2AC;HIST1H2AB;HIST1H2BB;HIST1H3F;HIST1H2BG;ELANE;HIST1H2BF;HIST2H2AB;HIST1H2BH;H2AFZ;ACTN4,132 (133),1.77e-08,7.68e-07,0,,2 (3),1,1,3.34e-07,7.11e-06
Vitamin B3 (nicotinate and nicotinamide) metabolism,EHMN,11,NUP107;NUP50;NUP133;NUP37;NT5C;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,47 (47),9.02e-07,2.45e-05,2,HMDB00538;HMDB00229,32 (36),0.0223,0.136,3.76e-07,7.92e-06
Progesterone-mediated oocyte maturation - Homo sapiens (human),KEGG,18,CDK2;CDC25A;BUB1;AURKA;KIF22;ANAPC1;CCNB1;CCNB2;FZR1;CDC16;PLK1;MAD2L1;CDK1;CDC23;CCNA2;MAD1L1;HSP90AB1;CDC25C,99 (99),2.21e-08,9.31e-07,0,,3 (4),1,1,4.12e-07,8.61e-06
Glycosphingolipid metabolism,EHMN,12,NUP107;NUP50;NUP133;GLA;B4GALT6;NUP62;NUP214;NUP188;NUP210;NUP37;NUP205;NUP88,69 (69),8.11e-06,0.000179,3,HMDB00095;HMDB00538;HMDB01176,40 (55),0.00277,0.062,4.18e-07,8.67e-06
Vitamin D3 (cholecalciferol) metabolism,EHMN,10,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,27 (27),2.28e-08,9.43e-07,0,,11 (12),1,1,4.24e-07,8.72e-06
Phosphorylation of the APC/C,Reactome,8,PLK1;ANAPC1;CDK1;CDC16;ANAPC15;UBE2C;CDC23;CCNB1,20 (20),3.02e-07,8.99e-06,0,,0 (0),1,1,3.02e-07,8.99e-06
Kinesins,Reactome,11,KIF20A;KIF15;CENPE;RACGAP1;KIF20B;KIF11;KIFC1;KIF22;KIF2C;KIF18B;KIF16B,43 (43),3.41e-07,9.97e-06,0,,0 (0),1,1,3.41e-07,9.97e-06
SIRT1 negatively regulates rRNA expression,Reactome,15,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;SUV39H1;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H2AK,69 (70),2.72e-08,1.08e-06,0,,4 (6),1,1,5.01e-07,1.02e-05
role of ran in mitotic spindle regulation,BioCarta,7,KIF15;AURKA;RAN;RANGAP1;TPX2;KPNB1;KPNA2,11 (11),2.8e-08,1.11e-06,0,,2 (2),1,1,5.16e-07,1.04e-05
ESR-mediated signaling,Reactome,20,HIST1H3C;SMC1A;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;FKBP4;HIST1H4D;GTF2F1;HIST1H2BG;HIST1H2BF;HIST1H2BH;HDAC1;MYB;HIST1H2AK;HSP90AB1,148 (150),6.05e-07,1.69e-05,1,HMDB00538,7 (9),0.0505,0.173,5.59e-07,1.12e-05
Glucose metabolism,Reactome,15,NUP107;PFKL;TPI1;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;PPP2R5D;NUP210;NDC1;NUP88;NUP205;PGP,90 (91),1.07e-06,2.83e-05,2,HMDB00094;HMDB00538,37 (44),0.0292,0.138,5.7e-07,1.14e-05
TP53 Regulates Transcription of Cell Cycle Genes,Reactome,11,CDC25C;AURKA;E2F7;RBL1;E2F1;E2F4;E2F8;CDK1;CDK2;CCNA2;CCNB1,51 (51),2.15e-06,5.43e-05,1,HMDB00538,2 (2),0.0147,0.119,5.78e-07,1.14e-05
Oxidative Stress Induced Senescence,Reactome,18,HIST1H3C;HIST1H3I;CDK4;H2AFX;H2AFZ;RBBP4;HIST1H4F;HIST1H2BB;CDK6;E2F1;HIST1H2AC;HIST1H2AB;HIST1H3F;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H4D;HIST1H2AK,125 (126),8.59e-07,2.35e-05,1,HMDB00538,7 (8),0.0505,0.173,7.79e-07,1.53e-05
Vitamin E metabolism,EHMN,11,NUP107;NUP50;NUP133;NUP37;ACAA2;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,43 (43),3.41e-07,9.97e-06,1,HMDB00538,20 (21),0.138,0.332,8.41e-07,1.64e-05
Formation of the beta-catenin:TCF transactivating complex,Reactome,17,HIST1H3C;HIST1H3I;SMARCA4;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;BCL9L;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HDAC1;HIST1H2AK,93 (94),5.02e-08,1.87e-06,0,,4 (4),1,1,8.94e-07,1.73e-05
De novo fatty acid biosynthesis,EHMN,11,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;CINP;NUP88,43 (43),3.41e-07,9.97e-06,1,HMDB00538,25 (59),0.17,0.392,1.02e-06,1.96e-05
SUMOylation of RNA binding proteins,Reactome,11,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,46 (46),7.14e-07,1.96e-05,0,,0 (0),1,1,7.14e-07,1.96e-05
mechanism of protein import into the nucleus,BioCarta,7,RAN;RANGAP1;NUP62;NUP214;NUP210;KPNB1;KPNA2,12 (12),6.51e-08,2.32e-06,0,,2 (2),1,1,1.14e-06,2.17e-05
Resolution of D-loop Structures through Holliday Junction Intermediates,Reactome,9,RAD51;BLM;BARD1;RAD51AP1;EME1;GEN1;PALB2;BRIP1;EXO1,33 (34),2.26e-06,5.62e-05,1,HMDB00538,4 (4),0.0292,0.138,1.16e-06,2.18e-05
Reproduction,Reactome,16,HIST1H3C;SMC1A;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;STAG3;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2AC;HIST1H2BF;HIST1H2BH;HIST1H2AK,103 (104),1.25e-06,3.25e-05,1,HMDB00538,8 (12),0.0575,0.186,1.25e-06,2.34e-05
Disease,Reactome,39,TGFB1;PIK3AP1;MET;LIG1;NCOR2;RAN;RANGAP1;GTF2F1;AP2S1;NDC1;HDAC6;FN1;AP2A2;NUP107;KPNB1;PAPD7;NUP37;CANX;NUP210;NUP50;NUP88;NUP133;NCBP1;NUP62;NUP214;NUP188;TAF1;SLC25A5;SSRP1;TAF9;CDC25A;CDC25C;PPIA;BANF1;HDAC1;HDAC2;KPNA1;NUP205;KPNA2,508 (510),1.55e-05,0.000313,3,HMDB00285;HMDB00538;HMDB00082,48 (104),0.00468,0.09,1.27e-06,2.35e-05
Meiotic recombination,Reactome,14,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H2AK,64 (65),7.29e-08,2.52e-06,0,,2 (3),1,1,1.27e-06,2.35e-05
CDK-mediated phosphorylation and removal of Cdc6,Reactome,8,ANAPC1;UBE2C;FZR1;CDC16;ANAPC15;CDK2;CDC23;CCNA2,28 (28),5.72e-06,0.000132,1,HMDB00538,2 (2),0.0147,0.119,1.45e-06,2.66e-05
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,Reactome,6,RBL1;E2F1;E2F4;CDK1;HDAC1;CCNA2,11 (11),1.03e-06,2.77e-05,0,,0 (0),1,1,1.03e-06,2.77e-05
cyclins and cell cycle regulation,BioCarta,8,CDC25A;CCNB1;RBL1;E2F1;CDK1;CDK2;CDK4;CDK6,23 (23),1.06e-06,2.83e-05,0,,0 (0),1,1,1.06e-06,2.83e-05
Glycine_ serine_ alanine and threonine metabolism,EHMN,14,NUP107;SLC38A1;GATM;NUP50;NUP133;NUP37;ALAS1;NUP62;NUP214;NUP188;NUP210;NUP205;TARS2;NUP88,78 (78),9.65e-07,2.61e-05,2,HMDB00538;HMDB00043,72 (88),0.0966,0.253,1.6e-06,2.91e-05
HDR through Single Strand Annealing (SSA),Reactome,9,RAD51;TOPBP1;EXO1;RPA1;RFC5;RHNO1;BRIP1;BLM;BARD1,37 (37),6.39e-06,0.000144,1,HMDB00538,2 (2),0.0147,0.119,1.61e-06,2.91e-05
Selenoamino acid metabolism,EHMN,10,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,36 (36),5.08e-07,1.44e-05,1,HMDB00538,29 (38),0.194,0.437,1.69e-06,3.03e-05
Prostaglandin formation from dihomo gama-linoleic acid,EHMN,10,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,31 (31),1.05e-07,3.49e-06,0,,5 (8),1,1,1.79e-06,3.19e-05
Resolution of D-Loop Structures,Reactome,9,RAD51;BLM;EXO1;RAD51AP1;EME1;GEN1;PALB2;BRIP1;BARD1,35 (36),3.88e-06,9.27e-05,1,HMDB00538,4 (4),0.0292,0.138,1.92e-06,3.4e-05
Deubiquitination,Reactome,28,TGFB1;HIST1H2AG;HIST1H2AK;PSMD13;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;BARD1;BABAM1;USP24;PSMC1;PSMD2;HIST1H2BB;PSMD1;HIST2H2AB;PSMD3;PSMD5;PSMD7;PSME3;CDK1;CDC20;CDC25A;HCFC1;HIST1H2AH;HIST1H2BH;CCNA2;RAD23B,296 (296),6.06e-06,0.000138,1,HMDB00538,3 (6),0.0219,0.134,2.24e-06,3.93e-05
APC/C:Cdc20 mediated degradation of Cyclin B,Reactome,8,ANAPC1;UBE2C;CDC16;ANAPC15;CDK1;CDC23;CCNB1;CDC20,24 (24),1.54e-06,3.98e-05,0,,0 (0),1,1,1.54e-06,3.98e-05
G2/M DNA replication checkpoint,Reactome,4,WEE1;CCNB1;CCNB2;CDK1,5 (5),9.31e-06,0.000202,1,HMDB00538,2 (2),0.0147,0.119,2.3e-06,4.01e-05
Presynaptic phase of homologous DNA pairing and strand exchange,Reactome,9,RAD51;TOPBP1;EXO1;RPA1;RFC5;RHNO1;BRIP1;BLM;BARD1,39 (39),1.02e-05,0.000213,1,HMDB00538,2 (2),0.0147,0.119,2.5e-06,4.33e-05
Squalene and cholesterol biosynthesis,EHMN,10,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,37 (37),6.73e-07,1.86e-05,1,HMDB00538,37 (42),0.241,0.53,2.7e-06,4.64e-05
Estrogen-dependent gene expression,Reactome,18,HIST1H3C;SMC1A;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;HIST1H4D;GTF2F1;HIST1H2BG;HIST1H2BF;HIST1H2BH;HDAC1;MYB;HIST1H2AK,140 (142),4.55e-06,0.000107,1,HMDB00538,5 (7),0.0363,0.149,2.74e-06,4.69e-05
Transcriptional regulation by RUNX1,Reactome,22,HIST1H3F;HIST1H2AK;SETD1A;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H3C;HIST1H3I;SMARCB1;HIST1H4D;HIST1H4F;H2AFZ;HIPK2;SMARCA4;H2AFX;SMARCC1;HIST1H2BB;HDAC1;MYB;CDK6,196 (198),4.04e-06,9.55e-05,1,HMDB00538,6 (9),0.0434,0.161,2.9e-06,4.93e-05
Oocyte meiosis - Homo sapiens (human),KEGG,19,MAD1L1;ESPL1;BUB1;AURKA;PLK1;ANAPC1;CCNB2;STAG3;CDC16;SMC1A;MAD2L1;CDK1;PPP2R5D;CDK2;CCNB1;CDC25C;PPP1CC;CDC23;CDC20,125 (125),1.79e-07,5.72e-06,0,,4 (4),1,1,2.97e-06,5e-05
AURKA Activation by TPX2,Reactome,12,CKAP5;PLK1;AURKA;CDK5RAP2;PLK4;NEK2;CEP152;CDK1;HMMR;PCNT;ODF2;TPX2,72 (72),1.28e-05,0.000262,1,HMDB00538,2 (2),0.0147,0.119,3.09e-06,5.18e-05
Urea cycle and metabolism of arginine_ proline_ glutamate_ aspartate and asparagine,EHMN,12,NUP107;SLC38A1;GATM;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,105 (106),0.000533,0.00886,5,HMDB02064;HMDB00201;HMDB03337;HMDB00538;HMDB00267,91 (125),0.000363,0.0115,3.18e-06,5.29e-05
cell cycle: g1/s check point,BioCarta,8,TGFB1;CDC25A;E2F1;CDK2;CDK1;HDAC1;CDK4;CDK6,25 (25),2.2e-06,5.48e-05,0,,0 (0),1,1,2.2e-06,5.48e-05
UCH proteinases,Reactome,17,TGFB1;BARD1;HIST1H2AG;PSMD2;HIST1H2AK;PSMD1;HIST2H2AB;PSMD3;HCFC1;PSMD5;PSMD7;HIST1H2AH;PSME3;PSMD13;PSMC1;HIST1H2AB;HIST1H2AC,102 (102),2.05e-07,6.31e-06,0,,1 (2),1,1,3.36e-06,5.55e-05
Glycolysis and Gluconeogenesis,EHMN,12,NUP107;DLAT;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;PFKL;NUP205;NUP88,66 (67),5.01e-06,0.000116,2,HMDB00094;HMDB00538,45 (52),0.042,0.161,3.45e-06,5.66e-05
Cellular response to heat stress,Reactome,15,NUP107;HDAC6;RPA1;NUP50;NUP133;NUP37;FKBP4;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;HSP90AB1;NUP88,99 (99),3.68e-06,8.86e-05,1,HMDB00538,8 (9),0.0575,0.186,3.47e-06,5.66e-05
RHO GTPases activate PKNs,Reactome,15,HIST1H3C;HIST1H3I;CDC25C;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H2AK,95 (96),2.17e-06,5.43e-05,1,HMDB00538,14 (15),0.0986,0.254,3.49e-06,5.66e-05
Transcriptional Regulation by E2F6,Wikipathways,5,RAD51;RBBP4;CBX5;CDC7;E2F1,10 (10),1.53e-05,0.00031,1,HMDB00538,2 (2),0.0147,0.119,3.67e-06,5.91e-05
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,Reactome,16,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;SETD1A;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HDAC1;HIST1H2AK,92 (94),2.55e-07,7.81e-06,0,,2 (2),1,1,4.13e-06,6.61e-05
Phosphatidylinositol phosphate metabolism,EHMN,14,NUP107;GPLD1;NUP50;NUP133;NUP37;PI4KA;NUP205;NUP62;NUP214;NUP188;OCRL;NUP210;GLA;NUP88,93 (93),8.38e-06,0.000184,2,HMDB00095;HMDB00538,39 (49),0.0323,0.149,4.36e-06,6.93e-05
Abortive elongation of HIV-1 transcript in the absence of Tat,Reactome,2,GTF2F1;NCBP1,23 (23),0.211,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,4.5e-06,7.11e-05
COPI-dependent Golgi-to-ER retrograde traffic,Reactome,13,KIF20A;KIF15;COPZ1;CENPE;RACGAP1;KIF20B;KIF11;KIFC1;KIF22;KIF2C;KIF18B;KIF16B;ZW10,82 (82),9.84e-06,0.000209,1,HMDB00538,4 (4),0.0292,0.138,4.61e-06,7.23e-05
RNA Polymerase II Pre-transcription Events,Reactome,5,TAF1;TAF9;GTF2F1;SSRP1;NCBP1,86 (88),0.218,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,4.63e-06,7.23e-05
B-WICH complex positively regulates rRNA expression,Reactome,16,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;DEK;HIST1H2AC;HIST1H2AB;HIST1H4D;MYBBP1A;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H2AK,93 (94),2.98e-07,8.99e-06,0,,2 (2),1,1,4.77e-06,7.41e-05
Packaging Of Telomere Ends,Reactome,11,H2AFX;H2AFZ;HIST1H4D;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H2AK,53 (54),3.22e-06,7.91e-05,0,,0 (1),1,1,3.22e-06,7.91e-05
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),Reactome,6,EXO1;RPA1;LIG1;MSH6;POLD1;MLH1,14 (15),6.1e-06,0.000138,1,HMDB00538,8 (9),0.0575,0.186,5.57e-06,8.58e-05
Activation of DNA fragmentation factor,Reactome,6,HIST1H1E;HMGB1;HMGB2;KPNA1;KPNB1;HIST1H1D,13 (13),3.6e-06,8.73e-05,0,,0 (1),1,1,3.6e-06,8.73e-05
Apoptosis induced DNA fragmentation,Reactome,6,HIST1H1E;HMGB1;HMGB2;KPNA1;KPNB1;HIST1H1D,13 (13),3.6e-06,8.73e-05,0,,0 (1),1,1,3.6e-06,8.73e-05
Regulation of HSF1-mediated heat shock response,Reactome,13,NUP107;RPA1;NUP50;NUP133;NUP37;FKBP4;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,81 (81),8.57e-06,0.000187,1,HMDB00538,6 (7),0.0434,0.161,5.88e-06,9.02e-05
Fanconi anemia pathway - Homo sapiens (human),KEGG,11,RAD51;BLM;MLH1;RPA1;USP1;FANCD2;EME1;FANCI;PALB2;BRIP1;REV1,54 (54),3.91e-06,9.3e-05,0,,0 (0),1,1,3.91e-06,9.3e-05
The role of GTSE1 in G2/M progression after G2 checkpoint,Reactome,5,CCNB1;PLK1;CCNB2;HSP90AB1;CDK1,11 (11),2.72e-05,0.000532,1,HMDB00538,2 (2),0.0147,0.119,6.29e-06,9.58e-05
UTP and CTP dephosphorylation II,HumanCyc,0,,4 (4),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,10 (11),4.12e-07,0.000214,6.48e-06,9.81e-05
tRNA processing,Reactome,14,NUP107;RAN;CSTF2;NSUN2;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NDC1;NUP205;NUP88,103 (103),2.76e-05,0.000535,2,HMDB00538;HMDB00082,27 (51),0.0161,0.129,6.95e-06,0.000105
Formation of the HIV-1 Early Elongation Complex,Reactome,2,GTF2F1;NCBP1,33 (33),0.35,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,7.23e-06,0.000108
Formation of the Early Elongation Complex,Reactome,2,GTF2F1;NCBP1,33 (33),0.35,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,7.23e-06,0.000108
Orc1 removal from chromatin,Reactome,7,MCM2;MCM3;MCM5;MCM6;CDT1;CDK2;CCNA2,26 (26),3.43e-05,0.000656,1,HMDB00538,2 (2),0.0147,0.119,7.8e-06,0.000115
Tat-mediated HIV elongation arrest and recovery,Reactome,2,GTF2F1;SSRP1,36 (38),0.391,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,8.01e-06,0.000117
Pausing and recovery of Tat-mediated HIV elongation,Reactome,2,GTF2F1;SSRP1,36 (38),0.391,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,8.01e-06,0.000117
Lagging Strand Synthesis,Reactome,5,POLD1;RFC5;LIG1;RPA1;POLA1,20 (20),0.000691,0.0112,2,HMDB00095;HMDB00538,6 (6),0.000753,0.0204,8.05e-06,0.000117
HIV elongation arrest and recovery,Reactome,2,GTF2F1;SSRP1,38 (40),0.417,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,8.51e-06,0.000122
Pausing and recovery of HIV elongation,Reactome,2,GTF2F1;SSRP1,38 (40),0.417,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,8.51e-06,0.000122
RNA Polymerase II Transcription Elongation,Reactome,3,GTF2F1;SSRP1;NCBP1,63 (65),0.42,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,8.55e-06,0.000122
Mismatch Repair,Reactome,6,MLH1;RPA1;LIG1;MSH6;POLD1;EXO1,15 (16),9.85e-06,0.000209,1,HMDB00538,8 (9),0.0575,0.186,8.71e-06,0.000124
DNA replication initiation,Reactome,2,POLE;POLA1,8 (8),0.0335,0.325,3,HMDB00285;HMDB00538;HMDB00082,8 (8),1.82e-05,0.000873,9.34e-06,0.000131
Telomere C-strand synthesis initiation,Reactome,2,POLE;POLA1,8 (8),0.0335,0.325,3,HMDB00285;HMDB00538;HMDB00082,8 (9),1.82e-05,0.000873,9.34e-06,0.000131
Meiotic synapsis,Reactome,9,SMC1A;H2AFX;HIST1H4D;HIST1H4F;HIST1H2BB;STAG3;HIST1H2BG;HIST1H2BF;HIST1H2BH,46 (47),4.2e-05,0.000793,1,HMDB00538,2 (3),0.0147,0.119,9.43e-06,0.000131
Generic Transcription Pathway,Reactome,68,TGFB1;RAD51;TRIM28;AURKA;FANCD2;HIST1H3F;HIST1H2AK;SETD1A;HSPD1;HIST1H2AC;CDK4;LRPPRC;GTF2F1;HIST1H2BG;BRIP1;HIST1H2BF;BARD1;EXO1;HDAC6;HIST1H3C;HIST1H3I;SMARCB1;EHMT2;HIST1H4D;HIST1H4F;NOC2L;CBX5;RBL1;FANCI;HDAC2;H2AFZ;BLM;TPX2;TOPBP1;MLH1;SMARCA4;H2AFX;SMARCC1;NCOR2;HIST1H2BB;CDK6;BIRC5;E2F1;E2F4;CDK2;CDK1;TAF1;HIPK2;HIST1H2AB;SSRP1;TAF9;RFC5;CDC25C;ATAD2;RPA1;DEK;CCNA2;MED24;RHNO1;E2F7;RBBP4;E2F8;HIST1H2BH;HDAC1;MYB;CCNB1;AURKB;CDC7,1099 (1107),2.11e-05,0.000419,2,HMDB03337;HMDB00538,37 (49),0.0292,0.138,9.43e-06,0.000131
Fanconi anemia pathway,PID,10,TOPBP1;RPA1;USP1;RFC5;FANCD2;FANCI;PALB2;BRIP1;H2AFX;BLM,46 (46),5.82e-06,0.000134,0,,0 (0),1,1,5.82e-06,0.000134
Regulation of PLK1 Activity at G2/M Transition,Reactome,13,CKAP5;PLK1;AURKA;CDK5RAP2;CCNB2;NEK2;CEP152;CDK1;CCNB1;BORA;PLK4;PCNT;ODF2,87 (87),1.91e-05,0.000382,1,HMDB00538,5 (5),0.0363,0.149,1.05e-05,0.000145
RNA Polymerase II Promoter Escape,Reactome,3,TAF1;TAF9;GTF2F1,46 (46),0.246,1,3,HMDB00285;HMDB00538;HMDB00082,5 (5),3.29e-06,0.000361,1.22e-05,0.000167
miR-targeted genes in epithelium - TarBase,Wikipathways,30,DHX15;SLC38A1;MET;SMC1A;ANP32B;PSAT1;CAND1;GALNT1;BRI3BP;VEZT;MTHFD2;CTSC;CHAF1A;C1QBP;HSD17B12;E2F1;ABCF2;ACAA2;PTBP1;PTMA;PLK1;GFM1;TRIP13;ATP2A2;AURKB;IQGAP3;PNP;CDK6;DCAF7;RAD23B,333 (333),7.52e-06,0.000168,0,,0 (0),1,1,7.52e-06,0.000168
RNA Polymerase II HIV Promoter Escape,Reactome,3,TAF1;TAF9;GTF2F1,47 (47),0.256,1,3,HMDB00285;HMDB00538;HMDB00082,5 (5),3.29e-06,0.000361,1.26e-05,0.000171
RNA Polymerase II Transcription Initiation,Reactome,3,TAF1;TAF9;GTF2F1,47 (47),0.256,1,3,HMDB00285;HMDB00538;HMDB00082,5 (5),3.29e-06,0.000361,1.26e-05,0.000171
HIV Transcription Initiation,Reactome,3,TAF1;TAF9;GTF2F1,47 (47),0.256,1,3,HMDB00285;HMDB00538;HMDB00082,5 (5),3.29e-06,0.000361,1.26e-05,0.000171
Tat-mediated elongation of the HIV-1 transcript,Reactome,3,GTF2F1;SSRP1;NCBP1,48 (50),0.266,1,3,HMDB00285;HMDB00538;HMDB00082,5 (5),3.29e-06,0.000361,1.31e-05,0.000175
HIV Transcription Elongation,Reactome,3,GTF2F1;SSRP1;NCBP1,48 (50),0.266,1,3,HMDB00285;HMDB00538;HMDB00082,5 (5),3.29e-06,0.000361,1.31e-05,0.000175
Activation of NIMA Kinases NEK9_ NEK6_ NEK7,Reactome,4,CCNB1;PLK1;CCNB2;CDK1,7 (7),6.14e-05,0.00114,1,HMDB00538,2 (2),0.0147,0.119,1.34e-05,0.000179
Synthesis of substrates in N-glycan biosythesis,Reactome,0,,63 (63),1,1,6,HMDB00285;HMDB01265;HMDB00082;HMDB00538;HMDB01176;HMDB00095,52 (68),9.99e-07,0.000214,1.48e-05,0.000196
RNA Polymerase III Abortive And Retractive Initiation,Reactome,1,GTF3A,41 (42),0.79,1,3,HMDB00285;HMDB00538;HMDB00082,4 (5),1.32e-06,0.000214,1.54e-05,0.000202
RNA Polymerase III Transcription,Reactome,1,GTF3A,41 (42),0.79,1,3,HMDB00285;HMDB00538;HMDB00082,4 (5),1.32e-06,0.000214,1.54e-05,0.000202
Spliceosome - Homo sapiens (human),KEGG,17,DHX15;SF3A3;TCERG1;SNRPD1;PRPF31;PRPF19;SNRNP40;NCBP1;DDX39B;SF3A1;ZMAT2;SNRPE;PPIL1;SF3B3;CHERP;SRSF4;EFTUD2,134 (134),1e-05,0.000212,0,,0 (0),1,1,1e-05,0.000212
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome,Wikipathways,7,SREBF1;RBBP4;CBX5;E2F1;SUV39H1;HDAC1;HDAC2,22 (22),1.01e-05,0.000212,0,,0 (0),1,1,1.01e-05,0.000212
DNA Damage Response,Wikipathways,13,RAD51;FANCD2;CDC25C;H2AFX;CDC25A;CCNB1;CCNB2;E2F1;SMC1A;CDK1;CDK2;CDK4;CDK6,68 (68),1.12e-06,2.94e-05,0,,1 (2),1,1,1.64e-05,0.000214
cRNA Synthesis,Reactome,0,,0 (0),1,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,1.32e-06,0.000214
vRNA Synthesis,Reactome,0,,0 (0),1,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,1.32e-06,0.000214
RNA Polymerase III Transcription,Wikipathways,0,,0 (0),1,1,3,HMDB00285;HMDB00538;HMDB00082,4 (5),1.32e-06,0.000214,1.32e-06,0.000214
Telomere Maintenance,Wikipathways,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,13 (14),1.39e-06,0.000214,1.39e-06,0.000214
Synthesis of DNA,Wikipathways,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,13 (13),1.39e-06,0.000214,1.39e-06,0.000214
mRNA Splicing - Major Pathway,Reactome,20,DHX15;SNRNP40;SNRPE;CSTF2;SNRPD1;PRPF31;PRPF19;SF3A3;NCBP1;CPSF2;FIP1L1;GTF2F1;SF3A1;SRSF4;SRRT;SF3B3;CHERP;PPIL1;PTBP1;EFTUD2,178 (178),1.09e-05,0.000225,0,,0 (0),1,1,1.09e-05,0.000225
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),Reactome,7,RAD51;BLM;EXO1;RAD51AP1;PALB2;BRIP1;BARD1,27 (27),4.48e-05,0.000839,1,HMDB00538,4 (4),0.0292,0.138,1.9e-05,0.000246
Nonhomologous End-Joining (NHEJ),Reactome,11,PAXIP1;BARD1;H2AFX;HIST1H4D;HIST1H4F;HIST1H2BB;HIST1H2BG;BABAM1;HIST1H2BF;HIST1H2BH;RNF168,69 (70),4.5e-05,0.000839,1,HMDB00538,4 (5),0.0292,0.138,1.91e-05,0.000246
RNA Polymerase III Chain Elongation,Reactome,0,,18 (19),1,1,3,HMDB00285;HMDB00538;HMDB00082,4 (4),1.32e-06,0.000214,1.92e-05,0.000247
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide_ LLO) and transfer to a nascent protein,Reactome,1,ALG10B,78 (78),0.949,1,6,HMDB00285;HMDB01265;HMDB00082;HMDB00538;HMDB01176;HMDB00095,55 (81),1.4e-06,0.000214,1.94e-05,0.000247
HATs acetylate histones,Reactome,19,TAF9;HIST1H3C;HIST1H3I;HIST1H2AG;HIST1H2AH;HIST1H3F;HIST1H4F;HIST1H2BB;HIST2H2AB;HCFC1;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2AC;HIST1H2BF;JADE1;HIST1H2BH;HIST1H2AK;RUVBL2,142 (142),1.35e-06,3.49e-05,0,,2 (2),1,1,1.95e-05,0.000248
Amyloid fiber formation,Reactome,14,HIST1H3C;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;HIST1H4D;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H2AK,81 (82),1.55e-06,3.98e-05,0,,3 (5),1,1,2.23e-05,0.000282
Mismatch repair - Homo sapiens (human),KEGG,7,RFC5;EXO1;RPA1;LIG1;MSH6;POLD1;MLH1,23 (23),1.41e-05,0.000287,0,,0 (0),1,1,1.41e-05,0.000287
Transcription of the HIV genome,Reactome,5,TAF1;TAF9;GTF2F1;SSRP1;NCBP1,75 (77),0.148,0.968,3,HMDB00285;HMDB00538;HMDB00082,7 (7),1.14e-05,0.000581,2.42e-05,0.000304
Transcription of E2F targets under negative control by DREAM complex,Reactome,6,CDC25A;RBBP4;RBL1;E2F1;TOP2A;E2F4,16 (16),1.53e-05,0.00031,0,,0 (0),1,1,1.53e-05,0.00031
Asparagine N-linked glycosylation,Reactome,10,COPZ1;B4GALT6;PSMC1;TRAPPC10;PRKCSH;CTSC;ALG10B;UGGT1;RAD23B;CANX,285 (286),0.625,1,6,HMDB00285;HMDB01265;HMDB00082;HMDB00538;HMDB01176;HMDB00095,62 (119),2.89e-06,0.000361,2.57e-05,0.000322
UTP and CTP dephosphorylation I,HumanCyc,0,,3 (3),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,14 (15),1.93e-06,0.000275,2.73e-05,0.000341
Cyclin A:Cdk2-associated events at S phase entry,Reactome,7,CDC25A;WEE1;CKS1B;FZR1;CDK2;CCNA2;CDK4,29 (29),7.38e-05,0.00135,1,HMDB00538,4 (4),0.0292,0.138,3.02e-05,0.000375
Signaling by Nuclear Receptors,Reactome,21,HIST1H3C;SMC1A;HIST1H3I;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;HIST1H2AC;HIST1H2AB;FKBP4;HIST1H4D;GTF2F1;HIST1H2BG;DLAT;HIST1H2BF;HIST1H2BH;HDAC1;MYB;HIST1H2AK;HSP90AB1,193 (195),1.09e-05,0.000225,1,HMDB00538,31 (36),0.206,0.46,3.13e-05,0.000386
Putative anti-Inflammatory metabolites formation from EPA,EHMN,10,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,42 (42),2.4e-06,5.93e-05,0,,7 (10),1,1,3.35e-05,0.000411
mRNA Splicing,Reactome,20,DHX15;SNRNP40;SNRPE;CSTF2;SNRPD1;PRPF31;PRPF19;SF3A3;NCBP1;PPIL1;FIP1L1;GTF2F1;SF3A1;SRSF4;SRRT;SF3B3;CHERP;CPSF2;PTBP1;EFTUD2,186 (186),2.09e-05,0.000417,0,,0 (0),1,1,2.09e-05,0.000417
Sialic acid metabolism,Wikipathways,0,,0 (0),1,1,4,HMDB00095;HMDB00538;HMDB01176;HMDB00082,17 (27),4.53e-06,0.000461,4.53e-06,0.000461
RNA Polymerase II Transcription Initiation And Promoter Clearance,Reactome,3,TAF1;TAF9;GTF2F1,47 (47),0.256,1,3,HMDB00285;HMDB00538;HMDB00082,7 (7),1.14e-05,0.000581,4.01e-05,0.00049
Influenza Life Cycle,Wikipathways,0,,0 (0),1,1,3,HMDB00285;HMDB00538;HMDB00082,6 (9),6.56e-06,0.000498,6.56e-06,0.000498
Interconversion of nucleotide di- and triphosphates,Wikipathways,0,,0 (0),1,1,5,HMDB00095;HMDB00285;HMDB00538;HMDB03337;HMDB00082,41 (51),7.29e-06,0.000498,7.29e-06,0.000498
Rolitetracycline Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,19 (20),7.31e-06,0.000498,7.31e-06,0.000498
Demeclocycline Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,19 (21),7.31e-06,0.000498,7.31e-06,0.000498
Arbekacin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,19 (20),7.31e-06,0.000498,7.31e-06,0.000498
Lymecycline Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,19 (20),7.31e-06,0.000498,7.31e-06,0.000498
Clomocycline Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,19 (20),7.31e-06,0.000498,7.31e-06,0.000498
Tobramycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Troleandomycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Clarithromycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Clindamycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Methacycline Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Azithromycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Streptomycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Spectinomycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Gentamicin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Erythromycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Josamycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Kanamycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Netilmicin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Neomycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Roxithromycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Amikacin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Telithromycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Doxycycline Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Oxytetracycline Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Minocycline Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Lincomycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Chloramphenicol Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Paromomycin Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Tetracycline Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
Tigecycline Action Pathway,SMPDB,0,,0 (0),1,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,20 (20),9.09e-06,0.000498,9.09e-06,0.000498
ATM pathway,PID,8,FANCD2;CDC25C;H2AFX;CDC25A;TRIM28;CTBP1;SMC1A;BLM,34 (34),2.74e-05,0.000533,0,,0 (0),1,1,2.74e-05,0.000533
CMP phosphorylation,HumanCyc,0,,11 (11),1,1,3,HMDB00095;HMDB00538;HMDB00082,5 (5),3.29e-06,0.000361,4.49e-05,0.000543
RNA polymerase II transcribes snRNA genes,Wikipathways,0,,7 (7),1,1,3,HMDB00285;HMDB00538;HMDB00082,5 (6),3.29e-06,0.000361,4.49e-05,0.000543
RNA Polymerase I Transcription,Wikipathways,0,,0 (0),1,1,3,HMDB00285;HMDB00538;HMDB00082,7 (7),1.14e-05,0.000581,1.14e-05,0.000581
NoRC negatively regulates rRNA expression,Wikipathways,0,,0 (0),1,1,3,HMDB00285;HMDB00538;HMDB00082,7 (7),1.14e-05,0.000581,1.14e-05,0.000581
Phosphate bond hydrolysis by NTPDase proteins,Reactome,1,ENTPD5,8 (8),0.262,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,22 (25),1.36e-05,0.000684,4.84e-05,0.000582
Metabolism of carbohydrates,Reactome,18,NUP107;PFKL;NUP210;NUP50;NUP133;PGP;NUP37;B4GALT6;NUP62;NUP214;VCAN;NUP188;PPP2R5D;HMMR;NDC1;NUP88;NUP205;TPI1,263 (264),0.00988,0.123,5,HMDB00094;HMDB00095;HMDB00285;HMDB00538;HMDB01176,91 (137),0.000363,0.0115,4.85e-05,0.000582
Alcoholism - Homo sapiens (human),KEGG,21,HIST1H3C;HIST1H3I;H2AFX;HIST1H2AH;HIST1H4D;HIST1H4F;HIST1H2AK;H2AFZ;HIST1H2AG;HIST1H2AC;HIST1H2AB;HIST1H2BB;HIST1H3F;HIST1H2BG;HDAC1;HIST1H2BF;HIST2H2AB;HIST1H2BH;HDAC2;HDAC6;PPP1CC,180 (180),3.61e-06,8.73e-05,0,,10 (10),1,1,4.89e-05,0.000583
Interconversion of nucleotide di- and triphosphates,Reactome,2,TAF9;DUT,34 (34),0.364,1,5,HMDB00095;HMDB03337;HMDB00538;HMDB00285;HMDB00082,44 (52),1.04e-05,0.000564,5.12e-05,0.000608
cdk regulation of dna replication,BioCarta,6,MCM2;MCM3;MCM5;MCM6;CDT1;CDK2,18 (18),3.32e-05,0.000637,0,,0 (0),1,1,3.32e-05,0.000637
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,Reactome,6,CDC25C;AURKA;RBL1;E2F4;CDK1;CCNB1,18 (18),3.32e-05,0.000637,0,,0 (0),1,1,3.32e-05,0.000637
Signaling by NOTCH,Reactome,8,NCOR2;E2F1;PLXND1;HDAC1;HDAC2;DLGAP5;TACC3;HDAC6,119 (120),0.0771,0.628,3,HMDB00095;HMDB00538;HMDB01176,11 (11),5.29e-05,0.00221,5.46e-05,0.000646
miR-targeted genes in lymphocytes - TarBase,Wikipathways,37,DHX15;SLC38A1;MET;ANP32B;PSAT1;RCOR1;CAND1;IQGAP3;GALNT1;CTSC;BRI3BP;EHMT2;ANAPC1;MTHFD2;UHRF1;SMC1A;CHAF1A;C1QBP;HSD17B12;ABCF2;E2F1;ACAA2;PLXND1;PTBP1;PLK1;GFM1;USP1;TRIP13;ATP2A2;AURKB;VEZT;CDK6;MYB;PNP;PTMA;DCAF7;RAD23B,489 (489),3.53e-05,0.000671,0,,0 (0),1,1,3.53e-05,0.000671
Purine metabolism,EHMN,23,MPO;NUP50;NUP107;PAPD7;POLA1;NUP37;POLD1;POLE;NUP210;ENTPD5;NUP88;NUP133;RFC5;NUP62;NUP214;NUP188;TAF9;POLQ;GFM1;ATP2A2;NT5C;TUFM;NUP205,222 (223),9.44e-06,0.000204,1,HMDB00538,85 (94),0.473,0.942,5.94e-05,0.000699
Sialic acid metabolism,Reactome,0,,33 (33),1,1,4,HMDB00095;HMDB00538;HMDB01176;HMDB00082,17 (27),4.53e-06,0.000461,6.03e-05,0.000705
mRNA Processing,Wikipathways,17,DHX15;SNRNP40;SREK1;CSTF2;SMC1A;SNRPD1;NONO;SNRPE;SF3A3;NCBP1;SRSF4;SF3A1;HNRNPAB;SF3B3;EFTUD2;PTBP1;CPSF2,127 (127),4.81e-06,0.000113,0,,2 (2),1,1,6.37e-05,0.000742
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,Reactome,7,ANAPC1;FZR1;CDC16;ANAPC15;UBE2C;CDC23;CDC20,20 (20),4.91e-06,0.000114,0,,2 (2),1,1,6.49e-05,0.000753
TCF dependent signaling in response to WNT,Reactome,19,HIST1H3C;HIST1H2BH;HIST1H3I;SMARCA4;H2AFX;H2AFZ;HIST1H3F;HIST1H4F;HIST1H2BB;BCL9L;HIST1H2AC;HIST1H2AB;HIST1H4D;LRP5;HIST1H2BG;HIST1H2BF;PPP2R5D;HDAC1;HIST1H2AK,188 (190),7.84e-05,0.00143,1,HMDB00538,9 (11),0.0645,0.198,6.67e-05,0.00077
RNA Polymerase II Transcription,Wikipathways,0,,0 (0),1,1,3,HMDB00285;HMDB00538;HMDB00082,8 (8),1.82e-05,0.000873,1.82e-05,0.000873
sumoylation by ranbp2 regulates transcriptional repression,BioCarta,6,RAN;NUP62;NUP214;NUP210;HDAC1;HDAC6,14 (14),6.1e-06,0.000138,0,,1 (1),1,1,7.94e-05,0.000912
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),Reactome,5,POLD1;EXO1;LIG1;MLH1;RPA1,14 (15),0.000107,0.00191,1,HMDB00538,8 (9),0.0575,0.186,8.03e-05,0.000919
Golgi-to-ER retrograde transport,Reactome,14,KIF20A;KIF15;COPZ1;CENPE;RACGAP1;KIF18B;KIF20B;KIF11;KIFC1;KIF22;KIF2C;GALNT1;KIF16B;ZW10,116 (116),0.000104,0.00188,1,HMDB00538,9 (10),0.0645,0.198,8.69e-05,0.00099
G2 Phase,Reactome,3,CDK2;CCNA2;E2F1,5 (5),0.000489,0.00819,1,HMDB00538,2 (2),0.0147,0.119,9.21e-05,0.00105
cycling of ran in nucleocytoplasmic transport,BioCarta,5,NUP210;RANGAP1;NUP62;NUP214;RAN,9 (9),7.9e-06,0.000175,0,,2 (2),1,1,0.000101,0.00114
DNA Double Strand Break Response,Reactome,11,KPNA2;BARD1;H2AFX;HIST1H4D;HIST1H4F;HIST1H2BB;HIST1H2BG;RNF168;HIST1H2BF;HIST1H2BH;BABAM1,77 (78),0.000126,0.00222,1,HMDB00538,9 (9),0.0645,0.198,0.000103,0.00116
Viral carcinogenesis - Homo sapiens (human),KEGG,20,CDK2;HDAC1;CDK4;PSMC1;HIST1H4D;HIST1H4F;DDB1;CDK1;RBL1;CDK6;HIST1H2BB;ACTN4;HIST1H2BG;HIST1H2BF;HDAC2;HIST1H2BH;CCNA2;MAD1L1;HDAC6;CDC20,201 (201),6.37e-05,0.00118,0,,0 (0),1,1,6.37e-05,0.00118
rb tumor suppressor/checkpoint signaling in response to dna damage,BioCarta,5,CDK2;CDK4;E2F1;WEE1;CDK1,13 (13),7.12e-05,0.00131,0,,0 (0),1,1,7.12e-05,0.00131
Sumoylation by RanBP2 regulates transcriptional repression,PID,6,RAN;RANGAP1;NUP62;NUP214;NUP210;HDAC1,15 (15),9.85e-06,0.000209,0,,1 (1),1,1,0.000123,0.00137
estrogen responsive protein efp controls cell cycle and breast tumors growth,BioCarta,6,CDK4;CCNB2;CDK1;CDK2;CCNB1;CDK6,15 (15),9.85e-06,0.000209,0,,1 (1),1,1,0.000123,0.00137
Methionine and cysteine metabolism,EHMN,11,NUP107;NUP50;NUP133;NUP37;NUP62;NUP214;NUP188;NUP210;DNMT1;NUP205;NUP88,78 (78),0.000142,0.00249,2,HMDB00099;HMDB00538,62 (80),0.0746,0.213,0.000132,0.00146
TGF_beta_Receptor,NetPath,18,TGFB1;CDC25A;STRAP;ANAPC1;CDK6;FZR1;CCNB2;RBL1;CDC16;E2F4;HDAC1;NUP214;CDK1;CDC23;CDK2;CDK4;EIF3I;KPNB1,173 (174),8.26e-05,0.0015,0,,0 (0),1,1,8.26e-05,0.0015
phosphatidylcholine biosynthesis pathway,BioCarta,0,,3 (3),1,1,3,HMDB00095;HMDB00538;HMDB00082,7 (8),1.14e-05,0.000581,0.000141,0.00156
HIV Life Cycle,Wikipathways,0,,0 (0),1,1,3,HMDB00285;HMDB00538;HMDB00082,10 (11),3.86e-05,0.0017,3.86e-05,0.0017
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,Reactome,5,E2F8;CDK2;CCNA2;E2F1;E2F7,14 (14),0.000107,0.00191,0,,0 (0),1,1,0.000107,0.00191
Mitotic Telophase/Cytokinesis,Reactome,5,KIF20A;SMC1A;PLK1;NUDC;PDS5B,14 (14),0.000107,0.00191,0,,0 (0),1,1,0.000107,0.00191
Loss of Nlp from mitotic centrosomes,Reactome,9,CKAP5;PLK1;CDK5RAP2;PLK4;NEK2;CEP152;CDK1;PCNT;ODF2,69 (69),0.00101,0.0159,1,HMDB00538,2 (2),0.0147,0.119,0.00018,0.00197
Loss of proteins required for interphase microtubule organization from the centrosome,Reactome,9,CKAP5;PLK1;CDK5RAP2;PLK4;NEK2;CEP152;CDK1;PCNT;ODF2,69 (69),0.00101,0.0159,1,HMDB00538,2 (2),0.0147,0.119,0.00018,0.00197
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,Reactome,4,CCNB1;WEE1;CDC25C;CDK1,13 (13),0.00105,0.0165,1,HMDB00538,2 (2),0.0147,0.119,0.000186,0.00203
Autodegradation of Cdh1 by Cdh1:APC/C,Reactome,6,ANAPC1;FZR1;CDC16;ANAPC15;UBE2C;CDC23,22 (22),0.000117,0.00208,0,,0 (0),1,1,0.000117,0.00208
Cyclin E associated events during G1/S transition ,Reactome,6,CDC25A;WEE1;CKS1B;CDK2;CCNA2;CDK4,29 (29),0.000599,0.00982,1,HMDB00538,4 (4),0.0292,0.138,0.000209,0.00227
Ciliary landscape,Wikipathways,20,NUP88;NUP133;SMC4;NUDC;PSMD7;WEE1;MCM2;MCM3;MCM5;MCM6;LRPPRC;EXOSC9;PSMD13;HDAC1;HDAC2;IQGAP3;MCM10;GLA;DCAF7;EFTUD2,213 (213),0.000142,0.00249,0,,0 (0),1,1,0.000142,0.00249
Pyrimidine nucleotides nucleosides metabolism,INOH,5,NT5C;UCK2;UMPS;ENTPD5;DUT,51 (51),0.0408,0.389,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,54 (56),0.000509,0.0151,0.000245,0.00264
APC/C:Cdc20 mediated degradation of Securin,Reactome,6,ANAPC1;CDC16;ANAPC15;UBE2C;CDC23;CDC20,23 (23),0.000154,0.00268,0,,0 (0),1,1,0.000154,0.00268
Histone Modifications,Wikipathways,10,HIST1H3C;HIST1H3I;EHMT2;HIST1H4D;HIST1H4F;SETD1A;HIST1H3F;SET;SUV39H1;DOT1L,66 (66),0.000154,0.00268,0,,0 (0),1,1,0.000154,0.00268
Proteasome Degradation,Wikipathways,11,PSMC1;H2AFX;H2AFZ;PSMD1;PSMD2;PSMD3;HIST1H2AB;PSMD7;PSME3;PSMD13;PSMD5,64 (64),2.17e-05,0.000429,0,,1 (1),1,1,0.000255,0.00274
miRNA Regulation of DNA Damage Response,Wikipathways,13,RAD51;FANCD2;CDC25C;H2AFX;CDC25A;CCNB1;CCNB2;E2F1;SMC1A;CDK1;CDK2;CDK4;CDK6,89 (89),2.45e-05,0.000482,0,,1 (2),1,1,0.000284,0.00304
Transcriptional Regulation by E2F6,Reactome,6,RAD51;EHMT2;RBBP4;CBX5;E2F1;CDC7,35 (35),0.00169,0.0255,1,HMDB00538,2 (2),0.0147,0.119,0.000288,0.00308
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,Reactome,10,BARD1;H2AFX;HIST1H4D;HIST1H4F;HIST1H2BB;HIST1H2BG;RNF168;HIST1H2BF;HIST1H2BH;BABAM1,76 (77),0.000501,0.00836,1,HMDB00538,7 (7),0.0505,0.173,0.000293,0.00311
Ub-specific processing proteases,Reactome,22,HIST1H2AG;HIST1H2AK;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;HIST1H2BH;USP24;PSMC1;HIST2H2AB;HIST1H2BB;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSME3;PSMD13;CDC20;CDC25A;HIST1H2AH;CCNA2,220 (220),2.56e-05,0.000503,0,,1 (1),1,1,0.000297,0.00314
Metabolism of nucleotides,Reactome,9,TAF9;UCK2;UMPS;NT5C;ATIC;PNP;ENTPD5;DUT;IMPDH2,105 (105),0.0166,0.186,5,HMDB00095;HMDB00285;HMDB00538;HMDB03337;HMDB00082,125 (152),0.00157,0.0381,0.000301,0.00317
TNFalpha,NetPath,21,PSMD2;FANCD2;PSMC1;SMARCA4;SMARCB1;SMARCC1;KPNA2;PSMD1;RPL4;PSMD3;MCM5;LRPPRC;PSMD7;GTF2I;DCAF7;PSMD13;HDAC1;HDAC2;HDAC6;HSP90AB1;PRC1,234 (234),0.000184,0.00319,0,,0 (1),1,1,0.000184,0.00319
phosphatidylethanolamine biosynthesis II,HumanCyc,0,,7 (7),1,1,3,HMDB00095;HMDB00538;HMDB00082,9 (12),2.72e-05,0.00127,0.000313,0.00328
Nucleobase catabolism,Reactome,3,NT5C;PNP;ENTPD5,37 (37),0.159,0.997,5,HMDB00095;HMDB00285;HMDB00538;HMDB03337;HMDB00082,79 (100),0.000185,0.00644,0.000337,0.00352
Pre-NOTCH Expression and Processing,Reactome,1,E2F1,42 (42),0.798,1,3,HMDB00095;HMDB00538;HMDB01176,10 (10),3.86e-05,0.0017,0.000351,0.00365
Golgi Cisternae Pericentriolar Stack Reorganization,Reactome,4,CCNB1;PLK1;CCNB2;CDK1,14 (14),0.00142,0.022,1,HMDB00538,3 (3),0.0219,0.134,0.000355,0.00368
chromatin remodeling by hswi/snf atp-dependent complexes,BioCarta,5,GTF2F1;GTF3A;SMARCA4;SMARCB1;SMARCC1,16 (16),0.00022,0.00379,0,,0 (0),1,1,0.00022,0.00379
Signaling events mediated by HDAC Class I,PID,10,RBBP4;NCOR2;RAN;RANGAP1;NUP62;SMG5;NUP210;HDAC1;HDAC2;NUP214,56 (56),3.64e-05,0.00069,0,,1 (1),1,1,0.000408,0.00421
UTP and CTP <i>de novo</i> biosynthesis,HumanCyc,0,,13 (13),1,1,3,HMDB00285;HMDB00538;HMDB00082,10 (11),3.86e-05,0.0017,0.000431,0.00441
phosphatidylcholine biosynthesis,HumanCyc,0,,7 (7),1,1,3,HMDB00095;HMDB00538;HMDB00082,10 (12),3.86e-05,0.0017,0.000431,0.00441
Centrosome maturation,Reactome,9,CKAP5;PLK1;CDK5RAP2;PLK4;NEK2;CEP152;CDK1;PCNT;ODF2,80 (80),0.00288,0.0415,1,HMDB00538,2 (2),0.0147,0.119,0.000468,0.00478
Metalloprotease DUBs,Reactome,8,BARD1;HIST1H2AG;HIST1H2AK;HIST2H2AB;HIST1H2AC;HIST1H2AB;HIST1H2AH;BABAM1,36 (36),4.28e-05,0.000805,0,,1 (1),1,1,0.000473,0.00481
Apoptotic execution phase,Reactome,7,HIST1H1E;HMGB1;HMGB2;STK26;KPNA1;KPNB1;HIST1H1D,52 (52),0.00302,0.0432,1,HMDB00538,2 (3),0.0147,0.119,0.000489,0.00494
Glycerophospholipid metabolism,EHMN,12,NUP107;SLC38A1;NUP50;NUP133;NUP37;NUP205;NUP62;NUP214;NUP188;NUP210;GLA;NUP88,136 (136),0.00491,0.0672,3,HMDB00095;HMDB00538;HMDB00082,61 (96),0.00917,0.119,0.000495,0.00499
O-linked glycosylation,Wikipathways,0,,0 (0),1,1,3,HMDB00095;HMDB00538;HMDB01176,15 (18),0.000143,0.00514,0.000143,0.00514
Activation of E2F1 target genes at G1/S,Reactome,5,CDC25A;CDT1;E2F1;POLA1;CDK1,17 (17),0.000303,0.00516,0,,0 (0),1,1,0.000303,0.00516
G1/S-Specific Transcription,Reactome,5,CDC25A;CDT1;E2F1;POLA1;CDK1,17 (17),0.000303,0.00516,0,,0 (0),1,1,0.000303,0.00516
tRNA processing in the mitochondrion,Wikipathways,0,,0 (0),1,1,2,HMDB00538;HMDB00082,3 (3),0.000153,0.00539,0.000153,0.00539
Aminosugars metabolism,INOH,0,,20 (20),1,1,4,HMDB00285;HMDB00538;HMDB01176;HMDB00082,30 (32),4.92e-05,0.00212,0.000537,0.00539
Regulation of mRNA stability by proteins that bind AU-rich elements,Reactome,6,EXOSC9;SET;NUP214;KHSRP;EXOSC6;EIF4G1,37 (37),0.00228,0.0335,1,HMDB00538,3 (3),0.0219,0.134,0.000545,0.00545
Termination of O-glycan biosynthesis,Reactome,0,,26 (26),1,1,2,HMDB00095;HMDB01176,2 (2),5.11e-05,0.00218,0.000556,0.00553
Pre-NOTCH Expression and Processing,Wikipathways,0,,5 (5),1,1,3,HMDB00095;HMDB00538;HMDB01176,11 (12),5.29e-05,0.00221,0.000573,0.00569
Nucleobase catabolism,Wikipathways,0,,0 (0),1,1,5,HMDB00095;HMDB03337;HMDB00538;HMDB00285;HMDB00082,77 (100),0.000164,0.00574,0.000164,0.00574
Processive synthesis on the lagging strand,Reactome,4,POLD1;LIG1;RPA1;POLA1,15 (15),0.00189,0.0282,1,HMDB00095,4 (4),0.0292,0.138,0.000594,0.00587
SCF(Skp2)-mediated degradation of p27/p21,Reactome,4,CDK2;CCNA2;CDK4;CKS1B,18 (18),0.00387,0.0539,1,HMDB00538,2 (2),0.0147,0.119,0.000612,0.00602
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,Reactome,2,CCNA2;CDK1,3 (3),0.00407,0.0561,1,HMDB00538,2 (2),0.0147,0.119,0.000641,0.00628
Pyrimidine metabolism - Homo sapiens (human),KEGG,9,UCK2;UMPS;POLA1;POLD1;NT5C;POLE;PNP;ENTPD5;DUT,101 (101),0.0131,0.153,3,HMDB00095;HMDB00285;HMDB00082,48 (66),0.00468,0.09,0.000656,0.00641
Necroptosis - Homo sapiens (human),KEGG,15,IFNGR1;SLC25A5;H2AFX;PPIA;H2AFZ;HIST1H2AG;HMGB1;AIFM1;HIST2H2AB;HIST1H2AC;PGAM5;HIST1H2AH;HIST1H2AB;HIST1H2AK;HSP90AB1,162 (162),0.00109,0.017,1,HMDB00538,8 (10),0.0575,0.186,0.000667,0.00648
Sialuria or French Type Sialuria,SMPDB,0,,17 (17),1,1,4,HMDB00285;HMDB00538;HMDB01176;HMDB00082,32 (32),6.39e-05,0.0025,0.000681,0.00648
Tay-Sachs Disease,SMPDB,0,,17 (17),1,1,4,HMDB00285;HMDB00538;HMDB01176;HMDB00082,32 (32),6.39e-05,0.0025,0.000681,0.00648
Amino Sugar Metabolism,SMPDB,0,,17 (17),1,1,4,HMDB00285;HMDB00538;HMDB01176;HMDB00082,32 (32),6.39e-05,0.0025,0.000681,0.00648
G(M2)-Gangliosidosis: Variant B_ Tay-sachs disease,SMPDB,0,,17 (17),1,1,4,HMDB00285;HMDB00538;HMDB01176;HMDB00082,32 (32),6.39e-05,0.0025,0.000681,0.00648
Salla Disease/Infantile Sialic Acid Storage Disease,SMPDB,0,,17 (17),1,1,4,HMDB00285;HMDB00538;HMDB01176;HMDB00082,32 (32),6.39e-05,0.0025,0.000681,0.00648
Sialuria or French Type Sialuria,SMPDB,0,,17 (17),1,1,4,HMDB00285;HMDB00538;HMDB01176;HMDB00082,32 (32),6.39e-05,0.0025,0.000681,0.00648
Signaling events mediated by HDAC Class II,PID,8,TUBA1B;NCOR2;RAN;RANGAP1;NUP62;NUP214;NUP210;HDAC6,38 (38),6.47e-05,0.00119,0,,1 (1),1,1,0.000689,0.00653
Pyrimidine metabolism,Wikipathways,7,UCK2;UMPS;POLA1;POLD1;NT5C;POLE;DUT,84 (84),0.0372,0.356,3,HMDB00095;HMDB00285;HMDB00082,35 (40),0.00188,0.0443,0.000739,0.00697
CMP-<i>N</i>-acetylneuraminate biosynthesis I (eukaryotes),HumanCyc,0,,4 (4),1,1,3,HMDB00538;HMDB01176;HMDB00082,12 (15),7.02e-05,0.0027,0.000741,0.00697
Formation of tubulin folding intermediates by CCT/TriC,Reactome,5,TUBA1B;CCT2;CCT6A;TCP1;TUBA1C,26 (26),0.00244,0.0355,1,HMDB00538,4 (4),0.0292,0.138,0.00075,0.00702
Leukotriene metabolism,EHMN,12,NUP107;NUP50;ECI2;NUP133;NUP37;ACAA2;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,103 (105),0.000446,0.00751,1,HMDB00538,24 (27),0.163,0.38,0.000767,0.00716
MASTL Facilitates Mitotic Progression,Reactome,3,MASTL;CCNB1;CDK1,10 (10),0.0051,0.0686,1,HMDB00538,2 (2),0.0147,0.119,0.000786,0.00731
Cleavage of Growing Transcript in the Termination Region ,Reactome,7,CPSF2;CSTF2;FIP1L1;SNRPE;NCBP1;DDX39B;SRSF4,67 (67),0.0122,0.144,1,HMDB00538,1 (1),0.00737,0.119,0.000926,0.00855
RNA Polymerase II Transcription Termination,Reactome,7,CPSF2;CSTF2;FIP1L1;SNRPE;NCBP1;DDX39B;SRSF4,67 (67),0.0122,0.144,1,HMDB00538,1 (1),0.00737,0.119,0.000926,0.00855
ATM Signaling Pathway,Wikipathways,5,CCNB1;CDC25A;CDC25C;RAD51;CDK1,19 (19),0.000534,0.00886,0,,0 (0),1,1,0.000534,0.00886
Cellular senescence - Homo sapiens (human),KEGG,17,TGFB1;FOXM1;CDK4;HIPK2;CDC25A;RBBP4;CCNB2;CDK6;RBL1;E2F1;E2F4;CDK2;CDK1;SLC25A5;CCNA2;CCNB1;PPP1CC,160 (160),9.98e-05,0.0018,0,,4 (5),1,1,0.00102,0.00937
Signaling by WNT,Reactome,22,HIST1H3F;HIST1H2AK;AP2S1;BCL9L;HIST1H2AC;HIST1H2AB;HIST1H2BG;HIST1H2BF;PPP2R5D;HIST1H2BH;HIST1H3C;AP2A2;HIST1H3I;HIST1H4D;HIST1H4F;SMARCA4;H2AFX;H2AFZ;LRP5;HIST1H2BB;CTBP1;HDAC1,276 (278),0.000682,0.0111,1,HMDB00538,22 (25),0.151,0.358,0.00105,0.00959
the information processing pathway at the ifn beta enhancer,BioCarta,6,SMARCA4;SMARCB1;SMARCC1;HMGB1;GTF2F1;GTF3A,29 (29),0.000599,0.00982,0,,0 (1),1,1,0.000599,0.00982
Folding of actin by CCT/TriC,Reactome,3,CCT2;CCT6A;TCP1,10 (10),0.0051,0.0686,1,HMDB00538,3 (3),0.0219,0.134,0.00113,0.0103
RNA polymerase II transcribes snRNA genes,Reactome,8,TAF9;INTS2;INTS7;SRRT;NCBP1;GTF2F1;INTS5;INTS1,77 (77),0.00784,0.101,1,HMDB00538,2 (3),0.0147,0.119,0.00116,0.0105
O-linked glycosylation,Reactome,3,GALNT6;B4GALT6;GALNT1,116 (116),0.813,1,3,HMDB00095;HMDB00538;HMDB01176,15 (18),0.000143,0.00514,0.00117,0.0106
DNA Damage Bypass,Reactome,7,RFC5;RPA1;USP1;DDB1;POLD1;POLE;REV1,49 (49),0.00213,0.0316,1,HMDB00538,8 (10),0.0575,0.186,0.00123,0.0111
p73 transcription factor network,PID,10,RAD51;BUB3;PLK1;BUB1;GRAMD4;CDK1;CDK2;CCNA2;CCNB1;CDK6,79 (79),0.000684,0.0111,0,,0 (0),1,1,0.000684,0.0111
Assembly of the pre-replicative complex,Reactome,5,MCM3;MCM2;CDT1;MCM5;MCM6,20 (20),0.000691,0.0112,0,,0 (0),1,1,0.000691,0.0112
One carbon metabolism and related pathways,Wikipathways,0,,52 (52),1,1,4,HMDB03337;HMDB00099;HMDB00267;HMDB00043,38 (42),0.000128,0.00474,0.00127,0.0115
Intra-Golgi and retrograde Golgi-to-ER traffic,Reactome,16,KIF20A;KIF15;COPZ1;CENPE;RACGAP1;M6PR;GALNT1;KIF20B;VPS52;KIF11;KIFC1;KIF22;KIF2C;KIF18B;KIF16B;ZW10,186 (186),0.00164,0.0249,1,HMDB00538,11 (12),0.0783,0.213,0.00128,0.0115
Cap-dependent Translation Initiation,Reactome,12,RPL13A;RPSA;RPL4;EIF4G1;RPS5;RPL9;EIF3B;EIF3C;EIF3D;EIF3I;RPL36A;RPLP0,131 (133),0.00363,0.051,1,HMDB00538,5 (6),0.0363,0.149,0.00131,0.0116
Eukaryotic Translation Initiation,Reactome,12,RPL13A;RPSA;RPL4;EIF4G1;RPS5;RPL9;EIF3B;EIF3C;EIF3D;EIF3I;RPL36A;RPLP0,131 (133),0.00363,0.051,1,HMDB00538,5 (6),0.0363,0.149,0.00131,0.0116
Host Interactions with Influenza Factors,Reactome,4,TGFB1;KPNA1;KPNB1;KPNA2,12 (12),0.000747,0.012,0,,0 (0),1,1,0.000747,0.012
Unwinding of DNA,Reactome,4,MCM2;MCM3;MCM5;MCM6,12 (12),0.000747,0.012,0,,0 (0),1,1,0.000747,0.012
cysteine biosynthesis,HumanCyc,0,,9 (9),1,1,3,HMDB00538;HMDB00099;HMDB00043,15 (16),0.000143,0.00514,0.00141,0.0125
Asparagine N-linked glycosylation,Wikipathways,0,,0 (0),1,1,4,HMDB00538;HMDB00285;HMDB01265;HMDB00082,51 (101),0.000407,0.0127,0.000407,0.0127
mRNA 3_-end processing,Reactome,6,CSTF2;FIP1L1;NCBP1;SRSF4;DDX39B;CPSF2,58 (58),0.0206,0.218,1,HMDB00538,1 (1),0.00737,0.119,0.00149,0.0131
tRNA processing in the mitochondrion,Reactome,0,,1 (1),1,1,2,HMDB00538;HMDB00082,3 (5),0.000153,0.00539,0.00149,0.0132
mucin core 1 and core 2 <i>O</i>-glycosylation,HumanCyc,2,GALNT6;GALNT1,30 (30),0.309,1,2,HMDB00095;HMDB01176,5 (8),0.000504,0.0151,0.00152,0.0134
Sulfur amino acid metabolism,Wikipathways,0,,0 (0),1,1,4,HMDB00538;HMDB03337;HMDB00099;HMDB00043,52 (67),0.000439,0.0136,0.000439,0.0136
Cyclin D associated events in G1,Reactome,6,CKS1B;E2F1;RBL1;E2F4;CDK4;CDK6,44 (44),0.00555,0.0739,1,HMDB00538,4 (4),0.0292,0.138,0.00157,0.0137
G1 Phase,Reactome,6,CKS1B;E2F1;RBL1;E2F4;CDK4;CDK6,44 (44),0.00555,0.0739,1,HMDB00538,4 (4),0.0292,0.138,0.00157,0.0137
Hereditary leiomyomatosis and renal cell carcinoma pathway,Wikipathways,3,ACACA;LDHA;EGLN1,20 (20),0.0368,0.352,2,HMDB00094;HMDB00538,14 (21),0.00441,0.0857,0.00158,0.0137
TP53 Regulates Transcription of Cell Cycle Genes,Wikipathways,3,CDC25C;E2F1;E2F7,13 (13),0.0112,0.137,1,HMDB00538,2 (2),0.0147,0.119,0.00159,0.0138
Recognition of DNA damage by PCNA-containing replication complex,Reactome,6,RFC5;RPA1;USP1;DDB1;POLD1;POLE,31 (31),0.000871,0.0139,0,,0 (0),1,1,0.000871,0.0139
Tumor suppressor activity of SMARCB1,Wikipathways,6,SMARCA4;SMARCB1;SMARCC1;RBBP4;CDK4;CDK6,31 (31),0.000871,0.0139,0,,0 (0),1,1,0.000871,0.0139
Arachidonic acid metabolism,EHMN,10,NUP133;NUP50;NUP107;NUP37;NUP62;NUP214;NUP188;NUP210;NUP205;NUP88,99 (101),0.00382,0.0534,2,HMDB03337;HMDB00538,46 (53),0.0437,0.162,0.00162,0.014
pyrimidine ribonucleosides salvage I,HumanCyc,1,UCK2,4 (4),0.141,0.943,2,HMDB00095;HMDB00538,8 (9),0.00139,0.034,0.00188,0.0161
Global Genome Nucleotide Excision Repair (GG-NER),Reactome,9,RFC5;RPA1;DDB1;POLD1;POLE;SUMO3;CHD1L;LIG1;RAD23B,84 (84),0.00401,0.0555,1,HMDB00538,7 (8),0.0505,0.173,0.00193,0.0163
Polymerase switching,Reactome,3,POLD1;RFC5;POLA1,14 (14),0.0138,0.159,1,HMDB00538,2 (2),0.0147,0.119,0.00193,0.0163
Leading Strand Synthesis,Reactome,3,POLD1;RFC5;POLA1,14 (14),0.0138,0.159,1,HMDB00538,2 (2),0.0147,0.119,0.00193,0.0163
Polymerase switching on the C-strand of the telomere,Reactome,3,POLD1;RFC5;POLA1,14 (14),0.0138,0.159,1,HMDB00538,2 (3),0.0147,0.119,0.00193,0.0163
TP53 Regulates Transcription of DNA Repair Genes,Wikipathways,3,FANCD2;MLH1;FANCI,14 (14),0.0138,0.159,1,HMDB00538,2 (2),0.0147,0.119,0.00193,0.0163
superpathway of pyrimidine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,1,UMPS,15 (15),0.435,1,3,HMDB00285;HMDB00538;HMDB00082,22 (23),0.000469,0.0143,0.00194,0.0163
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,Reactome,5,TUBA1B;CCT2;CCT6A;TCP1;TUBA1C,33 (33),0.0071,0.0915,1,HMDB00538,4 (4),0.0292,0.138,0.00196,0.0165
Interleukin-7 signaling,Reactome,4,HIST1H3F;HIST1H3C;HIST1H3I;SMARCA4,26 (26),0.0149,0.169,1,HMDB00538,2 (2),0.0147,0.119,0.00207,0.0173
Fanconi Anemia Pathway,Reactome,5,FANCD2;EME1;RPA1;USP1;FANCI,40 (41),0.0159,0.179,1,HMDB00538,2 (2),0.0147,0.119,0.00219,0.0183
TGF-beta super family signaling pathway canonical,INOH,12,TGFB1;PSMC1;SMARCA4;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13;HDAC1;HDAC2;HDAC6,115 (115),0.0012,0.0188,0,,0 (0),1,1,0.0012,0.0188
Glycerophospholipid Biosynthetic Pathway,Wikipathways,0,,0 (0),1,1,3,HMDB00095;HMDB00538;HMDB00082,25 (49),0.000691,0.0196,0.000691,0.0196
Proteasome - Homo sapiens (human),KEGG,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD7;PSME3;PSMD13,45 (45),0.00128,0.0199,0,,0 (0),1,1,0.00128,0.0199
Nonsense-Mediated Decay (NMD),Reactome,10,RPL13A;RPSA;RPL4;NCBP1;RPL36A;RPS5;RPL9;UPF1;EIF4G1;RPLP0,117 (118),0.0121,0.144,1,HMDB00538,3 (4),0.0219,0.134,0.00245,0.0203
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),Reactome,10,RPL13A;RPSA;RPL4;NCBP1;RPL36A;RPS5;RPL9;UPF1;EIF4G1;RPLP0,117 (118),0.0121,0.144,1,HMDB00538,3 (4),0.0219,0.134,0.00245,0.0203
basic mechanisms of sumoylation,BioCarta,2,SUMO3;UBA2,6 (6),0.0189,0.205,1,HMDB00538,2 (2),0.0147,0.119,0.00255,0.021
PTK6 Regulates Cell Cycle,Reactome,2,CDK2;CDK4,6 (6),0.0189,0.205,1,HMDB00538,2 (2),0.0147,0.119,0.00255,0.021
SUMO is conjugated to E1 (UBA2:SAE1),Reactome,2,SUMO3;UBA2,5 (5),0.0129,0.151,1,HMDB00538,3 (3),0.0219,0.134,0.0026,0.0213
akap95 role in mitosis and chromosome dynamics,BioCarta,4,PPP2R5D;CCNB1;NCAPD2;CDK1,14 (14),0.00142,0.022,0,,0 (0),1,1,0.00142,0.022
Synthesis of PE,Reactome,0,,14 (14),1,1,3,HMDB00095;HMDB00538;HMDB00082,19 (21),0.000299,0.0101,0.00273,0.0223
Validated targets of C-MYC transcriptional activation,PID,10,TAF9;CDC25A;LDHA;HSPD1;RUVBL2;CCNB1;BIRC5;PTMA;CDK4;EIF4G1,87 (87),0.00146,0.0224,0,,0 (0),1,1,0.00146,0.0224
C-MYB transcription factor network,PID,11,GSTM1;MPO;CCNB1;HIPK2;H2AFZ;TRIM28;ELANE;PRTN3;MYB;MAD1L1;CDK6,85 (85),0.000308,0.00523,0,,2 (2),1,1,0.00279,0.0228
superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,2,UMPS;DUT,22 (22),0.197,1,3,HMDB00285;HMDB00538;HMDB00082,33 (34),0.00158,0.0381,0.00283,0.023
Parkin-Ubiquitin Proteasomal System pathway,Wikipathways,9,PSMC1;TUBA1B;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;TUBA1C;PSMD13,73 (73),0.00152,0.0231,0,,0 (0),1,1,0.00152,0.0231
SLC-mediated transmembrane transport,Reactome,2,SLC38A1;SLCO4A1,244 (245),0.999,1,6,HMDB00094;HMDB00538;HMDB01176;HMDB00043;HMDB00095;HMDB03045,140 (166),0.000318,0.0107,0.00287,0.0233
Glycosaminoglycan metabolism,Wikipathways,0,,0 (0),1,1,3,HMDB00095;HMDB00538;HMDB01176,27 (58),0.000871,0.0234,0.000871,0.0234
Ribosomal scanning and start codon recognition,Reactome,7,RPSA;RPS5;EIF3B;EIF3C;EIF3D;EIF3I;EIF4G1,66 (68),0.0113,0.137,1,HMDB00538,4 (5),0.0292,0.138,0.00296,0.0239
Gamma-glutamyl-transpeptidase deficiency,SMPDB,0,,11 (11),1,1,3,HMDB03337;HMDB00538;HMDB00267,20 (22),0.000351,0.0113,0.00314,0.0249
5-oxoprolinase deficiency,SMPDB,0,,11 (11),1,1,3,HMDB03337;HMDB00538;HMDB00267,20 (22),0.000351,0.0113,0.00314,0.0249
Gamma-Glutamyltransferase Deficiency,SMPDB,0,,11 (11),1,1,3,HMDB03337;HMDB00538;HMDB00267,20 (22),0.000351,0.0113,0.00314,0.0249
Glutathione Metabolism,SMPDB,0,,11 (11),1,1,3,HMDB03337;HMDB00538;HMDB00267,20 (22),0.000351,0.0113,0.00314,0.0249
Glutathione Synthetase Deficiency,SMPDB,0,,11 (11),1,1,3,HMDB03337;HMDB00538;HMDB00267,20 (22),0.000351,0.0113,0.00314,0.0249
5-Oxoprolinuria,SMPDB,0,,11 (11),1,1,3,HMDB03337;HMDB00538;HMDB00267,20 (22),0.000351,0.0113,0.00314,0.0249
Nucleotide excision repair - Homo sapiens (human),KEGG,7,RFC5;RPA1;LIG1;POLD1;POLE;DDB1;RAD23B,47 (47),0.00167,0.0252,0,,0 (0),1,1,0.00167,0.0252
PKMTs methylate histone lysines,Reactome,10,HIST1H3C;HIST1H3I;EHMT2;HIST1H3F;HIST1H4F;SETD1A;RBBP4;HIST1H4D;SUV39H1;DOT1L,73 (73),0.00036,0.0061,0,,2 (2),1,1,0.00321,0.0253
Glycine Serine metabolism,INOH,4,HSD17B12;PSAT1;ALAS1;GATM,41 (41),0.0656,0.573,3,HMDB00099;HMDB00538;HMDB00043,51 (68),0.00556,0.105,0.00325,0.0253
Pyrimidine Metabolism,SMPDB,1,DUT,23 (23),0.583,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,57 (57),0.000627,0.0178,0.00326,0.0253
UMP Synthase Deiciency (Orotic Aciduria),SMPDB,1,DUT,23 (23),0.583,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,57 (57),0.000627,0.0178,0.00326,0.0253
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),SMPDB,1,DUT,23 (23),0.583,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,57 (57),0.000627,0.0178,0.00326,0.0253
Beta Ureidopropionase Deficiency,SMPDB,1,DUT,23 (23),0.583,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,57 (57),0.000627,0.0178,0.00326,0.0253
Dihydropyrimidinase Deficiency,SMPDB,1,DUT,23 (23),0.583,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB00082,57 (57),0.000627,0.0178,0.00326,0.0253
Clearance of Nuclear Envelope Membranes from Chromatin,Reactome,2,TMPO;BANF1,7 (7),0.0258,0.264,1,HMDB00538,2 (2),0.0147,0.119,0.00336,0.026
Processive synthesis on the C-strand of the telomere,Reactome,3,POLD1;LIG1;RPA1,11 (11),0.00682,0.0894,1,HMDB00095,8 (9),0.0575,0.186,0.00347,0.0267
tRNA processing in the nucleus,Wikipathways,0,,0 (0),1,1,2,HMDB00538;HMDB00082,7 (7),0.00105,0.027,0.00105,0.027
Removal of the Flap Intermediate,Reactome,3,POLD1;RPA1;POLA1,14 (14),0.0138,0.159,1,HMDB00095,4 (4),0.0292,0.138,0.00356,0.0273
mets affect on macrophage differentiation,BioCarta,5,HDAC2;NCOR2;RBL1;E2F4;E2F1,18 (18),0.000406,0.00685,0,,2 (2),1,1,0.00358,0.0274
Pantothenate and CoA Biosynthesis,SMPDB,0,,6 (6),1,1,3,HMDB00095;HMDB00538;HMDB00082,21 (21),0.000407,0.0127,0.00358,0.0274
O-Glycan biosynthesis,EHMN,2,GALNT6;GALNT1,37 (37),0.404,1,2,HMDB00095;HMDB01176,7 (17),0.00105,0.027,0.00372,0.0283
KSRP (KHSRP) binds and destabilizes mRNA,Reactome,3,EXOSC9;KHSRP;EXOSC6,16 (16),0.0201,0.215,1,HMDB00538,3 (3),0.0219,0.134,0.00386,0.0293
mRNA surveillance pathway - Homo sapiens (human),KEGG,10,DAZAP1;CSTF2;FIP1L1;NCBP1;DDX39B;PPP2R5D;SMG5;PPP1CC;UPF1;CPSF2,91 (91),0.00205,0.0305,0,,0 (0),1,1,0.00205,0.0305
Synthesis of PC,Reactome,0,,29 (29),1,1,3,HMDB00095;HMDB00538;HMDB00082,22 (28),0.000469,0.0143,0.00407,0.0308
Nucleotide Excision Repair,Reactome,10,RFC5;RPA1;DDB1;PRPF19;POLD1;POLE;SUMO3;CHD1L;LIG1;RAD23B,113 (113),0.00961,0.12,1,HMDB00538,7 (8),0.0505,0.173,0.00419,0.0316
HuR (ELAVL1) binds and stabilizes mRNA,Reactome,2,SET;NUP214,8 (8),0.0335,0.325,1,HMDB00538,2 (2),0.0147,0.119,0.00424,0.0319
3-phosphoinositide biosynthesis,HumanCyc,1,PI4KA,28 (28),0.656,1,2,HMDB00095;HMDB00538,6 (11),0.000753,0.0204,0.00425,0.0319
P2Y receptors,Reactome,0,,12 (12),1,1,2,HMDB00285;HMDB00538,5 (6),0.000504,0.0151,0.00433,0.0323
Pre-NOTCH Processing in Golgi,Reactome,0,,12 (12),1,1,2,HMDB00095;HMDB01176,5 (5),0.000504,0.0151,0.00433,0.0323
3-Phosphoglycerate dehydrogenase deficiency,SMPDB,3,PSAT1;ALAS1;GATM,27 (27),0.078,0.628,3,HMDB00099;HMDB00538;HMDB00043,55 (55),0.00687,0.119,0.00457,0.0333
Non Ketotic Hyperglycinemia,SMPDB,3,PSAT1;ALAS1;GATM,27 (27),0.078,0.628,3,HMDB00099;HMDB00538;HMDB00043,55 (55),0.00687,0.119,0.00457,0.0333
Glycine and Serine Metabolism,SMPDB,3,PSAT1;ALAS1;GATM,27 (27),0.078,0.628,3,HMDB00099;HMDB00538;HMDB00043,55 (55),0.00687,0.119,0.00457,0.0333
Dimethylglycine Dehydrogenase Deficiency,SMPDB,3,PSAT1;ALAS1;GATM,27 (27),0.078,0.628,3,HMDB00099;HMDB00538;HMDB00043,55 (55),0.00687,0.119,0.00457,0.0333
Hyperglycinemia_ non-ketotic,SMPDB,3,PSAT1;ALAS1;GATM,27 (27),0.078,0.628,3,HMDB00099;HMDB00538;HMDB00043,55 (55),0.00687,0.119,0.00457,0.0333
Dimethylglycine Dehydrogenase Deficiency,SMPDB,3,PSAT1;ALAS1;GATM,27 (27),0.078,0.628,3,HMDB00099;HMDB00538;HMDB00043,55 (55),0.00687,0.119,0.00457,0.0333
Sarcosinemia,SMPDB,3,PSAT1;ALAS1;GATM,27 (27),0.078,0.628,3,HMDB00099;HMDB00538;HMDB00043,55 (55),0.00687,0.119,0.00457,0.0333
Dihydropyrimidine Dehydrogenase Deficiency (DHPD),SMPDB,3,PSAT1;ALAS1;GATM,27 (27),0.078,0.628,3,HMDB00099;HMDB00538;HMDB00043,55 (55),0.00687,0.119,0.00457,0.0333
Lamivudine Metabolism Pathway,SMPDB,2,NT5C;ABCC1,18 (18),0.144,0.943,2,HMDB00285;HMDB00538,13 (13),0.0038,0.0765,0.00465,0.0337
Glycosphingolipid biosynthesis - globoseries,EHMN,2,B4GALT6;GLA,18 (18),0.144,0.943,2,HMDB00095;HMDB01176,13 (23),0.0038,0.0765,0.00465,0.0337
HDMs demethylate histones,Reactome,8,HIST1H3C;HIST1H3I;KDM2B;HIST1H3F;HIST1H4F;UTY;HIST1H4D;KDM5D,51 (51),0.000551,0.0091,0,,5 (5),1,1,0.00469,0.0339
DNA Damage/Telomere Stress Induced Senescence,Reactome,4,HIST1H1E;CDK2;CCNA2;HIST1H1D,28 (28),0.0193,0.207,1,HMDB00538,4 (5),0.0292,0.138,0.00477,0.0344
Trans-sulfuration and one carbon metabolism,Wikipathways,4,PSAT1;DNMT1;MTHFD2;MTHFD1L,31 (31),0.0272,0.274,2,HMDB00099;HMDB00043,31 (33),0.0209,0.134,0.00482,0.0346
Translation Factors,Wikipathways,7,EIF5A;CLUH;EIF3B;EIF3C;EIF3D;EIF3I;EIF4G1,50 (50),0.0024,0.0351,0,,0 (0),1,1,0.0024,0.0351
N-Glycan biosynthesis,EHMN,0,,42 (42),1,1,3,HMDB00095;HMDB01176;HMDB00082,24 (51),0.000611,0.0178,0.00513,0.0368
Signaling by TGF-beta Receptor Complex,Reactome,7,TGFB1;STRAP;NCOR2;RBL1;E2F4;HDAC1;PPP1CC,67 (67),0.0122,0.144,1,HMDB00538,7 (7),0.0505,0.173,0.00516,0.0369
polyadenylation of mrna,BioCarta,2,CPSF2;CSTF2,9 (9),0.0421,0.396,1,HMDB00538,2 (2),0.0147,0.119,0.00518,0.0369
Formation of Incision Complex in GG-NER,Reactome,5,DDB1;RPA1;SUMO3;CHD1L;RAD23B,43 (43),0.0213,0.225,1,HMDB00538,4 (4),0.0292,0.138,0.0052,0.0369
O-linked glycosylation of mucins,Reactome,3,GALNT6;B4GALT6;GALNT1,67 (67),0.459,1,2,HMDB00095;HMDB01176,8 (8),0.00139,0.034,0.00535,0.0379
Recruitment of NuMA to mitotic centrosomes,Reactome,9,CKAP5;PLK1;CDK5RAP2;PLK4;NEK2;CEP152;CDK1;PCNT;ODF2,79 (79),0.00264,0.0384,0,,0 (0),1,1,0.00264,0.0384
D-<i>myo</i>-inositol (1_4_5)-trisphosphate biosynthesis,HumanCyc,1,PI4KA,27 (27),0.642,1,2,HMDB00095;HMDB00538,7 (13),0.00105,0.027,0.0056,0.0395
DroToll-like,INOH,8,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13;ESPL1,65 (65),0.00277,0.0401,0,,0 (1),1,1,0.00277,0.0401
RHO GTPases activate CIT,Reactome,3,KIF14;CIT;PRC1,19 (19),0.0321,0.316,1,HMDB00538,3 (3),0.0219,0.134,0.00582,0.041
Recruitment of mitotic centrosome proteins and complexes,Reactome,9,CKAP5;PLK1;CDK5RAP2;PLK4;NEK2;CEP152;CDK1;PCNT;ODF2,80 (80),0.00288,0.0415,0,,0 (0),1,1,0.00288,0.0415
NAD salvage,HumanCyc,0,,4 (4),1,1,2,HMDB00538;HMDB00229,6 (7),0.000753,0.0204,0.00617,0.043
terminal <i>O</i>-glycans residues modification,HumanCyc,0,,12 (12),1,1,2,HMDB00095;HMDB01176,6 (9),0.000753,0.0204,0.00617,0.043
Nucleotide-like (purinergic) receptors,Reactome,0,,16 (16),1,1,2,HMDB00285;HMDB00538,6 (7),0.000753,0.0204,0.00617,0.043
GDP-L-fucose biosynthesis II (from L-fucose),HumanCyc,0,,2 (2),1,1,2,HMDB01265;HMDB00538,6 (8),0.000753,0.0204,0.00617,0.043
mRNA Splicing - Minor Pathway,Reactome,7,SNRNP40;SNRPD1;SNRPE;NCBP1;GTF2F1;SF3B3;EFTUD2,52 (52),0.00302,0.0432,0,,0 (0),1,1,0.00302,0.0432
G1/S DNA Damage Checkpoints,Reactome,3,CDK2;CCNA2;CDC25A,23 (23),0.0526,0.477,1,HMDB00538,2 (2),0.0147,0.119,0.00631,0.0438
Mitochondrial fatty acid synthesis pathway,Wikipathways,2,HSD17B12;ACACA,6 (6),0.0189,0.205,1,HMDB00538,6 (6),0.0434,0.161,0.00665,0.046
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,Reactome,5,POLD1;RFC5;POLE;RPA1;REV1,39 (39),0.0144,0.163,1,HMDB00538,8 (10),0.0575,0.186,0.00669,0.0462
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,Reactome,4,HIPK2;SMARCA4;SMARCB1;SMARCC1,39 (40),0.0564,0.508,1,HMDB00538,2 (2),0.0147,0.119,0.0067,0.0462
Formation of a pool of free 40S subunits,Reactome,11,RPL13A;RPSA;RPL4;RPS5;RPL9;EIF3B;EIF3C;EIF3D;EIF3I;RPL36A;RPLP0,113 (115),0.00329,0.0468,0,,0 (0),1,1,0.00329,0.0468
Trafficking of GluR2-containing AMPA receptors,Reactome,3,AP2A2;GRIA3;AP2S1,17 (17),0.0238,0.248,1,HMDB00538,5 (6),0.0363,0.149,0.00696,0.0478
PCNA-Dependent Long Patch Base Excision Repair,Reactome,5,POLD1;RFC5;POLE;RPA1;LIG1,21 (21),0.000879,0.014,0,,1 (2),1,1,0.00707,0.0484
Processing of Capped Intronless Pre-mRNA,Reactome,5,FIP1L1;SNRPE;NCBP1;CSTF2;CPSF2,28 (28),0.00342,0.0485,0,,0 (0),1,1,0.00342,0.0485
Methionine metabolism and related disorders,Wikipathways,0,,0 (0),1,1,2,HMDB00099;HMDB00043,10 (13),0.00222,0.051,0.00222,0.051
Docetaxel Action Pathway,SMPDB,2,TUBA1B;ABCC1,7 (7),0.0258,0.264,1,HMDB00538,5 (5),0.0363,0.149,0.00747,0.051
Regulation of Telomerase,PID,8,TGFB1;BLM;RBBP4;E2F1;SMG5;PIF1;HDAC1;HDAC2,68 (68),0.00368,0.0517,0,,0 (1),1,1,0.00368,0.0517
Dual incision in TC-NER,Reactome,6,RFC5;RPA1;DDB1;PRPF19;POLD1;POLE,69 (69),0.0435,0.408,1,HMDB00538,3 (3),0.0219,0.134,0.0076,0.0518
Glycosaminoglycan metabolism,Reactome,3,HMMR;B4GALT6;VCAN,119 (119),0.826,1,3,HMDB00095;HMDB00538;HMDB01176,30 (60),0.00119,0.03,0.00781,0.0531
Dual Incision in GG-NER,Reactome,6,RFC5;RPA1;DDB1;POLD1;POLE;CHD1L,41 (41),0.00388,0.054,0,,0 (0),1,1,0.00388,0.054
BARD1 signaling events,PID,5,RAD51;CDK2;FANCD2;BARD1;TOPBP1,29 (29),0.00401,0.0555,0,,0 (0),1,1,0.00401,0.0555
acetyl-CoA biosynthesis from citrate,HumanCyc,0,,1 (1),1,1,2,HMDB00094;HMDB00538,7 (7),0.00105,0.027,0.00825,0.0558
Glycosphingolipid biosynthesis - lactoseries,EHMN,0,,7 (7),1,1,2,HMDB00095;HMDB01176,7 (19),0.00105,0.027,0.00825,0.0558
Interaction between PHLDA1 and AURKA,Reactome,1,AURKA,2 (2),0.0733,0.603,1,HMDB00538,2 (2),0.0147,0.119,0.00843,0.0568
Paclitaxel Action Pathway,SMPDB,2,TUBA1B;ABCC1,7 (7),0.0258,0.264,1,HMDB00538,6 (6),0.0434,0.161,0.00873,0.0587
Processing and activation of SUMO,Reactome,2,SUMO3;UBA2,10 (10),0.0513,0.47,1,HMDB00538,3 (3),0.0219,0.134,0.00877,0.0588
Transport of small molecules,Reactome,12,AP2A2;SLC38A1;SLCO4A1;ATP2A2;ATP13A1;ABCC1;SOAT2;SCARB1;ABCF1;CAND1;LMF2;AP2S1,664 (666),0.999,1,6,HMDB00094;HMDB00538;HMDB01176;HMDB00043;HMDB00095;HMDB03045,177 (226),0.00113,0.029,0.00881,0.0589
Transcription-Coupled Nucleotide Excision Repair (TC-NER),Reactome,7,RFC5;RPA1;DDB1;PRPF19;POLD1;POLE;LIG1,81 (81),0.0314,0.312,1,HMDB00538,5 (6),0.0363,0.149,0.00886,0.0591
arsenate detoxification I (glutaredoxin),HumanCyc,2,PNP;GSTO1,4 (4),0.00794,0.101,1,HMDB03337,21 (24),0.144,0.344,0.0089,0.0593
Keratan sulfate biosynthesis,Reactome,1,B4GALT6,28 (28),0.656,1,2,HMDB00095;HMDB01176,9 (9),0.00178,0.0426,0.00907,0.0602
superpathway of pyrimidine deoxyribonucleoside salvage,HumanCyc,0,,17 (17),1,1,3,HMDB00285;HMDB00538;HMDB00082,30 (31),0.00119,0.03,0.00922,0.0609
pyrimidine deoxyribonucleosides salvage,HumanCyc,0,,5 (5),1,1,3,HMDB00285;HMDB00538;HMDB00082,30 (31),0.00119,0.03,0.00922,0.0609
Processing of Intronless Pre-mRNAs,Reactome,4,CSTF2;FIP1L1;CPSF2;NCBP1,19 (19),0.00476,0.0653,0,,0 (0),1,1,0.00476,0.0653
Lysine degradation,INOH,0,,22 (22),1,1,3,HMDB00094;HMDB00538;HMDB01325,31 (36),0.00131,0.0328,0.01,0.0661
Signaling by NOTCH3,Wikipathways,2,PLXND1;DLGAP5,11 (11),0.0612,0.54,1,HMDB00538,3 (3),0.0219,0.134,0.0102,0.0672
Nucleosome assembly,Reactome,6,RBBP4;HIST1H4F;OIP5;HIST1H4D;CENPT;CENPN,43 (43),0.00495,0.0674,0,,0 (1),1,1,0.00495,0.0674
Deposition of new CENPA-containing nucleosomes at the centromere,Reactome,6,RBBP4;HIST1H4F;OIP5;HIST1H4D;CENPT;CENPN,43 (43),0.00495,0.0674,0,,0 (1),1,1,0.00495,0.0674
Import of palmitoyl-CoA into the mitochondrial matrix,Wikipathways,0,,0 (0),1,1,2,HMDB00094;HMDB00538,12 (13),0.00323,0.0676,0.00323,0.0676
NS1 Mediated Effects on Host Pathways,Reactome,3,KPNA1;KPNB1;KPNA2,10 (10),0.0051,0.0686,0,,0 (0),1,1,0.0051,0.0686
Integration of provirus,Reactome,3,KPNA1;PPIA;BANF1,10 (10),0.0051,0.0686,0,,0 (0),1,1,0.0051,0.0686
Synthesis of PI,Reactome,0,,5 (5),1,1,2,HMDB00095;HMDB00082,8 (10),0.00139,0.034,0.0106,0.069
Glycosphingolipid biosynthesis - neolactoseries,EHMN,0,,16 (16),1,1,2,HMDB00095;HMDB01176,8 (48),0.00139,0.034,0.0106,0.069
Ubiquitin mediated proteolysis - Homo sapiens (human),KEGG,12,UBA2;DDB1;PRPF19;FZR1;CDC16;FBXW8;CDC23;UBE2C;UBE3C;TRIM37;ANAPC1;CDC20,137 (137),0.0052,0.0698,0,,0 (0),1,1,0.0052,0.0698
NOTCH1 Intracellular Domain Regulates Transcription,Reactome,4,HDAC1;HDAC2;NCOR2;HDAC6,47 (47),0.0974,0.745,1,HMDB00538,2 (2),0.0147,0.119,0.0108,0.0704
Human T-cell leukemia virus 1 infection - Homo sapiens (human),KEGG,18,TGFB1;BUB3;CDK4;SLC25A5;CCNB2;ANAPC1;ESPL1;RAN;E2F1;CDC16;CANX;CDC23;MAD2L1;CDK2;CCNA2;MAD1L1;BUB1B;CDC20,219 (219),0.00145,0.0223,0,,5 (5),1,1,0.0109,0.071
ATM Signaling Network in Development and Disease,Wikipathways,7,H2AFX;TRIM28;SMC1A;CDK1;BUB1;AURKB;RNF168,46 (46),0.00146,0.0224,0,,1 (1),1,1,0.011,0.0714
Removal of the Flap Intermediate from the C-strand,Reactome,2,POLD1;RPA1,10 (10),0.0513,0.47,1,HMDB00095,4 (5),0.0292,0.138,0.0112,0.0726
TP53 Regulates Transcription of DNA Repair Genes,Reactome,5,FANCD2;GTF2F1;MLH1;SSRP1;FANCI,67 (70),0.105,0.78,1,HMDB00538,2 (2),0.0147,0.119,0.0115,0.0741
Interleukin-1 family signaling,Wikipathways,2,PTPN7;PTPN9,15 (15),0.106,0.78,1,HMDB00538,2 (4),0.0147,0.119,0.0116,0.0748
Joubert syndrome,SMPDB,1,PI4KA,23 (23),0.583,1,2,HMDB00095;HMDB00538,11 (11),0.0027,0.0611,0.0117,0.0752
Phosphatidylinositol Phosphate Metabolism,SMPDB,1,PI4KA,23 (23),0.583,1,2,HMDB00095;HMDB00538,11 (11),0.0027,0.0611,0.0117,0.0752
MET activates STAT3,Reactome,1,MET,3 (3),0.108,0.78,1,HMDB00538,2 (2),0.0147,0.119,0.0118,0.0753
Glycerophospholipid biosynthesis,Wikipathways,0,,0 (0),1,1,3,HMDB00095;HMDB00538;HMDB00082,44 (94),0.00365,0.076,0.00365,0.076
S Phase,Wikipathways,1,CDC25A,1 (1),0.0373,0.356,1,HMDB00538,6 (6),0.0434,0.161,0.012,0.0767
Neddylation,Reactome,14,CCNF;PSMC1;PSMD2;DDB1;PSMD1;BIRC5;PSMD3;PSMD5;PSMD7;FBXW8;PSME3;PSMD13;CAND1;DCAF7,234 (235),0.056,0.507,1,HMDB00538,4 (4),0.0292,0.138,0.0121,0.077
Organelle biogenesis and maintenance,Reactome,16,CKAP5;PLK1;HDAC6;TCP1;ALAS1;KIF24;CDK5RAP2;PLK4;HCFC1;NEK2;CCT2;CEP152;CDK1;PCNT;ODF2;TFAM,240 (240),0.0181,0.201,1,HMDB00538,13 (14),0.0919,0.241,0.0123,0.0774
Resolution of AP sites via the multiple-nucleotide patch replacement pathway,Reactome,5,POLD1;RFC5;POLE;RPA1;LIG1,24 (24),0.00167,0.0253,0,,5 (6),1,1,0.0124,0.0774
Oncogene Induced Senescence,Reactome,3,CDK4;CDK6;E2F1,32 (32),0.116,0.83,1,HMDB00538,2 (2),0.0147,0.119,0.0125,0.0774
Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism_ cblG complementation type,SMPDB,1,DNMT1,20 (20),0.533,1,3,HMDB00538;HMDB00099;HMDB00043,42 (42),0.00319,0.0676,0.0125,0.0774
S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,SMPDB,1,DNMT1,20 (20),0.533,1,3,HMDB00538;HMDB00099;HMDB00043,42 (42),0.00319,0.0676,0.0125,0.0774
Methionine Metabolism,SMPDB,1,DNMT1,20 (20),0.533,1,3,HMDB00538;HMDB00099;HMDB00043,42 (42),0.00319,0.0676,0.0125,0.0774
Methionine Adenosyltransferase Deficiency,SMPDB,1,DNMT1,20 (20),0.533,1,3,HMDB00538;HMDB00099;HMDB00043,42 (42),0.00319,0.0676,0.0125,0.0774
Glycine N-methyltransferase Deficiency,SMPDB,1,DNMT1,20 (20),0.533,1,3,HMDB00538;HMDB00099;HMDB00043,42 (42),0.00319,0.0676,0.0125,0.0774
Hypermethioninemia,SMPDB,1,DNMT1,20 (20),0.533,1,3,HMDB00538;HMDB00099;HMDB00043,42 (42),0.00319,0.0676,0.0125,0.0774
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMPDB,1,DNMT1,20 (20),0.533,1,3,HMDB00538;HMDB00099;HMDB00043,42 (42),0.00319,0.0676,0.0125,0.0774
Cystathionine Beta-Synthase Deficiency,SMPDB,1,DNMT1,20 (20),0.533,1,3,HMDB00538;HMDB00099;HMDB00043,42 (42),0.00319,0.0676,0.0125,0.0774
Methionine Cysteine metabolism,INOH,1,LDHA,25 (25),0.614,1,3,HMDB00099;HMDB00538;HMDB00043,40 (45),0.00277,0.062,0.0126,0.0774
Glutathione metabolism,Wikipathways,1,GSTM1,20 (20),0.533,1,2,HMDB03337;HMDB00267,12 (19),0.00323,0.0676,0.0127,0.078
superpathway of methionine degradation,HumanCyc,0,,20 (20),1,1,3,HMDB00538;HMDB00099;HMDB00043,34 (36),0.00173,0.0414,0.0127,0.078
Vincristine Action Pathway,SMPDB,2,TUBA1B;ABCC1,10 (10),0.0513,0.47,1,HMDB00538,5 (5),0.0363,0.149,0.0136,0.0829
Vindesine Action Pathway,SMPDB,2,TUBA1B;ABCC1,10 (10),0.0513,0.47,1,HMDB00538,5 (5),0.0363,0.149,0.0136,0.0829
Early Phase of HIV Life Cycle,Reactome,4,LIG1;KPNA1;PPIA;BANF1,15 (15),0.00189,0.0282,0,,1 (2),1,1,0.0137,0.0836
how progesterone initiates the oocyte maturation,BioCarta,3,CCNB1;CDC25C;CDK1,23 (23),0.0526,0.477,1,HMDB00538,5 (5),0.0363,0.149,0.0139,0.0841
Galactose metabolism,EHMN,2,PFKL;GLA,44 (44),0.493,1,3,HMDB00285;HMDB00538;HMDB00082,45 (48),0.00389,0.078,0.0139,0.0841
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,Reactome,2,EXOSC9;EXOSC6,17 (17),0.131,0.915,1,HMDB00538,2 (2),0.0147,0.119,0.0139,0.0841
Tristetraprolin (TTP_ ZFP36) binds and destabilizes mRNA,Reactome,2,EXOSC9;EXOSC6,17 (17),0.131,0.915,1,HMDB00538,2 (2),0.0147,0.119,0.0139,0.0841
sumoylation as a mechanism to modulate ctbp-dependent gene responses,BioCarta,1,CTBP1,8 (8),0.262,1,1,HMDB00538,1 (1),0.00737,0.119,0.014,0.0844
Gap-filling DNA repair synthesis and ligation in GG-NER,Reactome,5,POLD1;RFC5;POLE;RPA1;LIG1,25 (25),0.00203,0.0302,0,,1 (2),1,1,0.0146,0.0878
superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle,HumanCyc,4,DLAT;PFKL;OGDH;TPI1,47 (48),0.0974,0.745,2,HMDB00094;HMDB00538,31 (36),0.0209,0.134,0.0147,0.088
Chaperonin-mediated protein folding,Reactome,7,NOP56;TCP1;TUBA1B;CCT6A;CCT2;TUBA1C;DCAF7,97 (97),0.0705,0.603,1,HMDB00538,4 (6),0.0292,0.138,0.0148,0.0883
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,Reactome,1,CDK2,4 (4),0.141,0.943,1,HMDB00538,2 (2),0.0147,0.119,0.0149,0.0883
TGFBR1 KD Mutants in Cancer,Reactome,1,TGFB1,4 (4),0.141,0.943,1,HMDB00538,2 (2),0.0147,0.119,0.0149,0.0883
Loss of Function of TGFBR1 in Cancer,Reactome,1,TGFB1,4 (4),0.141,0.943,1,HMDB00538,2 (2),0.0147,0.119,0.0149,0.0883
Nucleotide Excision Repair ,SMPDB,3,POLE;PAPD7;LIG1,11 (11),0.00682,0.0894,0,,0 (0),1,1,0.00682,0.0894
Regulation of Microtubule Cytoskeleton,Wikipathways,6,MAP1B;AURKB;SPRED1;STMN1;CDK1;KIF2C,46 (46),0.00692,0.09,0,,0 (0),1,1,0.00692,0.09
cell cycle: g2/m checkpoint,BioCarta,4,PI4KA;CCNB1;WEE1;CDK1,21 (21),0.00692,0.09,0,,0 (0),1,1,0.00692,0.09
L13a-mediated translational silencing of Ceruloplasmin expression,Reactome,12,RPL13A;RPSA;RPL4;EIF4G1;RPS5;RPL9;EIF3B;EIF3C;EIF3D;EIF3I;RPL36A;RPLP0,123 (125),0.00215,0.0317,0,,1 (1),1,1,0.0153,0.0908
Base excision repair - Homo sapiens (human),KEGG,5,POLD1;LIG1;HMGB1;POLE;NEIL3,33 (33),0.0071,0.0915,0,,0 (0),1,1,0.0071,0.0915
Sulfation Biotransformation Reaction,Wikipathways,0,,17 (17),1,1,2,HMDB03337;HMDB00538,10 (10),0.00222,0.051,0.0158,0.0927
Synthesis of PG,Reactome,0,,9 (9),1,1,2,HMDB00095;HMDB00082,10 (13),0.00222,0.051,0.0158,0.0927
methionine degradation,HumanCyc,0,,6 (6),1,1,2,HMDB00538;HMDB00043,10 (11),0.00222,0.051,0.0158,0.0927
Vinorelbine Action Pathway,SMPDB,2,TUBA1B;ABCC1,11 (11),0.0612,0.54,1,HMDB00538,5 (6),0.0363,0.149,0.0158,0.0927
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,Reactome,4,HDAC1;E2F4;NCOR2;RBL1,38 (38),0.0521,0.475,1,HMDB00538,6 (6),0.0434,0.161,0.016,0.0937
Translation,Reactome,20,MRPS31;RPL13A;RPL36A;GFM1;RPS5;MRPL12;FARSA;SRP72;RPL4;MRPL2;RPSA;TUFM;RPL9;EIF3B;EIF3C;EIF3D;EIF3I;EIF4G1;TARS2;RPLP0,307 (310),0.0113,0.137,1,HMDB00538,30 (78),0.2,0.449,0.016,0.0937
HSP90 chaperone cycle for steroid hormone receptors (SHR),Reactome,3,FKBP4;STIP1;HSP90AB1,19 (19),0.0321,0.316,1,HMDB00538,10 (11),0.0714,0.205,0.0162,0.0945
GTP hydrolysis and joining of the 60S ribosomal subunit,Reactome,12,RPL13A;RPSA;RPL4;EIF4G1;RPS5;RPL9;EIF3B;EIF3C;EIF3D;EIF3I;RPL36A;RPLP0,124 (126),0.0023,0.0337,0,,3 (4),1,1,0.0163,0.0946
Keratan sulfate/keratin metabolism,Reactome,1,B4GALT6,33 (33),0.715,1,2,HMDB00095;HMDB01176,12 (18),0.00323,0.0676,0.0163,0.0947
Optineurin and Myosin Phosphatase Negatively Regulate PLK1,Reactome,1,PLK1,3 (3),0.108,0.78,1,HMDB00538,3 (3),0.0219,0.134,0.0167,0.0965
Glycogen metabolism,Wikipathways,0,,0 (0),1,1,2,HMDB00285;HMDB00538,15 (16),0.00507,0.0967,0.00507,0.0967
Transport of bile salts and organic acids_ metal ions and amine compounds,Wikipathways,0,,0 (0),1,1,3,HMDB00094;HMDB03045;HMDB00043,50 (77),0.00525,0.0993,0.00525,0.0993
IL-1 JNK,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,62 (62),0.00807,0.102,0,,0 (0),1,1,0.00807,0.102
E2F mediated regulation of DNA replication,Reactome,4,CCNB1;E2F1;POLA1;CDK1,22 (22),0.00822,0.104,0,,0 (0),1,1,0.00822,0.104
Degradation of beta-catenin by the destruction complex,Reactome,3,PPP2R5D;HDAC1;CTBP1,39 (39),0.177,1,1,HMDB00538,2 (2),0.0147,0.119,0.0181,0.104
Protein folding,Reactome,7,NOP56;TCP1;TUBA1B;CCT6A;CCT2;TUBA1C;DCAF7,103 (103),0.0904,0.699,1,HMDB00538,4 (6),0.0292,0.138,0.0183,0.105
Vinblastine Action Pathway,SMPDB,2,TUBA1B;ABCC1,11 (11),0.0612,0.54,1,HMDB00538,6 (6),0.0434,0.161,0.0184,0.106
Apoptosis,Reactome,8,HIST1H1E;HMGB1;HMGB2;E2F1;STK26;KPNA1;KPNB1;HIST1H1D,118 (118),0.0742,0.609,1,HMDB00538,5 (6),0.0363,0.149,0.0186,0.106
p53-Dependent G1 DNA Damage Response,Reactome,2,CDK2;CCNA2,21 (21),0.184,1,1,HMDB00538,2 (2),0.0147,0.119,0.0187,0.106
p53-Dependent G1/S DNA damage checkpoint,Reactome,2,CDK2;CCNA2,21 (21),0.184,1,1,HMDB00538,2 (2),0.0147,0.119,0.0187,0.106
CDP-diacylglycerol biosynthesis,HumanCyc,0,,22 (22),1,1,2,HMDB00538;HMDB00082,11 (19),0.0027,0.0611,0.0187,0.106
Iron uptake and transport,Wikipathways,0,,0 (0),1,1,2,HMDB00094;HMDB00538,16 (20),0.00577,0.107,0.00577,0.107
Rett syndrome causing genes,Wikipathways,6,SMARCA4;NCOR2;SMC1A;HTT;HDAC1;IMPDH2,48 (48),0.00852,0.107,0,,0 (0),1,1,0.00852,0.107
Phase II - Conjugation of compounds,Wikipathways,0,,0 (0),1,1,4,HMDB03337;HMDB00538;HMDB00285;HMDB00267,104 (151),0.00588,0.108,0.00588,0.108
Glutathione metabolism - Homo sapiens (human),KEGG,3,GSTM1;TXNDC12;GSTO1,56 (56),0.348,1,2,HMDB03337;HMDB00267,19 (38),0.00811,0.119,0.0194,0.11
Metabolism,Reactome,68,GSTM1;CYC1;SGPP1;ACAD9;NUP50;ABCC1;NCOR2;RAN;PSAT1;LRPPRC;OCRL;NUP188;PPP2R5D;GATM;NDC1;NUP37;NUDT3;IMPDH2;MLX;NUP107;KPNB1;SLC25A5;PI4KA;RPL36A;MTHFD2;MTHFD1L;GLA;ESYT1;RPS5;VCAN;NUP210;ACACA;ENTPD5;DUT;NUP88;SREBF1;NUP133;AHR;ATIC;HSD17B12;DLAT;UCK2;UMPS;RPSA;ALAS1;NUP62;NUP214;ECI2;UQCRC1;HMMR;PFKL;PGP;TAF9;RPL13A;LDHA;GSTO1;ACAA2;RPLP0;OGDH;RPL4;NUP205;NT5C;B4GALT6;RPL9;PNP;PPP1CC;HSP90AB1;TPI1,1960 (1972),0.766,1,12,HMDB00094;HMDB00201;HMDB00285;HMDB00082;HMDB00538;HMDB00099;HMDB01176;HMDB00043;HMDB00095;HMDB01325;HMDB03337;HMDB00267,829 (1384),0.00375,0.0765,0.0197,0.112
One Carbon Metabolism,Wikipathways,4,DNMT1;MTHFD2;MTHFD1L;ATIC,28 (28),0.0193,0.207,1,HMDB00043,22 (25),0.151,0.358,0.0199,0.113
SMAD2/3 MH2 Domain Mutants in Cancer,Reactome,1,TGFB1,6 (6),0.204,1,1,HMDB00538,2 (2),0.0147,0.119,0.0204,0.115
Loss of Function of SMAD2/3 in Cancer,Reactome,1,TGFB1,6 (6),0.204,1,1,HMDB00538,2 (2),0.0147,0.119,0.0204,0.115
Fructose intolerance_ hereditary,SMPDB,2,PFKL;TPI1,18 (18),0.144,0.943,2,HMDB01265;HMDB00538,31 (31),0.0209,0.134,0.0205,0.115
Fructose and Mannose Degradation,SMPDB,2,PFKL;TPI1,18 (18),0.144,0.943,2,HMDB01265;HMDB00538,31 (31),0.0209,0.134,0.0205,0.115
Fructosuria,SMPDB,2,PFKL;TPI1,18 (18),0.144,0.943,2,HMDB01265;HMDB00538,31 (31),0.0209,0.134,0.0205,0.115
Depolymerisation of the Nuclear Lamina,Reactome,2,CCNB1;CDK1,11 (11),0.0612,0.54,1,HMDB00538,7 (7),0.0505,0.173,0.021,0.116
WNT5A-dependent internalization of FZD4,Reactome,2,AP2A2;AP2S1,15 (15),0.106,0.78,1,HMDB00538,4 (5),0.0292,0.138,0.021,0.116
Signaling by NOTCH1 in Cancer,Reactome,4,HDAC1;HDAC2;NCOR2;HDAC6,54 (54),0.142,0.943,1,HMDB00538,3 (3),0.0219,0.134,0.0211,0.116
Constitutive Signaling by NOTCH1 PEST Domain Mutants,Reactome,4,HDAC1;HDAC2;NCOR2;HDAC6,54 (54),0.142,0.943,1,HMDB00538,3 (3),0.0219,0.134,0.0211,0.116
Signaling by NOTCH1 PEST Domain Mutants in Cancer,Reactome,4,HDAC1;HDAC2;NCOR2;HDAC6,54 (54),0.142,0.943,1,HMDB00538,3 (3),0.0219,0.134,0.0211,0.116
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,Reactome,4,HDAC1;HDAC2;NCOR2;HDAC6,54 (54),0.142,0.943,1,HMDB00538,3 (3),0.0219,0.134,0.0211,0.116
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,Reactome,4,HDAC1;HDAC2;NCOR2;HDAC6,54 (54),0.142,0.943,1,HMDB00538,3 (3),0.0219,0.134,0.0211,0.116
Nicotinate Nicotinamide metabolism,INOH,2,NT5C;PNP,23 (24),0.211,1,2,HMDB00538;HMDB00229,26 (26),0.015,0.121,0.0214,0.117
UDP-<i>N</i>-acetyl-D-galactosamine biosynthesis II,HumanCyc,0,,9 (9),1,1,2,HMDB00285;HMDB00538,12 (16),0.00323,0.0676,0.0217,0.119
GDP-fucose biosynthesis,Reactome,0,,6 (6),1,1,2,HMDB01265;HMDB00538,12 (15),0.00323,0.0676,0.0217,0.119
Detoxification of Reactive Oxygen Species,Wikipathways,0,,0 (0),1,1,2,HMDB03337;HMDB00538,22 (26),0.0108,0.119,0.0108,0.119
Interleukin-15 signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Regulation of DNA replication,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Post-translational protein phosphorylation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Trafficking and processing of endosomal TLR,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0147,0.119
NIK---noncanonical NF-kB signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Signaling by BMP,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Interleukin-3_ Interleukin-5 and GM-CSF signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Interleukin-9 signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Signaling by Leptin,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Signaling by NODAL,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Apoptotic execution phase,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Signal regulatory protein family interactions,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Nephrin family interactions,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Gap junction trafficking and regulation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Signaling by Hippo,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Meiotic synapsis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Interleukin-2 family signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Mitotic Telophase-Cytokinesis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (7),0.0147,0.119,0.0147,0.119
Signaling by Activin,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
MAP kinase activation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (4),0.0147,0.119,0.0147,0.119
MyD88 cascade initiated on plasma membrane,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Caspase activation via Dependence Receptors in the absence of ligand,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Unfolded Protein Response (UPR),Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Mitophagy,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Kinesins,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Reelin signalling pathway,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
RET signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Interleukin-6 family signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0147,0.119
Genotoxicity pathway,Wikipathways,7,HIST1H1E;CENPE;E2F7;HIST1H2BB;HIST1H2BG;E2F8;TM7SF3,64 (64),0.00957,0.12,0,,0 (0),1,1,0.00957,0.12
IL-1 NFkB,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,64 (64),0.00957,0.12,0,,0 (0),1,1,0.00957,0.12
Anchoring of the basal body to the plasma membrane,Reactome,10,CKAP5;PLK1;KIF24;CDK5RAP2;PLK4;NEK2;CEP152;CDK1;PCNT;ODF2,97 (97),0.00329,0.0468,0,,2 (2),1,1,0.0221,0.121
The oncogenic action of Succinate,SMPDB,3,DLAT;EGLN1;OGDH,31 (31),0.108,0.78,2,HMDB00094;HMDB00538,38 (41),0.0307,0.144,0.0222,0.121
pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,1,DUT,16 (16),0.456,1,2,HMDB00538;HMDB00082,18 (19),0.00729,0.119,0.0223,0.121
TGF-beta receptor signaling activates SMADs,Reactome,3,TGFB1;STRAP;PPP1CC,32 (32),0.116,0.83,1,HMDB00538,4 (4),0.0292,0.138,0.0226,0.123
Transcriptional activation of mitochondrial biogenesis,Reactome,3,ALAS1;HCFC1;TFAM,27 (27),0.078,0.628,1,HMDB00538,6 (7),0.0434,0.161,0.0227,0.123
Signaling by TGF-beta family members,Reactome,7,TGFB1;STRAP;NCOR2;RBL1;E2F4;HDAC1;PPP1CC,96 (96),0.0674,0.588,1,HMDB00538,7 (7),0.0505,0.173,0.0228,0.123
Ubiquitin-dependent degradation of Cyclin D1,Reactome,1,CDK4,7 (7),0.234,1,1,HMDB00538,2 (2),0.0147,0.119,0.0229,0.123
Ubiquitin-dependent degradation of Cyclin D,Reactome,1,CDK4,7 (7),0.234,1,1,HMDB00538,2 (2),0.0147,0.119,0.0229,0.123
Signaling by TGF-beta Receptor Complex in Cancer,Reactome,1,TGFB1,7 (7),0.234,1,1,HMDB00538,2 (2),0.0147,0.119,0.0229,0.123
The oncogenic action of Fumarate,SMPDB,3,DLAT;EGLN1;OGDH,31 (31),0.108,0.78,2,HMDB00094;HMDB00538,39 (42),0.0323,0.149,0.0231,0.124
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,Reactome,2,E2F4;RBL1,25 (25),0.239,1,1,HMDB00538,2 (2),0.0147,0.119,0.0234,0.125
Programmed Cell Death,Reactome,8,HIST1H1E;HMGB1;HMGB2;E2F1;STK26;KPNA1;KPNB1;HIST1H1D,121 (121),0.0831,0.656,1,HMDB00538,6 (10),0.0434,0.161,0.0239,0.128
Photodynamic therapy-induced HIF-1 survival signaling,Wikipathways,5,LDHA;EGLN1;PFKL;BIRC5;NOS2,36 (36),0.0103,0.128,0,,0 (0),1,1,0.0103,0.128
ascorbate recycling (cytosolic),HumanCyc,1,GSTO1,2 (2),0.0733,0.603,1,HMDB03337,7 (10),0.0505,0.173,0.0244,0.13
Glutathione conjugation,Reactome,2,GSTM1;GSTO1,38 (39),0.417,1,2,HMDB00538;HMDB00267,20 (31),0.00898,0.119,0.0247,0.13
Glucuronidation,Wikipathways,0,,26 (26),1,1,2,HMDB00285;HMDB00538,13 (14),0.0038,0.0765,0.025,0.13
Glutathione synthesis and recycling,Reactome,0,,14 (15),1,1,2,HMDB00538;HMDB00267,13 (14),0.0038,0.0765,0.025,0.13
Import of palmitoyl-CoA into the mitochondrial matrix,Reactome,0,,13 (13),1,1,2,HMDB00094;HMDB00538,13 (14),0.0038,0.0765,0.025,0.13
Transport of nucleotide sugars,Reactome,0,,9 (9),1,1,2,HMDB00095;HMDB01176,13 (13),0.0038,0.0765,0.025,0.13
Pyruvate dehydrogenase deficiency (E3),SMPDB,2,DLAT;OGDH,21 (21),0.184,1,2,HMDB00094;HMDB00538,31 (33),0.0209,0.134,0.0253,0.13
2-ketoglutarate dehydrogenase complex deficiency,SMPDB,2,DLAT;OGDH,21 (21),0.184,1,2,HMDB00094;HMDB00538,31 (33),0.0209,0.134,0.0253,0.13
Mitochondrial complex II deficiency,SMPDB,2,DLAT;OGDH,21 (21),0.184,1,2,HMDB00094;HMDB00538,31 (33),0.0209,0.134,0.0253,0.13
Fumarase deficiency,SMPDB,2,DLAT;OGDH,21 (21),0.184,1,2,HMDB00094;HMDB00538,31 (33),0.0209,0.134,0.0253,0.13
Congenital lactic acidosis,SMPDB,2,DLAT;OGDH,21 (21),0.184,1,2,HMDB00094;HMDB00538,31 (33),0.0209,0.134,0.0253,0.13
Citric Acid Cycle,SMPDB,2,DLAT;OGDH,21 (21),0.184,1,2,HMDB00094;HMDB00538,31 (33),0.0209,0.134,0.0253,0.13
Pyruvate dehydrogenase deficiency (E2),SMPDB,2,DLAT;OGDH,21 (21),0.184,1,2,HMDB00094;HMDB00538,31 (33),0.0209,0.134,0.0253,0.13
p53-Independent DNA Damage Response,Reactome,1,CDC25A,8 (8),0.262,1,1,HMDB00538,2 (2),0.0147,0.119,0.0253,0.13
p53-Independent G1/S DNA damage checkpoint,Reactome,1,CDC25A,8 (8),0.262,1,1,HMDB00538,2 (2),0.0147,0.119,0.0253,0.13
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,Reactome,1,CDC25A,8 (8),0.262,1,1,HMDB00538,2 (2),0.0147,0.119,0.0253,0.13
Formation of HIV-1 elongation complex containing HIV-1 Tat,Reactome,3,GTF2F1;SSRP1;NCBP1,48 (50),0.266,1,1,HMDB00538,2 (2),0.0147,0.119,0.0256,0.132
Trafficking of AMPA receptors,Reactome,3,AP2A2;GRIA3;AP2S1,31 (31),0.108,0.78,1,HMDB00538,5 (6),0.0363,0.149,0.0256,0.132
Fatty acyl-CoA biosynthesis,Wikipathways,0,,0 (0),1,1,2,HMDB00094;HMDB00538,29 (42),0.0185,0.134,0.0185,0.134
Peroxisomal protein import,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
DNA Replication Pre-Initiation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
M-G1 Transition,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Regulation of mRNA stability by proteins that bind AU-rich elements,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Toll Like Receptor 3 (TLR3) Cascade,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Regulation of TP53 Activity through Phosphorylation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
MyD88 dependent cascade initiated on endosome,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Fanconi Anemia Pathway,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.0219,0.134
Regulated Necrosis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (5),0.0219,0.134,0.0219,0.134
MyD88-MAL(TIRAP) cascade initiated on plasma membrane,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (8),0.0219,0.134,0.0219,0.134
Rilpivirine Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.0219,0.134
Processing of Capped Intron-Containing Pre-mRNA,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Myogenesis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Nonsense-Mediated Decay (NMD),Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
MyD88-independent TLR4 cascade,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Potassium Channels,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.0219,0.134
ISG15 antiviral mechanism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Prolactin receptor signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
SUMOylation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Signaling by MST1,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
RHO GTPases activate CIT,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
TNF signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Deubiquitination,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (6),0.0219,0.134,0.0219,0.134
Protein ubiquitination,Wikipathways,0,,0 (0),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.0219,0.134
Pyrimidine salvage,Reactome,1,UCK2,11 (11),0.342,1,2,HMDB00095;HMDB00538,23 (23),0.0118,0.119,0.0263,0.135
regulation of p27 phosphorylation during cell cycle progression,BioCarta,3,CDK2;CKS1B;E2F1,13 (13),0.0112,0.137,0,,0 (0),1,1,0.0112,0.137
p53 signaling pathway,BioCarta,3,CDK2;CDK4;E2F1,13 (13),0.0112,0.137,0,,0 (0),1,1,0.0112,0.137
Homologous recombination,Wikipathways,3,POLD1;RAD51;RPA1,13 (13),0.0112,0.137,0,,0 (0),1,1,0.0112,0.137
IL-1 p38,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,66 (66),0.0113,0.137,0,,0 (0),1,1,0.0113,0.137
Glycerophospholipid biosynthesis,Reactome,0,,133 (133),1,1,3,HMDB00095;HMDB00538;HMDB00082,46 (93),0.00414,0.0827,0.0269,0.138
Glucose metabolism,Wikipathways,0,,0 (0),1,1,2,HMDB00094;HMDB00538,35 (43),0.0263,0.138,0.0263,0.138
G-protein beta-gamma signalling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (6),0.0292,0.138,0.0292,0.138
OAS antiviral response,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.0292,0.138
Methylhistidine Metabolism,SMPDB,0,,0 (0),1,1,1,HMDB00001#HMDB00479,4 (4),0.0292,0.138,0.0292,0.138
Stavudine Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Tenofovir  Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Adefovir Dipivoxil  Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Didanosine Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Lamivudine  Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Emtricitabine Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Smooth Muscle Contraction,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
RAB GEFs exchange GTP for GDP on RABs,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Mitochondrial protein import,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Gastrin-CREB signalling pathway via PKC and MAPK,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.0292,0.138
RAF-independent MAPK1-3 activation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
RHO GTPases Activate WASPs and WAVEs,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.0292,0.138
Endosomal Sorting Complex Required For Transport (ESCRT),Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Zidovudine Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Zalcitabine Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Nevirapine  Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Efavirenz Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Abacavir Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.0292,0.138
Delavirdine Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
MAPK targets- Nuclear events mediated by MAP kinases,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Neurotransmitter uptake and metabolism In glial cells,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (6),0.0292,0.138,0.0292,0.138
Protein folding,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Regulation of mitotic cell cycle,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Nonhomologous End-Joining (NHEJ),Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.0292,0.138
Striated Muscle Contraction,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Regulation of TP53 Activity through Methylation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Regulation of RUNX1 Expression and Activity,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Listeria monocytogenes entry into host cells,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Neddylation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.0292,0.138
Phosphatidylcholine catabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,4 (7),0.0292,0.138,0.0292,0.138
Branched-chain amino acid catabolism,Wikipathways,0,,0 (0),1,1,2,HMDB00538;HMDB01325,37 (46),0.0292,0.138,0.0292,0.138
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer_s disease models,Reactome,2,CDC25A;CDC25C,18 (18),0.144,0.943,1,HMDB00538,4 (4),0.0292,0.138,0.0271,0.138
Neurodegenerative Diseases,Reactome,2,CDC25A;CDC25C,18 (18),0.144,0.943,1,HMDB00538,4 (4),0.0292,0.138,0.0271,0.138
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Reactome,7,IGFBP6;CTSG;SPP1;PRKCSH;VCAN;FN1;IGFBP4,126 (127),0.192,1,1,HMDB00538,3 (8),0.0219,0.134,0.0272,0.138
Disassembly of the destruction complex and recruitment of AXIN to the membrane,Reactome,2,PPP2R5D;LRP5,29 (29),0.295,1,1,HMDB00538,2 (2),0.0147,0.119,0.0279,0.142
Interleukin-4 and Interleukin-13 signaling,Wikipathways,5,TGFB1;F13A1;NOS2;BIRC5;FN1,97 (97),0.296,1,1,HMDB00538,2 (2),0.0147,0.119,0.028,0.142
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,Reactome,0,,4 (4),1,1,2,HMDB03337;HMDB00538,14 (18),0.00441,0.0857,0.0283,0.142
Galactose metabolism,INOH,0,,13 (13),1,1,2,HMDB00285;HMDB00538,14 (15),0.00441,0.0857,0.0283,0.142
Beta Oxidation of Very Long Chain Fatty Acids,SMPDB,0,,10 (10),1,1,2,HMDB00201;HMDB00538,14 (14),0.00441,0.0857,0.0283,0.142
Adrenoleukodystrophy_ X-linked,SMPDB,0,,10 (10),1,1,2,HMDB00201;HMDB00538,14 (14),0.00441,0.0857,0.0283,0.142
Carnitine-acylcarnitine translocase deficiency,SMPDB,0,,10 (10),1,1,2,HMDB00201;HMDB00538,14 (14),0.00441,0.0857,0.0283,0.142
MET Receptor Activation,Reactome,1,MET,6 (6),0.204,1,1,HMDB00538,3 (3),0.0219,0.134,0.0287,0.143
MET activates PI3K/AKT signaling,Reactome,1,MET,6 (6),0.204,1,1,HMDB00538,3 (4),0.0219,0.134,0.0287,0.143
TNF,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,67 (67),0.0122,0.144,0,,0 (0),1,1,0.0122,0.144
Peroxisomal lipid metabolism,Wikipathways,0,,0 (0),1,1,2,HMDB00201;HMDB00538,38 (61),0.0307,0.144,0.0307,0.144
Translesion Synthesis by POLH,Reactome,2,RFC5;RPA1,19 (19),0.157,0.997,1,HMDB00538,4 (5),0.0292,0.138,0.0292,0.146
The NLRP3 inflammasome,Reactome,1,HSP90AB1,10 (10),0.317,1,1,HMDB00538,2 (2),0.0147,0.119,0.0296,0.147
MAPK3 (ERK1) activation,Reactome,1,CDK1,10 (10),0.317,1,1,HMDB00538,2 (2),0.0147,0.119,0.0296,0.147
The citric acid (TCA) cycle and respiratory electron transport,Wikipathways,0,,0 (0),1,1,2,HMDB00094;HMDB00538,40 (44),0.0338,0.149,0.0338,0.149
Signaling by NTRK2 (TRKB),Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.0363,0.149
Amino acid conjugation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.0363,0.149
COPI-mediated anterograde transport,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.0363,0.149
Signaling by TGF-beta Receptor Complex,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.0363,0.149
Uptake and function of anthrax toxins,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.0363,0.149
Signal amplification,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.0363,0.149
Signaling by Insulin receptor,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.0363,0.149
Eukaryotic Translation Initiation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.0363,0.149
DAP12 interactions,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.0363,0.149
NCAM signaling for neurite out-growth,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.0363,0.149
Signaling by SCF-KIT,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.0363,0.149
Growth hormone receptor signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.0363,0.149
mTOR signalling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.0363,0.149
RHO GTPases Activate ROCKs,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.0363,0.149
trans-Golgi Network Vesicle Budding,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.0363,0.149
Cellular hexose transport,Wikipathways,0,,0 (0),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.0363,0.149
Biochemical Pathways Part I,Wikipathways,0,,0 (0),1,1,7,HMDB00094;HMDB00285;HMDB00082;HMDB00538;HMDB00043;HMDB00095;HMDB03337,460 (467),0.0365,0.149,0.0365,0.149
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,Reactome,3,CCT2;CCT6A;TCP1,43 (43),0.216,1,1,HMDB00538,3 (3),0.0219,0.134,0.0301,0.149
G alpha (q) signalling events,Wikipathways,0,,0 (0),1,1,2,HMDB00285;HMDB00538,42 (52),0.037,0.151,0.037,0.151
Nucleotide salvage,Wikipathways,0,,0 (0),1,1,2,HMDB00095;HMDB00538,42 (45),0.037,0.151,0.037,0.151
superpathway of inositol phosphate compounds,HumanCyc,2,OCRL;PI4KA,70 (70),0.742,1,2,HMDB00095;HMDB00538,17 (26),0.00651,0.117,0.0306,0.151
Aurora C signaling,PID,2,INCENP;AURKB,5 (5),0.0129,0.151,0,,0 (0),1,1,0.0129,0.151
Signaling by NOTCH3,Reactome,3,PLXND1;DLGAP5;TACC3,44 (44),0.226,1,1,HMDB00538,3 (3),0.0219,0.134,0.0312,0.154
Nucleobase biosynthesis,Reactome,3,ATIC;UMPS;IMPDH2,15 (15),0.0168,0.187,1,HMDB00538,47 (48),0.296,0.627,0.0314,0.155
Regulation of TP53 Activity through Acetylation,Reactome,3,RBBP4;HDAC1;HDAC2,30 (30),0.0999,0.76,1,HMDB00538,7 (9),0.0505,0.173,0.0317,0.156
Glycogen metabolism,Reactome,0,,22 (22),1,1,2,HMDB00285;HMDB00538,15 (17),0.00507,0.0967,0.0319,0.156
Protein ubiquitination,Reactome,5,HIST1H2BH;HIST1H2BB;HIST1H2BG;HIST1H2BF;UBE2C,80 (80),0.179,1,1,HMDB00538,4 (4),0.0292,0.138,0.0326,0.16
Phospholipid metabolism,Reactome,2,OCRL;PI4KA,216 (216),0.998,1,3,HMDB00095;HMDB00538;HMDB00082,50 (103),0.00525,0.0993,0.0328,0.16
Selenoamino acid metabolism,Wikipathways,0,,0 (0),1,1,2,HMDB03337;HMDB00538,45 (59),0.042,0.161,0.042,0.161
COPII-mediated vesicle transport,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.0434,0.161
Glutamate binding_ activation of AMPA receptors and synaptic plasticity,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.0434,0.161
tRNA Aminoacylation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (26),0.0434,0.161,0.0434,0.161
EPH-Ephrin signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (9),0.0434,0.161,0.0434,0.161
RHO GTPases activate PAKs,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.0434,0.161
RHO GTPases activate PKNs,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.0434,0.161
Semaphorin interactions,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.0434,0.161
GPVI-mediated activation cascade,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.0434,0.161
Mitotic Metaphase and Anaphase,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.0434,0.161
Mitotic Prometaphase,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.0434,0.161
MHC class II antigen presentation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.0434,0.161
Glutamate binding_ activation of AMPA receptors and synaptic plasticity,Reactome,3,AP2A2;GRIA3;AP2S1,31 (31),0.108,0.78,1,HMDB00538,7 (8),0.0505,0.173,0.0338,0.165
Regulation of TP53 Degradation,Reactome,3,CDK2;CCNA2;CDK1,36 (36),0.15,0.977,1,HMDB00538,5 (5),0.0363,0.149,0.0338,0.165
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling,PID,6,TGFB1;DOCK1;GPLD1;ELANE;CTSG;FN1,44 (44),0.00555,0.0739,0,,2 (4),1,1,0.0344,0.167
TCA cycle,HumanCyc,1,OGDH,19 (19),0.515,1,2,HMDB00094;HMDB00538,22 (23),0.0108,0.119,0.0345,0.167
Post-translational protein phosphorylation,Reactome,5,SPP1;IGFBP4;PRKCSH;VCAN;FN1,109 (110),0.385,1,1,HMDB00538,2 (7),0.0147,0.119,0.0349,0.169
Regulation of RUNX3 expression and activity,Reactome,1,TGFB1,13 (13),0.39,1,1,HMDB00538,2 (2),0.0147,0.119,0.0353,0.17
pyrimidine deoxyribonucleotides biosynthesis from CTP,HumanCyc,0,,16 (16),1,1,2,HMDB00538;HMDB00082,16 (17),0.00577,0.107,0.0355,0.17
Synthesis of Dolichyl-phosphate,Reactome,0,,6 (6),1,1,2,HMDB00538;HMDB00082,16 (18),0.00577,0.107,0.0355,0.17
Surfactant metabolism,Wikipathways,0,,6 (6),1,1,2,HMDB00285;HMDB00538,16 (17),0.00577,0.107,0.0355,0.17
Regulation of TP53 Expression and Degradation,Reactome,3,CDK2;CCNA2;CDK1,37 (37),0.159,0.997,1,HMDB00538,5 (5),0.0363,0.149,0.0355,0.17
Iron uptake and transport,Reactome,1,CAND1,58 (58),0.89,1,2,HMDB00094;HMDB00538,17 (21),0.00651,0.117,0.0357,0.171
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Reactome,10,RPL13A;RPSA;RPL4;NCBP1;RPL36A;RPS5;RPL9;UPF1;EIF4G1;RPLP0,105 (106),0.0058,0.077,0,,1 (2),1,1,0.0357,0.171
miR-targeted genes in muscle cell - TarBase,Wikipathways,24,DHX15;SLC38A1;MET;MTHFD2;PSAT1;CAND1;GALNT1;EHMT2;ANAPC1;ANP32B;UHRF1;CTSC;C1QBP;HSD17B12;E2F1;ACAA2;PLK1;GFM1;USP1;ATP2A2;VEZT;CDK6;PTMA;RAD23B,400 (400),0.0152,0.172,0,,0 (0),1,1,0.0152,0.172
Glutaminolysis and Cancer,SMPDB,3,DLAT;LDHA;OGDH,37 (37),0.159,0.997,2,HMDB00094;HMDB00538,42 (44),0.037,0.151,0.0361,0.172
Signaling by NTRK3 (TRKC),Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.0505,0.173
PI3K Cascade,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.0505,0.173
TCR signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (9),0.0505,0.173,0.0505,0.173
Regulation of TP53 Activity through Acetylation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (9),0.0505,0.173,0.0505,0.173
Translocation of SLC2A4 (GLUT4) to the plasma membrane,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.0505,0.173
Signaling by FGFR1,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.0505,0.173
Deadenylation-dependent mRNA decay,Wikipathways,0,,0 (0),1,1,1,HMDB00095,7 (9),0.0505,0.173,0.0505,0.173
Energy dependent regulation of mTOR by LKB1-AMPK,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.0505,0.173
Signaling by PDGF,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.0505,0.173
Nucleotide Excision Repair,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (9),0.0505,0.173,0.0505,0.173
Rap1 signalling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.0505,0.173
L1CAM interactions,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (9),0.0505,0.173,0.0505,0.173
Signaling by FGFR4,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (9),0.0505,0.173,0.0505,0.173
Signaling by FGFR2,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (15),0.0505,0.173,0.0505,0.173
Hedgehog ligand biogenesis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.0505,0.173
Cargo recognition for clathrin-mediated endocytosis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (9),0.0505,0.173,0.0505,0.173
Signaling by MET,Wikipathways,0,,0 (0),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.0505,0.173
Sensing of DNA Double Strand Breaks,Reactome,1,KPNA2,6 (6),0.204,1,1,HMDB00538,4 (4),0.0292,0.138,0.0364,0.174
mRNA decay by 3_ to 5_ exoribonuclease,Reactome,2,EXOSC9;EXOSC6,16 (16),0.118,0.839,1,HMDB00095,7 (10),0.0505,0.173,0.0366,0.174
Glycine_ serine and threonine metabolism - Homo sapiens (human),KEGG,3,PSAT1;ALAS1;GATM,40 (40),0.187,1,2,HMDB00099;HMDB00043,39 (50),0.0323,0.149,0.0368,0.174
Phase II - Conjugation of compounds,Reactome,2,GSTM1;GSTO1,112 (115),0.925,1,4,HMDB00285;HMDB03337;HMDB00538;HMDB00267,107 (148),0.00651,0.117,0.0368,0.174
MTHFR deficiency,Wikipathways,2,DNMT1;EHMT2,10 (10),0.0513,0.47,1,HMDB00043,17 (20),0.118,0.292,0.0371,0.175
TCA Cycle (aka Krebs or citric acid cycle),Wikipathways,1,OGDH,17 (17),0.476,1,2,HMDB00094;HMDB00538,24 (24),0.0128,0.119,0.0372,0.176
Astrocytic Glutamate-Glutamine Uptake And Metabolism,Reactome,1,SLC38A1,4 (4),0.141,0.943,1,HMDB00538,6 (6),0.0434,0.161,0.0374,0.176
Neurotransmitter uptake and metabolism In glial cells,Reactome,1,SLC38A1,4 (4),0.141,0.943,1,HMDB00538,6 (6),0.0434,0.161,0.0374,0.176
Sulfur amino acid metabolism,Reactome,0,,26 (27),1,1,3,HMDB00099;HMDB00538;HMDB00043,53 (66),0.00619,0.114,0.0377,0.177
Termination of translesion DNA synthesis,Reactome,5,POLD1;RFC5;POLE;RPA1;REV1,32 (32),0.00621,0.0821,0,,2 (3),1,1,0.0378,0.177
Synthesis of PIPs at the ER membrane,Reactome,1,PI4KA,5 (5),0.173,1,1,HMDB00538,5 (9),0.0363,0.149,0.0382,0.178
Signaling by NOTCH1,Reactome,4,HDAC1;HDAC2;NCOR2;HDAC6,73 (74),0.29,1,1,HMDB00538,3 (3),0.0219,0.134,0.0385,0.18
Inflammasomes,Reactome,1,HSP90AB1,15 (15),0.435,1,1,HMDB00538,2 (4),0.0147,0.119,0.0387,0.18
InlB-mediated entry of Listeria monocytogenes into host cell,Reactome,1,MET,15 (15),0.435,1,1,HMDB00538,2 (2),0.0147,0.119,0.0387,0.18
Glycosphingolipid biosynthesis - ganglioseries,EHMN,0,,21 (21),1,1,2,HMDB00095;HMDB01176,17 (38),0.00651,0.117,0.0393,0.182
Synthesis of UDP-N-acetyl-glucosamine,Reactome,0,,8 (8),1,1,2,HMDB00285;HMDB00538,17 (21),0.00651,0.117,0.0393,0.182
Signaling by Erythropoietin,Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.0575,0.186
Signaling by EGFR,Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (14),0.0575,0.186,0.0575,0.186
Mismatch Repair,Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.0575,0.186
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (10),0.0575,0.186,0.0575,0.186
Costimulation by the CD28 family,Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.0575,0.186
DNA Damage Bypass,Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.0575,0.186
Effects of PIP2 hydrolysis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (13),0.0575,0.186,0.0575,0.186
Netrin-1 signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.0575,0.186
Vasopressin regulates renal water homeostasis via Aquaporins,Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.0575,0.186
rRNA modification in the nucleus and cytosol,Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.0575,0.186
Galactose catabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,8 (10),0.0575,0.186,0.0575,0.186
the prc2 complex sets long-term gene silencing through modification of histone tails,BioCarta,3,RBBP4;HDAC1;HDAC2,15 (15),0.0168,0.187,0,,0 (0),1,1,0.0168,0.187
Establishment of Sister Chromatid Cohesion,Reactome,3,CDCA5;SMC1A;PDS5B,11 (11),0.00682,0.0894,0,,2 (2),1,1,0.0408,0.189
Hair Follicle Development- Induction (Part 1 of 3),Wikipathways,2,LRP5;VCAN,42 (42),0.468,1,1,HMDB00538,2 (2),0.0147,0.119,0.0411,0.19
Direct p53 effectors,PID,12,TAF9;MLH1;SMARCA4;SPP1;MET;E2F1;VCAN;DGCR8;HTT;CSE1L;CCNB1;HDAC2,142 (143),0.00689,0.09,0,,1 (1),1,1,0.0412,0.19
Beta-catenin phosphorylation cascade,Reactome,1,PPP2R5D,17 (17),0.476,1,1,HMDB00538,2 (2),0.0147,0.119,0.0417,0.192
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Reactome,5,PRKCSH;PSMC1;CANX;UGGT1;RAD23B,33 (34),0.0071,0.0915,0,,5 (22),1,1,0.0422,0.194
Hemostasis,Reactome,35,KIF20A;TGFB1;DOCK1;HIST1H3F;TAGLN2;RCOR1;CD244;PPP2R5D;PRTN3;FN1;HIST1H3C;HIST1H3I;CENPE;WEE1;KIFC1;CBX5;HDAC2;KIF16B;KIF15;C1QBP;RACGAP1;ACTN4;HDAC1;KIF18B;PPIA;ATP2A2;NOS2;F10;KIF20B;F13A1;KIF11;CDK2;MYB;KIF22;KIF2C,667 (668),0.0262,0.267,1,HMDB00538,43 (67),0.274,0.592,0.0427,0.196
Hedgehog,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,72 (72),0.0176,0.196,0,,0 (0),1,1,0.0176,0.196
MET activates PTK2 signaling,Reactome,1,MET,18 (18),0.496,1,1,HMDB00538,2 (2),0.0147,0.119,0.0431,0.197
Synthesis of CL,Reactome,0,,1 (1),1,1,1,HMDB00095,1 (4),0.00737,0.119,0.0435,0.198
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,Reactome,0,,12 (12),1,1,1,HMDB00538,1 (1),0.00737,0.119,0.0435,0.198
NCAM1 interactions,Reactome,0,,37 (37),1,1,1,HMDB00538,1 (1),0.00737,0.119,0.0435,0.198
The NLRP1 inflammasome,Reactome,0,,3 (3),1,1,1,HMDB00538,1 (2),0.00737,0.119,0.0435,0.198
Transport of vitamins_ nucleosides_ and related molecules,Wikipathways,0,,0 (0),1,1,2,HMDB00095;HMDB01176,56 (60),0.0623,0.198,0.0623,0.198
G alpha (z) signalling events,Wikipathways,0,,0 (0),1,1,1,HMDB00538,9 (10),0.0645,0.198,0.0645,0.198
p75 NTR receptor-mediated signalling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.0645,0.198
Activation of NMDA receptors and postsynaptic events,Wikipathways,0,,0 (0),1,1,1,HMDB00538,9 (11),0.0645,0.198,0.0645,0.198
Integrin alphaIIb beta3 signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,9 (11),0.0645,0.198,0.0645,0.198
PIP3 activates AKT signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,9 (25),0.0645,0.198,0.0645,0.198
Signaling by FGFR3,Wikipathways,0,,0 (0),1,1,1,HMDB00538,9 (12),0.0645,0.198,0.0645,0.198
Macroautophagy,Wikipathways,0,,0 (0),1,1,1,HMDB00538,9 (11),0.0645,0.198,0.0645,0.198
DNA Double Strand Break Response,Wikipathways,0,,0 (0),1,1,1,HMDB00538,9 (14),0.0645,0.198,0.0645,0.198
regulators of bone mineralization,BioCarta,1,SPP1,11 (11),0.342,1,1,HMDB00538,3 (4),0.0219,0.134,0.0442,0.2
Interleukin-12 family signaling,Reactome,1,CANX,19 (19),0.515,1,1,HMDB00538,2 (2),0.0147,0.119,0.0445,0.201
Methylation,Reactome,1,GSTO1,14 (15),0.413,1,2,HMDB03337;HMDB00538,29 (37),0.0185,0.134,0.0448,0.202
biotin-carboxyl carrier protein assembly,HumanCyc,1,ACACA,3 (3),0.108,0.78,1,HMDB00538,10 (11),0.0714,0.205,0.0452,0.203
Fatty acyl-CoA biosynthesis,Reactome,2,HSD17B12;ACACA,38 (38),0.417,1,2,HMDB00094;HMDB00538,29 (42),0.0185,0.134,0.0452,0.203
p75NTR negatively regulates cell cycle via SC1,Reactome,2,HDAC1;HDAC2,6 (6),0.0189,0.205,0,,0 (0),1,1,0.0189,0.205
exRNA mechanism of action and biogenesis,Wikipathways,2,ERI1;DGCR8,6 (6),0.0189,0.205,0,,0 (1),1,1,0.0189,0.205
Signaling by NTRK1 (TRKA),Wikipathways,0,,0 (0),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.0714,0.205
Cell surface interactions at the vascular wall,Wikipathways,0,,0 (0),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.0714,0.205
Response to elevated platelet cytosolic Ca2+,Wikipathways,0,,0 (0),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.0714,0.205
RAF-MAP kinase cascade,Wikipathways,0,,0 (0),1,1,1,HMDB00538,10 (17),0.0714,0.205,0.0714,0.205
Signaling by ERBB2,Wikipathways,0,,0 (0),1,1,1,HMDB00538,10 (12),0.0714,0.205,0.0714,0.205
Cytosolic sensors of pathogen-associated DNA,Wikipathways,0,,0 (0),1,1,1,HMDB00538,10 (14),0.0714,0.205,0.0714,0.205
HSP90 chaperone cycle for steroid hormone receptors (SHR),Wikipathways,0,,0 (0),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.0714,0.205
The oncogenic action of 2-hydroxyglutarate,SMPDB,2,DLAT;OGDH,27 (27),0.267,1,2,HMDB00094;HMDB00538,37 (40),0.0292,0.138,0.0457,0.205
Trans-sulfuration pathway,Wikipathways,2,DNMT1;LDHA,47 (47),0.528,1,2,HMDB00538;HMDB00099,26 (28),0.015,0.121,0.0462,0.207
Teniposide Metabolism Pathway,SMPDB,2,TOP2A;MPO,4 (4),0.00794,0.101,0,,9 (9),1,1,0.0463,0.207
Teniposide Action Pathway,SMPDB,2,TOP2A;MPO,4 (4),0.00794,0.101,0,,9 (9),1,1,0.0463,0.207
influence of ras and rho proteins on g1 to s transition,BioCarta,4,CDK2;CDK4;CDK6;E2F1,28 (28),0.0193,0.207,0,,0 (0),1,1,0.0193,0.207
fig-met-1-last-solution,Wikipathways,2,LDHA;OGDH,14 (14),0.0941,0.724,1,HMDB00094,12 (14),0.0851,0.228,0.0467,0.208
folate transformations,HumanCyc,2,MTHFD2;MTHFD1L,11 (11),0.0612,0.54,1,HMDB00538,19 (21),0.132,0.319,0.0469,0.208
TLR JNK,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,62 (62),0.00807,0.102,0,,1 (1),1,1,0.047,0.208
GLUT-1 deficiency syndrome,SMPDB,0,,11 (11),1,1,2,HMDB00285;HMDB00538,19 (19),0.00811,0.119,0.0472,0.208
Lactose Synthesis,SMPDB,0,,11 (11),1,1,2,HMDB00285;HMDB00538,19 (19),0.00811,0.119,0.0472,0.208
Alanine and aspartate metabolism,Wikipathways,0,,12 (12),1,1,2,HMDB00094;HMDB00201,19 (20),0.00811,0.119,0.0472,0.208
Congenital disorder of glycosylation CDG-IId,SMPDB,0,,11 (11),1,1,2,HMDB00285;HMDB00538,19 (19),0.00811,0.119,0.0472,0.208
TP53 Regulates Metabolic Genes,Wikipathways,0,,9 (9),1,1,2,HMDB03337;HMDB00538,19 (25),0.00811,0.119,0.0472,0.208
fatty acid biosynthesis initiation,HumanCyc,1,ACACA,4 (4),0.141,0.943,1,HMDB00538,8 (9),0.0575,0.186,0.0472,0.208
Nucleotide salvage,Reactome,2,UCK2;PNP,23 (23),0.211,1,2,HMDB00095;HMDB00538,43 (45),0.0386,0.157,0.0474,0.208
Selenocysteine synthesis,Reactome,7,RPL13A;RPSA;RPL4;RPS5;RPL9;RPL36A;RPLP0,103 (104),0.0904,0.699,1,HMDB00538,13 (20),0.0919,0.241,0.0481,0.211
Biosynthesis of EPA-derived SPMs,Wikipathways,0,,0 (0),1,1,1,HMDB03337,11 (27),0.0783,0.213,0.0783,0.213
Clathrin-mediated endocytosis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,11 (15),0.0783,0.213,0.0783,0.213
Intra-Golgi and retrograde Golgi-to-ER traffic,Wikipathways,0,,0 (0),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.0783,0.213
RHO GTPases Activate NADPH Oxidases,Wikipathways,0,,0 (0),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.0783,0.213
DAG and IP3 signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.0783,0.213
Threonine catabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,11 (15),0.0783,0.213,0.0783,0.213
ID signaling pathway,Wikipathways,3,SREBF1;CDK2;RBL1,16 (16),0.0201,0.215,0,,0 (0),1,1,0.0201,0.215
RIP-mediated NFkB activation via ZBP1,Reactome,1,HMGB1,23 (23),0.583,1,1,HMDB00538,2 (6),0.0147,0.119,0.0493,0.215
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,Reactome,1,CDC25C,23 (23),0.583,1,1,HMDB00538,2 (2),0.0147,0.119,0.0493,0.215
Nephrin family interactions,Reactome,1,ACTN4,23 (23),0.583,1,1,HMDB00538,2 (2),0.0147,0.119,0.0493,0.215
proteasome complex,BioCarta,1,PSMD3,24 (24),0.599,1,1,HMDB00538,2 (2),0.0147,0.119,0.0504,0.219
TLR p38,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,63 (63),0.0088,0.111,0,,1 (1),1,1,0.0504,0.219
G alpha (i) signalling events,Wikipathways,0,,0 (0),1,1,2,HMDB00285;HMDB00538,65 (93),0.081,0.221,0.081,0.221
Metabolism of water-soluble vitamins and cofactors,Wikipathways,0,,0 (0),1,1,2,HMDB03337;HMDB00538,65 (79),0.081,0.221,0.081,0.221
Galactosemia III,SMPDB,0,,8 (8),1,1,2,HMDB00285;HMDB00538,20 (20),0.00898,0.119,0.0513,0.222
Galactosemia II (GALK),SMPDB,0,,8 (8),1,1,2,HMDB00285;HMDB00538,20 (20),0.00898,0.119,0.0513,0.222
Nucleotide Sugars Metabolism,SMPDB,0,,8 (8),1,1,2,HMDB00285;HMDB00538,20 (20),0.00898,0.119,0.0513,0.222
ESR-mediated signaling,Wikipathways,2,MYB;KPNA2,19 (19),0.157,0.997,1,HMDB00538,8 (9),0.0575,0.186,0.0515,0.222
Selenoamino acid metabolism,Reactome,7,RPL13A;RPSA;RPL4;RPS5;RPL9;RPL36A;RPLP0,129 (130),0.207,1,2,HMDB03337;HMDB00538,46 (61),0.0437,0.162,0.0517,0.222
The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria,SMPDB,2,DLAT;OGDH,29 (29),0.295,1,2,HMDB00094;HMDB00538,38 (41),0.0307,0.144,0.0517,0.222
TRAF6 mediated NF-kB activation,Reactome,1,HMGB1,26 (26),0.628,1,1,HMDB00538,2 (5),0.0147,0.119,0.0525,0.225
Signaling by the B Cell Receptor (BCR),Wikipathways,0,,0 (0),1,1,1,HMDB00538,12 (15),0.0851,0.228,0.0851,0.228
ZBP1(DAI) mediated induction of type I IFNs,Reactome,1,HMGB1,27 (27),0.642,1,1,HMDB00538,2 (6),0.0147,0.119,0.0534,0.229
The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria ,SMPDB,2,DLAT;OGDH,30 (30),0.309,1,2,HMDB00094;HMDB00538,38 (41),0.0307,0.144,0.0537,0.23
TP53 Regulates Metabolic Genes,Reactome,1,LRPPRC,86 (86),0.962,1,2,HMDB03337;HMDB00538,21 (25),0.00988,0.119,0.0538,0.23
UMP biosynthesis,HumanCyc,1,UMPS,2 (2),0.0733,0.603,1,HMDB00538,19 (20),0.132,0.319,0.0544,0.232
Citric acid cycle (TCA cycle),Reactome,1,OGDH,22 (22),0.567,1,2,HMDB00094;HMDB00538,28 (30),0.0173,0.134,0.0551,0.234
Transfer of Acetyl Groups into Mitochondria,SMPDB,0,,9 (9),1,1,2,HMDB00094;HMDB00538,21 (22),0.00988,0.119,0.0555,0.235
Betaine Metabolism,SMPDB,0,,8 (8),1,1,2,HMDB00538;HMDB00043,21 (22),0.00988,0.119,0.0555,0.235
MET activates RAS signaling,Reactome,1,MET,11 (11),0.342,1,1,HMDB00538,4 (4),0.0292,0.138,0.0559,0.236
Pre-NOTCH Transcription and Translation,Reactome,1,E2F1,30 (30),0.681,1,1,HMDB00538,2 (2),0.0147,0.119,0.056,0.236
hypoxia-inducible factor in the cardivascular system,BioCarta,1,LDHA,16 (16),0.456,1,1,HMDB00538,3 (5),0.0219,0.134,0.0561,0.236
Sema3A PAK dependent Axon repulsion,Reactome,1,HSP90AB1,16 (16),0.456,1,1,HMDB00538,3 (3),0.0219,0.134,0.0561,0.236
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),Reactome,1,TGFB1,16 (16),0.456,1,1,HMDB00538,3 (3),0.0219,0.134,0.0561,0.236
Recycling pathway of L1,Reactome,2,AP2A2;AP2S1,28 (29),0.281,1,1,HMDB00538,5 (6),0.0363,0.149,0.057,0.24
Synthesis of PIPs at the Golgi membrane,Reactome,2,OCRL;PI4KA,18 (18),0.144,0.943,1,HMDB00538,10 (15),0.0714,0.205,0.0573,0.24
Nicotinate and Nicotinamide Metabolism,SMPDB,1,PNP,14 (14),0.413,1,2,HMDB00538;HMDB00229,34 (35),0.0249,0.138,0.0575,0.241
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Reactome,1,HMGB1,32 (32),0.704,1,1,HMDB00538,2 (7),0.0147,0.119,0.0576,0.241
Serine biosynthesis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,13 (17),0.0919,0.241,0.0919,0.241
GABA synthesis_ release_ reuptake and degradation,Wikipathways,0,,0 (0),1,1,1,HMDB00043,13 (16),0.0919,0.241,0.0919,0.241
Formation of xylulose-5-phosphate,Wikipathways,0,,0 (0),1,1,1,HMDB00538,13 (16),0.0919,0.241,0.0919,0.241
ABC-family proteins mediated transport,Wikipathways,0,,0 (0),1,1,1,HMDB00538,13 (22),0.0919,0.241,0.0919,0.241
Choline catabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00043,13 (15),0.0919,0.241,0.0919,0.241
Antimicrobial peptides,Wikipathways,0,,0 (0),1,1,1,HMDB00538,13 (25),0.0919,0.241,0.0919,0.241
Plasma lipoprotein assembly_ remodeling_ and clearance,Reactome,5,AP2A2;SOAT2;AP2S1;SCARB1;LMF2,69 (69),0.115,0.827,1,HMDB00538,13 (25),0.0919,0.241,0.0585,0.244
Glycolysis Gluconeogenesis,INOH,2,PFKL;LDHA,45 (46),0.505,1,2,HMDB00285;HMDB00538,31 (34),0.0209,0.134,0.0587,0.245
Galactose Metabolism,SMPDB,1,GLA,13 (13),0.39,1,2,HMDB00285;HMDB00538,36 (36),0.0278,0.138,0.0599,0.249
Galactosemia,SMPDB,1,GLA,13 (13),0.39,1,2,HMDB00285;HMDB00538,36 (36),0.0278,0.138,0.0599,0.249
Mitochondrial biogenesis,Wikipathways,2,ALAS1;TFAM,17 (17),0.131,0.915,1,HMDB00538,12 (14),0.0851,0.228,0.0612,0.251
Interleukin-10 signaling,Wikipathways,1,CCR2,38 (38),0.765,1,1,HMDB00538,2 (2),0.0147,0.119,0.0616,0.251
Translation initiation complex formation,Reactome,7,RPSA;RPS5;EIF3B;EIF3C;EIF3D;EIF3I;EIF4G1,66 (68),0.0113,0.137,0,,1 (2),1,1,0.0618,0.251
Integrated Breast Cancer Pathway,Wikipathways,7,CDC25A;BARD1;AURKA;E2F1;AHR;RAD54L;HDAC1,66 (66),0.0113,0.137,0,,9 (20),1,1,0.0618,0.251
inosine-5_-phosphate biosynthesis,HumanCyc,1,ATIC,3 (3),0.108,0.78,1,HMDB00538,15 (16),0.105,0.266,0.0622,0.251
Sema4D mediated inhibition of cell attachment and migration,Reactome,1,MET,8 (8),0.262,1,1,HMDB00538,6 (6),0.0434,0.161,0.0624,0.251
Transport of bile salts and organic acids_ metal ions and amine compounds,Reactome,0,,86 (87),1,1,3,HMDB00094;HMDB03045;HMDB00043,66 (78),0.0114,0.119,0.0624,0.251
HSF1-dependent transactivation,Reactome,2,FKBP4;HSP90AB1,36 (36),0.391,1,1,HMDB00538,4 (4),0.0292,0.138,0.0624,0.251
Antigen processing: Ubiquitination & Proteasome degradation,Reactome,11,CCNF;ANAPC1;TRIM37;CDC16;FBXW8;TRAIP;UBE2C;CDC23;UBE3C;FZR1;CDC20,263 (264),0.393,1,1,HMDB00538,4 (4),0.0292,0.138,0.0627,0.251
Regulation of PTEN gene transcription,Reactome,4,RBBP4;HDAC1;HDAC2;RCOR1,62 (62),0.2,1,1,HMDB00538,8 (8),0.0575,0.186,0.063,0.251
Resolution of Abasic Sites (AP sites),Reactome,5,POLD1;RFC5;POLE;RPA1;LIG1,37 (37),0.0115,0.139,0,,6 (8),1,1,0.063,0.251
Base Excision Repair,Reactome,5,POLD1;RFC5;POLE;RPA1;LIG1,37 (37),0.0115,0.139,0,,15 (22),1,1,0.063,0.251
selenocysteine biosynthesis,HumanCyc,1,SEPHS1,6 (6),0.204,1,1,HMDB00538,8 (10),0.0575,0.186,0.0639,0.251
Pyruvate metabolism and Citric Acid (TCA) cycle,Reactome,3,DLAT;LDHA;OGDH,54 (54),0.328,1,2,HMDB00094;HMDB00538,42 (44),0.037,0.151,0.0656,0.251
Activation of the mRNA upon binding of the cap-binding complex and eIFs_ and subsequent binding to 43S,Reactome,7,RPSA;RPS5;EIF3B;EIF3C;EIF3D;EIF3I;EIF4G1,67 (69),0.0122,0.144,0,,1 (2),1,1,0.0659,0.251
Metabolism of amino acids and derivatives,Reactome,12,RPL13A;GATM;RPSA;DLAT;OGDH;RPL4;PSAT1;RPS5;NUP62;RPL9;RPL36A;RPLP0,339 (342),0.617,1,5,HMDB00538;HMDB03337;HMDB00099;HMDB01325;HMDB00043,227 (285),0.0203,0.134,0.0673,0.251
DCC mediated attractive signaling,Reactome,1,DOCK1,15 (15),0.435,1,1,HMDB00538,4 (5),0.0292,0.138,0.0681,0.251
Synaptic Vesicle Pathway,Wikipathways,3,AP2A2;SLC38A1;AP2S1,51 (51),0.297,1,1,HMDB00538,6 (7),0.0434,0.161,0.069,0.251
miRNA Biogenesis,Wikipathways,2,RAN;DGCR8,5 (5),0.0129,0.151,0,,1 (1),1,1,0.069,0.251
Alpha9 beta1 integrin signaling events,PID,4,SPP1;F13A1;NOS2;FN1,25 (25),0.013,0.152,0,,12 (13),1,1,0.0695,0.251
stathmin and breast cancer resistance to antimicrotubule agents,BioCarta,4,CCNB1;STMN1;TUBA1C;CDK1,25 (25),0.013,0.152,0,,2 (2),1,1,0.0695,0.251
Gap-filling DNA repair synthesis and ligation in TC-NER,Reactome,7,RFC5;RPA1;DDB1;PRPF19;POLD1;POLE;LIG1,68 (68),0.0132,0.153,0,,1 (2),1,1,0.0701,0.251
Interleukin-1 signaling,Reactome,1,HMGB1,60 (60),0.899,1,1,HMDB00538,2 (8),0.0147,0.119,0.0703,0.251
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc),Wikipathways,2,DLAT;OGDH,16 (16),0.118,0.839,1,HMDB00094,16 (19),0.112,0.28,0.0705,0.251
Gluconeogenesis,Reactome,1,TPI1,34 (35),0.726,1,2,HMDB00094;HMDB00538,29 (34),0.0185,0.134,0.0712,0.251
NOTCH3 Activation and Transmission of Signal to the Nucleus,Reactome,1,TACC3,25 (25),0.614,1,1,HMDB00538,3 (3),0.0219,0.134,0.0715,0.251
FGF signaling pathway,PID,2,SPP1;MET,56 (56),0.624,1,1,HMDB00538,3 (5),0.0219,0.134,0.0724,0.251
Lysosome Vesicle Biogenesis,Reactome,2,M6PR;DNAJC6,35 (35),0.378,1,1,HMDB00538,5 (6),0.0363,0.149,0.0725,0.251
Warburg Effect,SMPDB,3,DLAT;PFKL;OGDH,45 (45),0.236,1,2,HMDB00094;HMDB00538,54 (58),0.0584,0.189,0.0727,0.251
Vitamin B9 (folate) metabolism,EHMN,3,SLC25A5;MTHFD2;MTHFD1L,26 (26),0.0712,0.603,1,HMDB00538,29 (35),0.194,0.437,0.073,0.251
Oxidation of Branched Chain Fatty Acids,SMPDB,0,,12 (12),1,1,2,HMDB00201;HMDB00538,25 (25),0.0139,0.119,0.0732,0.251
Regulation of RUNX1 Expression and Activity,Reactome,1,CDK6,17 (18),0.476,1,1,HMDB00538,4 (4),0.0292,0.138,0.0733,0.251
Interleukin-1 family signaling,Reactome,1,HMGB1,77 (77),0.947,1,1,HMDB00538,2 (8),0.0147,0.119,0.0733,0.251
TLR NFkB,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,69 (69),0.0142,0.162,0,,1 (1),1,1,0.0746,0.251
Association of TriC/CCT with target proteins during biosynthesis,Reactome,5,NOP56;CCT2;CCT6A;DCAF7;TCP1,39 (39),0.0144,0.163,0,,1 (3),1,1,0.0753,0.251
RUNX2 regulates genes involved in cell migration,Reactome,0,,8 (8),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
PERK regulates gene expression,Reactome,0,,3 (3),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
p75NTR recruits signalling complexes,Reactome,0,,9 (9),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-20 family signaling,Reactome,0,,15 (15),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
NF-kB is activated and signals survival,Reactome,0,,13 (13),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
p75NTR signals via NF-kB,Reactome,0,,16 (16),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
BMP Signalling Pathway,HumanCyc,0,,21 (21),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-4 and 13 signaling,Reactome,0,,15 (15),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
NIK-->noncanonical NF-kB signaling,Reactome,0,,8 (8),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Degradation of GLI1 by the proteasome,Reactome,0,,15 (16),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
PKA-mediated phosphorylation of key metabolic factors,Reactome,0,,5 (5),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Constitutive Signaling by AKT1 E17K in Cancer,Reactome,0,,25 (25),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0766,0.251
IRS activation,Reactome,0,,5 (5),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
TP53 Regulates Transcription of Caspase Activators and Caspases,Reactome,0,,12 (12),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
TICAM1-dependent activation of IRF3/IRF7,Reactome,0,,8 (8),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0766,0.251
IRF3 mediated activation of type 1 IFN,Reactome,0,,5 (5),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Trafficking and processing of endosomal TLR,Reactome,0,,13 (13),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0766,0.251
Interleukin-20 family signaling,Wikipathways,0,,1 (1),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
NOD1/2 Signaling Pathway,Reactome,0,,33 (33),1,1,1,HMDB00538,2 (4),0.0147,0.119,0.0766,0.251
WNT mediated activation of DVL,Reactome,0,,9 (9),1,1,1,HMDB00538,2 (4),0.0147,0.119,0.0766,0.251
t(4;14) translocations of FGFR3,Reactome,0,,1 (1),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-3_ 5 and GM-CSF signaling,Reactome,0,,44 (44),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0766,0.251
TRAF6 mediated IRF7 activation,Reactome,0,,17 (17),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Mannose type O-glycan biosynthesis - Homo sapiens (human),KEGG,0,,23 (23),1,1,1,HMDB00082,2 (27),0.0147,0.119,0.0766,0.251
AKT phosphorylates targets in the cytosol,Reactome,0,,14 (14),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,Reactome,0,,5 (5),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Role of ABL in ROBO-SLIT signaling,Reactome,0,,8 (8),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
FCGR activation,Reactome,0,,90 (90),1,1,1,HMDB00538,2 (6),0.0147,0.119,0.0766,0.251
Interleukin-2 family signaling,Reactome,0,,38 (38),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0766,0.251
Dectin-1 mediated noncanonical NF-kB signaling,Reactome,0,,8 (8),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-12 signaling,Reactome,0,,10 (10),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Autodegradation of the E3 ubiquitin ligase COP1,Reactome,0,,7 (7),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Formation of apoptosome,Reactome,0,,3 (3),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Apoptotic factor-mediated response,Reactome,0,,7 (7),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Activation of SMO,Reactome,0,,10 (10),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,Reactome,0,,12 (12),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
TICAM1_TRAF6-dependent induction of TAK1 complex,Reactome,0,,7 (7),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0766,0.251
TNFR2 non-canonical NF-kB pathway,Reactome,0,,50 (50),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0766,0.251
Interleukin-2 signaling,Reactome,0,,12 (12),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Stimulation of the cell death response by PAK-2p34,Reactome,0,,2 (2),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Signaling by NODAL,Reactome,0,,21 (21),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
TRAF3-dependent IRF activation pathway,Reactome,0,,13 (13),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Activation of caspases through apoptosome-mediated cleavage,Reactome,0,,5 (5),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
FGFR4 mutant receptor activation,Reactome,0,,1 (1),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0766,0.251
Signaling by BMP,Reactome,0,,26 (26),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
IRF3-mediated induction of type I IFN,Reactome,0,,13 (13),1,1,1,HMDB00538,2 (6),0.0147,0.119,0.0766,0.251
Negative feedback regulation of MAPK pathway,Reactome,0,,6 (6),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Cytochrome c-mediated apoptotic response,Reactome,0,,5 (5),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Regulation of gap junction activity,Reactome,0,,3 (3),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
BDNF activates NTRK2 (TRKB) signaling,Reactome,0,,2 (2),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Gap junction trafficking and regulation,Reactome,0,,14 (14),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Signaling by FGFR2 amplification mutants,Reactome,0,,1 (1),1,1,1,HMDB00538,2 (6),0.0147,0.119,0.0766,0.251
PTK6 Regulates Proteins Involved in RNA Processing,Reactome,0,,5 (5),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Ligand-independent caspase activation via DCC,Reactome,0,,10 (10),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
PTK6 Activates STAT3,Reactome,0,,4 (4),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
CD22 mediated BCR regulation,Reactome,0,,71 (71),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
EGFR interacts with phospholipase C-gamma,Reactome,0,,3 (3),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Regulation of TNFR1 signaling,Reactome,0,,23 (23),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
MAP3K8 (TPL2)-dependent MAPK1/3 activation,Reactome,0,,16 (16),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Degradation of GLI2 by the proteasome,Reactome,0,,15 (15),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Deactivation of the beta-catenin transactivating complex,Reactome,0,,30 (30),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
TRKA activation by NGF,Reactome,0,,2 (2),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Downregulation of ERBB2:ERBB3 signaling,Reactome,0,,13 (13),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Negative regulators of DDX58/IFIH1 signaling,Reactome,0,,23 (23),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
IRAK2 mediated activation of TAK1 complex,Reactome,0,,6 (6),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
NTF4 activates NTRK2 (TRKB) signaling,Reactome,0,,2 (2),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-23 signaling,Reactome,0,,9 (9),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Regulation of KIT signaling,Reactome,0,,16 (16),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,Reactome,0,,9 (9),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
anthrax toxin mechanism of action,BioCarta,0,,2 (2),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
MAPK1 (ERK2) activation,Reactome,0,,9 (9),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
IRAK1 recruits IKK complex,Reactome,0,,12 (12),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Hedgehog _on_ state,Reactome,0,,38 (39),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,Reactome,0,,6 (6),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
PLC-gamma1 signalling,Reactome,0,,3 (3),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Asymmetric localization of PCP proteins,Reactome,0,,19 (19),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Netrin mediated repulsion signals,Reactome,0,,10 (10),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Reactome,0,,20 (20),1,1,1,HMDB00538,2 (4),0.0147,0.119,0.0766,0.251
Interaction between L1 and Ankyrins,Reactome,0,,29 (29),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
activated TAK1 mediates p38 MAPK activation,Reactome,0,,21 (21),1,1,1,HMDB00538,2 (4),0.0147,0.119,0.0766,0.251
Activated NTRK2 signals through PLCG1,Reactome,0,,4 (4),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Activated NTRK2 signals through FYN,Reactome,0,,4 (4),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Neurofascin interactions,Reactome,0,,7 (7),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Signaling by Activin,Reactome,0,,13 (13),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
ROBO receptors bind AKAP5,Reactome,0,,9 (9),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
CREB phosphorylation,Reactome,0,,7 (7),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Activation of the AP-1 family of transcription factors,Reactome,0,,10 (10),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Regulation of beta-cell development,Reactome,0,,4 (4),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
PECAM1 interactions,Reactome,0,,12 (12),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Signalling to STAT3,Reactome,0,,3 (3),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
PTK6 promotes HIF1A stabilization,Reactome,0,,6 (6),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
NRIF signals cell death from the nucleus,Reactome,0,,16 (16),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Signal regulatory protein family interactions,Reactome,0,,13 (13),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Signaling by Leptin,Reactome,0,,11 (11),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0766,0.251
Stabilization of p53,Reactome,0,,12 (12),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Regulation of TP53 Activity through Association with Co-factors,Reactome,0,,14 (14),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
AKT-mediated inactivation of FOXO1A,Reactome,0,,4 (4),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
ATP sensitive Potassium channels,Reactome,0,,4 (4),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Hedgehog _on_ state,Wikipathways,0,,5 (5),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Activated NTRK2 signals through FRS2 and FRS3,Reactome,0,,6 (6),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-6 signaling,Reactome,0,,11 (11),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Signaling by FGFR2 fusions,Reactome,0,,1 (1),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Signalling to ERK5,Reactome,0,,2 (2),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
RET signaling,Reactome,0,,35 (35),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
STAT6-mediated induction of chemokines,Reactome,0,,3 (3),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-10 signaling,Reactome,0,,6 (6),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
PLCG1 events in ERBB2 signaling,Reactome,0,,4 (4),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
RSK activation,Reactome,0,,6 (6),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
CRMPs in Sema3A signaling,Reactome,0,,16 (16),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Signaling by Hippo,Reactome,0,,20 (20),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Signaling by FGFR1 amplification mutants,Reactome,0,,1 (1),1,1,1,HMDB00538,2 (11),0.0147,0.119,0.0766,0.251
Signaling by plasma membrane FGFR1 fusions,Reactome,0,,3 (3),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Reelin signalling pathway,Reactome,0,,5 (5),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
c-src mediated regulation of Cx43 function and closure of gap junctions,Reactome,0,,3 (3),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
role of parkin in ubiquitin-proteasomal pathway,BioCarta,0,,8 (8),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-7 signaling,Wikipathways,0,,4 (4),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Degradation of beta-catenin by the destruction complex,Wikipathways,0,,4 (4),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
GLI3 is processed to GLI3R by the proteasome,Reactome,0,,15 (15),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Oncogene Induced Senescence,Wikipathways,0,,2 (2),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-6 family signaling,Reactome,0,,22 (22),1,1,1,HMDB00538,2 (3),0.0147,0.119,0.0766,0.251
Regulation of beta-cell development,Wikipathways,0,,21 (21),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-1 Induced Activation of NF-kappa-B,Wikipathways,0,,9 (9),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Regulation of TP53 Activity through Association with Co-factors,Wikipathways,0,,1 (1),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Regulation of signaling by CBL,Reactome,0,,18 (18),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Regulation of gene expression in beta cells,Reactome,0,,4 (4),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
MAP kinase cascade,HumanCyc,0,,9 (9),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
AKT phosphorylates targets in the nucleus,Reactome,0,,9 (9),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Interleukin-12 family signaling,Wikipathways,0,,2 (2),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
ERBB2 Activates PTK6 Signaling,Reactome,0,,13 (13),1,1,1,HMDB00538,2 (2),0.0147,0.119,0.0766,0.251
Endogenous TLR signaling,PID,4,TLR1;HSPD1;HMGB1;VCAN,26 (26),0.0149,0.169,0,,2 (2),1,1,0.0777,0.252
Transcriptional Regulation by MECP2,Wikipathways,1,MET,30 (30),0.681,1,1,HMDB00538,3 (3),0.0219,0.134,0.0778,0.252
ISG15 antiviral mechanism,Reactome,1,EIF4G1,30 (30),0.681,1,1,HMDB00538,3 (4),0.0219,0.134,0.0778,0.252
Antiviral mechanism by IFN-stimulated genes,Reactome,1,EIF4G1,30 (30),0.681,1,1,HMDB00538,3 (4),0.0219,0.134,0.0778,0.252
sarcosine oncometabolite pathway ,SMPDB,0,,13 (13),1,1,2,HMDB00538;HMDB00043,26 (26),0.015,0.121,0.0778,0.252
PTK6 Regulates RHO GTPases_ RAS GTPase and MAP kinases,Reactome,1,DOCK1,14 (14),0.413,1,1,HMDB00538,5 (5),0.0363,0.149,0.078,0.252
Transcriptional regulation by RUNX1,Wikipathways,1,MYB,19 (19),0.515,1,1,HMDB00538,4 (5),0.0292,0.138,0.078,0.252
Listeria monocytogenes entry into host cells,Reactome,1,MET,19 (19),0.515,1,1,HMDB00538,4 (4),0.0292,0.138,0.078,0.252
Folate Metabolism,SMPDB,2,MTHFD2;MTHFD1L,13 (13),0.0827,0.654,1,HMDB00538,27 (28),0.182,0.415,0.0781,0.252
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMPDB,2,MTHFD2;MTHFD1L,13 (13),0.0827,0.654,1,HMDB00538,27 (28),0.182,0.415,0.0781,0.252
Folate malabsorption_ hereditary,SMPDB,2,MTHFD2;MTHFD1L,13 (13),0.0827,0.654,1,HMDB00538,27 (28),0.182,0.415,0.0781,0.252
Mitotic Prophase,Wikipathways,0,,0 (0),1,1,1,HMDB00538,14 (16),0.0986,0.254,0.0986,0.254
Class I MHC mediated antigen processing & presentation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,14 (24),0.0986,0.254,0.0986,0.254
Synthesis of active ubiquitin: roles of E1 and E2 enzymes,Reactome,1,UBE2C,31 (31),0.693,1,1,HMDB00538,3 (3),0.0219,0.134,0.0789,0.254
XBP1(S) activates chaperone genes,Wikipathways,2,HDGF;DDX11,47 (47),0.528,1,1,HMDB00538,4 (4),0.0292,0.138,0.0797,0.256
Etoposide Metabolism Pathway,SMPDB,2,TOP2A;MPO,19 (19),0.157,0.997,1,HMDB00538,14 (14),0.0986,0.254,0.08,0.257
Etoposide Action Pathway,SMPDB,2,TOP2A;MPO,19 (19),0.157,0.997,1,HMDB00538,14 (14),0.0986,0.254,0.08,0.257
Methotrexate Action Pathway,SMPDB,2,MTHFD2;MTHFD1L,13 (13),0.0827,0.654,1,HMDB00538,28 (29),0.188,0.427,0.0802,0.257
Regulation of TP53 Activity through Methylation,Reactome,1,EHMT2,20 (20),0.533,1,1,HMDB00538,4 (4),0.0292,0.138,0.0803,0.257
Pyrimidine biosynthesis,Reactome,1,UMPS,3 (3),0.108,0.78,1,HMDB00538,21 (22),0.144,0.344,0.0804,0.257
folate polyglutamylation,HumanCyc,1,MTHFD1L,5 (5),0.173,1,1,HMDB00538,13 (13),0.0919,0.241,0.0818,0.261
citrulline-nitric oxide cycle,HumanCyc,1,NOS2,5 (5),0.173,1,1,HMDB00538,13 (14),0.0919,0.241,0.0818,0.261
Mitochondrial biogenesis,Reactome,3,ALAS1;HCFC1;TFAM,53 (53),0.317,1,1,HMDB00538,7 (8),0.0505,0.173,0.0823,0.262
CTLA4 inhibitory signaling,Reactome,1,PPP2R5D,21 (21),0.55,1,1,HMDB00538,4 (4),0.0292,0.138,0.0824,0.262
Negative regulation of MET activity,Reactome,1,MET,21 (21),0.55,1,1,HMDB00538,4 (4),0.0292,0.138,0.0824,0.262
Taste transduction - Homo sapiens (human),KEGG,0,,83 (83),1,1,2,HMDB00094;HMDB00538,27 (33),0.0161,0.129,0.0825,0.262
Aryl hydrocarbon receptor signalling,Reactome,2,AHR;HSP90AB1,7 (7),0.0258,0.264,0,,0 (1),1,1,0.0258,0.264
SUMO is transferred from E1 to E2 (UBE2I_ UBC9),Reactome,2,SUMO3;UBA2,7 (7),0.0258,0.264,0,,0 (0),1,1,0.0258,0.264
cdc25 and chk1 regulatory pathway in response to dna damage,BioCarta,2,WEE1;CDK1,7 (7),0.0258,0.264,0,,0 (0),1,1,0.0258,0.264
GPCR Dopamine D1like receptor,INOH,2,PPP2R5D;PPP1CC,50 (50),0.562,1,1,HMDB00538,4 (4),0.0292,0.138,0.0837,0.265
TGF-beta Signaling Pathway,Wikipathways,10,TGFB1;STRAP;MET;CCNB2;RBL1;E2F4;NUP214;CDK1;HDAC1;FN1,132 (132),0.026,0.266,0,,0 (0),1,1,0.026,0.266
Biosynthesis of DHA-derived SPMs,Wikipathways,0,,0 (0),1,1,1,HMDB03337,15 (72),0.105,0.266,0.105,0.266
Chromatin organization,Wikipathways,0,,0 (0),1,1,1,HMDB00538,15 (16),0.105,0.266,0.105,0.266
Abacavir transport and metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,15 (24),0.105,0.266,0.105,0.266
Vitamin B6 (pyridoxine) metabolism,EHMN,0,,0 (0),1,1,1,HMDB00538,15 (16),0.105,0.266,0.105,0.266
Fc epsilon receptor (FCERI) signaling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,15 (17),0.105,0.266,0.105,0.266
Fructose metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,15 (20),0.105,0.266,0.105,0.266
Ketone body metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,15 (16),0.105,0.266,0.105,0.266
Signal Transduction,Reactome,102,PIK3AP1;KNTC1;BCL9L;CENPN;INCENP;CENPE;CENPF;SPP1;SMC1A;DLGAP5;SPC25;CKAP5;NCBP1;NUF2;PLXND1;PTBP1;ARHGAP11A;BUB1;DSN1;RCC2;SPDL1;MET;HIST1H2AK;HIST1H2AC;HIST1H2AB;RCOR1;HIST1H2BG;HIST1H2BF;HIST1H2BH;HIST1H3C;AP2A2;HIST1H3I;NDC80;HIST1H4D;HIST1H4F;H2AFZ;NUP37;MAD1L1;BUB1B;KIF14;DLAT;TACC3;PLK1;IQGAP3;FKBP4;KIF2C;HSP90AB1;DOCK1;HIST1H3F;ZWILCH;RANGAP1;CENPT;HDAC6;FN1;NUP107;RBBP4;RBL1;ZW10;BIRC5;E2F1;NSL1;E2F4;CDK2;CCR2;OCRL;PLEKHG2;PRC1;TRIM27;SKA1;ECT2;CDCA8;CIT;PPP1CC;TGFB1;SPC24;AP2S1;NCOR2;GTF2F1;PPP2R5D;STRAP;EIF4G1;NUP133;SMARCA4;H2AFX;RACGAP1;LRP5;HIST1H2BB;SPRED1;CTBP1;CDK1;REEP4;HDAC2;CDC20;BUB3;CDC25C;NUDC;PMF1;MAD2L1;HDAC1;MYB;CDK4;AURKB,2633 (2647),0.352,1,4,HMDB00095;HMDB00285;HMDB00538;HMDB01176,192 (271),0.0467,0.172,0.0841,0.266
ERK/MAPK targets,Reactome,1,PPP2R5D,22 (22),0.567,1,1,HMDB00538,4 (4),0.0292,0.138,0.0844,0.266
Signaling by PTK6,Reactome,3,CDK2;CDK4;DOCK1,54 (54),0.328,1,1,HMDB00538,7 (7),0.0505,0.173,0.0844,0.266
Signaling by Non-Receptor Tyrosine Kinases,Reactome,3,CDK2;CDK4;DOCK1,54 (54),0.328,1,1,HMDB00538,7 (7),0.0505,0.173,0.0844,0.266
Notch,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,78 (79),0.0262,0.267,0,,0 (0),1,1,0.0262,0.267
Vitamin B6 metabolism,INOH,1,PSAT1,4 (5),0.141,0.943,1,HMDB00538,17 (17),0.118,0.292,0.0852,0.268
Ovarian tumor domain proteases,Reactome,1,CDK1,38 (38),0.765,1,1,HMDB00538,3 (5),0.0219,0.134,0.0854,0.268
Validated nuclear estrogen receptor beta network,PID,3,SMARCA4;SMARCB1;DDX54,15 (15),0.0168,0.187,0,,1 (1),1,1,0.0856,0.268
Etoposide Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,3,MPO;ABCC1;TOP2A,15 (15),0.0168,0.187,0,,3 (3),1,1,0.0856,0.268
Purine ribonucleoside monophosphate biosynthesis,Reactome,2,ATIC;IMPDH2,12 (12),0.0717,0.603,1,HMDB00538,36 (37),0.235,0.518,0.0857,0.269
sucrose degradation,HumanCyc,1,TPI1,8 (8),0.262,1,1,HMDB00538,9 (13),0.0645,0.198,0.086,0.269
Vitamin C (ascorbate) metabolism,Reactome,1,GSTO1,8 (8),0.262,1,1,HMDB03337,9 (12),0.0645,0.198,0.086,0.269
mTORC1-mediated signalling,Reactome,1,EIF4G1,23 (24),0.583,1,1,HMDB00538,4 (4),0.0292,0.138,0.0863,0.269
RAF-independent MAPK1/3 activation,Reactome,1,CDK1,23 (23),0.583,1,1,HMDB00538,4 (4),0.0292,0.138,0.0863,0.269
Metabolism of folate and pterines,Reactome,2,MTHFD2;MTHFD1L,17 (17),0.131,0.915,1,HMDB00538,19 (25),0.132,0.319,0.0871,0.271
&gamma;-glutamyl cycle,HumanCyc,0,,12 (13),1,1,2,HMDB00538;HMDB00267,28 (29),0.0173,0.134,0.0873,0.272
Lysine degradation - Homo sapiens (human),KEGG,5,EHMT2;SETD1A;DOT1L;OGDH;SUV39H1,59 (59),0.0686,0.596,1,HMDB01325,39 (55),0.252,0.553,0.0875,0.272
Platelet sensitization by LDL,Reactome,1,PPP2R5D,17 (17),0.476,1,1,HMDB00538,5 (6),0.0363,0.149,0.0875,0.272
HSF1 activation,Reactome,4,FKBP4;RPA1;HSP90AB1;HDAC6,31 (31),0.0272,0.274,0,,0 (0),1,1,0.0272,0.274
Deadenylation-dependent mRNA decay,Reactome,3,EXOSC9;EXOSC6;EIF4G1,56 (56),0.348,1,1,HMDB00095,7 (11),0.0505,0.173,0.0886,0.275
Transcriptional regulation by RUNX2,Reactome,4,CCNB1;CDK4;HDAC6;CDK1,75 (75),0.307,1,1,HMDB00538,8 (10),0.0575,0.186,0.0889,0.275
Cargo recognition for clathrin-mediated endocytosis,Reactome,5,AAK1;AP2A2;M6PR;FCHO1;AP2S1,99 (99),0.31,1,1,HMDB00538,8 (10),0.0575,0.186,0.0897,0.277
Nuclear Events (kinase and transcription factor activation),Reactome,1,PPP2R5D,25 (25),0.614,1,1,HMDB00538,4 (4),0.0292,0.138,0.0899,0.277
Epstein-Barr virus infection - Homo sapiens (human),KEGG,14,PSMC1;NCOR2;PSMD1;PSMD2;E2F1;PSMD3;PSMD7;HDAC1;PSMD13;CDK6;CDK2;CCNA2;CDK4;HDAC2,200 (201),0.0179,0.199,0,,3 (3),1,1,0.09,0.277
TCA cycle,EHMN,1,OGDH,30 (30),0.681,1,2,HMDB00094;HMDB00538,35 (36),0.0263,0.138,0.0901,0.277
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway,Wikipathways,3,TGFB1;FN1;SUV39H1,18 (18),0.0278,0.279,0,,0 (0),1,1,0.0278,0.279
tRNA modification in the nucleus and cytosol,Wikipathways,0,,0 (0),1,1,1,HMDB00538,16 (19),0.112,0.28,0.112,0.28
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Wikipathways,0,,0 (0),1,1,1,HMDB00538,16 (22),0.112,0.28,0.112,0.28
Fcgamma receptor (FCGR) dependent phagocytosis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,16 (18),0.112,0.28,0.112,0.28
Nucleotide-binding domain_ leucine rich repeat containing receptor (NLR) signaling pathways,Reactome,1,HSP90AB1,47 (47),0.833,1,1,HMDB00538,3 (6),0.0219,0.134,0.0915,0.281
Clathrin derived vesicle budding,Reactome,3,OCRL;M6PR;DNAJC6,72 (72),0.507,1,1,HMDB00538,5 (6),0.0363,0.149,0.092,0.282
trans-Golgi Network Vesicle Budding,Reactome,3,OCRL;M6PR;DNAJC6,72 (72),0.507,1,1,HMDB00538,5 (6),0.0363,0.149,0.092,0.282
Propanoate metabolism,EHMN,0,,18 (18),1,1,2,HMDB00094;HMDB00538,29 (33),0.0185,0.134,0.0921,0.282
Glutamate Glutamine metabolism,INOH,0,,27 (27),1,1,2,HMDB03337;HMDB00538,29 (34),0.0185,0.134,0.0921,0.282
Fructose and mannose metabolism,EHMN,0,,21 (21),1,1,2,HMDB00538;HMDB01265,29 (34),0.0185,0.134,0.0921,0.282
Citrate cycle,INOH,1,OGDH,32 (32),0.704,1,2,HMDB00094;HMDB00538,35 (35),0.0263,0.138,0.0926,0.283
Semaphorin interactions,Reactome,3,PLXND1;HSP90AB1;MET,64 (64),0.43,1,1,HMDB00538,6 (6),0.0434,0.161,0.0929,0.284
MET promotes cell motility,Reactome,1,MET,27 (27),0.642,1,1,HMDB00538,4 (4),0.0292,0.138,0.0932,0.284
urate biosynthesis/inosine 5_-phosphate degradation,HumanCyc,2,PNP;IMPDH2,6 (6),0.0189,0.205,0,,10 (11),1,1,0.0938,0.285
Telomere Extension By Telomerase,Reactome,2,RUVBL2;NHP2,6 (6),0.0189,0.205,0,,4 (5),1,1,0.0938,0.285
Benzene metabolism,Wikipathways,2,GSTM1;MPO,6 (6),0.0189,0.205,0,,7 (11),1,1,0.0938,0.285
p130Cas linkage to MAPK signaling for integrins,Reactome,1,FN1,15 (15),0.435,1,1,HMDB00538,6 (8),0.0434,0.161,0.0939,0.285
NRAGE signals death through JNK,Reactome,2,PLEKHG2;ECT2,59 (61),0.652,1,1,HMDB00538,4 (4),0.0292,0.138,0.0944,0.286
Prefoldin mediated transfer of substrate  to CCT/TriC,Reactome,4,CCT2;CCT6A;TCP1;TUBA1C,28 (28),0.0193,0.207,0,,1 (1),1,1,0.0955,0.289
DDX58/IFIH1-mediated induction of interferon-alpha/beta,Reactome,1,HMGB1,56 (56),0.882,1,1,HMDB00538,3 (6),0.0219,0.134,0.0957,0.289
Biotin transport and metabolism,Reactome,1,ACACA,11 (11),0.342,1,1,HMDB00538,8 (9),0.0575,0.186,0.097,0.29
Glycogenosis_ Type III. Cori disease_ Debrancher glycogenosis,SMPDB,0,,18 (18),1,1,2,HMDB00285;HMDB00538,30 (30),0.0197,0.134,0.097,0.29
Glycogenosis_ Type VI. Hers disease,SMPDB,0,,18 (18),1,1,2,HMDB00285;HMDB00538,30 (30),0.0197,0.134,0.097,0.29
Fructose Mannose metabolism,INOH,0,,30 (30),1,1,2,HMDB01265;HMDB00538,30 (33),0.0197,0.134,0.097,0.29
Glycogen synthetase deficiency,SMPDB,0,,18 (18),1,1,2,HMDB00285;HMDB00538,30 (30),0.0197,0.134,0.097,0.29
Mucopolysaccharidosis VI. Sly syndrome,SMPDB,0,,18 (18),1,1,2,HMDB00285;HMDB00538,30 (30),0.0197,0.134,0.097,0.29
Sucrase-isomaltase deficiency,SMPDB,0,,18 (18),1,1,2,HMDB00285;HMDB00538,30 (30),0.0197,0.134,0.097,0.29
Glycogenosis_ Type IV. Amylopectinosis_ Anderson disease,SMPDB,0,,18 (18),1,1,2,HMDB00285;HMDB00538,30 (30),0.0197,0.134,0.097,0.29
Starch and Sucrose Metabolism,SMPDB,0,,18 (18),1,1,2,HMDB00285;HMDB00538,30 (30),0.0197,0.134,0.097,0.29
Transcriptional regulation by RUNX3,Wikipathways,1,SPP1,13 (13),0.39,1,1,HMDB00538,7 (7),0.0505,0.173,0.0971,0.29
Lysosome - Homo sapiens (human),KEGG,4,M6PR;CTSC;GLA;CTSG,123 (123),0.679,1,1,HMDB00538,4 (4),0.0292,0.138,0.0975,0.29
Activation of BH3-only proteins,Reactome,1,E2F1,30 (30),0.681,1,1,HMDB00538,4 (4),0.0292,0.138,0.0977,0.29
Translesion synthesis by REV1,Reactome,3,RFC5;RPA1;REV1,16 (16),0.0201,0.215,0,,2 (3),1,1,0.0988,0.29
MAPK targets/ Nuclear events mediated by MAP kinases,Reactome,1,PPP2R5D,31 (31),0.693,1,1,HMDB00538,4 (4),0.0292,0.138,0.099,0.29
Mitochondrial protein import,Reactome,2,CYC1;HSPD1,65 (65),0.704,1,1,HMDB00538,4 (4),0.0292,0.138,0.1,0.29
Osteopontin-mediated events,PID,1,SPP1,32 (32),0.704,1,1,HMDB00538,4 (6),0.0292,0.138,0.1,0.29
Peroxisomal lipid metabolism,Reactome,1,ECI2,29 (29),0.669,1,2,HMDB00201;HMDB00538,38 (60),0.0307,0.144,0.1,0.29
rRNA modification in the nucleus and cytosol,Reactome,6,NOP56;NHP2;UTP6;DHX37;HEATR1;UTP3,58 (59),0.0206,0.218,0,,4 (12),1,1,0.101,0.29
rRNA processing in the nucleus and cytosol,Reactome,6,NOP56;NHP2;UTP6;DHX37;HEATR1;UTP3,58 (59),0.0206,0.218,0,,4 (12),1,1,0.101,0.29
Constitutive Signaling by Aberrant PI3K in Cancer,Reactome,2,MET;PIK3AP1,69 (69),0.735,1,1,HMDB00538,4 (17),0.0292,0.138,0.104,0.29
Signaling by Interleukins,Reactome,8,HIST1H3C;HIST1H3I;SMARCA4;HIST1H3F;HMGB1;CANX;PPP2R5D;PRTN3,254 (254),0.737,1,1,HMDB00538,4 (14),0.0292,0.138,0.104,0.29
Cell-Cell communication,Reactome,1,ACTN4,123 (124),0.991,1,1,HMDB00538,3 (3),0.0219,0.134,0.105,0.29
RUNX2 regulates osteoblast differentiation,Reactome,1,HDAC6,24 (24),0.599,1,1,HMDB00538,5 (6),0.0363,0.149,0.105,0.29
ER-Phagosome pathway,Reactome,1,TLR1,24 (24),0.599,1,1,HMDB00538,5 (11),0.0363,0.149,0.105,0.29
Clathrin-mediated endocytosis,Reactome,7,AAK1;AP2A2;DNAJC6;M6PR;FCHO1;AP2S1;OCRL,138 (138),0.257,1,1,HMDB00538,12 (16),0.0851,0.228,0.105,0.29
FGFR2b ligand binding and activation,Reactome,0,,10 (10),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
FGFR2c ligand binding and activation,Reactome,0,,13 (13),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Regulation of RUNX2 expression and activity,Wikipathways,0,,2 (2),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
FGFR3b ligand binding and activation,Reactome,0,,7 (7),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,Reactome,0,,13 (13),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
FGFR2 ligand binding and activation,Reactome,0,,20 (20),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
betaKlotho-mediated ligand binding,Reactome,0,,3 (3),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
FGFR4 ligand binding and activation,Reactome,0,,14 (14),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Signaling by activated point mutants of FGFR1,Reactome,0,,11 (11),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Spry regulation of FGF signaling,Reactome,0,,14 (14),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,Reactome,0,,13 (13),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
Prolactin receptor signaling,Reactome,0,,14 (14),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
AMPK inhibits chREBP transcriptional activation activity,Reactome,0,,8 (8),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Signaling by cytosolic FGFR1 fusion mutants,Reactome,0,,18 (18),1,1,1,HMDB00538,3 (8),0.0219,0.134,0.106,0.29
gata3 participate in activating the th2 cytokine genes expression,BioCarta,0,,19 (19),1,1,1,HMDB00538,3 (5),0.0219,0.134,0.106,0.29
signaling pathway from g-protein families,BioCarta,0,,26 (26),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Role of LAT2/NTAL/LAB on calcium mobilization,Reactome,0,,93 (93),1,1,1,HMDB00538,3 (5),0.0219,0.134,0.106,0.29
CD28 dependent PI3K/Akt signaling,Reactome,0,,22 (22),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
FGFR3 mutant receptor activation,Reactome,0,,12 (12),1,1,1,HMDB00538,3 (12),0.0219,0.134,0.106,0.29
Activation of AKT2,Reactome,0,,4 (4),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
PD-1 signaling,Reactome,0,,31 (31),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Activated point mutants of FGFR2,Reactome,0,,17 (17),1,1,1,HMDB00538,3 (10),0.0219,0.134,0.106,0.29
Signaling by MST1,Reactome,0,,5 (5),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Dectin-2 family,Reactome,0,,29 (29),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
Inhibition of TSC complex formation by PKB,Reactome,0,,3 (3),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
endocytotic role of ndk phosphins and dynamin,BioCarta,0,,17 (17),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
RIPK1-mediated regulated necrosis,Reactome,0,,16 (16),1,1,1,HMDB00538,3 (6),0.0219,0.134,0.106,0.29
Regulated Necrosis,Reactome,0,,16 (16),1,1,1,HMDB00538,3 (6),0.0219,0.134,0.106,0.29
CaMK IV-mediated phosphorylation of CREB,Reactome,0,,3 (3),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
TNF signaling,Reactome,0,,37 (37),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,Reactome,0,,20 (20),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Activation of TRKA receptors,Reactome,0,,6 (6),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
CDO in myogenesis,Reactome,0,,29 (29),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Myogenesis,Reactome,0,,29 (29),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
PRPP biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB00538,3 (6),0.0219,0.134,0.106,0.29
Signaling by activated point mutants of FGFR3,Reactome,0,,12 (12),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
PI3K/AKT activation,Reactome,0,,9 (9),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
Caspase activation via extrinsic apoptotic signalling pathway,Reactome,0,,26 (26),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
DSCAM interactions,Reactome,0,,7 (7),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Inwardly rectifying K+ channels,Reactome,0,,31 (31),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Caloric restriction and aging,Wikipathways,0,,9 (9),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
TRAF6-mediated induction of TAK1 complex within TLR4 complex,Reactome,0,,11 (11),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
FGFR2 mutant receptor activation,Reactome,0,,17 (17),1,1,1,HMDB00538,3 (11),0.0219,0.134,0.106,0.29
Activation of CaMK IV,Reactome,0,,2 (2),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
CREB phosphorylation through the activation of CaMKK,Reactome,0,,4 (4),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
PI3K events in ERBB4 signaling,Reactome,0,,10 (10),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,Reactome,0,,10 (10),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
PI3K events in ERBB2 signaling,Reactome,0,,16 (16),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
Adefovir Dipivoxil Metabolism Pathway,SMPDB,0,,5 (5),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
Tenofovir Metabolism Pathway,SMPDB,0,,5 (5),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
Cell Cycle Checkpoints,Wikipathways,0,,1 (1),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
DDX58-IFIH1-mediated induction of interferon-alpha-beta,Wikipathways,0,,1 (1),1,1,1,HMDB00538,3 (6),0.0219,0.134,0.106,0.29
G beta:gamma signalling through PI3Kgamma,Reactome,0,,48 (48),1,1,1,HMDB00538,3 (5),0.0219,0.134,0.106,0.29
Signaling by NOTCH1,Wikipathways,0,,6 (6),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Signaling by NOTCH4,Wikipathways,0,,6 (6),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
FGFR1b ligand binding and activation,Reactome,0,,6 (6),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
FGFR1c ligand binding and activation,Reactome,0,,12 (12),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
FGFR1c and Klotho ligand binding and activation,Reactome,0,,3 (3),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
FGFR1 ligand binding and activation,Reactome,0,,16 (16),1,1,1,HMDB00538,3 (3),0.0219,0.134,0.106,0.29
Regulation of RUNX2 expression and activity,Reactome,0,,28 (28),1,1,1,HMDB00538,3 (4),0.0219,0.134,0.106,0.29
D-<i>myo</i>-inositol (1_3_4)-trisphosphate biosynthesis,HumanCyc,1,OCRL,15 (15),0.435,1,1,HMDB00538,7 (8),0.0505,0.173,0.106,0.29
Class A-1 (Rhodopsin-like receptors),Wikipathways,0,,0 (0),1,1,2,HMDB00285;HMDB00538,81 (104),0.118,0.292,0.118,0.292
Ion channel transport,Wikipathways,0,,0 (0),1,1,1,HMDB00538,17 (23),0.118,0.292,0.118,0.292
PI Metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,17 (29),0.118,0.292,0.118,0.292
Metabolism of folate and pterines,Wikipathways,0,,0 (0),1,1,1,HMDB00538,17 (26),0.118,0.292,0.118,0.292
Formation of the ternary complex_ and subsequently_ the 43S complex,Reactome,6,RPSA;RPS5;EIF3B;EIF3C;EIF3D;EIF3I,59 (61),0.0222,0.235,0,,1 (1),1,1,0.107,0.292
Histidine metabolism - Homo sapiens (human),KEGG,0,,23 (23),1,1,2,HMDB00001#HMDB00479;HMDB03045,32 (47),0.0223,0.136,0.107,0.292
RAF activation,Reactome,1,PPP2R5D,25 (25),0.614,1,1,HMDB00538,5 (5),0.0363,0.149,0.107,0.292
Regulation of PTEN stability and activity,Reactome,1,TRIM27,25 (25),0.614,1,1,HMDB00538,5 (5),0.0363,0.149,0.107,0.292
Gemcitabine Action Pathway,SMPDB,1,NT5C,13 (13),0.39,1,1,HMDB00538,8 (8),0.0575,0.186,0.108,0.293
Gemcitabine Metabolism Pathway,SMPDB,1,NT5C,13 (13),0.39,1,1,HMDB00538,8 (8),0.0575,0.186,0.108,0.293
PTEN Regulation,Reactome,5,RBBP4;HDAC1;RCOR1;TRIM27;HDAC2,96 (96),0.289,1,1,HMDB00538,11 (11),0.0783,0.213,0.108,0.294
Platelet degranulation ,Reactome,6,TGFB1;PPIA;ACTN4;F13A1;TAGLN2;FN1,129 (129),0.351,1,1,HMDB00538,9 (15),0.0645,0.198,0.108,0.294
Golgi Associated Vesicle Biogenesis,Reactome,2,OCRL;DNAJC6,56 (56),0.624,1,1,HMDB00538,5 (5),0.0363,0.149,0.108,0.294
Cell death signalling via NRAGE_ NRIF and NADE,Reactome,2,PLEKHG2;ECT2,76 (78),0.782,1,1,HMDB00538,4 (4),0.0292,0.138,0.109,0.295
PCP/CE pathway,Reactome,2,AP2A2;AP2S1,47 (47),0.528,1,1,HMDB00538,6 (7),0.0434,0.161,0.11,0.297
The citric acid (TCA) cycle and respiratory electron transport,Reactome,7,ACAD9;LDHA;OGDH;DLAT;LRPPRC;CYC1;UQCRC1,173 (173),0.469,1,2,HMDB00094;HMDB00538,49 (56),0.049,0.173,0.11,0.297
Chronic myeloid leukemia - Homo sapiens (human),KEGG,7,TGFB1;E2F1;CTBP1;HDAC1;HDAC2;CDK4;CDK6,76 (76),0.0231,0.243,0,,1 (1),1,1,0.11,0.297
Cilium Assembly,Reactome,13,CKAP5;PLK1;HDAC6;TCP1;KIF24;CDK5RAP2;PLK4;NEK2;CCT2;CEP152;CDK1;PCNT;ODF2,187 (187),0.0232,0.243,0,,6 (6),1,1,0.11,0.298
Intrinsic Pathway for Apoptosis,Reactome,1,E2F1,43 (43),0.806,1,1,HMDB00538,4 (4),0.0292,0.138,0.112,0.301
Gastric Cancer Network 2,Wikipathways,4,TOP2A;ATAD2;UBE2C;FANCI,32 (32),0.0302,0.301,0,,0 (0),1,1,0.0302,0.301
Arachidonic acid metabolism,Wikipathways,0,,0 (0),1,1,2,HMDB03337;HMDB00538,83 (107),0.123,0.302,0.123,0.302
Hepatocellular carcinoma - Homo sapiens (human),KEGG,12,GSTM1;TGFB1;SMARCB1;GSTO1;SMARCC1;MET;PHF10;E2F1;LRP5;CDK4;CDK6;SMARCA4,168 (168),0.0236,0.248,0,,9 (14),1,1,0.112,0.302
glycolysis,HumanCyc,2,PFKL;TPI1,24 (25),0.225,1,1,HMDB00538,15 (20),0.105,0.266,0.112,0.302
Translesion synthesis by POLK,Reactome,3,RFC5;RPA1;REV1,17 (17),0.0238,0.248,0,,3 (5),1,1,0.113,0.303
Translesion synthesis by POLI,Reactome,3,RFC5;RPA1;REV1,17 (17),0.0238,0.248,0,,2 (3),1,1,0.113,0.303
Platelet calcium homeostasis,Reactome,1,ATP2A2,28 (28),0.656,1,1,HMDB00538,5 (7),0.0363,0.149,0.113,0.303
Amino Acid metabolism,Wikipathways,2,LDHA;OGDH,91 (91),0.859,1,3,HMDB00094;HMDB03337;HMDB00099,92 (108),0.0278,0.138,0.113,0.303
Retrograde transport at the Trans-Golgi-Network,Reactome,2,M6PR;VPS52,49 (49),0.551,1,1,HMDB00538,6 (6),0.0434,0.161,0.113,0.303
Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human),KEGG,2,ATP2A2;TGFB1,83 (83),0.822,1,1,HMDB00538,4 (5),0.0292,0.138,0.113,0.303
Triglyceride metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,18 (30),0.125,0.306,0.125,0.306
MyD88 cascade initiated on plasma membrane,Reactome,2,PPP2R5D;HMGB1,87 (87),0.841,1,1,HMDB00538,4 (9),0.0292,0.138,0.115,0.308
Toll Like Receptor 10 (TLR10) Cascade,Reactome,2,PPP2R5D;HMGB1,87 (87),0.841,1,1,HMDB00538,4 (9),0.0292,0.138,0.115,0.308
Toll Like Receptor 5 (TLR5) Cascade,Reactome,2,PPP2R5D;HMGB1,87 (87),0.841,1,1,HMDB00538,4 (9),0.0292,0.138,0.115,0.308
Interferon gamma signaling,Reactome,2,IRF8;IFNGR1,94 (94),0.871,1,1,HMDB00538,4 (5),0.0292,0.138,0.119,0.313
PI3K/AKT Signaling in Cancer,Reactome,2,MET;PIK3AP1,94 (94),0.871,1,1,HMDB00538,4 (17),0.0292,0.138,0.119,0.313
RUNX2 regulates bone development,Reactome,1,HDAC6,32 (32),0.704,1,1,HMDB00538,5 (6),0.0363,0.149,0.119,0.313
Toll Like Receptor TLR1:TLR2 Cascade,Reactome,3,PPP2R5D;TLR1;HMGB1,97 (97),0.707,1,1,HMDB00538,5 (15),0.0363,0.149,0.12,0.313
Toll Like Receptor TLR6:TLR2 Cascade,Reactome,3,PPP2R5D;TLR1;HMGB1,97 (97),0.707,1,1,HMDB00538,5 (15),0.0363,0.149,0.12,0.313
Toll Like Receptor 2 (TLR2) Cascade,Reactome,3,PPP2R5D;TLR1;HMGB1,97 (97),0.707,1,1,HMDB00538,5 (15),0.0363,0.149,0.12,0.313
MyD88:Mal cascade initiated on plasma membrane,Reactome,3,PPP2R5D;TLR1;HMGB1,97 (97),0.707,1,1,HMDB00538,5 (15),0.0363,0.149,0.12,0.313
Toll Like Receptor 3 (TLR3) Cascade,Reactome,2,PPP2R5D;HMGB1,97 (97),0.882,1,1,HMDB00538,4 (10),0.0292,0.138,0.12,0.313
APOBEC3G mediated resistance to HIV-1 infection,Reactome,2,PPIA;BANF1,7 (7),0.0258,0.264,0,,2 (2),1,1,0.12,0.313
regulation of ck1/cdk5 by type 1 glutamate receptors,BioCarta,1,PPP2R5D,24 (24),0.599,1,1,HMDB00538,6 (7),0.0434,0.161,0.121,0.313
Sema4D in semaphorin signaling,Reactome,1,MET,24 (24),0.599,1,1,HMDB00538,6 (6),0.0434,0.161,0.121,0.313
Antigen Presentation: Folding_ assembly and peptide loading of class I MHC,Reactome,1,CANX,24 (24),0.599,1,1,HMDB00538,6 (8),0.0434,0.161,0.121,0.313
Signaling by FGFR2,Reactome,3,GTF2F1;PTBP1;NCBP1,73 (73),0.516,1,1,HMDB00538,7 (9),0.0505,0.173,0.121,0.313
Cellular response to heat stress,Wikipathways,1,FKBP4,16 (16),0.456,1,1,HMDB00538,8 (9),0.0575,0.186,0.122,0.313
Metabolism of lipids,Reactome,15,SREBF1;SGPP1;KPNB1;ACAA2;HSD17B12;ABCC1;NCOR2;RAN;GLA;ESYT1;PI4KA;ECI2;OCRL;PPP1CC;ACACA,659 (664),0.988,1,6,HMDB00094;HMDB00201;HMDB00082;HMDB00538;HMDB00095;HMDB03337,334 (620),0.0267,0.138,0.122,0.313
Signaling by FGFR,Reactome,4,SPRED1;GTF2F1;PTBP1;NCBP1,87 (87),0.409,1,1,HMDB00538,9 (11),0.0645,0.198,0.122,0.313
Di-unsaturated fatty acid beta-oxidation,EHMN,2,ACAA2;ECI2,23 (23),0.211,1,1,HMDB00538,18 (19),0.125,0.306,0.122,0.313
COPII-mediated vesicle transport,Reactome,2,CTSC;TRAPPC10,69 (69),0.735,1,1,HMDB00538,5 (9),0.0363,0.149,0.123,0.313
Interleukin-17 signaling,Reactome,1,PPP2R5D,65 (65),0.916,1,1,HMDB00538,4 (6),0.0292,0.138,0.123,0.313
MAP kinase activation,Reactome,1,PPP2R5D,65 (65),0.916,1,1,HMDB00538,4 (6),0.0292,0.138,0.123,0.313
Synthesis of pyrophosphates in the cytosol,Reactome,1,NUDT3,11 (11),0.342,1,1,HMDB00538,11 (19),0.0783,0.213,0.124,0.313
Interferon alpha/beta signaling,Reactome,1,IRF8,70 (70),0.931,1,1,HMDB00538,4 (11),0.0292,0.138,0.125,0.313
Lissencephaly gene (LIS1) in neuronal migration and development,PID,4,PPP2R5D;MAP1B;NUDC;LRPAP1,31 (31),0.0272,0.274,0,,1 (1),1,1,0.125,0.313
Ethanol effects on histone modifications,Wikipathways,4,HDAC1;HDAC2;HDAC6;EHMT2,31 (31),0.0272,0.274,0,,16 (21),1,1,0.125,0.313
Pyruvate metabolism,INOH,3,DLAT;LDHA;ACACA,34 (34),0.132,0.922,1,HMDB00538,31 (31),0.206,0.46,0.126,0.313
Response to elevated platelet cytosolic Ca2+,Reactome,6,TGFB1;PPIA;ACTN4;F13A1;TAGLN2;FN1,134 (134),0.384,1,1,HMDB00538,10 (17),0.0714,0.205,0.126,0.313
Doxorubicin Pathway (Cancer Cell)_ Pharmacodynamics,PharmGKB,3,TOP2A;ABCC1;MLH1,18 (18),0.0278,0.279,0,,1 (1),1,1,0.127,0.313
Drug metabolism - other enzymes - Homo sapiens (human),KEGG,7,GSTM1;MPO;GSTO1;UCK2;UMPS;DUT;IMPDH2,79 (79),0.0278,0.279,0,,12 (52),1,1,0.128,0.313
Signaling by BRAF and RAF fusions,Reactome,2,PAPD7;FN1,58 (58),0.643,1,1,HMDB00538,6 (8),0.0434,0.161,0.128,0.313
COPI-mediated anterograde transport,Reactome,1,COPZ1,83 (83),0.958,1,1,HMDB00538,4 (4),0.0292,0.138,0.128,0.313
Folate Metabolism,Wikipathways,3,MPO;SCARB1;MTHFD2,66 (66),0.449,1,2,HMDB00538;HMDB00099,56 (66),0.0623,0.198,0.128,0.313
MAPK6/MAPK4 signaling,Reactome,1,CDK1,39 (39),0.774,1,1,HMDB00538,5 (5),0.0363,0.149,0.128,0.313
RAB GEFs exchange GTP for GDP on RABs,Reactome,1,TRAPPC10,91 (91),0.969,1,1,HMDB00538,4 (4),0.0292,0.138,0.129,0.313
Negative regulation of MAPK pathway,Reactome,1,PPP2R5D,40 (40),0.782,1,1,HMDB00538,5 (5),0.0363,0.149,0.13,0.313
Potassium Channels,Reactome,1,KCNN3,100 (100),0.978,1,1,HMDB00538,4 (4),0.0292,0.138,0.13,0.313
Serine biosynthesis,Reactome,1,PSAT1,9 (9),0.29,1,1,HMDB00538,14 (17),0.0986,0.254,0.13,0.313
PI3K-AKT-mTOR - VitD3 Signalling,Wikipathways,1,LDHA,22 (22),0.567,1,1,HMDB00538,7 (8),0.0505,0.173,0.13,0.313
Trans-sulfuration pathway,Wikipathways,1,DNMT1,10 (10),0.317,1,1,HMDB00538,13 (14),0.0919,0.241,0.132,0.313
Oncogenic MAPK signaling,Reactome,2,PAPD7;FN1,61 (61),0.67,1,1,HMDB00538,6 (11),0.0434,0.161,0.132,0.313
GPCR signaling-cholera toxin,INOH,1,TGFB1,270 (270),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
GPCR signaling-G alpha s Epac and ERK,INOH,1,TGFB1,272 (272),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
GPCR signaling-G alpha s PKA and ERK,INOH,1,TGFB1,285 (285),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Negative regulation of FGFR2 signaling,Reactome,0,,34 (34),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Phospholipase C-mediated cascade; FGFR2,Reactome,0,,18 (18),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Oxidative phosphorylation,Wikipathways,0,,61 (61),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
PI-3K cascade:FGFR2,Reactome,0,,23 (23),1,1,1,HMDB00538,4 (6),0.0292,0.138,0.132,0.313
XBP1(S) activates chaperone genes,Reactome,0,,8 (8),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
PI-3K cascade:FGFR3,Reactome,0,,18 (18),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Negative regulation of FGFR3 signaling,Reactome,0,,29 (29),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
adenine and adenosine salvage II,HumanCyc,0,,1 (1),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Hh mutants that don_t undergo autocatalytic processing are degraded by ERAD,Reactome,0,,11 (11),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
creatine-phosphate biosynthesis,HumanCyc,0,,5 (5),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
PI-3K cascade:FGFR4,Reactome,0,,20 (20),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Negative regulation of FGFR4 signaling,Reactome,0,,31 (31),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
cardiolipin biosynthesis,HumanCyc,0,,4 (4),1,1,1,HMDB00095,4 (9),0.0292,0.138,0.132,0.313
PI-3K cascade:FGFR1,Reactome,0,,21 (21),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Growth hormone receptor signaling,Reactome,0,,19 (19),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
glycogen biosynthesis,HumanCyc,0,,8 (8),1,1,1,HMDB00285,4 (7),0.0292,0.138,0.132,0.313
IRE1alpha activates chaperones,Reactome,0,,10 (10),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Unfolded Protein Response (UPR),Reactome,0,,21 (21),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Phosphorylation of CD3 and TCR zeta chains,Reactome,0,,30 (30),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Translocation of ZAP-70 to Immunological synapse,Reactome,0,,27 (27),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
FGFR1 mutant receptor activation,Reactome,0,,31 (31),1,1,1,HMDB00538,4 (15),0.0292,0.138,0.132,0.313
SHC1 events in ERBB4 signaling,Reactome,0,,14 (14),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Pancreas Function,SMPDB,0,,6 (6),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Signal transduction by L1,Reactome,0,,22 (22),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Phospholipase C-mediated cascade; FGFR4,Reactome,0,,15 (15),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Interferon gamma signaling,Wikipathways,0,,7 (7),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Endosomal Sorting Complex Required For Transport (ESCRT),Reactome,0,,32 (32),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Activation of NF-kappaB in B cells,Reactome,0,,18 (18),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
SHC1 events in EGFR signaling,Reactome,0,,8 (8),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Activation of BAD and translocation to mitochondria ,Reactome,0,,15 (15),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Cellular roles of Anthrax toxin,PID,0,,22 (22),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
EPHA-mediated growth cone collapse,Reactome,0,,15 (15),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
The proton buffering model,Reactome,0,,5 (5),1,1,1,HMDB00538,4 (6),0.0292,0.138,0.132,0.313
STING mediated induction of host immune responses,Reactome,0,,16 (16),1,1,1,HMDB00538,4 (8),0.0292,0.138,0.132,0.313
RHO GTPases Activate WASPs and WAVEs,Reactome,0,,37 (37),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Ephrin signaling,Reactome,0,,19 (19),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
EPH-ephrin mediated repulsion of cells,Reactome,0,,8 (8),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
thiamin salvage III,HumanCyc,0,,1 (1),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Synthesis of PIPs in the nucleus,Reactome,0,,4 (4),1,1,1,HMDB00538,4 (6),0.0292,0.138,0.132,0.313
Type II diabetes mellitus,Wikipathways,0,,22 (22),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
phospholipase c-epsilon pathway,BioCarta,0,,12 (12),1,1,1,HMDB00538,4 (6),0.0292,0.138,0.132,0.313
Smooth Muscle Contraction,Reactome,0,,35 (35),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
regulation of spermatogenesis by crem,BioCarta,0,,10 (10),1,1,1,HMDB00538,4 (7),0.0292,0.138,0.132,0.313
Striated Muscle Contraction,Reactome,0,,35 (35),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Disinhibition of SNARE formation,Reactome,0,,5 (5),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Downregulation of ERBB2 signaling,Reactome,0,,29 (29),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
GPCR Adenosine A2A receptor,INOH,0,,36 (36),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Mitochondrial Uncoupling Proteins,Reactome,0,,5 (5),1,1,1,HMDB00538,4 (8),0.0292,0.138,0.132,0.313
Activated NTRK2 signals through RAS,Reactome,0,,9 (9),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Activated NTRK2 signals through CDK5,Reactome,0,,6 (6),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Signaling by NTRK2 (TRKB),Reactome,0,,20 (20),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Tie2 Signaling,Reactome,0,,18 (18),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
ADP signalling through P2Y purinoceptor 1,Reactome,0,,24 (24),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Sema4D induced cell migration and growth-cone collapse,Reactome,0,,20 (20),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Sodium-coupled sulphate_ di- and tri-carboxylate transporters,Reactome,0,,5 (5),1,1,1,HMDB00094,4 (4),0.0292,0.138,0.132,0.313
SeMet incorporation into proteins,Reactome,0,,11 (11),1,1,1,HMDB00538,4 (6),0.0292,0.138,0.132,0.313
PTK6 Down-Regulation,Reactome,0,,3 (3),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
hydrogen sulfide biosynthesis (trans-sulfuration),HumanCyc,0,,3 (3),1,1,1,HMDB00099,4 (6),0.0292,0.138,0.132,0.313
Intra-Golgi traffic,Reactome,0,,45 (45),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
FCERI mediated NF-kB activation,Reactome,0,,99 (99),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Formation of ATP by chemiosmotic coupling,Reactome,0,,18 (18),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Gliclazide Action Pathway,SMPDB,0,,6 (6),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
SHC-related events triggered by IGF1R,Reactome,0,,9 (9),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Erlotinib Action Pathway,SMPDB,0,,3 (3),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
Hh mutants abrogate ligand secretion,Reactome,0,,11 (11),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
lipoate salvage,HumanCyc,0,,2 (2),1,1,1,HMDB00538,4 (6),0.0292,0.138,0.132,0.313
glutathione redox reactions II,HumanCyc,0,,2 (2),1,1,1,HMDB03337,4 (5),0.0292,0.138,0.132,0.313
Gastrin-CREB signalling pathway via PKC and MAPK,Reactome,0,,19 (19),1,1,1,HMDB00538,4 (5),0.0292,0.138,0.132,0.313
G-protein beta:gamma signalling,Reactome,0,,51 (51),1,1,1,HMDB00538,4 (7),0.0292,0.138,0.132,0.313
Interferon alpha-beta signaling,Wikipathways,0,,21 (21),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Intrinsic Pathway for Apoptosis,Wikipathways,0,,4 (4),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Nucleotide-binding domain_ leucine rich repeat containing receptor (NLR) signaling pathways,Wikipathways,0,,1 (1),1,1,1,HMDB00538,4 (10),0.0292,0.138,0.132,0.313
Negative regulation of FGFR1 signaling,Reactome,0,,33 (33),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Phospholipase C-mediated cascade: FGFR1,Reactome,0,,16 (16),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Senescence-Associated Secretory Phenotype (SASP),Wikipathways,0,,6 (6),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
DNA Damage-Telomere Stress Induced Senescence,Wikipathways,0,,1 (1),1,1,1,HMDB00538,4 (9),0.0292,0.138,0.132,0.313
Phospholipase C-mediated cascade; FGFR3,Reactome,0,,13 (13),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer_s disease models,Wikipathways,0,,4 (4),1,1,1,HMDB00538,4 (4),0.0292,0.138,0.132,0.313
Antimicrobial peptides,Reactome,5,TLR1;PRTN3;ELANE;CCR2;CTSG,100 (106),0.318,1,1,HMDB00538,13 (23),0.0919,0.241,0.132,0.313
Folate metabolism,INOH,3,MTHFD2;MTHFD1L;ATIC,31 (31),0.108,0.78,1,HMDB00538,43 (46),0.274,0.592,0.134,0.315
Regulation of nuclear beta catenin signaling and target gene transcription,PID,7,INCENP;SMARCA4;RUVBL2;CTBP1;VCAN;HDAC1;HDAC2,80 (80),0.0296,0.296,0,,2 (2),1,1,0.134,0.315
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Reactome,2,PPP2R5D;HMGB1,88 (88),0.846,1,1,HMDB00538,5 (11),0.0363,0.149,0.138,0.324
PI5P_ PP2A and IER3 Regulate PI3K/AKT Signaling,Reactome,3,PPP2R5D;MET;PIK3AP1,97 (97),0.707,1,1,HMDB00538,6 (12),0.0434,0.161,0.138,0.324
brca1 dependent ub ligase activity,BioCarta,2,FANCD2;BARD1,8 (8),0.0335,0.325,0,,0 (0),1,1,0.0335,0.325
Nef Mediated CD8 Down-regulation,Reactome,2,AP2A2;AP2S1,8 (8),0.0335,0.325,0,,0 (0),1,1,0.0335,0.325
Toll Like Receptor 7/8 (TLR7/8) Cascade,Reactome,2,PPP2R5D;HMGB1,90 (90),0.855,1,1,HMDB00538,5 (11),0.0363,0.149,0.139,0.326
MyD88 dependent cascade initiated on endosome,Reactome,2,PPP2R5D;HMGB1,90 (90),0.855,1,1,HMDB00538,5 (11),0.0363,0.149,0.139,0.326
1D-<i>myo</i>-inositol hexakisphosphate biosynthesis II (mammalian),HumanCyc,1,OCRL,15 (15),0.435,1,1,HMDB00538,10 (11),0.0714,0.205,0.139,0.326
Cytosolic sensors of pathogen-associated DNA ,Reactome,1,HMGB1,51 (51),0.857,1,1,HMDB00538,5 (13),0.0363,0.149,0.139,0.326
Toll Like Receptor 4 (TLR4) Cascade,Reactome,3,PPP2R5D;TLR1;HMGB1,127 (127),0.858,1,1,HMDB00538,5 (15),0.0363,0.149,0.139,0.326
p75 NTR receptor-mediated signalling,Reactome,4,HDAC1;HDAC2;ECT2;PLEKHG2,96 (99),0.484,1,1,HMDB00538,9 (9),0.0645,0.198,0.139,0.326
Wnt Canonical,INOH,9,PSMC1;SMARCA4;LRP5;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,119 (119),0.034,0.328,0,,0 (0),1,1,0.034,0.328
Wnt Mammals,INOH,9,PSMC1;SMARCA4;LRP5;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,119 (119),0.034,0.328,0,,0 (0),1,1,0.034,0.328
Signaling by high-kinase activity BRAF mutants,Reactome,1,FN1,34 (34),0.726,1,1,HMDB00538,6 (11),0.0434,0.161,0.141,0.329
Toll Like Receptor 9 (TLR9) Cascade,Reactome,2,PPP2R5D;HMGB1,94 (94),0.871,1,1,HMDB00538,5 (11),0.0363,0.149,0.141,0.329
rRNA processing,Reactome,6,NOP56;NHP2;UTP6;DHX37;HEATR1;UTP3,64 (65),0.0317,0.315,0,,4 (12),1,1,0.141,0.33
LDL clearance,Reactome,3,AP2A2;SOAT2;AP2S1,19 (19),0.0321,0.316,0,,5 (9),1,1,0.143,0.332
Nucleotide Metabolism,Wikipathways,3,POLD1;MTHFD2;POLA1,19 (19),0.0321,0.316,0,,17 (18),1,1,0.143,0.332
Tetrahydrobiopterin (BH4) synthesis_ recycling_ salvage and regulation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,20 (27),0.138,0.332,0.138,0.332
Gamma carboxylation_ hypusine formation and arylsulfatase activation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,20 (30),0.138,0.332,0.138,0.332
Histidine Metabolism,SMPDB,0,,15 (15),1,1,2,HMDB00538;HMDB00001#HMDB00479,39 (40),0.0323,0.149,0.143,0.333
Histidinemia,SMPDB,0,,15 (15),1,1,2,HMDB00538;HMDB00001#HMDB00479,39 (40),0.0323,0.149,0.143,0.333
Signaling by RAS mutants,Reactome,1,FN1,36 (36),0.746,1,1,HMDB00538,6 (8),0.0434,0.161,0.144,0.334
TRIF(TICAM1)-mediated TLR4 signaling ,Reactome,2,PPP2R5D;HMGB1,101 (101),0.895,1,1,HMDB00538,5 (10),0.0363,0.149,0.144,0.334
MyD88-independent TLR4 cascade ,Reactome,2,PPP2R5D;HMGB1,101 (101),0.895,1,1,HMDB00538,5 (10),0.0363,0.149,0.144,0.334
Notch-mediated HES/HEY network,PID,5,HDAC1;MYB;NCOR2;E2F1;CTBP1,48 (48),0.0325,0.32,0,,3 (3),1,1,0.144,0.334
Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids,SMPDB,1,ACAA2,8 (8),0.262,1,1,HMDB00538,18 (19),0.125,0.306,0.145,0.335
Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD),SMPDB,1,ACAA2,8 (8),0.262,1,1,HMDB00538,18 (19),0.125,0.306,0.145,0.335
MAP2K and MAPK activation,Reactome,1,FN1,38 (38),0.765,1,1,HMDB00538,6 (8),0.0434,0.161,0.146,0.338
Signaling by moderate kinase activity BRAF mutants,Reactome,1,FN1,38 (38),0.765,1,1,HMDB00538,6 (8),0.0434,0.161,0.146,0.338
Paradoxical activation of RAF signaling by kinase inactive BRAF,Reactome,1,FN1,38 (38),0.765,1,1,HMDB00538,6 (9),0.0434,0.161,0.146,0.338
Plasma lipoprotein clearance,Reactome,4,AP2A2;SOAT2;SCARB1;AP2S1,33 (33),0.0333,0.325,0,,5 (9),1,1,0.147,0.338
HIF-1 signaling pathway - Homo sapiens (human),KEGG,5,LDHA;EGLN1;PFKL;IFNGR1;NOS2,100 (100),0.318,1,1,HMDB00538,15 (15),0.105,0.266,0.147,0.339
HIF1A and PPARG regulation of glycolysis,Wikipathways,2,LDHA;TPI1,8 (8),0.0335,0.325,0,,7 (10),1,1,0.147,0.339
Irinotecan Action Pathway,SMPDB,1,ABCC1,23 (23),0.583,1,1,HMDB00538,8 (12),0.0575,0.186,0.147,0.339
Irinotecan Metabolism Pathway,SMPDB,1,ABCC1,23 (23),0.583,1,1,HMDB00538,8 (12),0.0575,0.186,0.147,0.339
Creatine metabolism,Reactome,1,GATM,11 (11),0.342,1,1,HMDB00538,14 (15),0.0986,0.254,0.148,0.339
TP53 Regulates Transcription of Cell Death Genes,Wikipathways,1,BIRC5,29 (29),0.669,1,1,HMDB00538,7 (10),0.0505,0.173,0.148,0.339
Cannabinoid receptor signaling,Wikipathways,1,AHR,20 (20),0.533,1,1,HMDB00538,9 (20),0.0645,0.198,0.15,0.339
Fatty acid metabolism,Reactome,5,HSD17B12;ACAA2;ABCC1;ACACA;ECI2,185 (189),0.825,1,4,HMDB00094;HMDB00201;HMDB03337;HMDB00538,186 (367),0.0423,0.161,0.152,0.339
insulin Mam,INOH,2,PPP2R5D;EIF4G1,82 (82),0.816,1,1,HMDB00285,6 (7),0.0434,0.161,0.154,0.339
NOD-like receptor signaling pathway - Homo sapiens (human),KEGG,1,HSP90AB1,168 (168),0.998,1,1,HMDB00538,5 (15),0.0363,0.149,0.157,0.339
SHC-mediated cascade:FGFR2,Reactome,0,,23 (23),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
Methylation Pathways,Wikipathways,0,,9 (9),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
activation of camp-dependent protein kinase pka,BioCarta,0,,31 (31),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,Reactome,0,,35 (35),1,1,1,HMDB00538,5 (7),0.0363,0.149,0.157,0.339
FRS-mediated FGFR2 signaling,Reactome,0,,25 (25),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
FRS-mediated FGFR4 signaling,Reactome,0,,22 (22),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
CREB phosphorylation through the activation of CaMKII,Reactome,0,,15 (15),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
DAP12 signaling,Reactome,0,,30 (30),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
Defective CFTR causes cystic fibrosis,Reactome,0,,16 (16),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
FGFR3 ligand binding and activation,Reactome,0,,13 (13),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
SHC-mediated cascade:FGFR3,Reactome,0,,18 (18),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Constitutive Signaling by EGFRvIII,Reactome,0,,13 (13),1,1,1,HMDB00538,5 (9),0.0363,0.149,0.157,0.339
adenosine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,0,,12 (12),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
CD28 dependent Vav1 pathway,Reactome,0,,12 (12),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Regulation of Ras family activation,PID,0,,33 (34),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
DAP12 interactions,Reactome,0,,45 (45),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
Arf1 pathway,PID,0,,20 (20),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
Elevation of cytosolic Ca2+ levels,Reactome,0,,16 (16),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
Uptake and function of anthrax toxins,Reactome,0,,10 (10),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
SHC-mediated cascade:FGFR4,Reactome,0,,20 (20),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Abacavir transmembrane transport,Reactome,0,,5 (5),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
ARMS-mediated activation,Reactome,0,,7 (7),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Prolonged ERK activation events,Reactome,0,,11 (11),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
PKA activation,Reactome,0,,17 (17),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
FRS-mediated FGFR1 signaling,Reactome,0,,23 (23),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Signalling to RAS,Reactome,0,,18 (18),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Mitochondrial ABC transporters,Reactome,0,,4 (4),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
NCAM signaling for neurite out-growth,Reactome,0,,59 (59),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Signal amplification,Reactome,0,,31 (31),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
RHO GTPases Activate ROCKs,Reactome,0,,19 (19),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
EGFR downregulation,Reactome,0,,25 (25),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
Signaling by Ligand-Responsive EGFR Variants in Cancer,Reactome,0,,15 (15),1,1,1,HMDB00538,5 (9),0.0363,0.149,0.157,0.339
p38MAPK events,Reactome,0,,11 (11),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Generation of second messenger molecules,Reactome,0,,41 (41),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
Signaling by SCF-KIT,Reactome,0,,43 (43),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
Frs2-mediated activation,Reactome,0,,9 (9),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Type II diabetes mellitus - Homo sapiens (human),KEGG,0,,46 (46),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
Cellular hexose transport,Reactome,0,,21 (21),1,1,1,HMDB00538,5 (7),0.0363,0.149,0.157,0.339
SHC-mediated cascade:FGFR1,Reactome,0,,21 (21),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
FCERI mediated MAPK activation,Reactome,0,,109 (109),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
fructose 2_6-bisphosphate synthesis,HumanCyc,0,,5 (5),1,1,1,HMDB00538,5 (7),0.0363,0.149,0.157,0.339
activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor,BioCarta,0,,45 (45),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,Reactome,0,,14 (14),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
GAB1 signalosome,Reactome,0,,11 (11),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
CD28 co-stimulation,Reactome,0,,33 (33),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
FGFR3c ligand binding and activation,Reactome,0,,13 (13),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Glibenclamide Action Pathway,SMPDB,0,,6 (6),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
homocarnosine biosynthesis,HumanCyc,0,,1 (1),1,1,1,HMDB00538,5 (7),0.0363,0.149,0.157,0.339
MAPK6-MAPK4 signaling,Wikipathways,0,,8 (8),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
FRS-mediated FGFR3 signaling,Reactome,0,,20 (20),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Downstream signal transduction,Reactome,0,,30 (30),1,1,1,HMDB00538,5 (7),0.0363,0.149,0.157,0.339
Signaling by EGFRvIII in Cancer,Reactome,0,,13 (13),1,1,1,HMDB00538,5 (9),0.0363,0.149,0.157,0.339
Signaling by EGFR in Cancer,Reactome,0,,15 (15),1,1,1,HMDB00538,5 (9),0.0363,0.149,0.157,0.339
NADH repair,HumanCyc,0,,3 (3),1,1,1,HMDB00538,5 (8),0.0363,0.149,0.157,0.339
PKA activation in glucagon signalling,Reactome,0,,17 (17),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Signaling by FGFR3 fusions in cancer,Reactome,0,,10 (10),1,1,1,HMDB00538,5 (6),0.0363,0.149,0.157,0.339
CREB phosphorylation through the activation of Adenylate Cyclase,Reactome,0,,7 (7),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Signaling by FGFR4 in disease,Reactome,0,,11 (11),1,1,1,HMDB00538,5 (7),0.0363,0.149,0.157,0.339
methionine salvage,HumanCyc,0,,3 (3),1,1,1,HMDB00043,5 (8),0.0363,0.149,0.157,0.339
Regulation of TP53 Expression and Degradation,Wikipathways,0,,4 (4),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,Reactome,0,,15 (15),1,1,1,HMDB00538,5 (9),0.0363,0.149,0.157,0.339
Repaglinide Action Pathway,SMPDB,0,,6 (6),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Nateglinide Action Pathway,SMPDB,0,,6 (6),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
transcription factor creb and its extracellular signals,BioCarta,0,,27 (27),1,1,1,HMDB00538,5 (5),0.0363,0.149,0.157,0.339
Citrate cycle (TCA cycle) - Homo sapiens (human),KEGG,2,DLAT;OGDH,30 (30),0.309,1,1,HMDB00094,17 (20),0.118,0.292,0.158,0.34
One carbon pool by folate - Homo sapiens (human),KEGG,3,MTHFD2;MTHFD1L;ATIC,20 (20),0.0368,0.352,0,,9 (9),1,1,0.158,0.341
Pentose phosphate pathway,Wikipathways,0,,0 (0),1,1,1,HMDB00538,21 (31),0.144,0.344,0.144,0.344
Opioid Signalling,Wikipathways,0,,0 (0),1,1,1,HMDB00538,21 (22),0.144,0.344,0.144,0.344
Metabolic reprogramming in colon cancer,Wikipathways,3,PSAT1;LDHA;PFKL,42 (42),0.206,1,1,HMDB00094,27 (35),0.182,0.415,0.161,0.346
Negative regulation of the PI3K/AKT network,Reactome,3,PPP2R5D;MET;PIK3AP1,104 (104),0.751,1,1,HMDB00538,7 (14),0.0505,0.173,0.162,0.349
superpathway of D-<i>myo</i>-inositol (1_4_5)-trisphosphate metabolism,HumanCyc,1,OCRL,20 (20),0.533,1,1,HMDB00538,10 (11),0.0714,0.205,0.162,0.349
guanosine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,1,IMPDH2,13 (13),0.39,1,1,HMDB00538,14 (15),0.0986,0.254,0.164,0.352
Regulation of cytoplasmic and nuclear SMAD2/3 signaling,PID,3,NUP214;KPNA2;KPNB1,20 (20),0.0368,0.352,0,,0 (0),1,1,0.0368,0.352
Branched-chain amino acid catabolism,Reactome,0,,23 (23),1,1,2,HMDB01325;HMDB00538,43 (47),0.0386,0.157,0.164,0.353
ER to Golgi Anterograde Transport,Reactome,3,COPZ1;CTSC;TRAPPC10,137 (137),0.89,1,1,HMDB00538,6 (10),0.0434,0.161,0.164,0.353
Omega-6 fatty acid metabolism,EHMN,2,ACAA2;ECI2,28 (28),0.281,1,1,HMDB00538,20 (23),0.138,0.332,0.165,0.353
Signaling by NTRK1 (TRKA),Reactome,3,PPP2R5D;AP2A2;AP2S1,76 (76),0.544,1,1,HMDB00538,10 (11),0.0714,0.205,0.165,0.353
Propanoate metabolism,INOH,2,ACAA2;LDHA,25 (25),0.239,1,1,HMDB00538,24 (26),0.163,0.38,0.166,0.355
Pertussis - Homo sapiens (human),KEGG,2,IRF8;NOS2,76 (76),0.782,1,1,HMDB00538,7 (10),0.0505,0.173,0.167,0.357
Platelet homeostasis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,22 (28),0.151,0.358,0.151,0.358
Netrin-1 signaling,Reactome,1,DOCK1,41 (41),0.79,1,1,HMDB00538,7 (8),0.0505,0.173,0.168,0.36
Purine catabolism,Reactome,2,NT5C;PNP,19 (19),0.157,0.997,1,HMDB03337,40 (53),0.258,0.562,0.17,0.362
Interferon Signaling,Reactome,3,IRF8;IFNGR1;EIF4G1,158 (158),0.938,1,1,HMDB00538,6 (15),0.0434,0.161,0.171,0.362
TP53 Regulates Transcription of Cell Death Genes,Reactome,1,BIRC5,44 (44),0.813,1,1,HMDB00538,7 (10),0.0505,0.173,0.172,0.362
Integrin alphaIIb beta3 signaling,Reactome,1,FN1,27 (27),0.642,1,1,HMDB00538,9 (12),0.0645,0.198,0.173,0.362
Integrin signaling,Reactome,1,FN1,27 (27),0.642,1,1,HMDB00538,9 (12),0.0645,0.198,0.173,0.362
Mycophenolic Acid Metabolism Pathway,SMPDB,1,IMPDH2,16 (16),0.456,1,1,HMDB00538,13 (16),0.0919,0.241,0.175,0.362
Arginine Proline metabolism,INOH,2,NOS2;GATM,55 (55),0.614,1,2,HMDB02064;HMDB00538,59 (68),0.0683,0.205,0.175,0.362
Regulation of actin dynamics for phagocytic cup formation,Reactome,2,DOCK1;HSP90AB1,141 (141),0.97,1,1,HMDB00538,6 (12),0.0434,0.161,0.176,0.362
Pentose phosphate cycle,INOH,2,PFKL;UMPS,24 (24),0.225,1,1,HMDB00538,28 (31),0.188,0.427,0.176,0.362
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,Reactome,1,PIK3AP1,97 (97),0.975,1,1,HMDB00538,6 (8),0.0434,0.161,0.176,0.362
Class I MHC mediated antigen processing & presentation,Reactome,13,CCNF;ANAPC1;TRIM37;CDC16;FBXW8;CANX;UBE2C;TLR1;CDC23;UBE3C;FZR1;TRAIP;CDC20,323 (324),0.431,1,1,HMDB00538,14 (24),0.0986,0.254,0.177,0.362
Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids,SMPDB,1,ACAA2,8 (8),0.262,1,1,HMDB00538,24 (25),0.163,0.38,0.178,0.362
Signaling by FGFR1,Reactome,1,SPRED1,50 (50),0.851,1,1,HMDB00538,7 (8),0.0505,0.173,0.178,0.362
Mono-unsaturated fatty acid beta-oxidation,EHMN,1,ACAA2,21 (21),0.55,1,1,HMDB00538,11 (12),0.0783,0.213,0.179,0.362
Rab regulation of trafficking,Reactome,1,TRAPPC10,126 (126),0.992,1,1,HMDB00538,6 (6),0.0434,0.161,0.179,0.362
Bopindolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,9 (9),0.0645,0.198,0.179,0.362
Arbutamine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,9 (10),0.0645,0.198,0.179,0.362
Alprenolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,9 (10),0.0645,0.198,0.179,0.362
Muscle/Heart Contraction,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,9 (9),0.0645,0.198,0.179,0.362
Bupranolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,9 (9),0.0645,0.198,0.179,0.362
Isradipine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,9 (9),0.0645,0.198,0.179,0.362
Felodipine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,9 (10),0.0645,0.198,0.179,0.362
Transcriptional regulation by RUNX3,Reactome,1,TGFB1,51 (52),0.857,1,1,HMDB00538,7 (7),0.0505,0.173,0.179,0.362
Downstream signaling of activated FGFR2,Reactome,0,,30 (30),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.18,0.362
cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway,BioCarta,0,,22 (22),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
Downstream signaling of activated FGFR4,Reactome,0,,27 (27),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
NAD phosphorylation and dephosphorylation,HumanCyc,0,,2 (2),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
Transferrin endocytosis and recycling,Reactome,0,,31 (31),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.18,0.362
Disorders of transmembrane transporters,Reactome,0,,17 (17),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
Hedgehog _off_ state,Reactome,0,,43 (44),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
Transport and synthesis of PAPS,Reactome,0,,6 (6),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
Glucagon signaling in metabolic regulation,Reactome,0,,33 (33),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
Signaling by FGFR1 in disease,Reactome,0,,38 (38),1,1,1,HMDB00538,6 (17),0.0434,0.161,0.18,0.362
Downstream TCR signaling,Reactome,0,,51 (51),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.18,0.362
choline degradation,HumanCyc,0,,2 (2),1,1,1,HMDB00043,6 (7),0.0434,0.161,0.18,0.362
Downstream signaling of activated FGFR3,Reactome,0,,25 (25),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
guanosine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,0,,12 (12),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
PDE3B signalling,Reactome,0,,2 (2),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
PKB-mediated events,Reactome,0,,2 (2),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
carnosine biosynthesis,HumanCyc,0,,1 (1),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
Signaling by FGFR2 in disease,Reactome,0,,27 (27),1,1,1,HMDB00538,6 (15),0.0434,0.161,0.18,0.362
PKA-mediated phosphorylation of CREB,Reactome,0,,18 (18),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
iron-sulfur cluster biosynthesis,HumanCyc,0,,1 (1),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
RHO GTPases activate PAKs,Reactome,0,,21 (21),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
GPVI-mediated activation cascade,Reactome,0,,33 (33),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.18,0.362
glutamine biosynthesis,HumanCyc,0,,1 (1),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
Signalling to ERKs,Reactome,0,,29 (29),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
inositol pyrophosphates biosynthesis,HumanCyc,0,,7 (7),1,1,1,HMDB00538,6 (10),0.0434,0.161,0.18,0.362
D-<i>myo</i>-inositol-5-phosphate metabolism,HumanCyc,0,,20 (20),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.18,0.362
<i>N</i>-acetylglucosamine degradation II,HumanCyc,0,,4 (4),1,1,1,HMDB00538,6 (9),0.0434,0.161,0.18,0.362
sulfate activation for sulfonation,HumanCyc,0,,2 (2),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
acetate conversion to acetyl-CoA,HumanCyc,0,,3 (3),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
Reuptake of GABA,Reactome,0,,4 (4),1,1,1,HMDB00043,6 (6),0.0434,0.161,0.18,0.362
cysteine biosynthesis/homocysteine degradation (trans-sulfuration),HumanCyc,0,,3 (3),1,1,1,HMDB00099,6 (7),0.0434,0.161,0.18,0.362
Signaling by ROBO receptors,Reactome,0,,66 (66),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.18,0.362
PI5P Regulates TP53 Acetylation,Reactome,0,,9 (9),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.18,0.362
flavin biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
S-adenosyl-L-methionine biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
Signaling by FGFR3 point mutants in cancer,Reactome,0,,22 (22),1,1,1,HMDB00538,6 (16),0.0434,0.161,0.18,0.362
Signaling by FGFR3 in disease,Reactome,0,,22 (22),1,1,1,HMDB00538,6 (16),0.0434,0.161,0.18,0.362
cardiac protection against ros,BioCarta,0,,12 (12),1,1,1,HMDB00538,6 (10),0.0434,0.161,0.18,0.362
Signaling by FGFR in disease,Reactome,0,,47 (47),1,1,1,HMDB00538,6 (20),0.0434,0.161,0.18,0.362
Signaling by ERBB4,Reactome,0,,44 (44),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.18,0.362
CD209 (DC-SIGN) signaling,Reactome,0,,19 (19),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
Signaling by ROBO receptors,Wikipathways,0,,4 (4),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.18,0.362
Downstream signaling of activated FGFR1,Reactome,0,,31 (31),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
mRNA decay by 5_ to 3_ exoribonuclease,Reactome,0,,15 (15),1,1,1,HMDB00095,6 (7),0.0434,0.161,0.18,0.362
Transcriptional activity of SMAD2-SMAD3-SMAD4 heterotrimer,Wikipathways,0,,5 (5),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
Signaling by ERBB4,Wikipathways,0,,5 (5),1,1,1,HMDB00538,6 (8),0.0434,0.161,0.18,0.362
Hedgehog _off_ state,Wikipathways,0,,3 (3),1,1,1,HMDB00538,6 (6),0.0434,0.161,0.18,0.362
ABC transporter disorders,Reactome,0,,17 (17),1,1,1,HMDB00538,6 (7),0.0434,0.161,0.18,0.362
Methionine De Novo and Salvage Pathway,Wikipathways,0,,21 (21),1,1,2,HMDB00538;HMDB00043,46 (47),0.0437,0.162,0.181,0.364
Signaling by PDGF,Reactome,1,SPP1,54 (54),0.872,1,1,HMDB00538,7 (13),0.0505,0.173,0.182,0.365
Metabolism of nitric oxide,Wikipathways,0,,0 (0),1,1,1,HMDB00538,23 (26),0.157,0.369,0.157,0.369
Regulation of pyruvate dehydrogenase (PDH) complex,Reactome,1,DLAT,16 (16),0.456,1,1,HMDB00538,14 (14),0.0986,0.254,0.184,0.371
L1CAM interactions,Reactome,2,AP2A2;AP2S1,102 (103),0.899,1,1,HMDB00538,7 (9),0.0505,0.173,0.186,0.372
Hyperinsulinism-Hyperammonemia Syndrome,SMPDB,0,,23 (23),1,1,2,HMDB03337;HMDB00538,47 (49),0.0455,0.168,0.186,0.372
Succinic semialdehyde dehydrogenase deficiency,SMPDB,0,,23 (23),1,1,2,HMDB03337;HMDB00538,47 (49),0.0455,0.168,0.186,0.372
Homocarnosinosis,SMPDB,0,,23 (23),1,1,2,HMDB03337;HMDB00538,47 (49),0.0455,0.168,0.186,0.372
2-Hydroxyglutric Aciduria (D And L Form),SMPDB,0,,23 (23),1,1,2,HMDB03337;HMDB00538,47 (49),0.0455,0.168,0.186,0.372
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMPDB,0,,23 (23),1,1,2,HMDB03337;HMDB00538,47 (49),0.0455,0.168,0.186,0.372
Glutamate Metabolism,SMPDB,0,,23 (23),1,1,2,HMDB03337;HMDB00538,47 (49),0.0455,0.168,0.186,0.372
Signaling by MET,Reactome,1,MET,61 (61),0.902,1,1,HMDB00538,7 (8),0.0505,0.173,0.186,0.372
Membrane Trafficking,Reactome,24,KIF20A;VPS52;AP2S1;GALNT1;KIF15;AP2A2;COPZ1;CENPE;CTSC;KIF16B;AAK1;TRAPPC10;RACGAP1;OCRL;KIF18B;ZW10;DNAJC6;M6PR;FCHO1;KIF20B;KIF11;KIFC1;KIF22;KIF2C,582 (582),0.336,1,1,HMDB00538,20 (30),0.138,0.332,0.189,0.374
DARPP-32 events,Reactome,1,PPP2R5D,24 (25),0.599,1,1,HMDB00538,11 (12),0.0783,0.213,0.19,0.374
Doxorubicin Metabolism Pathway,SMPDB,1,ABCC1,17 (17),0.476,1,1,HMDB00538,14 (14),0.0986,0.254,0.191,0.374
Common Pathway of Fibrin Clot Formation,Reactome,3,PRTN3;F13A1;F10,22 (22),0.047,0.439,0,,1 (4),1,1,0.191,0.374
Oxprenolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Verapamil Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Procainamide (Antiarrhythmic) Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Disopyramide Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Timolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Carteolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Bevantolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Practolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Dobutamine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Isoprenaline Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Amiodarone Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Levobunolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Metipranolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Mexiletine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Sotalol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Epinephrine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Betaxolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Atenolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Acebutolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Diltiazem Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Propranolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Pindolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Penbutolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Metoprolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Esmolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Bisoprolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Nebivolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Amlodipine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Nitrendipine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Nisoldipine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Nimodipine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Ibutilide Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Tocainide Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Flecainide Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Nifedipine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Nadolol Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Quinidine Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,10 (10),0.0714,0.205,0.193,0.374
Cytokine Signaling in Immune system,Reactome,11,HIST1H3C;HIST1H3I;IFNGR1;SMARCA4;HIST1H3F;HMGB1;IRF8;CANX;PPP2R5D;PRTN3;EIF4G1,458 (458),0.959,1,1,HMDB00538,7 (27),0.0505,0.173,0.195,0.377
Carvedilol Action Pathway,SMPDB,2,ATP2A2;ALG10B,62 (62),0.679,1,1,HMDB00538,10 (10),0.0714,0.205,0.195,0.377
Labetalol Action Pathway,SMPDB,2,ATP2A2;ALG10B,62 (62),0.679,1,1,HMDB00538,10 (10),0.0714,0.205,0.195,0.377
Plasma lipoprotein remodeling,Reactome,1,LMF2,30 (30),0.681,1,1,HMDB00538,10 (20),0.0714,0.205,0.196,0.377
Neuroactive ligand-receptor interaction - Homo sapiens (human),KEGG,2,GRIA3;CTSG,277 (277),1,1,2,HMDB00285;HMDB00538,49 (130),0.049,0.173,0.197,0.377
Synaptic vesicle cycle - Homo sapiens (human),KEGG,2,AP2A2;AP2S1,63 (63),0.687,1,1,HMDB00538,10 (12),0.0714,0.205,0.197,0.377
Transport of vitamins_ nucleosides_ and related molecules,Reactome,1,SLCO4A1,39 (39),0.774,1,2,HMDB00095;HMDB01176,57 (64),0.0643,0.198,0.199,0.377
Synthesis of IP3 and IP4 in the cytosol,Reactome,1,OCRL,27 (27),0.642,1,1,HMDB00538,11 (14),0.0783,0.213,0.201,0.377
mTOR signalling,Reactome,1,EIF4G1,40 (41),0.782,1,1,HMDB00538,9 (9),0.0645,0.198,0.201,0.377
Pyruvate metabolism,Reactome,2,DLAT;LDHA,30 (30),0.309,1,1,HMDB00538,24 (25),0.163,0.38,0.201,0.377
SHC1 events in ERBB2 signaling,Reactome,0,,22 (22),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.201,0.377
Transcriptional regulation by RUNX2,Wikipathways,0,,11 (11),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.201,0.377
Signaling by PTK6,Wikipathways,0,,2 (2),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
ABC transporters in lipid homeostasis,Reactome,0,,18 (18),1,1,1,HMDB00538,7 (11),0.0505,0.173,0.201,0.377
Signaling by FGFR4,Reactome,0,,41 (41),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.201,0.377
1D-<i>myo</i>-inositol hexakisphosphate biosynthesis V (from Ins(1_3_4)P3),HumanCyc,0,,3 (3),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.201,0.377
Conjugation of salicylate with glycine,Reactome,0,,8 (8),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.201,0.377
TCR signaling,Reactome,0,,72 (72),1,1,1,HMDB00538,7 (9),0.0505,0.173,0.201,0.377
Biotinidase Deficiency,SMPDB,0,,3 (3),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Translocation of GLUT4 to the plasma membrane,Reactome,0,,32 (32),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Biosynthesis of E-series 18(R)-resolvins,Reactome,0,,4 (4),1,1,1,HMDB03337,7 (14),0.0505,0.173,0.201,0.377
Rap1 signalling,Reactome,0,,16 (16),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.201,0.377
Biosynthesis of aspirin-triggered D-series resolvins,Reactome,0,,3 (3),1,1,1,HMDB03337,7 (19),0.0505,0.173,0.201,0.377
trehalose degradation,HumanCyc,0,,4 (4),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.201,0.377
Energy dependent regulation of mTOR by LKB1-AMPK,Reactome,0,,29 (29),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Hedgehog ligand biogenesis,Reactome,0,,20 (20),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Oxidative Stress Induced Senescence,Wikipathways,0,,8 (8),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.201,0.377
PI3K Cascade,Reactome,0,,41 (41),1,1,1,HMDB00538,7 (9),0.0505,0.173,0.201,0.377
lipoate biosynthesis and incorporation,HumanCyc,0,,3 (3),1,1,1,HMDB00538,7 (8),0.0505,0.173,0.201,0.377
phospho-PLA2 pathway,Reactome,0,,2 (2),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
RHO GTPases Activate Formins,Wikipathways,0,,1 (1),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Adenylate cyclase activating pathway,Reactome,0,,10 (10),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Vasopressin regulates renal water homeostasis via Aquaporins,Reactome,0,,40 (40),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
CREB phosphorylation through the activation of Ras,Reactome,0,,27 (27),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Acetylcholine regulates insulin secretion,Reactome,0,,10 (10),1,1,1,HMDB00538,7 (9),0.0505,0.173,0.201,0.377
Corticotropin Activation of Cortisol Production,SMPDB,0,,7 (7),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Vasopressin Regulation of Water Homeostasis,SMPDB,0,,7 (7),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Intracellular Signalling Through PGD2 receptor and Prostaglandin D2,SMPDB,0,,6 (6),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Synthesis of diphthamide-EEF2,Reactome,0,,8 (8),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Biotin Metabolism,SMPDB,0,,3 (3),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin,SMPDB,0,,10 (10),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone,SMPDB,0,,10 (10),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Multiple carboxylase deficiency_ neonatal or early onset form,SMPDB,0,,3 (3),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Dopamine Activation of Neurological Reward System,SMPDB,0,,6 (6),1,1,1,HMDB00538,7 (7),0.0505,0.173,0.201,0.377
Sphingolipid Metabolism,SMPDB,2,B4GALT6;GLA,22 (22),0.197,1,1,HMDB00538,40 (40),0.258,0.562,0.203,0.377
Gaucher Disease,SMPDB,2,B4GALT6;GLA,22 (22),0.197,1,1,HMDB00538,40 (40),0.258,0.562,0.203,0.377
Globoid Cell Leukodystrophy,SMPDB,2,B4GALT6;GLA,22 (22),0.197,1,1,HMDB00538,40 (40),0.258,0.562,0.203,0.377
Metachromatic Leukodystrophy (MLD),SMPDB,2,B4GALT6;GLA,22 (22),0.197,1,1,HMDB00538,40 (40),0.258,0.562,0.203,0.377
Fabry disease,SMPDB,2,B4GALT6;GLA,22 (22),0.197,1,1,HMDB00538,40 (40),0.258,0.562,0.203,0.377
Krabbe disease,SMPDB,2,B4GALT6;GLA,22 (22),0.197,1,1,HMDB00538,40 (40),0.258,0.562,0.203,0.377
Signaling by NTRKs,Reactome,3,PPP2R5D;AP2A2;AP2S1,89 (89),0.651,1,1,HMDB00538,11 (12),0.0783,0.213,0.203,0.377
guanosine nucleotides <i>de novo</i> biosynthesis,HumanCyc,1,IMPDH2,16 (16),0.456,1,1,HMDB00538,16 (17),0.112,0.28,0.203,0.378
chrebp regulation by carbohydrates and camp,BioCarta,1,PPP2R5D,42 (42),0.798,1,1,HMDB00538,9 (12),0.0645,0.198,0.204,0.38
Signaling by Retinoic Acid,Wikipathways,0,,0 (0),1,1,1,HMDB00538,24 (31),0.163,0.38,0.163,0.38
Pyrimidine metabolism and related diseases,Wikipathways,0,,0 (0),1,1,1,HMDB00082,24 (31),0.163,0.38,0.163,0.38
Ion transport by P-type ATPases,Reactome,2,ATP2A2;ATP13A1,55 (55),0.614,1,1,HMDB00538,12 (17),0.0851,0.228,0.206,0.384
Fosphenytoin (Antiarrhythmic) Action Pathway,SMPDB,2,ATP2A2;ALG10B,61 (61),0.67,1,1,HMDB00538,11 (11),0.0783,0.213,0.207,0.384
Signaling events mediated by PRL,PID,3,TUBA1B;CDK2;CCNA2,23 (23),0.0526,0.477,0,,1 (1),1,1,0.208,0.385
Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,SMPDB,1,ACAA2,10 (10),0.317,1,1,HMDB00538,25 (26),0.17,0.392,0.211,0.391
G alpha (s) signalling events,Wikipathways,0,,0 (0),1,1,1,HMDB00538,25 (25),0.17,0.392,0.17,0.392
Signaling by VEGF,Wikipathways,0,,0 (0),1,1,1,HMDB00538,25 (28),0.17,0.392,0.17,0.392
Death Receptor Signalling,Reactome,4,HDAC1;HDAC2;ECT2;PLEKHG2,138 (141),0.762,1,1,HMDB00538,10 (11),0.0714,0.205,0.213,0.394
Costimulation by the CD28 family,Reactome,1,PPP2R5D,77 (77),0.947,1,1,HMDB00538,8 (9),0.0575,0.186,0.213,0.394
fatty acid &beta;-oxidation,HumanCyc,2,ACAA2;ECI2,19 (19),0.157,0.997,1,HMDB00538,57 (84),0.347,0.718,0.213,0.394
Antigen processing-Cross presentation,Reactome,1,TLR1,49 (49),0.846,1,1,HMDB00538,9 (18),0.0645,0.198,0.213,0.394
Amino sugar and nucleotide sugar metabolism - Homo sapiens (human),KEGG,0,,48 (48),1,1,2,HMDB01265;HMDB01176,52 (108),0.0546,0.186,0.213,0.394
G alpha (q) signalling events,Reactome,0,,213 (213),1,1,2,HMDB00285;HMDB00538,52 (63),0.0546,0.186,0.213,0.394
sonic hedgehog receptor ptc1 regulates cell cycle,BioCarta,2,CCNB1;CDK1,9 (9),0.0421,0.396,0,,0 (0),1,1,0.0421,0.396
cyclin e destruction pathway,BioCarta,2,CDK2;E2F1,9 (9),0.0421,0.396,0,,0 (0),1,1,0.0421,0.396
Nef Mediated CD4 Down-regulation,Reactome,2,AP2A2;AP2S1,9 (9),0.0421,0.396,0,,0 (0),1,1,0.0421,0.396
E2F-enabled inhibition of pre-replication complex formation,Reactome,2,CCNB1;CDK1,9 (9),0.0421,0.396,0,,0 (0),1,1,0.0421,0.396
ATR Signaling,Wikipathways,2,TOPBP1;RPA1,9 (9),0.0421,0.396,0,,0 (0),1,1,0.0421,0.396
Ion homeostasis,Reactome,1,ATP2A2,52 (52),0.862,1,1,HMDB00538,9 (10),0.0645,0.198,0.216,0.397
Calcium signaling pathway - Homo sapiens (human),KEGG,3,ATP2A2;NOS2;SLC25A5,185 (186),0.971,1,1,HMDB00538,8 (10),0.0575,0.186,0.217,0.397
Pyruvate Dehydrogenase Complex Deficiency,SMPDB,2,DLAT;ACACA,22 (22),0.197,1,1,HMDB00538,45 (46),0.285,0.608,0.218,0.397
Primary hyperoxaluria II_ PH2,SMPDB,2,DLAT;ACACA,22 (22),0.197,1,1,HMDB00538,45 (46),0.285,0.608,0.218,0.397
Pyruvate kinase deficiency,SMPDB,2,DLAT;ACACA,22 (22),0.197,1,1,HMDB00538,45 (46),0.285,0.608,0.218,0.397
Leigh Syndrome,SMPDB,2,DLAT;ACACA,22 (22),0.197,1,1,HMDB00538,45 (46),0.285,0.608,0.218,0.397
Pyruvate Metabolism,SMPDB,2,DLAT;ACACA,22 (22),0.197,1,1,HMDB00538,45 (46),0.285,0.608,0.218,0.397
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMPDB,2,DLAT;ACACA,22 (22),0.197,1,1,HMDB00538,45 (46),0.285,0.608,0.218,0.397
Formation of Fibrin Clot (Clotting Cascade),Reactome,4,PRTN3;F13A1;C1QBP;F10,39 (39),0.0564,0.508,0,,2 (7),1,1,0.219,0.397
Ion influx/efflux at host-pathogen interface,Reactome,0,,4 (4),1,1,1,HMDB00538,8 (11),0.0575,0.186,0.222,0.397
pyrimidine deoxyribonucleotide phosphorylation,HumanCyc,0,,12 (12),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.222,0.397
Signaling by EGFR,Reactome,0,,43 (43),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
Excitatory Neural Signalling Through 5-HTR 4 and Serotonin,SMPDB,0,,8 (8),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.222,0.397
Conjugation of benzoate with glycine,Reactome,0,,6 (6),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.222,0.397
Conjugation of phenylacetate with glutamine,Reactome,0,,2 (2),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.222,0.397
Circadian Clock,Wikipathways,0,,10 (10),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
CaM pathway,Reactome,0,,26 (26),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
Polycystic Kidney Disease Pathway,Wikipathways,0,,18 (18),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.222,0.397
propionyl-CoA degradation,HumanCyc,0,,4 (4),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
Macroautophagy,Reactome,0,,57 (57),1,1,1,HMDB00538,8 (10),0.0575,0.186,0.222,0.397
Homocysteine Degradation,SMPDB,0,,3 (3),1,1,1,HMDB00099,8 (8),0.0575,0.186,0.222,0.397
glutathione biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
EPHB-mediated forward signaling,Reactome,0,,35 (35),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
dolichol and dolichyl phosphate biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB00082,8 (10),0.0575,0.186,0.222,0.397
L-glutamine tRNA biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
EPH-Ephrin signaling,Reactome,0,,74 (74),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
Calmodulin induced events,Reactome,0,,26 (26),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
glycerol degradation,HumanCyc,0,,5 (5),1,1,1,HMDB00538,8 (10),0.0575,0.186,0.222,0.397
Cysteine formation from homocysteine,Reactome,0,,3 (3),1,1,1,HMDB00099,8 (9),0.0575,0.186,0.222,0.397
D-<i>myo</i>-inositol (1_4_5_6)-tetrakisphosphate biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
D-galactose degradation V (Leloir pathway),HumanCyc,0,,6 (6),1,1,1,HMDB00538,8 (11),0.0575,0.186,0.222,0.397
D-<i>myo</i>-inositol (3_4_5_6)-tetrakisphosphate biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
Galactose catabolism,Reactome,0,,6 (6),1,1,1,HMDB00538,8 (10),0.0575,0.186,0.222,0.397
5-Phosphoribose 1-diphosphate biosynthesis,Reactome,0,,3 (3),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.222,0.397
diphthamide biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB00538,8 (9),0.0575,0.186,0.222,0.397
UDP-<i>N</i>-acetyl-D-glucosamine biosynthesis II,HumanCyc,0,,5 (5),1,1,1,HMDB00285,8 (11),0.0575,0.186,0.222,0.397
Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin ,SMPDB,0,,8 (8),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.222,0.397
Excitatory Neural Signalling Through 5-HTR 6 and Serotonin ,SMPDB,0,,8 (8),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.222,0.397
Intracellular Signalling Through Histamine H2 Receptor and Histamine,SMPDB,0,,8 (8),1,1,1,HMDB00538,8 (8),0.0575,0.186,0.222,0.397
Gamma-cystathionase deficiency (CTH),SMPDB,0,,3 (3),1,1,1,HMDB00099,8 (8),0.0575,0.186,0.222,0.397
Homocystinuria_ cystathionine beta-synthase deficiency,SMPDB,0,,3 (3),1,1,1,HMDB00099,8 (8),0.0575,0.186,0.222,0.397
tRNA splicing,HumanCyc,0,,5 (5),1,1,1,HMDB00538,8 (11),0.0575,0.186,0.222,0.397
PIP3 activates AKT signaling,Reactome,8,TRIM27;PIK3AP1;RBBP4;MET;RCOR1;PPP2R5D;HDAC1;HDAC2,214 (214),0.549,1,1,HMDB00538,15 (22),0.105,0.266,0.223,0.398
Calnexin/calreticulin cycle,Reactome,3,CANX;UGGT1;PRKCSH,24 (25),0.0585,0.526,0,,5 (15),1,1,0.225,0.402
Small cell lung cancer - Homo sapiens (human),KEGG,7,NOS2;CKS1B;E2F1;CDK2;CDK4;CDK6;FN1,93 (93),0.0588,0.527,0,,3 (3),1,1,0.225,0.403
ABC-family proteins mediated transport,Reactome,2,ABCC1;ABCF1,58 (59),0.643,1,1,HMDB00538,13 (21),0.0919,0.241,0.226,0.404
Platelet Aggregation (Plug Formation),Reactome,1,FN1,37 (37),0.756,1,1,HMDB00538,11 (14),0.0783,0.213,0.226,0.404
Integration of energy metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,26 (33),0.176,0.404,0.176,0.404
Gamma carboxylation_ hypusine formation and arylsulfatase activation,Reactome,2,EIF5A;F10,39 (40),0.43,1,1,HMDB00538,20 (33),0.138,0.332,0.227,0.405
Mitochondrial Electron Transport Chain,SMPDB,1,UQCRC1,20 (20),0.533,1,1,HMDB00538,16 (17),0.112,0.28,0.228,0.406
Nicotinate and nicotinamide metabolism - Homo sapiens (human),KEGG,2,NT5C;PNP,30 (30),0.309,1,1,HMDB00229,29 (55),0.194,0.437,0.229,0.407
Metabolism of water-soluble vitamins and cofactors,Reactome,5,GSTO1;ABCC1;MTHFD2;MTHFD1L;ACACA,111 (114),0.4,1,2,HMDB03337;HMDB00538,94 (122),0.15,0.358,0.229,0.408
Activation of NMDA receptor and postsynaptic events,Reactome,1,GRIA3,39 (39),0.774,1,1,HMDB00538,11 (11),0.0783,0.213,0.23,0.41
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Wikipathways,4,GSTO1;TCP1;PPIA;RPLP0,36 (36),0.044,0.412,0,,0 (0),1,1,0.044,0.412
Diseases of signal transduction,Reactome,9,TGFB1;PIK3AP1;MET;NCOR2;PAPD7;HDAC1;HDAC2;HDAC6;FN1,248 (248),0.582,1,1,HMDB00538,15 (52),0.105,0.266,0.232,0.413
Cardiac conduction,Reactome,1,ATP2A2,131 (131),0.993,1,1,HMDB00538,9 (10),0.0645,0.198,0.24,0.417
Tyrosinemia Type 3 (TYRO3),SMPDB,1,FARSA,11 (11),0.342,1,1,HMDB00538,28 (28),0.188,0.427,0.241,0.417
Phenylalanine and Tyrosine Metabolism,SMPDB,1,FARSA,11 (11),0.342,1,1,HMDB00538,28 (28),0.188,0.427,0.241,0.417
Phenylketonuria,SMPDB,1,FARSA,11 (11),0.342,1,1,HMDB00538,28 (28),0.188,0.427,0.241,0.417
Tyrosinemia Type 2 (or Richner-Hanhart syndrome),SMPDB,1,FARSA,11 (11),0.342,1,1,HMDB00538,28 (28),0.188,0.427,0.241,0.417
Electron Transport Chain (OXPHOS system in mitochondria),Wikipathways,2,UQCRC1;SLC25A5,103 (103),0.902,1,1,HMDB00538,10 (12),0.0714,0.205,0.241,0.417
Muscle contraction,Reactome,1,ATP2A2,195 (195),0.999,1,1,HMDB00538,9 (10),0.0645,0.198,0.241,0.417
Signaling by FGFR3,Reactome,0,,40 (40),1,1,1,HMDB00538,9 (10),0.0645,0.198,0.241,0.417
Formation of the active cofactor_ UDP-glucuronate,Reactome,0,,3 (3),1,1,1,HMDB00285,9 (10),0.0645,0.198,0.241,0.417
Post NMDA receptor activation events,Reactome,0,,35 (35),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
GDP-glucose biosynthesis II,HumanCyc,0,,6 (6),1,1,1,HMDB00538,9 (11),0.0645,0.198,0.241,0.417
HDL assembly,Reactome,0,,8 (8),1,1,1,HMDB00538,9 (10),0.0645,0.198,0.241,0.417
Amino acid conjugation of benzoic acid,Wikipathways,0,,4 (4),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine,SMPDB,0,,38 (38),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine,SMPDB,0,,38 (38),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Vitamin B1 (thiamin) metabolism,Reactome,0,,5 (5),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
IRS-mediated signalling,Reactome,0,,45 (45),1,1,1,HMDB00538,9 (11),0.0645,0.198,0.241,0.417
Propionyl-CoA catabolism,Reactome,0,,5 (5),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Uptake and actions of bacterial toxins,Reactome,0,,25 (25),1,1,1,HMDB00538,9 (11),0.0645,0.198,0.241,0.417
Effects of PIP2 hydrolysis,Reactome,0,,27 (27),1,1,1,HMDB00538,9 (13),0.0645,0.198,0.241,0.417
Lactose Degradation,SMPDB,0,,11 (11),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
mitochondrial L-carnitine shuttle,HumanCyc,0,,6 (6),1,1,1,HMDB00201,9 (12),0.0645,0.198,0.241,0.417
Downstream signaling events of B Cell Receptor (BCR),Reactome,0,,30 (30),1,1,1,HMDB00538,9 (10),0.0645,0.198,0.241,0.417
&gamma;-linolenate biosynthesis,HumanCyc,0,,14 (14),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Glycogen synthesis,Reactome,0,,11 (11),1,1,1,HMDB00285,9 (10),0.0645,0.198,0.241,0.417
Synthesis of PIPs at the late endosome membrane,Reactome,0,,11 (11),1,1,1,HMDB00538,9 (12),0.0645,0.198,0.241,0.417
superoxide radicals degradation,HumanCyc,0,,12 (12),1,1,1,HMDB03337,9 (11),0.0645,0.198,0.241,0.417
Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin,SMPDB,0,,8 (8),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Clopidogrel Metabolism Pathway,SMPDB,0,,9 (9),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
IRS-related events triggered by IGF1R,Reactome,0,,49 (49),1,1,1,HMDB00538,9 (11),0.0645,0.198,0.241,0.417
IGF1R signaling cascade,Reactome,0,,50 (50),1,1,1,HMDB00538,9 (11),0.0645,0.198,0.241,0.417
Clopidogrel Action Pathway,SMPDB,0,,9 (9),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Phenylacetate Metabolism,SMPDB,0,,3 (3),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Lactose Intolerance,SMPDB,0,,11 (11),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Thiamine Metabolism,SMPDB,0,,4 (4),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Nicotine Activity on Dopaminergic Neurons,Wikipathways,0,,21 (21),1,1,1,HMDB00538,9 (9),0.0645,0.198,0.241,0.417
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),Reactome,0,,51 (51),1,1,1,HMDB00538,9 (11),0.0645,0.198,0.241,0.417
TCF dependent signaling in response to WNT,Wikipathways,0,,3 (3),1,1,1,HMDB00538,9 (12),0.0645,0.198,0.241,0.417
molybdenum cofactor biosynthesis,HumanCyc,0,,4 (4),1,1,1,HMDB00538,9 (13),0.0645,0.198,0.241,0.417
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human),KEGG,3,PIGO;PIGU;GPLD1,25 (25),0.0647,0.567,0,,6 (16),1,1,0.242,0.418
Inositol Phosphate Metabolism,SMPDB,1,NUDT3,14 (14),0.413,1,1,HMDB00538,23 (23),0.157,0.369,0.242,0.419
tRNA charging,HumanCyc,2,FARSA;TARS2,38 (38),0.417,1,1,HMDB00538,23 (24),0.157,0.369,0.244,0.421
Butanoate metabolism,INOH,1,DLAT,17 (17),0.476,1,1,HMDB00538,20 (23),0.138,0.332,0.245,0.421
Inositol phosphate metabolism,INOH,2,OCRL;PI4KA,41 (41),0.456,1,1,HMDB00538,21 (25),0.144,0.344,0.245,0.421
Purine Nucleoside Phosphorylase Deficiency,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Xanthine Dehydrogenase Deficiency (Xanthinuria),SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Adenylosuccinate Lyase Deficiency,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Adenine phosphoribosyltransferase deficiency (APRT),SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Mitochondrial DNA depletion syndrome,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Myoadenylate deaminase deficiency,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Purine Metabolism,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Molybdenum Cofactor Deficiency,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Adenosine Deaminase Deficiency,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Gout or Kelley-Seegmiller Syndrome,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Lesch-Nyhan Syndrome (LNS),SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Xanthinuria type I,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Xanthinuria type II,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
AICA-Ribosiduria,SMPDB,3,PNP;ENTPD5;ATIC,37 (37),0.159,0.997,1,HMDB00538,72 (73),0.418,0.836,0.246,0.421
Selenoamino Acid Metabolism,SMPDB,1,METTL6,12 (12),0.367,1,1,HMDB00538,27 (28),0.182,0.415,0.247,0.422
Triglyceride catabolism,Reactome,1,PPP1CC,24 (24),0.599,1,1,HMDB00538,16 (19),0.112,0.28,0.248,0.423
Synthesis of PIPs at the plasma membrane,Reactome,1,OCRL,53 (53),0.867,1,1,HMDB00538,11 (17),0.0783,0.213,0.251,0.427
Fructose and mannose metabolism - Homo sapiens (human),KEGG,2,PFKL;TPI1,33 (33),0.35,1,1,HMDB01265,29 (54),0.194,0.437,0.251,0.427
sphingosine and sphingosine-1-phosphate metabolism,HumanCyc,1,SGPP1,9 (9),0.29,1,1,HMDB00538,36 (59),0.235,0.518,0.251,0.428
Transmission across Chemical Synapses,Reactome,4,AP2A2;SLC38A1;GRIA3;AP2S1,223 (224),0.969,1,2,HMDB00538;HMDB00043,60 (65),0.0704,0.205,0.251,0.428
Cell surface interactions at the vascular wall,Reactome,4,CD244;TGFB1;PPIA;FN1,218 (219),0.965,1,1,HMDB00538,10 (13),0.0714,0.205,0.253,0.43
Neuronal System,Reactome,5,AP2A2;SLC38A1;GRIA3;KCNN3;AP2S1,367 (368),0.998,1,2,HMDB00538;HMDB00043,60 (65),0.0704,0.205,0.257,0.43
CD4 T cell receptor signaling-NFkB cascade,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,97 (97),0.0705,0.603,0,,3 (4),1,1,0.257,0.43
Glycogenosis_ Type VII. Tarui disease,SMPDB,1,TPI1,15 (15),0.435,1,1,HMDB00538,24 (24),0.163,0.38,0.259,0.43
Fanconi-bickel syndrome,SMPDB,1,TPI1,15 (15),0.435,1,1,HMDB00538,24 (24),0.163,0.38,0.259,0.43
Glycolysis,SMPDB,1,TPI1,15 (15),0.435,1,1,HMDB00538,24 (24),0.163,0.38,0.259,0.43
RXR and RAR heterodimerization with other nuclear receptor,PID,3,TGFB1;SREBF1;NCOR2,26 (26),0.0712,0.603,0,,6 (6),1,1,0.259,0.43
Downregulation of TGF-beta receptor signaling,Reactome,3,TGFB1;STRAP;PPP1CC,26 (26),0.0712,0.603,0,,2 (2),1,1,0.259,0.43
Spinal Cord Injury,Wikipathways,8,TGFB1;NOS2;E2F1;CCR2;VCAN;CDK1;CDK2;CDK4,117 (117),0.0713,0.603,0,,5 (8),1,1,0.26,0.43
asparagine biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Anileridine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Oxybuprocaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Plasma lipoprotein assembly,Reactome,0,,19 (19),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Escitalopram Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Synthesis of 12-eicosatetraenoic acid derivatives,Reactome,0,,7 (7),1,1,1,HMDB03337,10 (12),0.0714,0.205,0.26,0.43
Insulin receptor signalling cascade,Reactome,0,,51 (51),1,1,1,HMDB00538,10 (12),0.0714,0.205,0.26,0.43
Carfentanil Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Signaling by ERBB2,Reactome,0,,50 (50),1,1,1,HMDB00538,10 (12),0.0714,0.205,0.26,0.43
Biosynthesis of E-series 18(S)-resolvins,Reactome,0,,5 (5),1,1,1,HMDB03337,10 (19),0.0714,0.205,0.26,0.43
Signaling by Insulin receptor,Reactome,0,,75 (75),1,1,1,HMDB00538,10 (13),0.0714,0.205,0.26,0.43
Biosynthesis of D-series resolvins,Reactome,0,,4 (4),1,1,1,HMDB03337,10 (23),0.0714,0.205,0.26,0.43
Vitamin B2 (riboflavin) metabolism,Reactome,0,,7 (7),1,1,1,HMDB00538,10 (10),0.0714,0.205,0.26,0.43
Alvimopan Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,10 (10),0.0714,0.205,0.26,0.43
ion channels and their functional role in vascular endothelium,BioCarta,0,,47 (47),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
CLEC7A (Dectin-1) signaling,Reactome,0,,40 (40),1,1,1,HMDB00538,10 (12),0.0714,0.205,0.26,0.43
Dimethylthiambutene Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Synthesis of IPs in the nucleus,Reactome,0,,4 (4),1,1,1,HMDB00538,10 (14),0.0714,0.205,0.26,0.43
purine deoxyribonucleosides salvage,HumanCyc,0,,13 (13),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Methadyl Acetate Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,10 (10),0.0714,0.205,0.26,0.43
Stimuli-sensing channels,Reactome,0,,102 (102),1,1,1,HMDB00538,10 (13),0.0714,0.205,0.26,0.43
Synthesis of PIPs at the early endosome membrane,Reactome,0,,16 (16),1,1,1,HMDB00538,10 (16),0.0714,0.205,0.26,0.43
HDL remodeling,Reactome,0,,10 (10),1,1,1,HMDB00538,10 (17),0.0714,0.205,0.26,0.43
Fructose catabolism,Reactome,0,,5 (5),1,1,1,HMDB00538,10 (16),0.0714,0.205,0.26,0.43
glycine betaine degradation,HumanCyc,0,,5 (5),1,1,1,HMDB00043,10 (11),0.0714,0.205,0.26,0.43
VEGFR2 mediated cell proliferation,Reactome,0,,19 (19),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Trehalose Degradation,SMPDB,0,,12 (12),1,1,1,HMDB00538,10 (10),0.0714,0.205,0.26,0.43
Fentanyl Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
3-Methylthiofentanyl Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Vitamin B1 (thiamin) metabolism,EHMN,0,,3 (3),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Vitamin H (biotin) metabolism,EHMN,0,,6 (6),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,Wikipathways,0,,2 (2),1,1,1,HMDB00538,10 (11),0.0714,0.205,0.26,0.43
Glycogen breakdown (glycogenolysis),Reactome,0,,16 (16),1,1,1,HMDB00538,10 (12),0.0714,0.205,0.26,0.43
purine nucleotides degradation,HumanCyc,2,PNP;IMPDH2,12 (12),0.0717,0.603,0,,18 (19),1,1,0.261,0.43
carm1 and regulation of the estrogen receptor,BioCarta,2,GTF2F1;GTF3A,12 (12),0.0717,0.603,0,,1 (1),1,1,0.261,0.43
MicroRNA (miRNA) biogenesis,Reactome,2,RAN;DGCR8,12 (12),0.0717,0.603,0,,5 (6),1,1,0.261,0.43
Acetaminophen Metabolism Pathway,SMPDB,1,ABCC1,30 (31),0.681,1,1,HMDB00538,15 (16),0.105,0.266,0.261,0.43
Cytoplasmic Ribosomal Proteins,Wikipathways,7,RPL13A;RPS5;RPL4;RPSA;RPL9;RPL36A;RPLP0,88 (88),0.046,0.43,0,,0 (0),1,1,0.046,0.43
Biological oxidations,Reactome,4,GSTM1;AHR;GSTO1;HSP90AB1,226 (231),0.972,1,4,HMDB03337;HMDB00538;HMDB00267;HMDB00285,224 (321),0.0749,0.213,0.264,0.434
Toll-Like Receptors Cascades,Reactome,3,PPP2R5D;TLR1;HMGB1,154 (154),0.931,1,1,HMDB00538,11 (29),0.0783,0.213,0.264,0.434
creatine biosynthesis,HumanCyc,1,GATM,2 (2),0.0733,0.603,0,,7 (8),1,1,0.265,0.434
Minus-strand DNA synthesis,Reactome,1,PPIA,2 (2),0.0733,0.603,0,,1 (2),1,1,0.265,0.434
guanine and guanosine salvage,HumanCyc,1,PNP,2 (2),0.0733,0.603,0,,7 (7),1,1,0.265,0.434
purine deoxyribonucleosides degradation,HumanCyc,1,PNP,2 (2),0.0733,0.603,0,,8 (10),1,1,0.265,0.434
Fatty Acid Biosynthesis,SMPDB,1,ACACA,2 (2),0.0733,0.603,0,,31 (31),1,1,0.265,0.434
Reverse Transcription of HIV RNA,Reactome,1,PPIA,2 (2),0.0733,0.603,0,,1 (2),1,1,0.265,0.434
RORA activates gene expression,Wikipathways,1,SREBF1,2 (2),0.0733,0.603,0,,5 (5),1,1,0.265,0.434
tRNA Aminoacylation,Reactome,2,FARSA;TARS2,42 (42),0.468,1,1,HMDB00538,23 (66),0.157,0.369,0.266,0.435
MAPK1/MAPK3 signaling,Reactome,5,PPP2R5D;MET;FN1;SPRED1;CDK1,202 (203),0.878,1,1,HMDB00538,12 (18),0.0851,0.228,0.268,0.437
Pentose Phosphate Pathway,SMPDB,1,PFKL,14 (14),0.413,1,1,HMDB00538,27 (29),0.182,0.415,0.27,0.437
Glucose-6-phosphate dehydrogenase deficiency,SMPDB,1,PFKL,14 (14),0.413,1,1,HMDB00538,27 (29),0.182,0.415,0.27,0.437
Ribose-5-phosphate isomerase deficiency,SMPDB,1,PFKL,14 (14),0.413,1,1,HMDB00538,27 (29),0.182,0.415,0.27,0.437
Transaldolase deficiency,SMPDB,1,PFKL,14 (14),0.413,1,1,HMDB00538,27 (29),0.182,0.415,0.27,0.437
Insulin secretion - Homo sapiens (human),KEGG,1,KCNN3,85 (85),0.961,1,1,HMDB00538,11 (13),0.0783,0.213,0.27,0.437
Purine salvage,Reactome,1,PNP,13 (13),0.39,1,1,HMDB00538,29 (31),0.194,0.437,0.271,0.437
Vesicle-mediated transport,Reactome,25,KIF20A;VPS52;AP2S1;GALNT1;KIF15;AP2A2;COPZ1;CENPE;CTSC;SCARB1;KIF16B;AAK1;TRAPPC10;RACGAP1;OCRL;KIF18B;ZW10;DNAJC6;M6PR;FCHO1;KIF20B;KIF11;KIFC1;KIF22;KIF2C,620 (620),0.374,1,1,HMDB00538,31 (66),0.206,0.46,0.274,0.437
Axon guidance,Reactome,6,AP2A2;DOCK1;MET;AP2S1;PLXND1;HSP90AB1,357 (358),0.993,1,1,HMDB00538,11 (15),0.0783,0.213,0.276,0.437
AOP CYP2E1 Activation Leading To Neurodegeneration,Wikipathways,0,,8 (8),1,1,1,HMDB03337,11 (12),0.0783,0.213,0.278,0.437
Mepivacaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Chloroprocaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Benzocaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Ca-dependent events,Reactome,0,,28 (28),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.278,0.437
Dezocine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Propoxyphene Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Ropivacaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
adenosine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,0,,38 (38),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.278,0.437
Remifentanil Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
FCERI mediated Ca+2 mobilization,Reactome,0,,108 (108),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.278,0.437
Biosynthesis of EPA-derived SPMs,Reactome,0,,6 (6),1,1,1,HMDB03337,11 (27),0.0783,0.213,0.278,0.437
Buprenorphine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Metiamide Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,11 (13),0.0783,0.213,0.278,0.437
Prolactin signaling pathway - Homo sapiens (human),KEGG,0,,70 (70),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Naltrexone Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Folate-Alcohol and Cancer Pathway Hypotheses,Wikipathways,0,,9 (9),1,1,1,HMDB00099,11 (12),0.0783,0.213,0.278,0.437
ethanol degradation II,HumanCyc,0,,8 (8),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.278,0.437
RHO GTPases Activate NADPH Oxidases,Reactome,0,,13 (13),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.278,0.437
Signaling by Hedgehog,Reactome,0,,81 (82),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Visual signal transduction: Rods,PID,0,,24 (24),1,1,1,HMDB00538,11 (13),0.0783,0.213,0.278,0.437
G alpha (z) signalling events,Reactome,0,,47 (47),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.278,0.437
Levomethadyl Acetate Action Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Levallorphan Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Ethylmorphine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Pentazocine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Naloxone Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Dihydromorphine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Esomeprazole Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,11 (13),0.0783,0.213,0.278,0.437
Nalbuphine Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Ketobemidone  Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Cocaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Dibucaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Levobupivacaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Bupivacaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Gastric Acid Production,SMPDB,0,,11 (11),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.278,0.437
Levorphanol Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Tramadol Action Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Diphenoxylate Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Oxycodone Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Prilocaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Procaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Proparacaine Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Tramadol Metabolism Pathway,SMPDB,0,,7 (7),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.278,0.437
Alfentanil Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Oxymorphone Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Hydrocodone Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Hydromorphone Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Sufentanil Action Pathway,SMPDB,0,,29 (29),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Roxatidine acetate Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.278,0.437
Lipoate metabolism,EHMN,0,,7 (7),1,1,1,HMDB00538,11 (12),0.0783,0.213,0.278,0.437
DAG and IP3 signaling,Reactome,0,,32 (32),1,1,1,HMDB00538,11 (13),0.0783,0.213,0.278,0.437
phytol degradation,HumanCyc,0,,2 (2),1,1,1,HMDB00538,11 (14),0.0783,0.213,0.278,0.437
PTEN Regulation,Wikipathways,0,,1 (1),1,1,1,HMDB00538,11 (11),0.0783,0.213,0.278,0.437
Disorders of the Krebs cycle,Wikipathways,0,,1 (1),1,1,1,HMDB00538,11 (14),0.0783,0.213,0.278,0.437
Inositol phosphate metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,29 (41),0.194,0.437,0.194,0.437
Synthesis of very long-chain fatty acyl-CoAs,Reactome,1,HSD17B12,24 (24),0.599,1,1,HMDB00538,19 (27),0.132,0.319,0.279,0.439
RAF/MAP kinase cascade,Reactome,4,PPP2R5D;MET;SPRED1;FN1,196 (197),0.938,1,1,HMDB00538,12 (18),0.0851,0.228,0.282,0.443
Peptide chain elongation,Reactome,7,RPL13A;RPSA;RPL4;RPS5;RPL9;RPL36A;RPLP0,100 (101),0.0801,0.644,0,,3 (25),1,1,0.282,0.443
MAPK family signaling cascades,Reactome,5,PPP2R5D;MET;FN1;SPRED1;CDK1,236 (237),0.943,1,1,HMDB00538,12 (18),0.0851,0.228,0.283,0.444
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Reactome,4,UQCRC1;LRPPRC;CYC1;ACAD9,123 (123),0.679,1,1,HMDB00538,17 (23),0.118,0.292,0.283,0.444
Insulin resistance - Homo sapiens (human),KEGG,3,SREBF1;MLX;PPP1CC,107 (107),0.768,1,1,HMDB00201,15 (21),0.105,0.266,0.284,0.445
Lidocaine (Antiarrhythmic) Action Pathway,SMPDB,2,ATP2A2;ALG10B,63 (63),0.687,1,1,HMDB00538,17 (25),0.118,0.292,0.286,0.448
Initiation of Nuclear Envelope Reformation,Reactome,2,TMPO;BANF1,13 (13),0.0827,0.654,0,,2 (2),1,1,0.289,0.452
Nuclear Envelope Reassembly,Reactome,2,TMPO;BANF1,13 (13),0.0827,0.654,0,,2 (2),1,1,0.289,0.452
Class A/1 (Rhodopsin-like receptors),Reactome,1,CCR2,330 (330),1,1,2,HMDB00285;HMDB00538,66 (82),0.0831,0.226,0.29,0.453
Cobalamin (Cbl_ vitamin B12) transport and metabolism,Reactome,1,ABCC1,18 (19),0.496,1,1,HMDB00538,25 (28),0.17,0.392,0.292,0.456
Signaling by the B Cell Receptor (BCR),Reactome,1,PIK3AP1,127 (127),0.992,1,1,HMDB00538,12 (14),0.0851,0.228,0.293,0.456
Cimetidine Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,12 (13),0.0851,0.228,0.295,0.456
Role of phospholipids in phagocytosis,Reactome,0,,108 (108),1,1,1,HMDB00538,12 (17),0.0851,0.228,0.295,0.456
Famotidine Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,12 (13),0.0851,0.228,0.295,0.456
Synthesis of 5-eicosatetraenoic acids,Reactome,0,,9 (9),1,1,1,HMDB03337,12 (15),0.0851,0.228,0.295,0.456
Beta oxidation of butanoyl-CoA to acetyl-CoA,Reactome,0,,5 (5),1,1,1,HMDB00538,12 (14),0.0851,0.228,0.295,0.456
Visual signal transduction: Cones,PID,0,,23 (23),1,1,1,HMDB00538,12 (14),0.0851,0.228,0.295,0.456
ethanol degradation IV,HumanCyc,0,,6 (6),1,1,1,HMDB00538,12 (13),0.0851,0.228,0.295,0.456
Lansoprazole Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,12 (13),0.0851,0.228,0.295,0.456
Nizatidine Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,12 (13),0.0851,0.228,0.295,0.456
Ranitidine Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,12 (13),0.0851,0.228,0.295,0.456
Nevirapine Metabolism Pathway,SMPDB,0,,8 (8),1,1,1,HMDB00538,12 (13),0.0851,0.228,0.295,0.456
Betazole Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,12 (13),0.0851,0.228,0.295,0.456
Pirenzepine Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,12 (13),0.0851,0.228,0.295,0.456
Threonine catabolism,Reactome,0,,5 (5),1,1,1,HMDB00538,12 (15),0.0851,0.228,0.295,0.456
proline biosynthesis,HumanCyc,0,,4 (4),1,1,1,HMDB00538,12 (14),0.0851,0.228,0.295,0.456
coenzyme A biosynthesis,HumanCyc,0,,7 (7),1,1,1,HMDB00538,12 (13),0.0851,0.228,0.295,0.456
Steroids metabolism,INOH,1,SOAT2,16 (16),0.456,1,1,HMDB00538,28 (31),0.188,0.427,0.296,0.458
Glycolysis and Gluconeogenesis,Wikipathways,4,LDHA;DLAT;PFKL;TPI1,45 (45),0.0861,0.673,0,,14 (18),1,1,0.297,0.459
Integrin-linked kinase signaling,PID,4,RUVBL2;CKAP5;TACC3;AURKA,45 (45),0.0861,0.673,0,,3 (3),1,1,0.297,0.459
Pyrimidine catabolism,Reactome,1,NT5C,12 (12),0.367,1,1,HMDB00095,36 (39),0.235,0.518,0.298,0.459
Mitochondrial tRNA aminoacylation,Reactome,1,TARS2,21 (21),0.55,1,1,HMDB00538,23 (66),0.157,0.369,0.298,0.46
Thermogenesis,Wikipathways,3,SMARCA4;SMARCB1;SMARCC1,108 (108),0.773,1,1,HMDB00538,16 (25),0.112,0.28,0.298,0.46
Transport of inorganic cations-anions and amino acids-oligopeptides,Wikipathways,0,,0 (0),1,1,1,HMDB00043,31 (58),0.206,0.46,0.206,0.46
Neurotransmitter release cycle,Wikipathways,0,,0 (0),1,1,1,HMDB00538,31 (37),0.206,0.46,0.206,0.46
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,31 (42),0.206,0.46,0.206,0.46
Amino acid synthesis and interconversion (transamination),Wikipathways,0,,0 (0),1,1,1,HMDB00538,31 (40),0.206,0.46,0.206,0.46
gluconeogenesis,HumanCyc,1,TPI1,25 (26),0.614,1,1,HMDB00538,21 (26),0.144,0.344,0.303,0.467
Parkinson disease - Homo sapiens (human),KEGG,3,UQCRC1;CYC1;SLC25A5,142 (142),0.904,1,1,HMDB00538,14 (15),0.0986,0.254,0.305,0.469
SLBP independent Processing of Histone Pre-mRNAs,Reactome,2,SNRPE;NCBP1,10 (10),0.0513,0.47,0,,0 (0),1,1,0.0513,0.47
e2f1 destruction pathway,BioCarta,2,CDK2;E2F1,10 (10),0.0513,0.47,0,,0 (0),1,1,0.0513,0.47
Cohesin Loading onto Chromatin,Reactome,2,SMC1A;PDS5B,10 (10),0.0513,0.47,0,,0 (0),1,1,0.0513,0.47
SCF-beta-TrCP mediated degradation of Emi1,Reactome,2,FZR1;CDC20,10 (10),0.0513,0.47,0,,0 (0),1,1,0.0513,0.47
Signaling Pathways in Glioblastoma,Wikipathways,6,MET;MSH6;E2F1;CDK2;CDK4;CDK6,83 (83),0.0896,0.697,0,,1 (3),1,1,0.306,0.47
Eukaryotic Translation Termination,Reactome,7,RPL13A;RPSA;RPL4;RPS5;RPL9;RPL36A;RPLP0,103 (104),0.0904,0.699,0,,6 (10),1,1,0.308,0.473
Beta-catenin independent WNT signaling,Reactome,2,AP2A2;AP2S1,92 (92),0.863,1,1,HMDB00538,15 (17),0.105,0.266,0.309,0.473
Synthesis of Ketone Bodies,Reactome,0,,8 (8),1,1,1,HMDB00538,13 (14),0.0919,0.241,0.311,0.473
Coenzyme A biosynthesis,Reactome,0,,8 (8),1,1,1,HMDB00538,13 (13),0.0919,0.241,0.311,0.473
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde,HumanCyc,0,,5 (6),1,1,1,HMDB00538,13 (14),0.0919,0.241,0.311,0.473
L-carnitine biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB01325,13 (14),0.0919,0.241,0.311,0.473
eicosapentaenoate biosynthesis,HumanCyc,0,,13 (13),1,1,1,HMDB00538,13 (17),0.0919,0.241,0.311,0.473
pyridoxal 5_-phosphate salvage,HumanCyc,0,,5 (6),1,1,1,HMDB00538,13 (14),0.0919,0.241,0.311,0.473
Surfactant metabolism,Reactome,0,,26 (26),1,1,1,HMDB00538,13 (14),0.0919,0.241,0.311,0.473
Fc epsilon receptor (FCERI) signaling,Reactome,0,,150 (150),1,1,1,HMDB00538,13 (15),0.0919,0.241,0.311,0.473
Vitamin B2 (riboflavin) metabolism,EHMN,0,,5 (5),1,1,1,HMDB00538,13 (14),0.0919,0.241,0.311,0.473
Molybdenum cofactor biosynthesis,Reactome,0,,6 (6),1,1,1,HMDB00538,13 (20),0.0919,0.241,0.311,0.473
Triglyceride biosynthesis,Reactome,0,,14 (14),1,1,1,HMDB00538,13 (18),0.0919,0.241,0.311,0.473
2-oxobutanoate degradation,HumanCyc,0,,8 (8),1,1,1,HMDB00538,13 (14),0.0919,0.241,0.311,0.473
Carnitine synthesis,Reactome,0,,4 (4),1,1,1,HMDB01325,13 (15),0.0919,0.241,0.311,0.473
Pantoprazole Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,13 (14),0.0919,0.241,0.311,0.473
Rabeprazole Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,13 (14),0.0919,0.241,0.311,0.473
Omeprazole Action Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,13 (14),0.0919,0.241,0.311,0.473
Plasmalogen Synthesis,SMPDB,0,,5 (5),1,1,1,HMDB00095,13 (14),0.0919,0.241,0.311,0.473
Heroin Action Pathway,SMPDB,0,,32 (32),1,1,1,HMDB00538,13 (14),0.0919,0.241,0.311,0.473
Plasma lipoprotein assembly_ remodeling_ and clearance,Wikipathways,0,,5 (5),1,1,1,HMDB00538,13 (21),0.0919,0.241,0.311,0.473
p53 signaling pathway - Homo sapiens (human),KEGG,6,CDK4;CCNB2;CDK1;CDK2;CCNB1;CDK6,72 (72),0.0518,0.473,0,,0 (0),1,1,0.0518,0.473
Cytosolic tRNA aminoacylation,Reactome,1,FARSA,24 (24),0.599,1,1,HMDB00538,23 (66),0.157,0.369,0.316,0.48
Retrograde neurotrophin signalling,Reactome,2,AP2A2;AP2S1,14 (14),0.0941,0.724,0,,4 (4),1,1,0.317,0.48
Fcgamma receptor (FCGR) dependent phagocytosis,Reactome,2,DOCK1;HSP90AB1,159 (159),0.984,1,1,HMDB00538,14 (20),0.0986,0.254,0.323,0.49
Eukaryotic Translation Elongation,Reactome,7,RPL13A;RPSA;RPL4;RPS5;RPL9;RPL36A;RPLP0,105 (106),0.0976,0.746,0,,3 (25),1,1,0.325,0.49
Platelet activation - Homo sapiens (human),KEGG,1,PPP1CC,123 (123),0.991,1,1,HMDB00538,14 (15),0.0986,0.254,0.325,0.49
PI Metabolism,Reactome,2,OCRL;PI4KA,84 (84),0.827,1,1,HMDB00538,17 (29),0.118,0.292,0.326,0.49
Transport to the Golgi and subsequent modification,Reactome,4,CTSC;COPZ1;B4GALT6;TRAPPC10,168 (168),0.878,1,1,HMDB00538,16 (36),0.112,0.28,0.326,0.49
ornithine <i>de novo </i> biosynthesis,HumanCyc,0,,5 (5),1,1,1,HMDB00538,14 (15),0.0986,0.254,0.327,0.49
Conjugation of carboxylic acids,Reactome,0,,9 (9),1,1,1,HMDB00538,14 (15),0.0986,0.254,0.327,0.49
Amino Acid conjugation,Reactome,0,,9 (9),1,1,1,HMDB00538,14 (15),0.0986,0.254,0.327,0.49
Synthesis of 15-eicosatetraenoic acid derivatives,Reactome,0,,6 (6),1,1,1,HMDB03337,14 (16),0.0986,0.254,0.327,0.49
Bile salt and organic anion SLC transporters,Reactome,0,,14 (14),1,1,1,HMDB00094,14 (17),0.0986,0.254,0.327,0.49
putrescine degradation III,HumanCyc,0,,10 (10),1,1,1,HMDB02064,14 (15),0.0986,0.254,0.327,0.49
Ethanol oxidation,Reactome,0,,12 (12),1,1,1,HMDB00538,14 (15),0.0986,0.254,0.327,0.49
Abacavir metabolism,Reactome,0,,5 (5),1,1,1,HMDB00538,14 (23),0.0986,0.254,0.327,0.49
Choline catabolism,Reactome,0,,6 (6),1,1,1,HMDB00043,14 (15),0.0986,0.254,0.327,0.49
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,Reactome,0,,14 (14),1,1,1,HMDB00538,14 (29),0.0986,0.254,0.327,0.49
C-type lectin receptors (CLRs),Reactome,0,,83 (83),1,1,1,HMDB00538,14 (18),0.0986,0.254,0.327,0.49
Catabolism of glucuronate to xylulose-5-phosphate,Reactome,0,,5 (5),1,1,1,HMDB00538,14 (16),0.0986,0.254,0.327,0.49
Ca2+ pathway,Reactome,0,,53 (53),1,1,1,HMDB00538,14 (16),0.0986,0.254,0.327,0.49
oxidative ethanol degradation III,HumanCyc,0,,7 (7),1,1,1,HMDB00538,14 (15),0.0986,0.254,0.327,0.49
superpathway of choline degradation to L-serine,HumanCyc,0,,7 (7),1,1,1,HMDB00043,14 (16),0.0986,0.254,0.327,0.49
Aquaporin-mediated transport,Reactome,0,,49 (49),1,1,1,HMDB00538,14 (14),0.0986,0.254,0.327,0.49
Beta-catenin independent WNT signaling,Wikipathways,0,,2 (2),1,1,1,HMDB00538,14 (16),0.0986,0.254,0.327,0.49
Bile acid biosynthesis,EHMN,3,SLC38A1;SOAT2;SLCO4A1,53 (53),0.317,1,1,HMDB00538,50 (55),0.312,0.66,0.328,0.49
bile acid biosynthesis_ neutral pathway,HumanCyc,1,ACAA2,15 (15),0.435,1,1,HMDB00538,35 (44),0.229,0.507,0.33,0.493
Retinoic acid receptors-mediated signaling,PID,3,HDAC1;NCOR2;CDK1,30 (30),0.0999,0.76,0,,2 (2),1,1,0.33,0.493
Porphyrin metabolism,EHMN,2,ABCC1;ALAS1,34 (34),0.364,1,1,HMDB00538,43 (48),0.274,0.592,0.33,0.493
Oxidative phosphorylation - Homo sapiens (human),KEGG,2,UQCRC1;CYC1,133 (133),0.962,1,1,HMDB00538,15 (16),0.105,0.266,0.333,0.497
Malonyl-coa decarboxylase deficiency,SMPDB,1,ACACA,14 (14),0.413,1,1,HMDB00538,38 (38),0.247,0.541,0.335,0.498
Malonic Aciduria,SMPDB,1,ACACA,14 (14),0.413,1,1,HMDB00538,38 (38),0.247,0.541,0.335,0.498
Propanoate Metabolism,SMPDB,1,ACACA,14 (14),0.413,1,1,HMDB00538,38 (38),0.247,0.541,0.335,0.498
Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMPDB,1,ACACA,14 (14),0.413,1,1,HMDB00538,38 (38),0.247,0.541,0.335,0.498
Platelet homeostasis,Reactome,3,ATP2A2;PPP2R5D;NOS2,89 (89),0.651,1,1,HMDB00538,23 (28),0.157,0.369,0.335,0.499
RNA Polymerase I Transcription Initiation,Reactome,4,RBBP4;HDAC1;HDAC2;EHMT2,48 (48),0.103,0.78,0,,2 (2),1,1,0.338,0.503
Central carbon metabolism in cancer - Homo sapiens (human),KEGG,3,LDHA;MET;PFKL,65 (65),0.44,1,1,HMDB00094,36 (37),0.235,0.518,0.338,0.503
Fluoxetine Action Pathway,SMPDB,0,,34 (34),1,1,1,HMDB00538,15 (16),0.105,0.266,0.342,0.506
Fructose metabolism,Reactome,0,,7 (7),1,1,1,HMDB00538,15 (21),0.105,0.266,0.342,0.506
Beta-oxidation of pristanoyl-CoA,Reactome,0,,9 (9),1,1,1,HMDB00201,15 (22),0.105,0.266,0.342,0.506
Abacavir transport and metabolism,Reactome,0,,10 (10),1,1,1,HMDB00538,15 (24),0.105,0.266,0.342,0.506
Desipramine Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB00538,15 (16),0.105,0.266,0.342,0.506
Ketone body metabolism,Reactome,0,,10 (10),1,1,1,HMDB00538,15 (16),0.105,0.266,0.342,0.506
4-hydroxybenzoate biosynthesis,HumanCyc,0,,1 (1),1,1,1,HMDB00538,15 (17),0.105,0.266,0.342,0.506
GABA synthesis_ release_ reuptake and degradation,Reactome,0,,19 (19),1,1,1,HMDB00043,15 (16),0.105,0.266,0.342,0.506
fatty acid &alpha;-oxidation III,HumanCyc,0,,3 (3),1,1,1,HMDB00538,15 (22),0.105,0.266,0.342,0.506
Omega-3 fatty acid metabolism,EHMN,0,,16 (16),1,1,1,HMDB00538,15 (16),0.105,0.266,0.342,0.506
Factors involved in megakaryocyte development and platelet production,Wikipathways,0,,18 (18),1,1,1,HMDB00538,15 (16),0.105,0.266,0.342,0.506
Intracellular signaling by second messengers,Reactome,8,TRIM27;PIK3AP1;RBBP4;MET;RCOR1;PPP2R5D;HDAC1;HDAC2,245 (245),0.7,1,1,HMDB00538,22 (30),0.151,0.358,0.343,0.506
Visual phototransduction,Wikipathways,0,,0 (0),1,1,1,HMDB00538,35 (57),0.229,0.507,0.229,0.507
Nicotinate metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,35 (55),0.229,0.507,0.229,0.507
Signaling events mediated by HDAC Class III,PID,4,TUBA1B;HIST1H4F;HIST1H4D;HIST1H1E,39 (39),0.0564,0.508,0,,0 (0),1,1,0.0564,0.508
Glycosphingolipid metabolism,Reactome,2,ESYT1;GLA,46 (47),0.517,1,1,HMDB00538,31 (41),0.206,0.46,0.345,0.509
Regulation of cholesterol biosynthesis by SREBP (SREBF),Reactome,3,SREBF1;RAN;KPNB1,31 (31),0.108,0.78,0,,1 (1),1,1,0.348,0.512
tetrahydrofolate salvage from 5_10-methenyltetrahydrofolate,HumanCyc,1,MTHFD2,3 (3),0.108,0.78,0,,6 (7),1,1,0.348,0.512
purine ribonucleosides degradation to ribose-1-phosphate,HumanCyc,1,PNP,3 (3),0.108,0.78,0,,12 (15),1,1,0.348,0.512
adenine and adenosine salvage III,HumanCyc,1,PNP,3 (3),0.108,0.78,0,,11 (12),1,1,0.348,0.512
2-oxoglutarate decarboxylation to succinyl-CoA,HumanCyc,1,OGDH,3 (3),0.108,0.78,0,,6 (7),1,1,0.348,0.512
fatty acid &beta;-oxidation (unsaturated_ odd number),HumanCyc,1,ECI2,3 (3),0.108,0.78,0,,8 (10),1,1,0.348,0.512
RAC1-PAK1-p38-MMP2 Pathway,Wikipathways,5,RAD51;NOS2;BIRC5;STMN1;FN1,68 (68),0.11,0.791,0,,1 (1),1,1,0.352,0.517
Inositol Metabolism,SMPDB,1,PI4KA,22 (22),0.567,1,1,HMDB00538,29 (31),0.194,0.437,0.353,0.518
Triglyceride metabolism,Reactome,1,PPP1CC,38 (38),0.765,1,1,HMDB00538,21 (28),0.144,0.344,0.354,0.518
Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency),SMPDB,1,ACAA2,14 (14),0.413,1,1,HMDB00538,42 (43),0.269,0.581,0.355,0.518
Long chain acyl-CoA dehydrogenase deficiency (LCAD),SMPDB,1,ACAA2,14 (14),0.413,1,1,HMDB00538,42 (43),0.269,0.581,0.355,0.518
Trifunctional protein deficiency,SMPDB,1,ACAA2,14 (14),0.413,1,1,HMDB00538,42 (43),0.269,0.581,0.355,0.518
Carnitine palmitoyl transferase deficiency (II),SMPDB,1,ACAA2,14 (14),0.413,1,1,HMDB00538,42 (43),0.269,0.581,0.355,0.518
Very-long-chain acyl coa dehydrogenase deficiency (VLCAD),SMPDB,1,ACAA2,14 (14),0.413,1,1,HMDB00538,42 (43),0.269,0.581,0.355,0.518
Fatty acid Metabolism,SMPDB,1,ACAA2,14 (14),0.413,1,1,HMDB00538,42 (43),0.269,0.581,0.355,0.518
Glutaric Aciduria Type I,SMPDB,1,ACAA2,14 (14),0.413,1,1,HMDB00538,42 (43),0.269,0.581,0.355,0.518
Ethylmalonic Encephalopathy,SMPDB,1,ACAA2,14 (14),0.413,1,1,HMDB00538,42 (43),0.269,0.581,0.355,0.518
Carnitine palmitoyl transferase deficiency (I),SMPDB,1,ACAA2,14 (14),0.413,1,1,HMDB00538,42 (43),0.269,0.581,0.355,0.518
Medium chain acyl-coa dehydrogenase deficiency (MCAD),SMPDB,1,ACAA2,14 (14),0.413,1,1,HMDB00538,42 (43),0.269,0.581,0.355,0.518
stearate biosynthesis,HumanCyc,0,,13 (13),1,1,1,HMDB00538,16 (17),0.112,0.28,0.357,0.518
Kennedy pathway from Sphingolipids,Wikipathways,0,,13 (13),1,1,1,HMDB00095,16 (18),0.112,0.28,0.357,0.518
Renin secretion - Homo sapiens (human),KEGG,0,,65 (65),1,1,1,HMDB00538,16 (21),0.112,0.28,0.357,0.518
5-aminoimidazole ribonucleotide biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB00538,16 (17),0.112,0.28,0.357,0.518
Inactivation_ recovery and regulation of the phototransduction cascade,Reactome,0,,34 (34),1,1,1,HMDB00538,16 (18),0.112,0.28,0.357,0.518
urea cycle,HumanCyc,0,,6 (6),1,1,1,HMDB00538,16 (17),0.112,0.28,0.357,0.518
mevalonate pathway,HumanCyc,0,,10 (10),1,1,1,HMDB00538,16 (17),0.112,0.28,0.357,0.518
Methadone Action Pathway,SMPDB,0,,36 (36),1,1,1,HMDB00538,16 (17),0.112,0.28,0.357,0.518
Morphine Action Pathway,SMPDB,0,,44 (44),1,1,1,HMDB00538,16 (16),0.112,0.28,0.357,0.518
Inositol phosphate metabolism,Reactome,2,OCRL;NUDT3,50 (50),0.562,1,1,HMDB00538,30 (43),0.2,0.449,0.358,0.519
Mercaptopurine Action Pathway,SMPDB,3,PNP;ENTPD5;ATIC,47 (47),0.256,1,1,HMDB00538,77 (84),0.439,0.878,0.358,0.519
Phenytoin (Antiarrhythmic) Action Pathway,SMPDB,2,ATP2A2;ALG10B,82 (82),0.816,1,1,HMDB00538,20 (21),0.138,0.332,0.359,0.52
Azathioprine Action Pathway,SMPDB,3,PNP;ENTPD5;ATIC,47 (47),0.256,1,1,HMDB00538,78 (86),0.444,0.886,0.36,0.522
Thioguanine Action Pathway,SMPDB,3,PNP;ENTPD5;ATIC,47 (47),0.256,1,1,HMDB00538,78 (85),0.444,0.886,0.36,0.522
Selenium Micronutrient Network,Wikipathways,2,MPO;SCARB1,83 (83),0.822,1,2,HMDB00538;HMDB00099,90 (103),0.14,0.337,0.364,0.527
FoxO family signaling,PID,4,CCNB1;CDK2;PLK1;RAN,50 (50),0.116,0.83,0,,2 (2),1,1,0.365,0.528
Neurotransmitter receptors and postsynaptic signal transmission,Reactome,3,AP2A2;GRIA3;AP2S1,152 (153),0.927,1,1,HMDB00538,18 (19),0.125,0.306,0.366,0.528
Thermogenesis - Homo sapiens (human),KEGG,5,UQCRC1;CYC1;SMARCA4;SMARCB1;SMARCC1,229 (229),0.933,1,1,HMDB00538,18 (25),0.125,0.306,0.367,0.53
JAK STAT pathway and regulation,INOH,16,PLK1;PSMC1;MET;PSMD13;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;IFNGR1;CDK1;CDK6;CDK2;CDK4;CDC7;WEE1,309 (310),0.117,0.837,0,,2 (2),1,1,0.368,0.53
Glucagon signaling pathway - Homo sapiens (human),KEGG,3,LDHA;PFKL;ACACA,103 (103),0.745,1,1,HMDB00094,23 (26),0.157,0.369,0.368,0.53
Ion channel transport,Reactome,2,ATP2A2;ATP13A1,179 (179),0.992,1,1,HMDB00538,17 (24),0.118,0.292,0.369,0.53
Circadian rhythm pathway,PID,2,NONO;TIMELESS,16 (16),0.118,0.839,0,,3 (3),1,1,0.371,0.53
Regulation of TLR by endogenous ligand,Reactome,2,TLR1;HMGB1,16 (16),0.118,0.839,0,,6 (12),1,1,0.371,0.53
Cori Cycle,Wikipathways,2,LDHA;TPI1,16 (16),0.118,0.839,0,,18 (24),1,1,0.371,0.53
G-protein mediated events,Reactome,0,,45 (45),1,1,1,HMDB00538,17 (19),0.118,0.292,0.371,0.53
PLC beta mediated events,Reactome,0,,44 (44),1,1,1,HMDB00538,17 (19),0.118,0.292,0.371,0.53
Biosynthesis of DHA-derived SPMs,Reactome,0,,17 (19),1,1,1,HMDB03337,17 (72),0.118,0.292,0.371,0.53
Vitamins B6 activation to pyridoxal phosphate,Reactome,0,,3 (4),1,1,1,HMDB00538,17 (18),0.118,0.292,0.371,0.53
VEGFR2 mediated vascular permeability,Reactome,0,,27 (27),1,1,1,HMDB00538,17 (17),0.118,0.292,0.371,0.53
Lactic Acidemia,SMPDB,0,,5 (5),1,1,1,HMDB00538,17 (17),0.118,0.292,0.371,0.53
Vitamin B5 (pantothenate) metabolism,Reactome,0,,14 (14),1,1,1,HMDB00538,17 (17),0.118,0.292,0.371,0.53
Primary Hyperoxaluria Type I,SMPDB,0,,5 (5),1,1,1,HMDB00538,17 (17),0.118,0.292,0.371,0.53
Pyruvate Carboxylase Deficiency,SMPDB,0,,5 (5),1,1,1,HMDB00538,17 (17),0.118,0.292,0.371,0.53
Alanine Metabolism,SMPDB,0,,5 (5),1,1,1,HMDB00538,17 (17),0.118,0.292,0.371,0.53
Ethanol Degradation,SMPDB,0,,7 (7),1,1,1,HMDB00538,17 (18),0.118,0.292,0.371,0.53
Spermidine and Spermine Biosynthesis,SMPDB,0,,6 (6),1,1,1,HMDB00538,17 (18),0.118,0.292,0.371,0.53
fatty acid &alpha;-oxidation,HumanCyc,0,,5 (5),1,1,1,HMDB00538,17 (20),0.118,0.292,0.371,0.53
Tyrosine metabolism,EHMN,3,MPO;NUP62;SLCO4A1,108 (110),0.773,1,2,HMDB03337;HMDB00538,96 (105),0.156,0.369,0.375,0.536
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,Reactome,2,SNRPE;NCBP1,11 (11),0.0612,0.54,0,,0 (0),1,1,0.0612,0.54
granzyme a mediated apoptosis pathway,BioCarta,2,SET;HMGB2,11 (11),0.0612,0.54,0,,0 (0),1,1,0.0612,0.54
apoptotic dna-fragmentation and tissue homeostasis,BioCarta,2,HMGB1;HMGB2,11 (11),0.0612,0.54,0,,0 (0),1,1,0.0612,0.54
Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,SMPDB,1,TPI1,22 (22),0.567,1,1,HMDB00538,33 (34),0.218,0.484,0.382,0.543
Gluconeogenesis,SMPDB,1,TPI1,22 (22),0.567,1,1,HMDB00538,33 (34),0.218,0.484,0.382,0.543
Glycogenosis_ Type IA. Von gierke disease,SMPDB,1,TPI1,22 (22),0.567,1,1,HMDB00538,33 (34),0.218,0.484,0.382,0.543
Glycogenosis_ Type IC,SMPDB,1,TPI1,22 (22),0.567,1,1,HMDB00538,33 (34),0.218,0.484,0.382,0.543
Triosephosphate isomerase,SMPDB,1,TPI1,22 (22),0.567,1,1,HMDB00538,33 (34),0.218,0.484,0.382,0.543
Fructose-1_6-diphosphatase deficiency,SMPDB,1,TPI1,22 (22),0.567,1,1,HMDB00538,33 (34),0.218,0.484,0.382,0.543
Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),SMPDB,1,TPI1,22 (22),0.567,1,1,HMDB00538,33 (34),0.218,0.484,0.382,0.543
Glycogenosis_ Type IB,SMPDB,1,TPI1,22 (22),0.567,1,1,HMDB00538,33 (34),0.218,0.484,0.382,0.543
Ferroptosis,Wikipathways,0,,40 (40),1,1,1,HMDB03337,18 (29),0.125,0.306,0.385,0.546
C-type lectin receptors (CLRs),Wikipathways,0,,3 (3),1,1,1,HMDB00538,18 (23),0.125,0.306,0.385,0.546
Lidocaine (Local Anaesthetic) Action Pathway,SMPDB,0,,31 (31),1,1,1,HMDB00538,18 (26),0.125,0.306,0.385,0.546
Mercaptopurine Metabolism Pathway,SMPDB,0,,15 (15),1,1,1,HMDB00538,18 (24),0.125,0.306,0.385,0.546
superpathway of purine nucleotide salvage,HumanCyc,2,PNP;IMPDH2,59 (59),0.652,1,1,HMDB00538,29 (30),0.194,0.437,0.388,0.55
miR-targeted genes in leukocytes - TarBase,Wikipathways,10,USP1;ATP2A2;ANAPC1;MTHFD2;ACAA2;CTSC;PLXND1;PNP;CDK6;DCAF7,154 (154),0.0628,0.554,0,,0 (0),1,1,0.0628,0.554
Integration of energy metabolism,Reactome,3,PPP2R5D;MLX;SLC25A5,94 (94),0.687,1,1,HMDB00538,28 (34),0.188,0.427,0.393,0.558
tRNA modification in the nucleus and cytosol,Reactome,1,NSUN2,42 (42),0.798,1,1,HMDB00538,24 (47),0.163,0.38,0.396,0.559
ACE Inhibitor Pathway,Wikipathways,2,TGFB1;CTSG,17 (17),0.131,0.915,0,,5 (10),1,1,0.397,0.559
Valproic Acid Pathway_ Pharmacodynamics,PharmGKB,2,HDAC1;OGDH,17 (17),0.131,0.915,0,,1 (1),1,1,0.397,0.559
Pathway_PA165964473,PharmGKB,2,HDAC1;OGDH,17 (17),0.131,0.915,0,,1 (1),1,1,0.397,0.559
Androgen Receptor Network in Prostate Cancer,Wikipathways,5,CDC25A;PLK1;DOCK1;SMARCA4;SMARCC1,72 (72),0.131,0.915,0,,12 (12),1,1,0.397,0.559
Developmental Biology,Reactome,8,AP2A2;MED24;DOCK1;MET;NCOR2;AP2S1;PLXND1;HSP90AB1,619 (620),1,1,1,HMDB00538,19 (26),0.132,0.319,0.398,0.559
Detoxification of Reactive Oxygen Species,Reactome,0,,36 (36),1,1,1,HMDB03337,19 (24),0.132,0.319,0.398,0.559
Threonine and 2-Oxobutanoate Degradation,SMPDB,0,,9 (9),1,1,1,HMDB00538,19 (19),0.132,0.319,0.398,0.559
Codeine Action Pathway,SMPDB,0,,32 (32),1,1,1,HMDB00538,19 (21),0.132,0.319,0.398,0.559
leucine degradation,HumanCyc,0,,12 (12),1,1,1,HMDB00538,19 (20),0.132,0.319,0.398,0.559
The phototransduction cascade,Reactome,0,,35 (35),1,1,1,HMDB00538,19 (21),0.132,0.319,0.398,0.559
Imipramine Action Pathway,SMPDB,0,,33 (33),1,1,1,HMDB00538,19 (20),0.132,0.319,0.398,0.559
Carnitine Synthesis,SMPDB,0,,5 (5),1,1,1,HMDB01325,19 (20),0.132,0.319,0.398,0.559
Riboflavin Metabolism,SMPDB,0,,5 (5),1,1,1,HMDB00538,19 (19),0.132,0.319,0.398,0.559
Butyrate Metabolism,SMPDB,0,,8 (8),1,1,1,HMDB00538,19 (19),0.132,0.319,0.398,0.559
Cardiac conduction,Wikipathways,0,,1 (1),1,1,1,HMDB00538,19 (25),0.132,0.319,0.398,0.559
Alpha4 beta1 integrin signaling events,PID,3,SPP1;DOCK1;FN1,34 (34),0.132,0.922,0,,4 (4),1,1,0.4,0.561
Amino acid transport across the plasma membrane,Reactome,1,SLC38A1,32 (32),0.704,1,1,HMDB00043,28 (32),0.188,0.427,0.4,0.561
Cholesterol biosynthesis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,40 (47),0.258,0.562,0.258,0.562
Nucleobase biosynthesis,Wikipathways,0,,0 (0),1,1,1,HMDB00538,40 (47),0.258,0.562,0.258,0.562
Neutrophil degranulation,Reactome,25,MPO;ILF2;CAND1;PRTN3;GLA;IMPDH2;AP2A2;MS4A3;PA2G4;CTSC;ELANE;HMGB1;PSMD1;PSMD2;PSMD3;CCT2;PSMD7;PSMD13;PFKL;PPIA;CTSG;DSN1;PNP;KPNB1;HSP90AB1,485 (490),0.0642,0.565,0,,0 (4),1,1,0.0642,0.565
Platelet activation_ signaling and aggregation,Reactome,6,TGFB1;PPIA;ACTN4;F13A1;TAGLN2;FN1,260 (260),0.927,1,1,HMDB00538,21 (33),0.144,0.344,0.403,0.565
Androgen and estrogen biosynthesis and metabolism,EHMN,4,HSD17B12;MPO;ABCC1;SLCO4A1,87 (89),0.409,1,1,HMDB00538,53 (62),0.327,0.685,0.403,0.565
Regulation of insulin secretion,Reactome,1,SLC25A5,70 (70),0.931,1,1,HMDB00538,21 (25),0.144,0.344,0.404,0.566
p53 pathway,PID,5,CDK2;CSE1L;TRIM28;HIPK2;CCNA2,58 (58),0.0647,0.567,0,,0 (0),1,1,0.0647,0.567
Thyroid hormone synthesis - Homo sapiens (human),KEGG,1,CANX,74 (74),0.941,1,1,HMDB03337,21 (21),0.144,0.344,0.407,0.57
Primary Focal Segmental Glomerulosclerosis FSGS,Wikipathways,5,TGFB1;ACTN4;MKI67;SMARCAL1;LRP5,73 (73),0.137,0.943,0,,1 (4),1,1,0.408,0.571
Opioid Signalling,Reactome,1,PPP2R5D,81 (82),0.955,1,1,HMDB00538,21 (24),0.144,0.344,0.411,0.573
Drug Induction of Bile Acid Pathway,Wikipathways,0,,17 (17),1,1,1,HMDB03337,20 (28),0.138,0.332,0.411,0.573
Linoleate metabolism,EHMN,0,,72 (74),1,1,1,HMDB03337,20 (24),0.138,0.332,0.411,0.573
Recycling of bile acids and salts,Reactome,0,,16 (16),1,1,1,HMDB00538,20 (24),0.138,0.332,0.411,0.573
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate),HumanCyc,0,,12 (12),1,1,1,HMDB00538,20 (21),0.138,0.332,0.411,0.573
The canonical retinoid cycle in rods (twilight vision),Reactome,0,,22 (22),1,1,1,HMDB00538,20 (33),0.138,0.332,0.411,0.573
Phytanic acid peroxisomal oxidation,EHMN,0,,16 (16),1,1,1,HMDB00538,20 (22),0.138,0.332,0.411,0.573
Purine metabolism - Homo sapiens (human),KEGG,8,POLA1;POLD1;NT5C;POLE;ATIC;PNP;ENTPD5;IMPDH2,173 (174),0.319,1,1,HMDB00538,77 (95),0.439,0.878,0.416,0.579
TET1_2_3 and TDG demethylate DNA,Reactome,1,TET3,4 (4),0.141,0.943,0,,7 (11),1,1,0.418,0.58
Hypusine synthesis from eIF5A-lysine,Reactome,1,EIF5A,4 (4),0.141,0.943,0,,7 (8),1,1,0.418,0.58
guanosine nucleotides degradation,HumanCyc,1,PNP,4 (4),0.141,0.943,0,,11 (12),1,1,0.418,0.58
serine biosynthesis (phosphorylated route),HumanCyc,1,PSAT1,4 (4),0.141,0.943,0,,9 (11),1,1,0.418,0.58
Activation of AMPA receptors,Reactome,1,GRIA3,4 (4),0.141,0.943,0,,3 (3),1,1,0.418,0.58
Lamivudine Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,2,NT5C;ABCC1,18 (18),0.144,0.943,0,,1 (1),1,1,0.423,0.586
Signaling by Retinoic Acid,Reactome,1,DLAT,45 (45),0.82,1,1,HMDB00538,26 (29),0.176,0.404,0.423,0.586
NAD <i>de novo</i> biosynthesis,HumanCyc,0,,12 (13),1,1,1,HMDB00538,21 (24),0.144,0.344,0.424,0.586
Sulfite oxidase deficiency,SMPDB,0,,7 (7),1,1,1,HMDB00538,21 (22),0.144,0.344,0.424,0.586
Linoleic acid (LA) metabolism,Reactome,0,,8 (8),1,1,1,HMDB00538,21 (24),0.144,0.344,0.424,0.586
Ferroptosis - Homo sapiens (human),KEGG,0,,40 (40),1,1,1,HMDB03337,21 (31),0.144,0.344,0.424,0.586
Sulfate/Sulfite Metabolism,SMPDB,0,,7 (7),1,1,1,HMDB00538,21 (22),0.144,0.344,0.424,0.586
fatty acid activation,HumanCyc,0,,8 (8),1,1,1,HMDB00538,21 (38),0.144,0.344,0.424,0.586
Regulation of nuclear SMAD2/3 signaling,PID,6,RBBP4;CTBP1;CDK2;HDAC1;HDAC2;CDK4,77 (78),0.0675,0.588,0,,0 (1),1,1,0.0675,0.588
Pancreatic cancer - Homo sapiens (human),KEGG,5,TGFB1;RAD51;CDK4;E2F1;CDK6,75 (75),0.148,0.968,0,,2 (2),1,1,0.431,0.596
Busulfan Pathway_ Pharmacodynamics,PharmGKB,3,GSTM1;MLH1;CDK1,36 (36),0.15,0.977,0,,1 (1),1,1,0.434,0.6
Histidine catabolism,Reactome,0,,8 (8),1,1,1,HMDB00538,22 (23),0.151,0.358,0.436,0.601
Urea cycle,Reactome,0,,10 (10),1,1,1,HMDB00538,22 (23),0.151,0.358,0.436,0.601
Tetrahydrobiopterin (BH4) synthesis_ recycling_ salvage and regulation,Reactome,0,,10 (10),1,1,1,HMDB00538,22 (27),0.151,0.358,0.436,0.601
VLDLR internalisation and degradation,Reactome,2,AP2A2;AP2S1,12 (12),0.0717,0.603,0,,0 (0),1,1,0.0717,0.603
protein kinase a at the centrosome,BioCarta,2,PPP2R5D;CDK1,12 (12),0.0717,0.603,0,,0 (1),1,1,0.0717,0.603
miR-targeted genes in squamous cell - TarBase,Wikipathways,10,SLC38A1;VEZT;ATP2A2;MET;ANP32B;PTMA;ACAA2;HSD17B12;PNP;GALNT1,158 (158),0.072,0.603,0,,0 (0),1,1,0.072,0.603
ChREBP activates metabolic gene expression,Reactome,1,MLX,2 (2),0.0733,0.603,0,,0 (0),1,1,0.0733,0.603
Plus-strand DNA synthesis,Reactome,1,PPIA,2 (2),0.0733,0.603,0,,0 (0),1,1,0.0733,0.603
Assembly of Viral Components at the Budding Site,Reactome,1,CANX,2 (2),0.0733,0.603,0,,0 (0),1,1,0.0733,0.603
Virus Assembly and Release,Reactome,1,CANX,2 (2),0.0733,0.603,0,,0 (1),1,1,0.0733,0.603
Influenza Virus Induced Apoptosis,Reactome,1,TGFB1,2 (2),0.0733,0.603,0,,0 (0),1,1,0.0733,0.603
Mitotic Metaphase/Anaphase Transition,Reactome,1,PLK1,2 (2),0.0733,0.603,0,,0 (0),1,1,0.0733,0.603
Uncoating of the HIV Virion,Reactome,1,PPIA,2 (2),0.0733,0.603,0,,0 (0),1,1,0.0733,0.603
purine nucleotides <i>de novo</i> biosynthesis,HumanCyc,2,IMPDH2;ATIC,59 (59),0.652,1,1,HMDB00538,36 (37),0.235,0.518,0.441,0.608
Cysteine and methionine metabolism - Homo sapiens (human),KEGG,2,DNMT1;LDHA,47 (47),0.528,1,1,HMDB00099,46 (61),0.291,0.617,0.441,0.608
Role of Calcineurin-dependent NFAT signaling in lymphocytes,PID,4,KPNA2;RAN;NUP214;KPNB1,56 (56),0.156,0.997,0,,2 (2),1,1,0.446,0.613
Mitochondrial Gene Expression,Wikipathways,2,TFAM;HCFC1,19 (19),0.157,0.997,0,,3 (3),1,1,0.448,0.613
Glucuronidation,Reactome,0,,25 (25),1,1,1,HMDB00285,23 (31),0.157,0.369,0.448,0.613
Glycerolipid Metabolism,SMPDB,0,,13 (13),1,1,1,HMDB00538,23 (24),0.157,0.369,0.448,0.613
Vitamin A (retinol) metabolism,EHMN,0,,26 (26),1,1,1,HMDB00538,23 (28),0.157,0.369,0.448,0.613
Familial lipoprotein lipase deficiency,SMPDB,0,,13 (13),1,1,1,HMDB00538,23 (24),0.157,0.369,0.448,0.613
D-glyceric acidura,SMPDB,0,,13 (13),1,1,1,HMDB00538,23 (24),0.157,0.369,0.448,0.613
Alpha-oxidation of phytanate,Reactome,0,,6 (6),1,1,1,HMDB00538,23 (25),0.157,0.369,0.448,0.613
Organic cation transport,Reactome,0,,10 (11),1,1,1,HMDB03045,23 (29),0.157,0.369,0.448,0.613
Citalopram Action Pathway,SMPDB,0,,36 (36),1,1,1,HMDB00538,23 (27),0.157,0.369,0.448,0.613
Glycerol Kinase Deficiency,SMPDB,0,,13 (13),1,1,1,HMDB00538,23 (24),0.157,0.369,0.448,0.613
NAD Biosynthesis II (from tryptophan),Wikipathways,0,,8 (8),1,1,1,HMDB00538,23 (23),0.157,0.369,0.448,0.613
Metabolism of polyamines,Wikipathways,0,,0 (0),1,1,1,HMDB00538,46 (59),0.291,0.617,0.291,0.617
Sphingolipid de novo biosynthesis,Reactome,1,SGPP1,45 (45),0.82,1,1,HMDB00538,29 (35),0.194,0.437,0.452,0.618
Alanine_ aspartate and glutamate metabolism - Homo sapiens (human),KEGG,0,,35 (35),1,1,1,HMDB00094,24 (28),0.163,0.38,0.459,0.627
alpha-linolenic acid (ALA) metabolism,Reactome,0,,13 (13),1,1,1,HMDB00538,24 (32),0.163,0.38,0.459,0.627
Refsum Disease,SMPDB,0,,6 (6),1,1,1,HMDB00538,24 (24),0.163,0.38,0.459,0.627
Phytanic Acid Peroxisomal Oxidation,SMPDB,0,,6 (6),1,1,1,HMDB00538,24 (24),0.163,0.38,0.459,0.627
FGFR2 alternative splicing,Reactome,3,GTF2F1;PTBP1;NCBP1,27 (27),0.078,0.628,0,,0 (0),1,1,0.078,0.628
Purine nucleotides nucleosides metabolism,INOH,5,NT5C;IMPDH2;PNP;ENTPD5;ATIC,107 (108),0.37,1,1,HMDB00538,78 (80),0.444,0.886,0.461,0.629
Signaling events mediated by TCPTP,PID,3,MET;KPNB1;KPNA2,38 (38),0.168,1,0,,1 (2),1,1,0.468,0.629
Carboxyterminal post-translational modifications of tubulin,Reactome,3,TUBA1B;TTLL5;TUBA1C,38 (38),0.168,1,0,,7 (9),1,1,0.468,0.629
GPCR ligand binding,Reactome,1,CCR2,465 (466),1,1,2,HMDB00285;HMDB00538,101 (141),0.169,0.392,0.469,0.629
Hyperornithinemia with gyrate atrophy (HOGA),SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
Creatine deficiency_ guanidinoacetate methyltransferase deficiency,SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
L-arginine:glycine amidinotransferase deficiency,SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
Prolinemia Type II,SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
Prolidase Deficiency (PD),SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
Arginine and Proline Metabolism,SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
Hyperprolinemia Type I,SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
Hyperprolinemia Type II,SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
Ornithine Aminotransferase Deficiency (OAT Deficiency),SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),SMPDB,1,GATM,20 (20),0.533,1,1,HMDB00538,51 (52),0.317,0.666,0.469,0.629
G alpha (s) signalling events,Reactome,1,REEP4,580 (583),1,1,1,HMDB00538,25 (33),0.17,0.392,0.47,0.629
eNOS activation,Reactome,0,,11 (11),1,1,1,HMDB00538,25 (26),0.17,0.392,0.47,0.629
eNOS activation and regulation,Reactome,0,,16 (16),1,1,1,HMDB00538,25 (26),0.17,0.392,0.47,0.629
Valproic Acid Metabolism Pathway,SMPDB,0,,11 (11),1,1,1,HMDB00538,25 (31),0.17,0.392,0.47,0.629
Metabolism of nitric oxide,Reactome,0,,16 (16),1,1,1,HMDB00538,25 (26),0.17,0.392,0.47,0.629
Valine Leucine Isoleucine degradation,INOH,1,ACAA2,32 (32),0.704,1,1,HMDB00538,37 (40),0.241,0.53,0.471,0.629
Agents Acting on the Renin-Angiotensin System Pathway_ Pharmacodynamics,PharmGKB,2,TGFB1;CTSG,20 (20),0.17,1,0,,2 (3),1,1,0.472,0.629
Aminocaproic Acid Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,5 (5),1,1,0.472,0.629
Tranexamic Acid Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,5 (5),1,1,0.472,0.629
Urokinase Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (4),1,1,0.472,0.629
Reteplase Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (4),1,1,0.472,0.629
Streptokinase Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (4),1,1,0.472,0.629
Tenecteplase Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (4),1,1,0.472,0.629
Alteplase Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (4),1,1,0.472,0.629
Anistreplase Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (4),1,1,0.472,0.629
Aprotinin Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (4),1,1,0.472,0.629
Phenindione Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,5 (5),1,1,0.472,0.629
Dicoumarol Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,5 (5),1,1,0.472,0.629
Warfarin Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,5 (5),1,1,0.472,0.629
Acenocoumarol Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (5),1,1,0.472,0.629
Coagulation ,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (4),1,1,0.472,0.629
Bivalirudin Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (4),1,1,0.472,0.629
Argatroban Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,5 (5),1,1,0.472,0.629
Phenprocoumon Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (5),1,1,0.472,0.629
Dicumarol Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,5 (5),1,1,0.472,0.629
Ximelagatran Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (5),1,1,0.472,0.629
Lepirudin Action Pathway,SMPDB,2,F13A1;F10,20 (20),0.17,1,0,,4 (4),1,1,0.472,0.629
VEGFA-VEGFR2 Pathway,Reactome,1,DOCK1,92 (92),0.97,1,1,HMDB00538,26 (28),0.176,0.404,0.472,0.629
Inflammatory mediator regulation of TRP channels - Homo sapiens (human),KEGG,1,PPP1CC,99 (99),0.977,1,1,HMDB00538,26 (36),0.176,0.404,0.474,0.632
Signaling by VEGF,Reactome,1,DOCK1,100 (100),0.978,1,1,HMDB00538,26 (28),0.176,0.404,0.475,0.632
lactate fermentation (reoxidation of cytosolic NADH),HumanCyc,1,LDHA,5 (5),0.173,1,0,,4 (5),1,1,0.477,0.633
HDL clearance,Reactome,1,SCARB1,5 (5),0.173,1,0,,3 (4),1,1,0.477,0.633
tetrapyrrole biosynthesis,HumanCyc,1,ALAS1,5 (5),0.173,1,0,,10 (11),1,1,0.477,0.633
Extrinsic Pathway of Fibrin Clot Formation,Reactome,1,F10,5 (5),0.173,1,0,,1 (3),1,1,0.477,0.633
pyruvate decarboxylation to acetyl CoA,HumanCyc,1,DLAT,5 (5),0.173,1,0,,6 (7),1,1,0.477,0.633
Degradation pathway of sphingolipids_ including diseases,Wikipathways,1,GLA,5 (5),0.173,1,0,,10 (13),1,1,0.477,0.633
Pentose phosphate pathway (hexose monophosphate shunt),Reactome,0,,15 (15),1,1,1,HMDB00538,26 (31),0.176,0.404,0.481,0.637
Histidine degradation,INOH,0,,23 (23),1,1,1,HMDB00538,26 (28),0.176,0.404,0.481,0.637
Beta-mercaptolactate-cysteine disulfiduria,SMPDB,0,,9 (9),1,1,1,HMDB00538,26 (26),0.176,0.404,0.481,0.637
Cysteine Metabolism,SMPDB,0,,9 (9),1,1,1,HMDB00538,26 (26),0.176,0.404,0.481,0.637
Cystinosis_ ocular nonnephropathic,SMPDB,0,,9 (9),1,1,1,HMDB00538,26 (26),0.176,0.404,0.481,0.637
Pyruvate metabolism - Homo sapiens (human),KEGG,3,DLAT;LDHA;ACACA,39 (39),0.177,1,0,,25 (31),1,1,0.484,0.641
MHC class II antigen presentation,Reactome,4,AP2A2;CTSC;CANX;AP2S1,59 (59),0.178,1,0,,3 (3),1,1,0.485,0.641
E3 ubiquitin ligases ubiquitinate target proteins,Reactome,4,HIST1H2BH;HIST1H2BB;HIST1H2BG;HIST1H2BF,59 (59),0.178,1,0,,1 (1),1,1,0.485,0.641
Glucocorticoid receptor regulatory network,PID,5,FKBP4;HDAC1;HDAC2;SMARCA4;SMARCC1,80 (80),0.179,1,0,,1 (3),1,1,0.486,0.643
Valine_ leucine and isoleucine degradation,EHMN,2,ACAA2;SLC38A1,49 (49),0.551,1,1,HMDB00538,53 (62),0.327,0.685,0.489,0.646
fatty acid &beta;-oxidation (peroxisome),HumanCyc,1,ACAA2,19 (19),0.515,1,1,HMDB00538,58 (85),0.352,0.728,0.491,0.647
Vitamin B12 Metabolism,Wikipathways,2,MPO;SCARB1,51 (51),0.573,1,1,HMDB00099,51 (60),0.317,0.666,0.491,0.647
Argininemia,SMPDB,0,,13 (13),1,1,1,HMDB00538,27 (27),0.182,0.415,0.492,0.647
Citrullinemia Type I,SMPDB,0,,13 (13),1,1,1,HMDB00538,27 (27),0.182,0.415,0.492,0.647
Carbamoyl Phosphate Synthetase Deficiency,SMPDB,0,,13 (13),1,1,1,HMDB00538,27 (27),0.182,0.415,0.492,0.647
Argininosuccinic Aciduria,SMPDB,0,,13 (13),1,1,1,HMDB00538,27 (27),0.182,0.415,0.492,0.647
Urea Cycle,SMPDB,0,,13 (13),1,1,1,HMDB00538,27 (27),0.182,0.415,0.492,0.647
Ornithine Transcarbamylase Deficiency (OTC Deficiency),SMPDB,0,,13 (13),1,1,1,HMDB00538,27 (27),0.182,0.415,0.492,0.647
Sphingosine 1-phosphate (S1P) pathway,PID,2,SGPP1;ABCC1,21 (21),0.184,1,0,,4 (5),1,1,0.495,0.649
Downregulation of SMAD2/3:SMAD4 transcriptional activity,Reactome,2,HDAC1;NCOR2,21 (21),0.184,1,0,,4 (4),1,1,0.495,0.649
downregulated of mta-3 in er-negative breast tumors,BioCarta,2,HDAC1;TUBA1C,21 (21),0.184,1,0,,2 (2),1,1,0.495,0.649
phosphoinositides and their downstream targets,BioCarta,2,PFKL;GTF3A,21 (21),0.184,1,0,,1 (1),1,1,0.495,0.649
Ardeparin Action Pathway,SMPDB,2,F13A1;F10,21 (21),0.184,1,0,,4 (4),1,1,0.495,0.649
Heparin Action Pathway,SMPDB,2,F13A1;F10,21 (21),0.184,1,0,,5 (5),1,1,0.495,0.649
Fondaparinux Action Pathway,SMPDB,2,F13A1;F10,21 (21),0.184,1,0,,4 (5),1,1,0.495,0.649
Enoxaparin Action Pathway,SMPDB,2,F13A1;F10,21 (21),0.184,1,0,,4 (4),1,1,0.495,0.649
Huntington disease - Homo sapiens (human),KEGG,10,CYC1;SLC25A5;AP2A2;TFAM;HTT;RCOR1;AP2S1;UQCRC1;HDAC1;HDAC2,193 (193),0.186,1,0,,3 (3),1,1,0.498,0.652
Inhibition of replication initiation of damaged DNA by RB1/E2F1,Reactome,2,E2F1;POLA1,13 (13),0.0827,0.654,0,,0 (0),1,1,0.0827,0.654
Platinum Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,2,GSTM1;MPO,13 (13),0.0827,0.654,0,,0 (0),1,1,0.0827,0.654
Advanced glycosylation endproduct receptor signaling,Reactome,2,HMGB1;PRKCSH,13 (13),0.0827,0.654,0,,0 (3),1,1,0.0827,0.654
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,Reactome,3,DEK;ATAD2;HSPD1,40 (40),0.187,1,0,,1 (1),1,1,0.5,0.654
Na+/Cl- dependent neurotransmitter transporters,Reactome,0,,19 (19),1,1,1,HMDB00043,28 (31),0.188,0.427,0.502,0.656
Biosynthesis of specialized proresolving mediators (SPMs),Reactome,0,,19 (21),1,1,1,HMDB03337,28 (140),0.188,0.427,0.502,0.656
Arginine and proline metabolism - Homo sapiens (human),KEGG,2,NOS2;GATM,49 (50),0.551,1,1,HMDB02064,56 (78),0.342,0.715,0.503,0.657
Adaptive Immune System,Reactome,18,CTSC;CCNF;PIK3AP1;CDC20;AP2A2;ANAPC1;UBE2C;TRIM37;CDC16;FBXW8;CANX;AP2S1;PPP2R5D;CDC23;UBE3C;FZR1;TLR1;TRAIP,728 (732),0.979,1,1,HMDB00538,29 (54),0.194,0.437,0.506,0.66
Glyoxylate and dicarboxylate metabolism - Homo sapiens (human),KEGG,1,PGP,30 (30),0.681,1,1,HMDB00094,44 (62),0.28,0.604,0.507,0.661
Prostaglandin formation from arachidonate,EHMN,1,SLCO4A1,34 (34),0.726,1,1,HMDB00538,41 (48),0.263,0.573,0.508,0.662
Sphingolipid metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,51 (67),0.317,0.666,0.317,0.666
Amino acid synthesis and interconversion (transamination),Reactome,1,PSAT1,35 (35),0.736,1,1,HMDB00538,41 (46),0.263,0.573,0.512,0.667
Ammonia Recycling,SMPDB,0,,12 (12),1,1,1,HMDB00538,29 (29),0.194,0.437,0.512,0.667
Nicotine Action Pathway,SMPDB,0,,36 (36),1,1,1,HMDB00538,29 (30),0.194,0.437,0.512,0.667
NOTCH-Ncore,Signalink,3,SET;NCOR2;CTBP1,28 (28),0.085,0.671,0,,0 (0),1,1,0.085,0.671
Pathways Affected in Adenoid Cystic Carcinoma,Wikipathways,5,HIST1H1E;UHRF1;MYB;SMC1A;CTBP1,63 (63),0.0856,0.673,0,,0 (0),1,1,0.0856,0.673
Basal transcription factors - Homo sapiens (human),KEGG,4,TAF1;GTF2I;GTF2F1;TAF9,45 (45),0.0861,0.673,0,,0 (0),1,1,0.0861,0.673
Notch Signaling,Wikipathways,4,HDAC1;HDAC2;NCOR2;CTBP1,45 (45),0.0861,0.673,0,,0 (0),1,1,0.0861,0.673
Intrinsic Pathway of Fibrin Clot Formation,Reactome,2,C1QBP;F10,22 (22),0.197,1,0,,2 (6),1,1,0.518,0.673
Doxorubicin Pathway_ Pharmacokinetics,PharmGKB,2,ABCC1;NOS2,22 (22),0.197,1,0,,1 (1),1,1,0.518,0.673
Fatty Acid Biosynthesis,Wikipathways,2,ACAA2;ACACA,22 (22),0.197,1,0,,4 (9),1,1,0.518,0.673
Metabolism of vitamins and cofactors,Reactome,5,GSTO1;ABCC1;MTHFD2;MTHFD1L;ACACA,178 (181),0.799,1,2,HMDB03337;HMDB00538,130 (180),0.248,0.544,0.519,0.674
G alpha (i) signalling events,Reactome,2,PPP2R5D;CCR2,399 (400),1,1,2,HMDB00285;HMDB00538,112 (159),0.198,0.447,0.519,0.674
Transcriptional misregulation in cancer - Homo sapiens (human),KEGG,11,HIST1H3C;MPO;HIST1H3I;ELANE;HIST1H3F;MET;GRIA3;UTY;HDAC1;HDAC2;DOT1L,185 (186),0.0864,0.675,0,,0 (0),1,1,0.0864,0.675
Bile acid and bile salt metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,52 (76),0.322,0.675,0.322,0.675
Metabolism of ingested SeMet_ Sec_ MeSec into H2Se,Reactome,0,,10 (10),1,1,1,HMDB00538,30 (32),0.2,0.449,0.522,0.677
Organic cation/anion/zwitterion transport,Reactome,0,,15 (16),1,1,1,HMDB03045,30 (36),0.2,0.449,0.522,0.677
Nicotinamide salvaging,Reactome,0,,12 (12),1,1,1,HMDB00538,30 (38),0.2,0.449,0.522,0.677
histidine degradation,HumanCyc,1,MTHFD2,6 (6),0.204,1,0,,11 (12),1,1,0.528,0.683
Vitamin B6 metabolism - Homo sapiens (human),KEGG,1,PSAT1,6 (6),0.204,1,0,,17 (28),1,1,0.528,0.683
multi-drug resistance factors,BioCarta,1,ABCC1,6 (6),0.204,1,0,,2 (2),1,1,0.528,0.683
deregulation of cdk5 in alzheimers disease,BioCarta,1,PPP2R5D,6 (6),0.204,1,0,,1 (1),1,1,0.528,0.683
Fibronectin matrix formation,Reactome,1,FN1,6 (6),0.204,1,0,,1 (2),1,1,0.528,0.683
Scavenging by Class B Receptors,Reactome,1,SCARB1,6 (6),0.204,1,0,,7 (15),1,1,0.528,0.683
Amine compound SLC transporters,Reactome,0,,30 (30),1,1,1,HMDB00043,31 (35),0.206,0.46,0.531,0.686
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,Reactome,0,,13 (13),1,1,1,HMDB00538,31 (42),0.206,0.46,0.531,0.686
Integrins in angiogenesis,PID,4,SPP1;PI4KA;COL5A1;FN1,63 (63),0.208,1,0,,2 (2),1,1,0.535,0.69
MECP2 and Associated Rett Syndrome,Wikipathways,4,TAF1;HDAC1;E2F1;TET3,63 (63),0.208,1,0,,7 (8),1,1,0.535,0.69
Mitochondrial Fatty Acid Beta-Oxidation,Wikipathways,0,,0 (0),1,1,1,HMDB00538,54 (67),0.332,0.695,0.332,0.695
Glycolysis Pathway D (2),Wikipathways,2,LDHA;PFKL,23 (23),0.211,1,0,,10 (14),1,1,0.54,0.695
Canonical NF-kappaB pathway,PID,2,RAN;ERC1,23 (23),0.211,1,0,,1 (1),1,1,0.54,0.695
Signaling events mediated by the Hedgehog family,PID,2,STIL;LRPAP1,23 (23),0.211,1,0,,2 (2),1,1,0.54,0.695
Post-chaperonin tubulin folding pathway,Reactome,2,TUBA1B;TUBA1C,23 (23),0.211,1,0,,2 (2),1,1,0.54,0.695
BBSome-mediated cargo-targeting to cilium,Reactome,2,CCT2;TCP1,23 (23),0.211,1,0,,1 (1),1,1,0.54,0.695
SRP-dependent cotranslational protein targeting to membrane,Reactome,8,RPL13A;RPSA;SRP72;RPL4;RPS5;RPL9;RPL36A;RPLP0,123 (124),0.0893,0.696,0,,0 (1),1,1,0.0893,0.696
CD4 T cell receptor signaling,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,130 (130),0.213,1,0,,6 (7),1,1,0.542,0.697
Signaling by Receptor Tyrosine Kinases,Reactome,10,AP2A2;DOCK1;SPP1;MET;SPRED1;GTF2F1;NCBP1;AP2S1;PPP2R5D;PTBP1,423 (423),0.957,1,1,HMDB00538,34 (44),0.224,0.495,0.544,0.7
Sphingolipid metabolism,Reactome,3,ESYT1;SGPP1;GLA,91 (92),0.666,1,1,HMDB00538,52 (68),0.322,0.675,0.545,0.7
Validated nuclear estrogen receptor alpha network,PID,4,HDAC1;SET;NCOR2;DDX54,64 (64),0.216,1,0,,1 (1),1,1,0.547,0.703
Carnosinuria_ carnosinemia,SMPDB,0,,9 (9),1,1,1,HMDB00001#HMDB00479,33 (34),0.218,0.484,0.55,0.704
Ureidopropionase deficiency,SMPDB,0,,9 (9),1,1,1,HMDB00001#HMDB00479,33 (34),0.218,0.484,0.55,0.704
Beta-Alanine Metabolism,SMPDB,0,,9 (9),1,1,1,HMDB00001#HMDB00479,33 (34),0.218,0.484,0.55,0.704
Butanoate metabolism,EHMN,0,,23 (23),1,1,1,HMDB00538,33 (36),0.218,0.484,0.55,0.704
GABA-Transaminase Deficiency,SMPDB,0,,9 (9),1,1,1,HMDB00001#HMDB00479,33 (34),0.218,0.484,0.55,0.704
Aryl Hydrocarbon Receptor,Wikipathways,4,AHR;NCOR2;E2F1;CDK2,46 (46),0.0917,0.708,0,,0 (2),1,1,0.0917,0.708
Hypoacetylaspartia,SMPDB,0,,14 (14),1,1,1,HMDB00538,34 (34),0.224,0.495,0.559,0.715
Aspartate Metabolism,SMPDB,0,,14 (14),1,1,1,HMDB00538,34 (34),0.224,0.495,0.559,0.715
Canavan Disease,SMPDB,0,,14 (14),1,1,1,HMDB00538,34 (34),0.224,0.495,0.559,0.715
Vitamin digestion and absorption - Homo sapiens (human),KEGG,2,ABCC1;SCARB1,24 (24),0.225,1,0,,31 (39),1,1,0.561,0.716
Fluoropyrimidine Pathway_ Pharmacokinetics,PharmGKB,2,UCK2;UMPS,24 (24),0.225,1,0,,2 (2),1,1,0.561,0.716
Doxorubicin Pathway (Cardiomyocyte Cell)_ Pharmacodynamics,PharmGKB,2,ATP2A2;NOS2,24 (24),0.225,1,0,,1 (2),1,1,0.561,0.716
Amino acid and oligopeptide SLC transporters,Reactome,1,SLC38A1,52 (52),0.862,1,1,HMDB00043,41 (50),0.263,0.573,0.564,0.72
Repression of WNT target genes,Reactome,2,HDAC1;CTBP1,14 (14),0.0941,0.724,0,,0 (0),1,1,0.0941,0.724
Cytosolic sulfonation of small molecules,Reactome,0,,25 (26),1,1,1,HMDB00538,35 (47),0.229,0.507,0.567,0.724
Mitochondrial translation elongation,Reactome,5,MRPS31;GFM1;TUFM;MRPL2;MRPL12,88 (89),0.232,1,0,,3 (26),1,1,0.57,0.726
PP2A-mediated dephosphorylation of key metabolic factors,Reactome,1,PPP2R5D,7 (7),0.234,1,0,,2 (2),1,1,0.574,0.726
Attachment of GPI anchor to uPAR,Reactome,1,PIGU,7 (7),0.234,1,0,,1 (3),1,1,0.574,0.726
serine and glycine biosynthesis,HumanCyc,1,PSAT1,7 (7),0.234,1,0,,13 (15),1,1,0.574,0.726
POLB-Dependent Long Patch Base Excision Repair,Reactome,1,LIG1,7 (7),0.234,1,0,,5 (6),1,1,0.574,0.726
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,Reactome,1,HSPD1,7 (7),0.234,1,0,,1 (1),1,1,0.574,0.726
Methotrexate Pathway (Brain Cell)_ Pharmacokinetics,PharmGKB,1,ABCC1,7 (7),0.234,1,0,,1 (1),1,1,0.574,0.726
Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD),SMPDB,1,ACAA2,7 (7),0.234,1,0,,33 (34),1,1,0.574,0.726
Fatty Acid Elongation In Mitochondria,SMPDB,1,ACAA2,7 (7),0.234,1,0,,33 (34),1,1,0.574,0.726
Metabolism of Spingolipids in ER and Golgi apparatus,Wikipathways,1,GALNT1,7 (7),0.234,1,0,,10 (21),1,1,0.574,0.726
Purine metabolism,Wikipathways,1,ATIC,7 (7),0.234,1,0,,40 (42),1,1,0.574,0.726
B cell receptor signaling,INOH,7,PSMC1;PSMD1;PSMD2;PSMD3;PSMD5;PSMD7;PSMD13,134 (134),0.234,1,0,,6 (7),1,1,0.575,0.726
Metabolism of cofactors,Reactome,0,,19 (19),1,1,1,HMDB00538,36 (47),0.235,0.518,0.576,0.726
3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
3-Methylglutaconic Aciduria Type IV,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
3-Methylglutaconic Aciduria Type I,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
Valine_ Leucine and Isoleucine Degradation,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
Isovaleric Aciduria,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
Propionic Acidemia,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
Maple Syrup Urine Disease,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
Isobutyryl-coa dehydrogenase deficiency,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
3-hydroxyisobutyric aciduria,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
3-hydroxyisobutyric acid dehydrogenase deficiency,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
Isovaleric acidemia,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
Methylmalonic Aciduria,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
3-Methylglutaconic Aciduria Type III,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
Beta-Ketothiolase Deficiency,SMPDB,1,ACAA2,30 (30),0.681,1,1,HMDB00538,57 (58),0.347,0.718,0.577,0.726
Pancreatic adenocarcinoma pathway,Wikipathways,5,TGFB1;RAD51;CDK4;E2F1;CDK6,89 (89),0.239,1,0,,1 (2),1,1,0.58,0.729
mtor signaling pathway,BioCarta,2,PPP2R5D;EIF4G1,25 (25),0.239,1,0,,3 (3),1,1,0.581,0.73
skeletal muscle hypertrophy is regulated via akt-mtor pathway,BioCarta,2,PPP2R5D;EIF4G1,25 (25),0.239,1,0,,3 (3),1,1,0.581,0.73
Alanine Aspartate Asparagine metabolism,INOH,0,,25 (25),1,1,1,HMDB00538,38 (45),0.247,0.541,0.592,0.743
Metabolism of polyamines,Reactome,1,GATM,40 (40),0.782,1,1,HMDB00538,51 (60),0.317,0.666,0.594,0.744
Glycolysis / Gluconeogenesis - Homo sapiens (human),KEGG,4,LDHA;DLAT;PFKL;TPI1,68 (68),0.248,1,0,,23 (31),1,1,0.594,0.744
AMP-activated Protein Kinase (AMPK) Signaling,Wikipathways,4,SREBF1;CCNA2;CCNB1;ACACA,68 (68),0.248,1,0,,7 (7),1,1,0.594,0.744
Sterol Regulatory Element-Binding Proteins (SREBP) signalling,Wikipathways,4,SREBF1;ACACA;KPNB1;SCARB1,68 (68),0.248,1,0,,3 (5),1,1,0.594,0.744
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan catabolism,Reactome,2,NUP62;OGDH,48 (49),0.54,1,1,HMDB00538,82 (91),0.461,0.919,0.595,0.744
Validated transcriptional targets of deltaNp63 isoforms,PID,4,TOP2A;CCNB2;HELLS;COL5A1,47 (48),0.0974,0.745,0,,0 (0),1,1,0.0974,0.745
Mitochondrial Fatty Acid Beta-Oxidation,Reactome,1,ACAA2,38 (39),0.765,1,1,HMDB00538,53 (66),0.327,0.685,0.597,0.747
Nicotinate metabolism,Reactome,0,,24 (25),1,1,1,HMDB00538,39 (52),0.252,0.553,0.6,0.75
Sphingolipid metabolism - Homo sapiens (human),KEGG,3,SGPP1;B4GALT6;GLA,47 (47),0.256,1,0,,20 (25),1,1,0.605,0.755
mitochondrial fatty acid beta-oxidation of saturated fatty acids,Reactome,0,,11 (11),1,1,1,HMDB00538,40 (42),0.258,0.562,0.607,0.758
Cholesterol biosynthesis,Reactome,0,,25 (25),1,1,1,HMDB00538,40 (46),0.258,0.562,0.607,0.758
Human Complement System,Wikipathways,5,SPP1;F13A1;ELANE;C1QBP;F10,92 (92),0.26,1,0,,2 (5),1,1,0.61,0.761
Thiamine metabolic pathways,Wikipathways,1,OGDH,8 (8),0.262,1,0,,12 (21),1,1,0.614,0.764
Aflatoxin B1 metabolism,Wikipathways,1,GSTM1,8 (8),0.262,1,0,,4 (7),1,1,0.614,0.764
Effects of Nitric Oxide,Wikipathways,1,NOS2,8 (8),0.262,1,0,,7 (7),1,1,0.614,0.764
superpathway of cholesterol biosynthesis,HumanCyc,0,,25 (25),1,1,1,HMDB00538,41 (62),0.263,0.573,0.615,0.766
Hedgehog signaling events mediated by Gli proteins,PID,3,RBBP4;HDAC1;HDAC2,48 (48),0.266,1,0,,3 (3),1,1,0.618,0.769
il-2 receptor beta chain in t cell activation,BioCarta,3,CCNB1;E2F1;PPIA,48 (48),0.266,1,0,,2 (2),1,1,0.618,0.769
Neurotransmitter release cycle,Reactome,0,,51 (51),1,1,1,HMDB00043,42 (45),0.269,0.581,0.622,0.773
Histidine metabolism,EHMN,0,,35 (35),1,1,1,HMDB00538,42 (45),0.269,0.581,0.622,0.773
Pathways in clear cell renal cell carcinoma,Wikipathways,6,TGFB1;LDHA;ACACA;PSAT1;PFKL;TPI1,86 (86),0.102,0.775,0,,0 (1),1,1,0.102,0.775
Notch signaling pathway - Homo sapiens (human),KEGG,4,HDAC1;HDAC2;NCOR2;CTBP1,48 (48),0.103,0.78,0,,0 (0),1,1,0.103,0.78
Integrated Cancer Pathway,Wikipathways,2,CDC25A;PLK1,15 (15),0.106,0.78,0,,0 (0),1,1,0.106,0.78
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity,Wikipathways,2,CDK4;E2F1,15 (15),0.106,0.78,0,,0 (0),1,1,0.106,0.78
wnt signaling pathway,BioCarta,3,PPP2R5D;HDAC1;CTBP1,31 (31),0.108,0.78,0,,0 (1),1,1,0.108,0.78
Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors,Wikipathways,1,CCR2,3 (3),0.108,0.78,0,,0 (0),1,1,0.108,0.78
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,Reactome,1,SLC25A5,3 (3),0.108,0.78,0,,0 (0),1,1,0.108,0.78
inhibition of huntingtons disease neurodegeneration by histone deacetylase inhibitors,BioCarta,1,HTT,3 (3),0.108,0.78,0,,0 (0),1,1,0.108,0.78
opposing roles of aif in apoptosis and cell survival,BioCarta,1,AIFM1,3 (3),0.108,0.78,0,,0 (0),1,1,0.108,0.78
Mitochondrial transcription initiation,Reactome,1,TFAM,3 (3),0.108,0.78,0,,0 (0),1,1,0.108,0.78
Integration of viral DNA into host genomic DNA,Reactome,1,BANF1,3 (3),0.108,0.78,0,,0 (0),1,1,0.108,0.78
Autointegration results in viral DNA circles,Reactome,1,BANF1,3 (3),0.108,0.78,0,,0 (0),1,1,0.108,0.78
Mitochondrial translation,Reactome,5,MRPS31;GFM1;TUFM;MRPL2;MRPL12,94 (95),0.274,1,0,,5 (47),1,1,0.629,0.781
Malaria - Homo sapiens (human),KEGG,3,TGFB1;MET;COMP,49 (49),0.276,1,0,,3 (5),1,1,0.632,0.784
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan catabolism,Wikipathways,0,,0 (0),1,1,1,HMDB00538,66 (91),0.39,0.788,0.39,0.788
Attenuation phase,Reactome,2,FKBP4;HSP90AB1,28 (28),0.281,1,0,,2 (2),1,1,0.638,0.79
Amoebiasis - Homo sapiens (human),KEGG,5,TGFB1;ACTN4;NOS2;CTSG;FN1,95 (96),0.281,1,0,,11 (13),1,1,0.638,0.79
Melanoma - Homo sapiens (human),KEGG,4,MET;CDK4;E2F1;CDK6,72 (72),0.282,1,0,,1 (1),1,1,0.638,0.79
Innate Immune System,Reactome,31,DOCK1;MPO;CCR2;CAND1;PPP2R5D;PRTN3;GLA;IMPDH2;AP2A2;MS4A3;PA2G4;CTSC;TLR1;ILF2;ELANE;HMGB1;PSMD1;PSMD2;PSMD3;CCT2;PSMD7;PRKCSH;PSMD13;PFKL;PPIA;CTSG;NOS2;DSN1;PNP;KPNB1;HSP90AB1,1065 (1077),0.945,1,1,HMDB00538,48 (99),0.301,0.638,0.642,0.79
Mevalonic aciduria,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Smith-Lemli-Opitz Syndrome (SLOS),SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Chondrodysplasia Punctata II_ X Linked Dominant (CDPX2),SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Desmosterolosis,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Hypercholesterolemia,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Steroid Biosynthesis,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Rosuvastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (46),0.285,0.608,0.643,0.79
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,Reactome,0,,24 (24),1,1,1,HMDB00538,45 (51),0.285,0.608,0.643,0.79
Visual phototransduction,Reactome,0,,102 (102),1,1,1,HMDB00538,45 (65),0.285,0.608,0.643,0.79
Simvastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (46),0.285,0.608,0.643,0.79
Hyper-IgD syndrome,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Cholesteryl ester storage disease,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Lysosomal Acid Lipase Deficiency (Wolman Disease),SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Wolman disease,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Cerivastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (46),0.285,0.608,0.643,0.79
CHILD Syndrome,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Zoledronate Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (46),0.285,0.608,0.643,0.79
Ibandronate Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,45 (45),0.285,0.608,0.643,0.79
Human papillomavirus infection - Homo sapiens (human),KEGG,15,CDK4;PSMC1;SPP1;CDK6;RBL1;E2F1;HDAC2;CDK2;PPP2R5D;HDAC1;CCNA2;COMP;LLGL1;HDAC6;FN1,339 (339),0.286,1,0,,3 (3),1,1,0.644,0.79
Cholesterol metabolism - Homo sapiens (human),KEGG,3,LRPAP1;SCARB1;SOAT2,50 (50),0.286,1,0,,7 (10),1,1,0.645,0.79
Heme Biosynthesis,Wikipathways,1,ALAS1,9 (9),0.29,1,0,,15 (16),1,1,0.649,0.79
Ca2+ activated K+ channels,Reactome,1,KCNN3,9 (9),0.29,1,0,,1 (1),1,1,0.649,0.79
heme biosynthesis,HumanCyc,1,ALAS1,9 (9),0.29,1,0,,17 (18),1,1,0.649,0.79
adenosine nucleotides degradation,HumanCyc,1,PNP,9 (9),0.29,1,0,,12 (13),1,1,0.649,0.79
reversal of insulin resistance by leptin,BioCarta,1,ACACA,9 (9),0.29,1,0,,2 (3),1,1,0.649,0.79
MET activates RAP1 and RAC1,Reactome,1,MET,9 (9),0.29,1,0,,2 (2),1,1,0.649,0.79
no2-dependent il-12 pathway in nk cells,BioCarta,1,NOS2,9 (9),0.29,1,0,,3 (4),1,1,0.649,0.79
Glucocorticoid Pathway (Peripheral Tissue)_ Pharmacodynamics,PharmGKB,1,FKBP4,9 (9),0.29,1,0,,4 (5),1,1,0.649,0.79
Cyclophosphamide Action Pathway,SMPDB,1,GSTM1,9 (9),0.29,1,0,,15 (23),1,1,0.649,0.79
Cyclophosphamide Metabolism Pathway,SMPDB,1,GSTM1,9 (9),0.29,1,0,,15 (23),1,1,0.649,0.79
Chromosomal and microsatellite instability in colorectal cancer,Wikipathways,4,TGFB1;MSH6;BIRC5;MLH1,73 (73),0.29,1,0,,2 (2),1,1,0.649,0.79
Transport of inorganic cations/anions and amino acids/oligopeptides,Reactome,1,SLC38A1,105 (105),0.982,1,1,HMDB00043,47 (56),0.296,0.627,0.65,0.79
Pravastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,46 (46),0.291,0.617,0.65,0.79
Atorvastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,46 (46),0.291,0.617,0.65,0.79
Alendronate Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,46 (46),0.291,0.617,0.65,0.79
Risedronate Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,46 (46),0.291,0.617,0.65,0.79
Pamidronate Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,46 (46),0.291,0.617,0.65,0.79
Fluvastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,46 (46),0.291,0.617,0.65,0.79
Lovastatin Action Pathway,SMPDB,0,,22 (22),1,1,1,HMDB00538,46 (46),0.291,0.617,0.65,0.79
GPCR downstream signalling,Reactome,5,PPP2R5D;PLEKHG2;REEP4;ECT2;CCR2,1171 (1176),1,1,2,HMDB00285;HMDB00538,146 (209),0.293,0.621,0.652,0.793
mRNA Capping,Reactome,2,GTF2F1;NCBP1,29 (29),0.295,1,0,,6 (7),1,1,0.655,0.796
Regulation of Androgen receptor activity,PID,3,HDAC1;SMARCC1;EHMT2,51 (51),0.297,1,0,,3 (3),1,1,0.657,0.798
Signaling by GPCR,Reactome,5,PPP2R5D;PLEKHG2;REEP4;ECT2;CCR2,1234 (1240),1,1,2,HMDB00285;HMDB00538,148 (213),0.298,0.632,0.659,0.8
mechanism of gene regulation by peroxisome proliferators via ppara,BioCarta,3,NOS2;NCOR2;DUT,52 (52),0.307,1,0,,1 (9),1,1,0.67,0.812
Fatty acid elongation - Homo sapiens (human),KEGG,2,HSD17B12;ACAA2,30 (30),0.309,1,0,,28 (40),1,1,0.672,0.814
role of mef2d in t-cell apoptosis,BioCarta,2,HDAC1;HDAC2,30 (30),0.309,1,0,,1 (1),1,1,0.672,0.814
HDR through MMEJ (alt-NHEJ),Reactome,1,POLQ,10 (10),0.317,1,0,,4 (5),1,1,0.681,0.821
RUNX3 regulates p14-ARF,Reactome,1,TGFB1,10 (11),0.317,1,0,,5 (5),1,1,0.681,0.821
Hyaluronan uptake and degradation,Reactome,1,HMMR,10 (10),0.317,1,0,,5 (6),1,1,0.681,0.821
Gamma-carboxylation of protein precursors,Reactome,1,F10,10 (10),0.317,1,0,,3 (8),1,1,0.681,0.821
overview of telomerase protein component gene htert transcriptional regulation,BioCarta,1,HDAC1,10 (10),0.317,1,0,,1 (1),1,1,0.681,0.821
Vinka Alkaloid Pathway_ Pharmacokinetics,PharmGKB,1,ABCC1,10 (10),0.317,1,0,,1 (1),1,1,0.681,0.821
Gemcitabine Pathway_ Pharmacodynamics,PharmGKB,1,NT5C,10 (10),0.317,1,0,,1 (1),1,1,0.681,0.821
EV release from cardiac cells and their functional effects,Wikipathways,1,MYB,10 (10),0.317,1,0,,2 (3),1,1,0.681,0.821
Leptin and adiponectin,Wikipathways,1,ACACA,10 (10),0.317,1,0,,2 (3),1,1,0.681,0.821
Notch signaling pathway,PID,3,HDAC1;NCOR2;CTBP1,53 (54),0.317,1,0,,1 (1),1,1,0.682,0.822
Pathways in cancer - Homo sapiens (human),KEGG,22,GSTM1;TGFB1;IFNGR1;MET;CKS1B;MSH6;FN1;EGLN1;RAD51;MLH1;LRP5;BIRC5;E2F1;CTBP1;CDK2;GSTO1;NOS2;HDAC1;HDAC2;CDK4;CDK6;HSP90AB1,526 (526),0.321,1,0,,28 (35),1,1,0.686,0.827
Synthesis of bile acids and bile salts,Reactome,0,,34 (34),1,1,1,HMDB00538,52 (75),0.322,0.675,0.687,0.828
Mucin type O-glycan biosynthesis - Homo sapiens (human),KEGG,2,GALNT6;GALNT1,31 (31),0.323,1,0,,1 (16),1,1,0.688,0.828
Galactose metabolism - Homo sapiens (human),KEGG,2,PFKL;GLA,31 (31),0.323,1,0,,32 (46),1,1,0.688,0.828
Activation of Matrix Metalloproteinases,Reactome,2,ELANE;CTSG,31 (31),0.323,1,0,,1 (2),1,1,0.688,0.828
Bile acid and bile salt metabolism,Reactome,0,,43 (43),1,1,1,HMDB00538,53 (80),0.327,0.685,0.693,0.833
Adipogenesis,Wikipathways,8,SREBF1;TGFB1;AHR;NCOR2;E2F1;RBL1;E2F4;GTF3A,131 (131),0.117,0.837,0,,0 (0),1,1,0.117,0.837
Tryptophan degradation,INOH,0,,66 (69),1,1,1,HMDB00538,54 (62),0.332,0.695,0.698,0.839
Phagosome - Homo sapiens (human),KEGG,7,MPO;TUBA1B;M6PR;SCARB1;TUBA1C;COMP;CANX,151 (152),0.334,1,0,,1 (1),1,1,0.7,0.841
Ribosome - Homo sapiens (human),KEGG,9,RPL13A;MRPL12;RPSA;RPL4;RPL36A;RPS5;RPL9;MRPL2;RPLP0,153 (153),0.119,0.843,0,,0 (0),1,1,0.119,0.843
Glyoxylate metabolism and glycine degradation,Reactome,2,DLAT;OGDH,32 (32),0.337,1,0,,33 (43),1,1,0.703,0.844
Metformin Pathway_ Pharmacodynamic,PharmGKB,2,SREBF1;ACACA,32 (32),0.337,1,0,,1 (1),1,1,0.703,0.844
Propanoate metabolism - Homo sapiens (human),KEGG,2,LDHA;ACACA,32 (32),0.337,1,0,,40 (48),1,1,0.703,0.844
glutathione redox reactions I,HumanCyc,0,,9 (9),1,1,1,HMDB03337,55 (100),0.337,0.705,0.704,0.844
Human metabolism overview,Wikipathways,0,,0 (0),1,1,1,HMDB00094,73 (113),0.422,0.845,0.422,0.845
Immune System,Reactome,52,IFNGR1;DOCK1;CCNF;PIK3AP1;MPO;HIST1H3F;CCR2;FZR1;CAND1;FBXW8;AP2S1;PPP2R5D;PRTN3;GLA;IMPDH2;HIST1H3C;AP2A2;HIST1H3I;MS4A3;ANAPC1;PA2G4;CDC16;CTSC;TRAIP;TLR1;UBE2C;EIF4G1;CANX;IRF8;SMARCA4;ILF2;ELANE;HMGB1;PSMD1;PSMD2;PSMD3;CCT2;PSMD7;PRKCSH;PSMD13;UBE3C;PFKL;CDC20;PPIA;CTSG;NOS2;DSN1;TRIM37;CDC23;PNP;KPNB1;HSP90AB1,1827 (1840),0.989,1,1,HMDB00538,56 (136),0.342,0.715,0.705,0.845
Dermatan sulfate biosynthesis,Reactome,1,VCAN,11 (11),0.342,1,0,,2 (2),1,1,0.709,0.847
Heme biosynthesis,Reactome,1,ALAS1,11 (11),0.342,1,0,,25 (28),1,1,0.709,0.847
Gamma-carboxylation_ transport_ and amino-terminal cleavage of proteins,Reactome,1,F10,11 (11),0.342,1,0,,3 (8),1,1,0.709,0.847
Beta-oxidation of very long chain fatty acids,Reactome,1,ECI2,11 (11),0.342,1,0,,15 (26),1,1,0.709,0.847
Androgen biosynthesis,Reactome,1,HSD17B12,11 (11),0.342,1,0,,15 (17),1,1,0.709,0.847
RHO GTPases activate IQGAPs,Reactome,1,IQGAP3,11 (11),0.342,1,0,,2 (2),1,1,0.709,0.847
NAD metabolism_ sirtuins and aging,Wikipathways,1,TFAM,11 (11),0.342,1,0,,3 (4),1,1,0.709,0.847
3-oxo-10R-octadecatrienoate beta-oxidation,EHMN,1,ACAA2,11 (11),0.342,1,0,,9 (10),1,1,0.709,0.847
superpathway of tryptophan utilization,HumanCyc,0,,43 (45),1,1,1,HMDB00538,57 (70),0.347,0.718,0.715,0.853
Netrin-mediated signaling events,PID,2,DOCK1;MAP1B,33 (33),0.35,1,0,,5 (5),1,1,0.718,0.856
ECM proteoglycans,Reactome,3,TGFB1;VCAN;COMP,57 (57),0.359,1,0,,2 (3),1,1,0.726,0.866
Tryptophan Metabolism,SMPDB,0,,19 (19),1,1,1,HMDB00538,60 (60),0.362,0.748,0.73,0.868
Type 2 papillary renal cell carcinoma,Wikipathways,2,TGFB1;EGLN1,34 (34),0.364,1,0,,3 (3),1,1,0.732,0.868
Fluoropyrimidine Activity,Wikipathways,2,UCK2;UMPS,34 (34),0.364,1,0,,6 (16),1,1,0.732,0.868
FoxO signaling pathway - Homo sapiens (human),KEGG,6,TGFB1;PLK1;PLK4;CCNB2;CDK2;CCNB1,131 (132),0.364,1,0,,5 (5),1,1,0.732,0.868
Platelet-mediated interactions with vascular and circulating cells,Wikipathways,1,TGFB1,12 (12),0.367,1,0,,1 (1),1,1,0.735,0.868
Hyaluronan metabolism,Reactome,1,HMMR,12 (12),0.367,1,0,,5 (6),1,1,0.735,0.868
Lysine catabolism,Reactome,1,OGDH,12 (12),0.367,1,0,,26 (32),1,1,0.735,0.868
Reduction of cytosolic Ca++ levels,Reactome,1,ATP2A2,12 (12),0.367,1,0,,2 (3),1,1,0.735,0.868
map kinase inactivation of smrt corepressor,BioCarta,1,NCOR2,12 (12),0.367,1,0,,2 (2),1,1,0.735,0.868
Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation,EHMN,1,ACAA2,12 (12),0.367,1,0,,9 (10),1,1,0.735,0.868
Josephin domain DUBs,Reactome,1,RAD23B,12 (12),0.367,1,0,,1 (1),1,1,0.735,0.868
Transport of organic anions,Reactome,1,SLCO4A1,12 (12),0.367,1,0,,13 (19),1,1,0.735,0.868
ECM-receptor interaction - Homo sapiens (human),KEGG,4,SPP1;HMMR;FN1;COMP,82 (82),0.367,1,0,,1 (1),1,1,0.735,0.868
Bile Acid Biosynthesis,SMPDB,0,,17 (17),1,1,1,HMDB00538,61 (62),0.367,0.755,0.735,0.868
27-Hydroxylase Deficiency,SMPDB,0,,17 (17),1,1,1,HMDB00538,61 (62),0.367,0.755,0.735,0.868
Congenital Bile Acid Synthesis Defect Type III,SMPDB,0,,17 (17),1,1,1,HMDB00538,61 (62),0.367,0.755,0.735,0.868
Congenital Bile Acid Synthesis Defect Type II,SMPDB,0,,17 (17),1,1,1,HMDB00538,61 (62),0.367,0.755,0.735,0.868
Cerebrotendinous Xanthomatosis (CTX),SMPDB,0,,17 (17),1,1,1,HMDB00538,61 (62),0.367,0.755,0.735,0.868
Zellweger Syndrome,SMPDB,0,,17 (17),1,1,1,HMDB00538,61 (62),0.367,0.755,0.735,0.868
Familial Hypercholanemia (FHCA),SMPDB,0,,17 (17),1,1,1,HMDB00538,61 (62),0.367,0.755,0.735,0.868
HGF,INOH,2,DOCK1;MET,35 (35),0.378,1,0,,2 (2),1,1,0.745,0.871
ABC transporters - Homo sapiens (human),KEGG,1,ABCC1,44 (44),0.813,1,1,HMDB00043,85 (129),0.473,0.942,0.752,0.871
Nepafenac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (72),0.386,0.788,0.753,0.871
Lornoxicam Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (71),0.386,0.788,0.753,0.871
Salsalate Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (72),0.386,0.788,0.753,0.871
Tiaprofenic Acid Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (72),0.386,0.788,0.753,0.871
Valdecoxib Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (72),0.386,0.788,0.753,0.871
Rofecoxib Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (72),0.386,0.788,0.753,0.871
Arachidonic Acid Metabolism,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (71),0.386,0.788,0.753,0.871
Leukotriene C4 Synthesis Deficiency,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (71),0.386,0.788,0.753,0.871
Flurbiprofen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (72),0.386,0.788,0.753,0.871
Antrafenine Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (71),0.386,0.788,0.753,0.871
Lumiracoxib Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (72),0.386,0.788,0.753,0.871
Trisalicylate-choline Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (71),0.386,0.788,0.753,0.871
Tenoxicam Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (71),0.386,0.788,0.753,0.871
Nabumetone Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (72),0.386,0.788,0.753,0.871
Bromfenac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,65 (72),0.386,0.788,0.753,0.871
Metabolism of steroids,Reactome,4,HSD17B12;SREBF1;KPNB1;RAN,127 (127),0.703,1,1,HMDB00538,106 (144),0.552,1,0.755,0.871
Phenylalanine and tyrosine catabolism,Reactome,1,NUP62,13 (13),0.39,1,0,,30 (31),1,1,0.758,0.871
Fatty acid biosynthesis - Homo sapiens (human),KEGG,1,ACACA,13 (13),0.39,1,0,,11 (50),1,1,0.758,0.871
hemoglobins chaperone,BioCarta,1,ALAS1,13 (13),0.39,1,0,,3 (3),1,1,0.758,0.871
extrinsic prothrombin activation pathway,BioCarta,1,F10,13 (13),0.39,1,0,,1 (3),1,1,0.758,0.871
D-<i>myo</i>-inositol (1_4_5)-trisphosphate degradation,HumanCyc,1,OCRL,13 (13),0.39,1,0,,6 (6),1,1,0.758,0.871
ERKs are inactivated,Reactome,1,PPP2R5D,13 (13),0.39,1,0,,2 (2),1,1,0.758,0.871
Taxane Pathway_ Pharmacokinetics,PharmGKB,1,ABCC1,13 (13),0.39,1,0,,2 (2),1,1,0.758,0.871
Antimetabolite Pathway - Folate Cycle_ Pharmacodynamics,PharmGKB,1,ATIC,13 (13),0.39,1,0,,2 (4),1,1,0.758,0.871
Methotrexate Pathway_ Pharmacokinetics,PharmGKB,1,ABCC1,13 (13),0.39,1,0,,1 (1),1,1,0.758,0.871
Mycophenolic acid Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,IMPDH2,13 (13),0.39,1,0,,1 (2),1,1,0.758,0.871
Irinotecan Pathway_ Pharmacokinetics,PharmGKB,1,ABCC1,13 (13),0.39,1,0,,1 (1),1,1,0.758,0.871
Irinotecan Pathway,Wikipathways,1,ABCC1,13 (13),0.39,1,0,,1 (4),1,1,0.758,0.871
FGFRL1 modulation of FGFR1 signaling,Reactome,1,SPRED1,13 (13),0.39,1,0,,1 (1),1,1,0.758,0.871
Valproic acid pathway,Wikipathways,1,HDAC1,13 (13),0.39,1,0,,11 (11),1,1,0.758,0.871
Acetaminophen  Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Magnesium salicylate Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Phenylbutazone Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Salicylate-sodium Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Naproxen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Antipyrine Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
chondroitin sulfate degradation (metazoa),HumanCyc,0,,7 (7),1,1,1,HMDB01176,66 (134),0.39,0.788,0.758,0.871
dermatan sulfate degradation (metazoa),HumanCyc,0,,7 (7),1,1,1,HMDB01176,66 (135),0.39,0.788,0.758,0.871
Piroxicam Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Etodolac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Ketoprofen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Acetylsalicylic Acid Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Diflunisal Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Sulindac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Diclofenac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Etoricoxib Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Carprofen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Fenoprofen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Tolmetin Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Salicylic Acid Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Oxaprozin Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Indomethacin Action Pathway,SMPDB,0,,31 (31),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Meloxicam Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Suprofen Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Mefenamic Acid Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
Ketorolac Action Pathway,SMPDB,0,,30 (30),1,1,1,HMDB03337,66 (72),0.39,0.788,0.758,0.871
IGF signaling,INOH,2,IGFBP6;IGFBP4,36 (36),0.391,1,0,,3 (4),1,1,0.758,0.872
VEGF,INOH,8,PLK1;MET;CDK1;CDC7;WEE1;CDK2;CDK4;CDK6,187 (188),0.398,1,0,,3 (4),1,1,0.765,0.879
Coregulation of Androgen receptor activity,PID,3,FKBP4;PA2G4;CDK6,61 (61),0.399,1,0,,2 (2),1,1,0.766,0.88
Tryptophan metabolism,EHMN,0,,22 (22),1,1,1,HMDB00538,68 (78),0.4,0.806,0.766,0.88
Colorectal cancer - Homo sapiens (human),KEGG,4,TGFB1;BIRC5;MSH6;MLH1,86 (86),0.401,1,0,,1 (1),1,1,0.767,0.88
Celecoxib Action Pathway,SMPDB,0,,36 (36),1,1,1,HMDB03337,69 (76),0.404,0.815,0.77,0.883
IL2 signaling events mediated by PI3K,PID,2,MYB;E2F1,37 (37),0.404,1,0,,6 (6),1,1,0.77,0.883
Ibuprofen Action Pathway,SMPDB,0,,50 (50),1,1,1,HMDB03337,70 (77),0.409,0.824,0.774,0.887
Ras signaling in the CD4+ TCR pathway,PID,1,PTPN7,14 (14),0.413,1,0,,1 (1),1,1,0.778,0.889
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,Reactome,1,BIRC5,14 (14),0.413,1,0,,4 (7),1,1,0.778,0.889
Assembly of active LPL and LIPC lipase complexes,Reactome,1,LMF2,14 (14),0.413,1,0,,3 (6),1,1,0.778,0.889
Synthesis of IP2_ IP_ and Ins in the cytosol,Reactome,1,OCRL,14 (14),0.413,1,0,,17 (18),1,1,0.778,0.889
Regulation of IFNG signaling,Reactome,1,IFNGR1,14 (14),0.413,1,0,,2 (3),1,1,0.778,0.889
Warfarin Pathway_ Pharmacodynamics,PharmGKB,1,F10,14 (14),0.413,1,0,,1 (1),1,1,0.778,0.889
PIWI-interacting RNA (piRNA) biogenesis,Reactome,1,PIWIL2,14 (14),0.413,1,0,,2 (3),1,1,0.778,0.889
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,Wikipathways,1,HSPD1,14 (14),0.413,1,0,,1 (1),1,1,0.778,0.889
Regulation of RAC1 activity,PID,2,DOCK1;RACGAP1,38 (39),0.417,1,0,,3 (3),1,1,0.782,0.892
DNA Damage Recognition in GG-NER,Reactome,2,DDB1;RAD23B,38 (38),0.417,1,0,,2 (2),1,1,0.782,0.892
Arachidonic acid metabolism,Reactome,1,ABCC1,61 (62),0.902,1,1,HMDB03337,83 (104),0.465,0.926,0.784,0.894
N-Glycan antennae elongation,Reactome,1,B4GALT6,15 (15),0.435,1,0,,2 (5),1,1,0.797,0.904
Glycosphingolipid biosynthesis - globo and isoglobo series - Homo sapiens (human),KEGG,1,GLA,15 (15),0.435,1,0,,3 (23),1,1,0.797,0.904
telomeres telomerase cellular aging and immortality,BioCarta,1,PPP2R5D,15 (15),0.435,1,0,,1 (3),1,1,0.797,0.904
GRB2:SOS provides linkage to MAPK signaling for Integrins ,Reactome,1,FN1,15 (15),0.435,1,0,,4 (6),1,1,0.797,0.904
Methotrexate Pathway (Cancer Cell)_ Pharmacodynamics,PharmGKB,1,ATIC,15 (15),0.435,1,0,,1 (1),1,1,0.797,0.904
Hereditary Coproporphyria (HCP),SMPDB,1,ALAS1,15 (15),0.435,1,0,,39 (39),1,1,0.797,0.904
Porphyria Variegata (PV),SMPDB,1,ALAS1,15 (15),0.435,1,0,,39 (39),1,1,0.797,0.904
Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,SMPDB,1,ALAS1,15 (15),0.435,1,0,,39 (39),1,1,0.797,0.904
Acute Intermittent Porphyria,SMPDB,1,ALAS1,15 (15),0.435,1,0,,39 (39),1,1,0.797,0.904
Porphyrin Metabolism,SMPDB,1,ALAS1,15 (15),0.435,1,0,,39 (39),1,1,0.797,0.904
Biopterin metabolism,EHMN,1,SLC38A1,15 (15),0.435,1,0,,23 (24),1,1,0.797,0.904
Disulfiram Action Pathway,SMPDB,0,,25 (25),1,1,1,HMDB00538,76 (77),0.435,0.871,0.797,0.904
Formation of Senescence-Associated Heterochromatin Foci (SAHF),Reactome,2,HIST1H1E;HIST1H1D,17 (17),0.131,0.915,0,,0 (1),1,1,0.131,0.915
Non-small cell lung cancer,Wikipathways,3,CDK4;E2F1;CDK6,66 (66),0.449,1,0,,5 (5),1,1,0.809,0.916
Aminoacyl-tRNA biosynthesis - Homo sapiens (human),KEGG,3,FARSA;GATC;TARS2,66 (66),0.449,1,0,,23 (52),1,1,0.809,0.916
Non-small cell lung cancer - Homo sapiens (human),KEGG,3,CDK4;E2F1;CDK6,66 (66),0.449,1,0,,6 (6),1,1,0.809,0.916
Carbamazepine Pathway_ Pharmacokinetics,PharmGKB,1,MPO,16 (16),0.456,1,0,,1 (1),1,1,0.814,0.921
Osteoclast Signaling,Wikipathways,1,SPP1,16 (16),0.456,1,0,,2 (4),1,1,0.814,0.921
Integrin cell surface interactions,Reactome,3,SPP1;FN1;COMP,67 (67),0.459,1,0,,1 (1),1,1,0.817,0.924
AMPK signaling pathway - Homo sapiens (human),KEGG,5,SREBF1;PPP2R5D;CCNA2;PFKL;ACACA,120 (120),0.466,1,0,,20 (23),1,1,0.822,0.929
Amphetamine addiction - Homo sapiens (human),KEGG,3,HDAC1;GRIA3;PPP1CC,68 (68),0.469,1,0,,10 (10),1,1,0.824,0.931
Assembly Of The HIV Virion,Reactome,1,PPIA,17 (17),0.476,1,0,,2 (2),1,1,0.83,0.935
Metabolism of Angiotensinogen to Angiotensins,Reactome,1,CTSG,17 (17),0.476,1,0,,7 (9),1,1,0.83,0.935
Selenocompound metabolism - Homo sapiens (human),KEGG,1,SEPHS1,17 (17),0.476,1,0,,13 (27),1,1,0.83,0.935
ucalpain and friends in cell spread,BioCarta,1,ACTN4,17 (17),0.476,1,0,,1 (1),1,1,0.83,0.935
Mycophenolic acid Pathway_ Pharmacokinetics,PharmGKB,1,IMPDH2,17 (17),0.476,1,0,,1 (2),1,1,0.83,0.935
Unblocking of NMDA receptor_ glutamate binding and activation,Reactome,1,GRIA3,17 (17),0.476,1,0,,5 (5),1,1,0.83,0.935
Simplified Depiction of MYD88 Distinct Input-Output Pathway,Wikipathways,1,TLR1,17 (17),0.476,1,0,,1 (1),1,1,0.83,0.935
Renal cell carcinoma - Homo sapiens (human),KEGG,3,TGFB1;MET;EGLN1,69 (69),0.479,1,0,,3 (3),1,1,0.831,0.936
Apoptosis-related network due to altered Notch3 in ovarian cancer,Wikipathways,4,HDAC1;BIRC5;HELLS;HSPD1,53 (53),0.135,0.939,0,,0 (0),1,1,0.135,0.939
Gastric cancer - Homo sapiens (human),KEGG,6,TGFB1;MLH1;MET;E2F1;LRP5;CDK2,149 (149),0.484,1,0,,3 (4),1,1,0.835,0.94
RORA activates gene expression,Reactome,1,SREBF1,4 (4),0.141,0.943,0,,0 (0),1,1,0.141,0.943
ahr signal transduction pathway,BioCarta,1,AHR,4 (4),0.141,0.943,0,,0 (1),1,1,0.141,0.943
antisense pathway,BioCarta,1,NONO,4 (4),0.141,0.943,0,,0 (0),1,1,0.141,0.943
TGFBR2 Kinase Domain Mutants in Cancer,Reactome,1,TGFB1,4 (4),0.141,0.943,0,,0 (0),1,1,0.141,0.943
Loss of Function of TGFBR2 in Cancer,Reactome,1,TGFB1,4 (4),0.141,0.943,0,,0 (0),1,1,0.141,0.943
miR-222 in Exercise-Induced Cardiac Growth,Wikipathways,1,HIPK2,4 (4),0.141,0.943,0,,0 (0),1,1,0.141,0.943
Transcription from mitochondrial promoters,Reactome,1,TFAM,4 (4),0.141,0.943,0,,0 (0),1,1,0.141,0.943
eIF5A regulation in response to inhibition of the nuclear export system,Wikipathways,1,EIF5A,4 (4),0.141,0.943,0,,0 (0),1,1,0.141,0.943
atm signaling pathway,BioCarta,2,RAD51;RPA1,18 (18),0.144,0.943,0,,0 (0),1,1,0.144,0.943
regulation of cell cycle progression by plk3,BioCarta,2,CCNB1;CDK1,18 (18),0.144,0.943,0,,0 (0),1,1,0.144,0.943
internal ribosome entry pathway,BioCarta,2,PTBP1;EIF4G1,18 (18),0.144,0.943,0,,0 (0),1,1,0.144,0.943
miR-509-3p alteration of YAP1-ECM axis,Wikipathways,2,COL5A1;FN1,18 (18),0.144,0.943,0,,0 (0),1,1,0.144,0.943
AP-1 transcription factor network,PID,3,TGFB1;MYB;CDK1,70 (70),0.488,1,0,,1 (5),1,1,0.838,0.943
Fatty acid degradation - Homo sapiens (human),KEGG,2,ACAA2;ECI2,44 (44),0.493,1,0,,38 (50),1,1,0.842,0.946
Tacrolimus/Cyclosporine Pathway_ Pharmacodynamics,PharmGKB,2,TGFB1;PPIA,44 (44),0.493,1,0,,1 (2),1,1,0.842,0.946
Estrogen metabolism,Wikipathways,1,GSTM1,18 (18),0.496,1,0,,19 (23),1,1,0.844,0.948
Synthesis of glycosylphosphatidylinositol (GPI),Reactome,1,PIGO,18 (18),0.496,1,0,,11 (18),1,1,0.844,0.948
Glioma - Homo sapiens (human),KEGG,3,CDK4;E2F1;CDK6,71 (71),0.498,1,0,,4 (4),1,1,0.845,0.948
ER Quality Control Compartment (ERQC),Reactome,1,UGGT1,19 (20),0.515,1,0,,4 (12),1,1,0.857,0.96
Steroid biosynthesis - Homo sapiens (human),KEGG,1,SOAT2,19 (19),0.515,1,0,,41 (50),1,1,0.857,0.96
Metabolism of porphyrins,Reactome,1,ALAS1,19 (19),0.515,1,0,,33 (37),1,1,0.857,0.96
Overview of nanoparticle effects,Wikipathways,1,FN1,19 (19),0.515,1,0,,1 (2),1,1,0.857,0.96
Respiratory electron transport,Reactome,4,UQCRC1;LRPPRC;CYC1;ACAD9,100 (100),0.516,1,0,,12 (15),1,1,0.857,0.96
Cushing syndrome - Homo sapiens (human),KEGG,6,AHR;E2F1;SCARB1;CDK2;CDK4;CDK6,154 (154),0.516,1,0,,13 (14),1,1,0.858,0.96
Leishmaniasis - Homo sapiens (human),KEGG,3,TGFB1;IFNGR1;NOS2,73 (74),0.516,1,0,,6 (6),1,1,0.858,0.96
Hepatitis C - Homo sapiens (human),KEGG,6,E2F1;SCARB1;CDK2;CDK4;CDK6;PSME3,155 (155),0.523,1,0,,1 (2),1,1,0.862,0.964
Inositol phosphate metabolism - Homo sapiens (human),KEGG,3,OCRL;PI4KA;TPI1,74 (74),0.526,1,0,,25 (47),1,1,0.864,0.966
Transcriptional regulation of white adipocyte differentiation,Reactome,2,NCOR2;MED24,47 (47),0.528,1,0,,4 (4),1,1,0.865,0.967
Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human),KEGG,2,AP2A2;AP2S1,47 (47),0.528,1,0,,8 (9),1,1,0.865,0.967
Urea cycle and metabolism of amino groups,Wikipathways,1,GATM,20 (20),0.533,1,0,,29 (32),1,1,0.868,0.967
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),Reactome,1,NCOR2,20 (20),0.533,1,0,,5 (5),1,1,0.868,0.967
Chondroitin sulfate biosynthesis,Reactome,1,VCAN,20 (20),0.533,1,0,,5 (5),1,1,0.868,0.967
S1P1 pathway,PID,1,ABCC1,20 (20),0.533,1,0,,4 (5),1,1,0.868,0.967
3-phosphoinositide degradation,HumanCyc,1,OCRL,20 (20),0.533,1,0,,2 (5),1,1,0.868,0.967
Nanomaterial induced apoptosis,Wikipathways,1,AIFM1,20 (20),0.533,1,0,,1 (1),1,1,0.868,0.967
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,Wikipathways,6,HSPD1;FOXM1;CDCA7L;MAZ;HDAC1;MYB,159 (159),0.548,1,0,,12 (14),1,1,0.877,0.977
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,Reactome,1,EGLN1,21 (21),0.55,1,0,,4 (4),1,1,0.879,0.977
Arginine biosynthesis - Homo sapiens (human),KEGG,1,NOS2,21 (21),0.55,1,0,,18 (23),1,1,0.879,0.977
Synaptic adhesion-like molecules,Reactome,1,GRIA3,21 (21),0.55,1,0,,2 (2),1,1,0.879,0.977
Regulation of FZD by ubiquitination,Reactome,1,LRP5,21 (21),0.55,1,0,,1 (1),1,1,0.879,0.977
Calcineurin-regulated NFAT-dependent transcription in lymphocytes,PID,2,CDK4;E2F1,49 (49),0.551,1,0,,1 (3),1,1,0.879,0.977
Cardiac muscle contraction - Homo sapiens (human),KEGG,3,UQCRC1;CYC1;ATP2A2,78 (78),0.561,1,0,,3 (4),1,1,0.885,0.983
glutathione-mediated detoxification,HumanCyc,1,GSTM1,22 (22),0.567,1,0,,13 (14),1,1,0.889,0.985
Synthesis of Leukotrienes (LT) and Eoxins (EX),Reactome,1,ABCC1,22 (23),0.567,1,0,,23 (28),1,1,0.889,0.985
Terpenoid backbone biosynthesis - Homo sapiens (human),KEGG,1,PCYOX1,22 (22),0.567,1,0,,20 (45),1,1,0.889,0.985
Nanoparticle triggered autophagic cell death,Wikipathways,1,CHAF1A,22 (22),0.567,1,0,,1 (1),1,1,0.889,0.985
Wnt-beta-catenin Signaling Pathway in Leukemia,Wikipathways,1,LRP5,22 (22),0.567,1,0,,1 (1),1,1,0.889,0.985
Dengue-2 Interactions with Blood Clotting Cascade,Wikipathways,1,F10,22 (22),0.567,1,0,,1 (2),1,1,0.889,0.985
Th17 cell differentiation - Homo sapiens (human),KEGG,4,TGFB1;IFNGR1;AHR;HSP90AB1,107 (107),0.57,1,0,,4 (4),1,1,0.89,0.986
Cargo trafficking to the periciliary membrane,Reactome,2,CCT2;TCP1,51 (51),0.573,1,0,,4 (4),1,1,0.892,0.987
Apoptosis - Homo sapiens (human),KEGG,5,TUBA1B;CTSC;BIRC5;AIFM1;TUBA1C,136 (136),0.577,1,0,,4 (4),1,1,0.894,0.99
Regulation of Hypoxia-inducible Factor (HIF) by oxygen,Reactome,1,EGLN1,23 (23),0.583,1,0,,4 (4),1,1,0.898,0.99
Cellular response to hypoxia,Reactome,1,EGLN1,23 (23),0.583,1,0,,4 (4),1,1,0.898,0.99
Regulation of RAS by GAPs,Reactome,1,SPRED1,23 (24),0.583,1,0,,2 (2),1,1,0.898,0.99
Renin-angiotensin system - Homo sapiens (human),KEGG,1,CTSG,23 (23),0.583,1,0,,3 (11),1,1,0.898,0.99
eicosanoid metabolism,BioCarta,1,MPO,23 (23),0.583,1,0,,8 (9),1,1,0.898,0.99
intrinsic prothrombin activation pathway,BioCarta,1,F10,23 (23),0.583,1,0,,1 (4),1,1,0.898,0.99
Blood Clotting Cascade,Wikipathways,1,F10,23 (23),0.583,1,0,,1 (2),1,1,0.898,0.99
Hematopoietic Stem Cell Gene Regulation by GABP alpha-beta Complex,Wikipathways,2,DNMT1;SMARCA4,19 (19),0.157,0.997,0,,0 (0),1,1,0.157,0.997
Type II interferon signaling (IFNG),Wikipathways,3,IRF8;IFNGR1;NOS2,37 (37),0.159,0.997,0,,0 (0),1,1,0.159,0.997
Plexin-D1 Signaling,PID,1,PLXND1,24 (24),0.599,1,0,,2 (2),1,1,0.906,0.997
Xenobiotics,Reactome,1,AHR,24 (26),0.599,1,0,,41 (52),1,1,0.906,0.997
Pathway_PA165986194 -need delete,PharmGKB,1,ABCC1,24 (24),0.599,1,0,,1 (2),1,1,0.906,0.997
Acetaminophen Pathway_ Pharmacokinetics,PharmGKB,1,ABCC1,24 (24),0.599,1,0,,1 (2),1,1,0.906,0.997
Rho GTPase cycle,Reactome,5,ARHGAP11A;PLEKHG2;OCRL;ECT2;RACGAP1,140 (144),0.603,1,0,,3 (3),1,1,0.908,0.999
RAC1 signaling pathway,PID,2,RACGAP1;IQGAP3,54 (54),0.604,1,0,,3 (3),1,1,0.909,0.999
Focal Adhesion,Wikipathways,7,DOCK1;SPP1;MET;ACTN4;COMP;PPP1CC;FN1,198 (198),0.612,1,0,,1 (2),1,1,0.912,1
Tight junction - Homo sapiens (human),KEGG,6,MICALL2;TUBA1B;ACTN4;TUBA1C;CDK4;LLGL1,170 (170),0.613,1,0,,1 (1),1,1,0.913,1
Phase I - Functionalization of compounds,Reactome,2,AHR;HSP90AB1,107 (109),0.913,1,1,HMDB00538,146 (193),0.672,1,0.913,1
Legionellosis - Homo sapiens (human),KEGG,2,HSPD1;BCL2L13,55 (55),0.614,1,0,,1 (2),1,1,0.913,1
Pathogenic Escherichia coli infection - Homo sapiens (human),KEGG,2,TUBA1B;TUBA1C,55 (55),0.614,1,0,,1 (1),1,1,0.913,1
regulation of eif-4e and p70s6 kinase,BioCarta,1,EIF4G1,25 (25),0.614,1,0,,2 (2),1,1,0.913,1
Deadenylation of mRNA,Reactome,1,EIF4G1,25 (25),0.614,1,0,,2 (4),1,1,0.913,1
Statin Pathway_ Pharmacodynamics,PharmGKB,1,SCARB1,25 (25),0.614,1,0,,4 (6),1,1,0.913,1
Saturated fatty acids beta-oxidation,EHMN,1,ACAA2,25 (25),0.614,1,0,,41 (43),1,1,0.913,1
Nitric oxide stimulates guanylate cyclase,Reactome,1,NOS2,25 (25),0.614,1,0,,11 (11),1,1,0.913,1
Focal adhesion - Homo sapiens (human),KEGG,7,DOCK1;SPP1;MET;ACTN4;FN1;PPP1CC;COMP,199 (199),0.617,1,0,,1 (2),1,1,0.915,1
Pathogenic Escherichia coli infection,Wikipathways,2,TUBA1B;TUBA1C,56 (56),0.624,1,0,,1 (1),1,1,0.918,1
A tetrasaccharide linker sequence is required for GAG synthesis,Reactome,1,VCAN,26 (26),0.628,1,0,,5 (6),1,1,0.92,1
N-glycan antennae elongation in the medial/trans-Golgi,Reactome,1,B4GALT6,26 (26),0.628,1,0,,11 (22),1,1,0.92,1
Glypican 1 network,PID,1,TGFB1,26 (26),0.628,1,0,,2 (2),1,1,0.92,1
Basigin interactions,Reactome,1,PPIA,26 (27),0.628,1,0,,1 (1),1,1,0.92,1
Sphingolipid pathway,Wikipathways,1,B4GALT6,26 (26),0.628,1,0,,15 (16),1,1,0.92,1
Formation of TC-NER Pre-Incision Complex,Reactome,2,DDB1;PRPF19,57 (57),0.634,1,0,,1 (1),1,1,0.923,1
Thyroid hormone signaling pathway - Homo sapiens (human),KEGG,4,ATP2A2;HDAC1;HDAC2;MED24,116 (116),0.634,1,0,,9 (11),1,1,0.923,1
Biosynthesis of unsaturated fatty acids - Homo sapiens (human),KEGG,1,HSD17B12,27 (27),0.642,1,0,,32 (55),1,1,0.927,1
Endogenous sterols,Reactome,1,AHR,27 (27),0.642,1,0,,32 (43),1,1,0.927,1
Gap junction - Homo sapiens (human),KEGG,3,TUBA1B;TUBA1C;CDK1,88 (88),0.643,1,0,,10 (11),1,1,0.927,1
Mitochondrial translation initiation,Reactome,3,MRPS31;MRPL2;MRPL12,88 (89),0.643,1,0,,5 (8),1,1,0.927,1
Mitochondrial translation termination,Reactome,3,MRPS31;MRPL2;MRPL12,88 (89),0.643,1,0,,3 (25),1,1,0.927,1
adp-ribosylation factor,BioCarta,1,GPLD1,28 (28),0.656,1,0,,2 (2),1,1,0.932,1
role of erbb2 in signal transduction and oncology,BioCarta,1,LRPPRC,28 (28),0.656,1,0,,2 (2),1,1,0.932,1
Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human),KEGG,5,SREBF1;CYC1;TGFB1;UQCRC1;MLX,149 (149),0.658,1,0,,1 (2),1,1,0.933,1
Allograft Rejection,Wikipathways,3,TGFB1;COL5A1;TUBA1B,91 (91),0.666,1,0,,5 (10),1,1,0.937,1
Insulin-mediated glucose transport,PID,1,PPP1CC,29 (29),0.669,1,0,,3 (3),1,1,0.938,1
nfkb activation by nontypeable hemophilus influenzae,BioCarta,1,TGFB1,29 (29),0.669,1,0,,1 (1),1,1,0.938,1
Lipid Metabolism Pathway,Wikipathways,1,ACACA,29 (29),0.669,1,0,,8 (14),1,1,0.938,1
Signaling events mediated by focal adhesion kinase,PID,2,ACTN4;DOCK1,62 (62),0.679,1,0,,3 (3),1,1,0.942,1
Longevity regulating pathway - multiple species - Homo sapiens (human),KEGG,2,HDAC1;HDAC2,62 (62),0.679,1,0,,2 (2),1,1,0.942,1
Beta2 integrin cell surface interactions,PID,1,F10,30 (30),0.681,1,0,,1 (6),1,1,0.943,1
Regulation of CDC42 activity,PID,1,RACGAP1,30 (30),0.681,1,0,,3 (3),1,1,0.943,1
Pentose phosphate pathway - Homo sapiens (human),KEGG,1,PFKL,30 (30),0.681,1,0,,22 (35),1,1,0.943,1
Dopaminergic Neurogenesis,Wikipathways,1,TGFB1,30 (30),0.681,1,0,,1 (1),1,1,0.943,1
Integrin,INOH,4,DOCK1;COL5A1;VCAN;FN1,124 (124),0.685,1,0,,2 (2),1,1,0.944,1
Breast cancer pathway,Wikipathways,5,RAD51;LRP5;CDK4;E2F1;CDK6,154 (154),0.686,1,0,,4 (4),1,1,0.945,1
Post-translational modification: synthesis of GPI-anchored proteins,Reactome,3,PIGO;PIGU;GPLD1,94 (95),0.687,1,0,,13 (21),1,1,0.945,1
Endochondral Ossification,Wikipathways,2,TGFB1;SPP1,63 (63),0.687,1,0,,2 (4),1,1,0.945,1
Statin Pathway,Wikipathways,1,SCARB1,31 (31),0.693,1,0,,8 (17),1,1,0.947,1
amb2 Integrin signaling,PID,1,HMGB1,31 (31),0.693,1,0,,2 (6),1,1,0.947,1
erk and pi-3 kinase are necessary for collagen binding in corneal epithelia,BioCarta,1,ACTN4,31 (31),0.693,1,0,,1 (1),1,1,0.947,1
Peroxisomal protein import,Reactome,2,NOS2;ECI2,64 (64),0.696,1,0,,1 (1),1,1,0.948,1
mTOR signaling pathway,PID,2,SREBF1;CDK2,64 (65),0.696,1,0,,5 (5),1,1,0.948,1
Monoamine Transport,Wikipathways,1,CDC25C,32 (32),0.704,1,0,,8 (14),1,1,0.951,1
Alpha-synuclein signaling,PID,1,PPP2R5D,32 (32),0.704,1,0,,3 (3),1,1,0.951,1
White fat cell differentiation,Wikipathways,1,SREBF1,32 (32),0.704,1,0,,1 (2),1,1,0.951,1
Syndecan-4-mediated signaling events,PID,1,FN1,32 (32),0.704,1,0,,2 (2),1,1,0.951,1
Thiopurine Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,GSTM1,32 (32),0.704,1,0,,3 (4),1,1,0.951,1
ROS_ RNS production in phagocytes,Reactome,1,NOS2,32 (32),0.704,1,0,,16 (21),1,1,0.951,1
Prostate cancer - Homo sapiens (human),KEGG,3,CDK2;E2F1;HSP90AB1,97 (97),0.707,1,0,,11 (11),1,1,0.952,1
Metabolism of steroid hormones,Reactome,1,HSD17B12,33 (33),0.715,1,0,,30 (36),1,1,0.955,1
ceramide signaling pathway,BioCarta,1,AIFM1,33 (33),0.715,1,0,,2 (2),1,1,0.955,1
Cargo concentration in the ER,Reactome,1,CTSC,33 (33),0.715,1,0,,1 (5),1,1,0.955,1
Endothelin Pathways,Wikipathways,1,ATP2A2,33 (33),0.715,1,0,,12 (12),1,1,0.955,1
AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human),KEGG,3,TGFB1;CDK4;FN1,99 (99),0.72,1,0,,6 (10),1,1,0.957,1
PI3K-Akt Signaling Pathway,Wikipathways,11,PIK3AP1;SPP1;MET;COMP;PPP2R5D;CDK2;MYB;CDK4;CDK6;HSP90AB1;FN1,339 (340),0.725,1,0,,3 (4),1,1,0.958,1
Measles - Homo sapiens (human),KEGG,4,CDK2;IFNGR1;CDK6;CDK4,131 (132),0.726,1,0,,1 (1),1,1,0.958,1
Fatty Acid Beta Oxidation,Wikipathways,1,TPI1,34 (34),0.726,1,0,,29 (34),1,1,0.959,1
COPI-independent Golgi-to-ER retrograde traffic,Reactome,1,GALNT1,34 (34),0.726,1,0,,7 (8),1,1,0.959,1
Collagen degradation,Reactome,1,ELANE,35 (35),0.736,1,0,,3 (5),1,1,0.962,1
Signaling mediated by p38-alpha and p38-beta,PID,1,NOS2,35 (35),0.736,1,0,,1 (1),1,1,0.962,1
Arf6 signaling events,PID,1,MET,35 (35),0.736,1,0,,4 (4),1,1,0.962,1
Prion diseases - Homo sapiens (human),KEGG,1,STIP1,35 (35),0.736,1,0,,3 (3),1,1,0.962,1
Chagas disease (American trypanosomiasis) - Homo sapiens (human),KEGG,3,TGFB1;NOS2;IFNGR1,102 (102),0.739,1,0,,7 (7),1,1,0.963,1
Drug metabolism - cytochrome P450 - Homo sapiens (human),KEGG,2,GSTM1;GSTO1,70 (72),0.742,1,0,,31 (88),1,1,0.963,1
Protein processing in endoplasmic reticulum - Homo sapiens (human),KEGG,5,PRKCSH;CANX;HSP90AB1;UGGT1;RAD23B,165 (165),0.743,1,0,,1 (6),1,1,0.964,1
Glycogen Synthesis and Degradation,Wikipathways,1,PPP2R5D,36 (36),0.746,1,0,,5 (6),1,1,0.965,1
N-cadherin signaling events,PID,1,LRP5,36 (36),0.746,1,0,,5 (5),1,1,0.965,1
Fibrin Complement Receptor 3 Signaling Pathway,Wikipathways,1,NOS2,36 (36),0.746,1,0,,1 (2),1,1,0.965,1
GMCSF-mediated signaling events,PID,1,IRF8,37 (37),0.756,1,0,,2 (3),1,1,0.967,1
Wnt Signaling in Kidney Disease,Wikipathways,1,LRP5,37 (37),0.756,1,0,,1 (1),1,1,0.967,1
Degradation of the extracellular matrix,Reactome,3,SPP1;ELANE;CTSG,105 (105),0.757,1,0,,5 (8),1,1,0.968,1
JAK-STAT,Wikipathways,3,AURKA;PPIA;ACACA,106 (106),0.762,1,0,,1 (2),1,1,0.969,1
Fluid shear stress and atherosclerosis - Homo sapiens (human),KEGG,4,GSTM1;SUMO3;HSP90AB1;GSTO1,139 (139),0.767,1,0,,8 (8),1,1,0.971,1
Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human),KEGG,2,GSTM1;GSTO1,74 (76),0.769,1,0,,19 (121),1,1,0.971,1
Arrhythmogenic Right Ventricular Cardiomyopathy,Wikipathways,2,ATP2A2;ACTN4,74 (74),0.769,1,0,,2 (2),1,1,0.971,1
PI3K-Akt signaling pathway - Homo sapiens (human),KEGG,11,PIK3AP1;SPP1;MET;COMP;PPP2R5D;CDK2;MYB;CDK4;CDK6;HSP90AB1;FN1,353 (354),0.772,1,0,,3 (4),1,1,0.972,1
Viral Acute Myocarditis,Wikipathways,2,TGFB1;EIF4G1,76 (76),0.782,1,0,,3 (6),1,1,0.974,1
inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages,BioCarta,1,PPP2R5D,40 (40),0.782,1,0,,2 (3),1,1,0.974,1
Nicotine addiction - Homo sapiens (human),KEGG,1,GRIA3,40 (40),0.782,1,0,,7 (7),1,1,0.974,1
Tryptophan metabolism - Homo sapiens (human),KEGG,1,OGDH,40 (40),0.782,1,0,,53 (81),1,1,0.974,1
Binding and Uptake of Ligands by Scavenger Receptors,Reactome,1,SCARB1,41 (41),0.79,1,0,,15 (41),1,1,0.976,1
Fat digestion and absorption - Homo sapiens (human),KEGG,1,SCARB1,41 (41),0.79,1,0,,6 (13),1,1,0.976,1
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),Wikipathways,1,ALAS1,41 (41),0.79,1,0,,13 (15),1,1,0.976,1
insulin,INOH,2,PPP2R5D;EIF4G1,78 (78),0.794,1,0,,4 (5),1,1,0.977,1
Porphyrin and chlorophyll metabolism - Homo sapiens (human),KEGG,1,ALAS1,42 (42),0.798,1,0,,52 (141),1,1,0.978,1
Stabilization and expansion of the E-cadherin adherens junction,PID,1,MET,42 (42),0.798,1,0,,3 (3),1,1,0.978,1
IFN-gamma pathway,PID,1,IFNGR1,42 (42),0.798,1,0,,3 (4),1,1,0.978,1
Toxoplasmosis - Homo sapiens (human),KEGG,3,TGFB1;NOS2;IFNGR1,113 (113),0.799,1,0,,3 (3),1,1,0.978,1
Tuberculosis - Homo sapiens (human),KEGG,5,TGFB1;HSPD1;NOS2;IFNGR1;TLR1,178 (179),0.799,1,0,,7 (9),1,1,0.978,1
Complement and coagulation cascades - Homo sapiens (human),KEGG,2,F13A1;F10,79 (79),0.8,1,0,,1 (2),1,1,0.978,1
Breast cancer - Homo sapiens (human),KEGG,4,LRP5;CDK4;E2F1;CDK6,147 (147),0.804,1,0,,3 (3),1,1,0.979,1
Type I diabetes mellitus - Homo sapiens (human),KEGG,1,HSPD1,43 (43),0.806,1,0,,3 (3),1,1,0.98,1
Vitamin A and Carotenoid Metabolism,Wikipathways,1,SCARB1,43 (43),0.806,1,0,,21 (21),1,1,0.98,1
Steroid hormones,Reactome,1,HSD17B12,43 (43),0.806,1,0,,33 (40),1,1,0.98,1
Human immunodeficiency virus 1 infection - Homo sapiens (human),KEGG,6,CDC25C;WEE1;DDB1;CCNB2;CDK1;CCNB1,212 (212),0.808,1,0,,4 (5),1,1,0.98,1
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),PID,2,MET;KPNB1,81 (82),0.811,1,0,,4 (4),1,1,0.981,1
nfat and hypertrophy of the heart ,BioCarta,1,ATP2A2,44 (44),0.813,1,0,,4 (5),1,1,0.981,1
Prader-Willi and Angelman Syndrome,Wikipathways,1,E2F1,44 (44),0.813,1,0,,2 (3),1,1,0.981,1
Chemical carcinogenesis - Homo sapiens (human),KEGG,2,GSTM1;GSTO1,82 (82),0.816,1,0,,26 (99),1,1,0.982,1
a6b1 and a6b4 Integrin signaling,PID,1,MET,45 (45),0.82,1,0,,3 (3),1,1,0.983,1
RhoA signaling pathway,PID,1,CIT,45 (45),0.82,1,0,,1 (1),1,1,0.983,1
Sphingolipid signaling pathway - Homo sapiens (human),KEGG,3,PPP2R5D;SGPP1;ABCC1,118 (118),0.822,1,0,,16 (16),1,1,0.983,1
Tryptophan metabolism,Wikipathways,1,OGDH,46 (46),0.827,1,0,,23 (27),1,1,0.984,1
Regulation of RhoA activity,PID,1,ECT2,46 (48),0.827,1,0,,3 (3),1,1,0.984,1
Intestinal immune network for IgA production - Homo sapiens (human),KEGG,1,TGFB1,47 (49),0.833,1,0,,2 (2),1,1,0.985,1
NO-cGMP-PKG mediated Neuroprotection,Wikipathways,1,NOS2,47 (47),0.833,1,0,,13 (16),1,1,0.985,1
Myometrial Relaxation and Contraction Pathways,Wikipathways,4,ATP2A2;IGFBP6;GSTO1;IGFBP4,155 (155),0.835,1,0,,4 (4),1,1,0.986,1
Salmonella infection - Homo sapiens (human),KEGG,2,NOS2;IFNGR1,86 (86),0.836,1,0,,3 (4),1,1,0.986,1
Differentiation Pathway,Wikipathways,1,TGFB1,48 (48),0.839,1,0,,9 (13),1,1,0.986,1
Ceramide signaling pathway,PID,1,AIFM1,48 (48),0.839,1,0,,2 (2),1,1,0.986,1
Valine_ leucine and isoleucine degradation - Homo sapiens (human),KEGG,1,ACAA2,48 (48),0.839,1,0,,33 (42),1,1,0.986,1
G alpha (12/13) signalling events,Reactome,2,PLEKHG2;ECT2,87 (89),0.841,1,0,,5 (5),1,1,0.987,1
N-Glycan biosynthesis - Homo sapiens (human),KEGG,1,ALG10B,49 (49),0.846,1,0,,9 (36),1,1,0.987,1
Ovarian steroidogenesis - Homo sapiens (human),KEGG,1,SCARB1,49 (49),0.846,1,0,,23 (24),1,1,0.987,1
Dilated cardiomyopathy (DCM) - Homo sapiens (human),KEGG,2,TGFB1;ATP2A2,89 (90),0.85,1,0,,4 (4),1,1,0.988,1
Chondroitin sulfate/dermatan sulfate metabolism,Reactome,1,VCAN,50 (50),0.851,1,0,,12 (25),1,1,0.988,1
Angiopoietin receptor Tie2-mediated signaling,PID,1,FN1,50 (50),0.851,1,0,,9 (10),1,1,0.988,1
Protein alkylation leading to liver fibrosis,Wikipathways,1,TGFB1,50 (50),0.851,1,0,,6 (11),1,1,0.988,1
Apoptosis Modulation and Signaling,Wikipathways,2,AIFM1;BIRC5,91 (91),0.859,1,0,,1 (1),1,1,0.99,1
Signaling events mediated by Stem cell factor receptor (c-Kit),PID,1,SPRED1,52 (52),0.862,1,0,,2 (4),1,1,0.99,1
cGMP-PKG signaling pathway - Homo sapiens (human),KEGG,4,ATP2A2;GTF2I;SLC25A5;PPP1CC,163 (163),0.863,1,0,,11 (14),1,1,0.99,1
Extracellular matrix organization,Reactome,8,TGFB1;ELANE;SPP1;COL5A1;CTSG;VCAN;FN1;COMP,294 (294),0.863,1,0,,21 (30),1,1,0.99,1
TNF alpha Signaling Pathway,Wikipathways,2,PLK1;PSMD2,93 (93),0.867,1,0,,2 (3),1,1,0.991,1
Peptide hormone metabolism,Reactome,1,CTSG,53 (53),0.867,1,0,,10 (17),1,1,0.991,1
Cardiac Progenitor Differentiation,Wikipathways,1,TGFB1,53 (53),0.867,1,0,,1 (1),1,1,0.991,1
keratinocyte differentiation,BioCarta,1,PPP2R5D,53 (53),0.867,1,0,,3 (5),1,1,0.991,1
Posttranslational regulation of adherens junction stability and dissassembly,PID,1,MET,53 (53),0.867,1,0,,3 (3),1,1,0.991,1
Dopaminergic synapse - Homo sapiens (human),KEGG,3,PPP2R5D;GRIA3;PPP1CC,131 (131),0.872,1,0,,12 (12),1,1,0.991,1
Heparan sulfate/heparin (HS-GAG) metabolism,Reactome,1,VCAN,54 (54),0.872,1,0,,22 (35),1,1,0.991,1
IL2-mediated signaling events,PID,1,CDK2,54 (54),0.872,1,0,,2 (3),1,1,0.991,1
Cardiac Hypertrophic Response,Wikipathways,1,TGFB1,54 (54),0.872,1,0,,4 (5),1,1,0.991,1
t cell receptor signaling pathway,BioCarta,1,PTPN7,55 (55),0.877,1,0,,4 (5),1,1,0.992,1
Antiarrhythmic Pathway_ Pharmacodynamics,PharmGKB,1,ATP2A2,55 (55),0.877,1,0,,20 (23),1,1,0.992,1
Complex I biogenesis,Reactome,1,ACAD9,55 (55),0.877,1,0,,2 (2),1,1,0.992,1
Copper homeostasis,Wikipathways,1,STEAP4,55 (55),0.877,1,0,,1 (2),1,1,0.992,1
Influenza A - Homo sapiens (human),KEGG,4,IFNGR1;KPNA1;KPNA2;DDX39B,171 (171),0.886,1,0,,2 (3),1,1,0.993,1
Caspase Cascade in Apoptosis,PID,1,SREBF1,57 (57),0.886,1,0,,1 (2),1,1,0.993,1
C21-steroid hormone biosynthesis and metabolism,EHMN,1,HSD17B12,57 (59),0.886,1,0,,48 (61),1,1,0.993,1
Phosphatidylinositol signaling system - Homo sapiens (human),KEGG,2,OCRL;PI4KA,99 (99),0.889,1,0,,21 (29),1,1,0.994,1
Endometrial cancer - Homo sapiens (human),KEGG,1,MLH1,58 (58),0.89,1,0,,1 (1),1,1,0.994,1
Celecoxib Pathway_ Pharmacodynamics,PharmGKB,1,ATP2A2,58 (58),0.89,1,0,,1 (1),1,1,0.994,1
Apelin signaling pathway - Homo sapiens (human),KEGG,3,SPP1;NOS2;TFAM,137 (137),0.89,1,0,,7 (9),1,1,0.994,1
Insulin signaling pathway - Homo sapiens (human),KEGG,3,SREBF1;PPP1CC;ACACA,137 (137),0.89,1,0,,3 (4),1,1,0.994,1
Complement and Coagulation Cascades,Wikipathways,1,F10,59 (59),0.895,1,0,,1 (2),1,1,0.994,1
SHP2 signaling,PID,1,IFNGR1,59 (59),0.895,1,0,,6 (8),1,1,0.994,1
MET in type 1 papillary renal cell carcinoma,Wikipathways,1,MET,59 (59),0.895,1,0,,4 (4),1,1,0.994,1
Long-term depression - Homo sapiens (human),KEGG,1,GRIA3,60 (60),0.899,1,0,,8 (9),1,1,0.995,1
Steroid hormone biosynthesis - Homo sapiens (human),KEGG,1,HSD17B12,60 (60),0.899,1,0,,83 (99),1,1,0.995,1
Dengue-2 Interactions with Complement and Coagulation Cascades,Wikipathways,1,F10,60 (60),0.899,1,0,,1 (2),1,1,0.995,1
MicroRNAs in cardiomyocyte hypertrophy,Wikipathways,2,TGFB1;LRP5,102 (102),0.899,1,0,,3 (3),1,1,0.995,1
Glycerolipid metabolism - Homo sapiens (human),KEGG,1,GLA,61 (61),0.902,1,0,,12 (36),1,1,0.995,1
Regulation of actin cytoskeleton - Homo sapiens (human),KEGG,5,ACTN4;FN1;PPP1CC;IQGAP3;DOCK1,213 (213),0.904,1,0,,3 (6),1,1,0.995,1
Adrenergic signaling in cardiomyocytes - Homo sapiens (human),KEGG,3,PPP2R5D;ATP2A2;PPP1CC,144 (144),0.909,1,0,,10 (11),1,1,0.996,1
Neurotrophic factor-mediated Trk receptor signaling,PID,1,DOCK1,63 (63),0.91,1,0,,2 (2),1,1,0.996,1
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection,Wikipathways,1,CDK4,63 (63),0.91,1,0,,2 (2),1,1,0.996,1
miRNAs involvement in the immune response in sepsis,Wikipathways,1,ELANE,64 (64),0.913,1,0,,1 (1),1,1,0.996,1
Cortisol synthesis and secretion - Homo sapiens (human),KEGG,1,SCARB1,64 (64),0.913,1,0,,13 (13),1,1,0.996,1
Shigellosis - Homo sapiens (human),KEGG,1,DOCK1,65 (65),0.916,1,0,,1 (2),1,1,0.996,1
Association Between Physico-Chemical Features and Toxicity Associated Pathways,Wikipathways,1,FN1,65 (65),0.916,1,0,,8 (8),1,1,0.996,1
Cytochrome P450 - arranged by substrate type,Reactome,1,AHR,66 (68),0.919,1,0,,91 (121),1,1,0.997,1
Acute myeloid leukemia - Homo sapiens (human),KEGG,1,MPO,66 (66),0.919,1,0,,1 (1),1,1,0.997,1
Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human),KEGG,4,CDK6;IFNGR1;E2F1;CDK4,186 (186),0.921,1,0,,5 (5),1,1,0.997,1
Long-term potentiation - Homo sapiens (human),KEGG,1,PPP1CC,67 (67),0.922,1,0,,7 (7),1,1,0.997,1
Collagen biosynthesis and modifying enzymes,Reactome,1,COL5A1,68 (68),0.925,1,0,,9 (9),1,1,0.997,1
Signaling events mediated by VEGFR1 and VEGFR2,PID,1,HSP90AB1,68 (68),0.925,1,0,,8 (8),1,1,0.997,1
Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human),KEGG,1,MET,68 (68),0.925,1,0,,4 (7),1,1,0.997,1
Downstream signaling in na&#xef;ve CD8+ T cells,PID,1,PTPN7,69 (69),0.928,1,0,,2 (9),1,1,0.997,1
Wnt Signaling,Wikipathways,2,LRP5;CTBP1,114 (114),0.93,1,0,,1 (1),1,1,0.997,1
Glutamatergic synapse - Homo sapiens (human),KEGG,2,SLC38A1;GRIA3,114 (114),0.93,1,0,,8 (8),1,1,0.997,1
B cell receptor signaling pathway - Homo sapiens (human),KEGG,1,PIK3AP1,70 (71),0.931,1,0,,4 (4),1,1,0.998,1
p75(NTR)-mediated signaling,PID,1,E2F1,70 (71),0.931,1,0,,2 (2),1,1,0.998,1
Bile secretion - Homo sapiens (human),KEGG,1,SCARB1,71 (71),0.933,1,0,,112 (162),1,1,0.998,1
CDC42 signaling events,PID,1,IQGAP3,71 (71),0.933,1,0,,5 (5),1,1,0.998,1
Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human),KEGG,1,ATP2A2,72 (72),0.936,1,0,,2 (2),1,1,0.998,1
Peptide GPCRs,Wikipathways,1,CCR2,75 (75),0.943,1,0,,2 (2),1,1,0.998,1
Proteoglycans in cancer - Homo sapiens (human),KEGG,4,TGFB1;MET;PPP1CC;FN1,201 (201),0.946,1,0,,5 (7),1,1,0.998,1
Osteoclast differentiation - Homo sapiens (human),KEGG,2,TGFB1;IFNGR1,127 (128),0.953,1,0,,3 (3),1,1,0.999,1
Alzheimer disease - Homo sapiens (human),KEGG,3,UQCRC1;CYC1;ATP2A2,171 (171),0.957,1,0,,7 (7),1,1,0.999,1
Natural killer cell mediated cytotoxicity - Homo sapiens (human),KEGG,2,CD244;IFNGR1,130 (131),0.958,1,0,,4 (4),1,1,0.999,1
Relaxin signaling pathway - Homo sapiens (human),KEGG,2,TGFB1;NOS2,130 (130),0.958,1,0,,6 (6),1,1,0.999,1
Estrogen signaling pathway - Homo sapiens (human),KEGG,2,FKBP4;HSP90AB1,136 (137),0.965,1,0,,8 (9),1,1,0.999,1
GABAergic synapse - Homo sapiens (human),KEGG,1,SLC38A1,88 (88),0.965,1,0,,9 (9),1,1,0.999,1
Protein-protein interactions at synapses,Reactome,1,GRIA3,88 (88),0.965,1,0,,2 (2),1,1,0.999,1
Rheumatoid arthritis - Homo sapiens (human),KEGG,1,TGFB1,89 (90),0.967,1,0,,2 (4),1,1,0.999,1
Longevity regulating pathway - Homo sapiens (human),KEGG,1,EHMT2,89 (89),0.967,1,0,,8 (8),1,1,0.999,1
Protein digestion and absorption - Homo sapiens (human),KEGG,1,COL5A1,90 (90),0.968,1,0,,44 (47),1,1,0.999,1
Th1 and Th2 cell differentiation - Homo sapiens (human),KEGG,1,IFNGR1,92 (92),0.97,1,0,,3 (3),1,1,1,1
Collagen formation,Reactome,1,COL5A1,92 (92),0.97,1,0,,14 (14),1,1,1,1
NF-kappa B signaling pathway - Homo sapiens (human),KEGG,1,ERC1,94 (95),0.972,1,0,,3 (3),1,1,1,1
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway,Wikipathways,2,SPP1;GRIA3,144 (144),0.973,1,0,,4 (4),1,1,1,1
Aldosterone synthesis and secretion - Homo sapiens (human),KEGG,1,SCARB1,96 (96),0.974,1,0,,21 (24),1,1,1,1
Circadian entrainment - Homo sapiens (human),KEGG,1,GRIA3,96 (96),0.974,1,0,,9 (11),1,1,1,1
Pancreatic secretion - Homo sapiens (human),KEGG,1,ATP2A2,96 (96),0.974,1,0,,12 (17),1,1,1,1
Wnt signaling pathway - Homo sapiens (human),KEGG,2,LRP5;CTBP1,148 (149),0.976,1,0,,1 (1),1,1,1,1
Regulation of Actin Cytoskeleton,Wikipathways,2,DOCK1;FN1,151 (151),0.979,1,0,,4 (5),1,1,1,1
T cell receptor signaling pathway - Homo sapiens (human),KEGG,1,CDK4,101 (101),0.979,1,0,,4 (4),1,1,1,1
cAMP signaling pathway - Homo sapiens (human),KEGG,3,ATP2A2;GRIA3;PPP1CC,199 (199),0.981,1,0,,23 (40),1,1,1,1
Parathyroid hormone synthesis_ secretion and action - Homo sapiens (human),KEGG,1,LRP5,106 (106),0.983,1,0,,9 (10),1,1,1,1
Leukocyte transendothelial migration - Homo sapiens (human),KEGG,1,ACTN4,112 (112),0.986,1,0,,3 (4),1,1,1,1
ESC Pluripotency Pathways,Wikipathways,1,LRP5,116 (116),0.988,1,0,,4 (5),1,1,1,1
Vascular smooth muscle contraction - Homo sapiens (human),KEGG,1,PPP1CC,121 (121),0.99,1,0,,17 (26),1,1,1,1
Axon guidance - Homo sapiens (human),KEGG,2,MET;SEMA6B,175 (175),0.99,1,0,,1 (1),1,1,1,1
Human cytomegalovirus infection - Homo sapiens (human),KEGG,3,CDK4;E2F1;CDK6,225 (225),0.991,1,0,,5 (6),1,1,1,1
PDGFR-beta signaling pathway,PID,1,ACTN4,127 (127),0.992,1,0,,6 (7),1,1,1,1
Autophagy - animal - Homo sapiens (human),KEGG,1,HMGB1,128 (128),0.993,1,0,,4 (4),1,1,1,1
Regulation of Complement cascade,Reactome,1,ELANE,129 (130),0.993,1,0,,2 (8),1,1,1,1
Angiopoietin Like Protein 8 Regulatory Pathway,Wikipathways,1,SREBF1,131 (131),0.993,1,0,,6 (8),1,1,1,1
Endocytosis - Homo sapiens (human),KEGG,3,AP2A2;DNAJC6;AP2S1,244 (244),0.995,1,0,,4 (6),1,1,1,1
Complement cascade,Reactome,1,ELANE,140 (141),0.995,1,0,,4 (15),1,1,1,1
MAPK Signaling Pathway,Wikipathways,3,TGFB1;PTPN7;STMN1,246 (246),0.995,1,0,,5 (5),1,1,1,1
MAPK signaling pathway - Homo sapiens (human),KEGG,4,TGFB1;MET;PTPN7;STMN1,295 (295),0.996,1,0,,5 (5),1,1,1,1
Alzheimers Disease,Wikipathways,1,ATP2A2,145 (145),0.996,1,0,,7 (8),1,1,1,1
Retrograde endocannabinoid signaling - Homo sapiens (human),KEGG,1,GRIA3,148 (148),0.997,1,0,,17 (19),1,1,1,1
Calcium Regulation in the Cardiac Cell,Wikipathways,1,ATP2A2,149 (149),0.997,1,0,,10 (10),1,1,1,1
mTOR signaling pathway - Homo sapiens (human),KEGG,1,LRP5,150 (151),0.997,1,0,,3 (3),1,1,1,1
Oxytocin signaling pathway - Homo sapiens (human),KEGG,1,PPP1CC,152 (152),0.997,1,0,,11 (13),1,1,1,1
Chemokine signaling pathway,Wikipathways,1,CCR2,165 (165),0.998,1,0,,5 (5),1,1,1,1
Ras Signaling,Wikipathways,1,MET,184 (184),0.999,1,0,,7 (7),1,1,1,1
Chemokine signaling pathway - Homo sapiens (human),KEGG,1,CCR2,189 (189),0.999,1,0,,5 (5),1,1,1,1
Peptide ligand-binding receptors,Reactome,1,CCR2,194 (194),0.999,1,0,,3 (5),1,1,1,1
Rap1 signaling pathway - Homo sapiens (human),KEGG,1,MET,206 (206),1,1,0,,5 (5),1,1,1,1
Ras signaling pathway - Homo sapiens (human),KEGG,1,MET,232 (232),1,1,0,,7 (7),1,1,1,1
GPCRs_ Class A Rhodopsin-like,Wikipathways,1,CCR2,261 (261),1,1,0,,6 (10),1,1,1,1
GPCR signaling-G alpha i,INOH,1,TGFB1,262 (262),1,1,0,,2 (2),1,1,1,1
GPCR signaling-pertussis toxin,INOH,1,TGFB1,262 (262),1,1,0,,2 (2),1,1,1,1
GPCR signaling-G alpha q,INOH,1,TGFB1,274 (274),1,1,0,,5 (6),1,1,1,1
NOTCH3 Intracellular Domain Regulates Transcription,Reactome,2,PLXND1;DLGAP5,20 (20),0.17,1,0,,0 (0),1,1,0.17,1
ACE Inhibitor Pathway_ Pharmacodynamics,PharmGKB,2,TGFB1;CTSG,20 (20),0.17,1,0,,0 (0),1,1,0.17,1
Hepatitis B - Homo sapiens (human),KEGG,8,TGFB1;DDB1;BIRC5;E2F1;CDK2;CCNA2;CDK4;CDK6,144 (144),0.171,1,0,,0 (0),1,1,0.171,1
RNA degradation - Homo sapiens (human),KEGG,5,EXOSC6;HSPD1;PFKL;PAPD7;EXOSC9,79 (79),0.172,1,0,,0 (0),1,1,0.172,1
PLK3 signaling events,PID,1,CDC25C,5 (5),0.173,1,0,,0 (0),1,1,0.173,1
Activation of NOXA and translocation to mitochondria,Reactome,1,E2F1,5 (5),0.173,1,0,,0 (0),1,1,0.173,1
Binding and entry of HIV virion,Reactome,1,PPIA,5 (5),0.173,1,0,,0 (0),1,1,0.173,1
MET interacts with TNS proteins,Reactome,1,MET,5 (5),0.173,1,0,,0 (0),1,1,0.173,1
MET activates PTPN11,Reactome,1,MET,5 (5),0.173,1,0,,0 (0),1,1,0.173,1
miR-517 relationship with ARCN1 and USP1,Wikipathways,1,USP1,5 (5),0.173,1,0,,0 (0),1,1,0.173,1
ATF-2 transcription factor network,PID,4,RUVBL2;CCNA2;NOS2;CDK4,60 (60),0.185,1,0,,0 (3),1,1,0.185,1
Extracellular vesicles in the crosstalk of cardiac cells,Wikipathways,2,SPP1;BIRC5,22 (22),0.197,1,0,,0 (0),1,1,0.197,1
hypoxia and p53 in the cardiovascular system,BioCarta,2,TAF1;RPA1,22 (22),0.197,1,0,,0 (0),1,1,0.197,1
role of brca1 brca2 and atr in cancer susceptibility,BioCarta,2,RAD51;FANCD2,22 (22),0.197,1,0,,0 (0),1,1,0.197,1
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,Reactome,2,AP2A2;AP2S1,22 (22),0.197,1,0,,0 (0),1,1,0.197,1
miRNAs involved in DNA damage response,Wikipathways,4,CDC25A;E2F1;H2AFX;CDK6,62 (62),0.2,1,0,,0 (0),1,1,0.2,1
SUMO is proteolytically processed,Reactome,1,SUMO3,6 (6),0.204,1,0,,0 (0),1,1,0.204,1
AUF1 (hnRNP D0) binds and destabilizes mRNA,Reactome,1,EIF4G1,6 (6),0.204,1,0,,0 (0),1,1,0.204,1
ifn gamma signaling pathway,BioCarta,1,IFNGR1,6 (6),0.204,1,0,,0 (1),1,1,0.204,1
IFN gamma signaling,INOH,1,IFNGR1,6 (6),0.204,1,0,,0 (1),1,1,0.204,1
SMAD2/3 Phosphorylation Motif Mutants in Cancer,Reactome,1,TGFB1,6 (6),0.204,1,0,,0 (0),1,1,0.204,1
mir-124 predicted interactions with cell cycle and differentiation,Wikipathways,1,PTBP1,6 (6),0.204,1,0,,0 (0),1,1,0.204,1
ctcf: first multivalent nuclear factor,BioCarta,2,TGFB1;PPP2R5D,23 (23),0.211,1,0,,0 (0),1,1,0.211,1
Syndecan-1-mediated signaling events,PID,3,TGFB1;MET;COL5A1,43 (43),0.216,1,0,,0 (0),1,1,0.216,1
Lung fibrosis,Wikipathways,4,TGFB1;SPP1;CCR2;DPP9,64 (64),0.216,1,0,,0 (1),1,1,0.216,1
GABA receptor Signaling,Wikipathways,2,AP2A2;AP2S1,24 (24),0.225,1,0,,0 (0),1,1,0.225,1
Beta3 integrin cell surface interactions,PID,3,SPP1;HMGB1;FN1,44 (44),0.226,1,0,,0 (3),1,1,0.226,1
Beta1 integrin cell surface interactions,PID,4,SPP1;COL5A1;F13A1;FN1,66 (66),0.232,1,0,,0 (2),1,1,0.232,1
HIF-1-alpha transcription factor network,PID,4,EGLN1;PFKL;LDHA;NOS2,66 (66),0.232,1,0,,0 (3),1,1,0.232,1
2-LTR circle formation,Reactome,1,BANF1,7 (7),0.234,1,0,,0 (0),1,1,0.234,1
srebp control of lipid synthesis,BioCarta,1,SREBF1,7 (7),0.234,1,0,,0 (0),1,1,0.234,1
DDX1 as a regulatory component of the Drosha microprocessor,Wikipathways,1,DGCR8,7 (7),0.234,1,0,,0 (0),1,1,0.234,1
TGF-Ncore,Signalink,3,HIPK2;NUP214;PPP1CC,45 (45),0.236,1,0,,0 (0),1,1,0.236,1
C-MYC pathway,PID,2,TAF9;RUVBL2,25 (25),0.239,1,0,,0 (0),1,1,0.239,1
Presenilin action in Notch and Wnt signaling,PID,3,PPP2R5D;HDAC1;CTBP1,46 (46),0.246,1,0,,0 (0),1,1,0.246,1
ID,NetPath,2,CDK2;RBL1,26 (26),0.253,1,0,,0 (0),1,1,0.253,1
PPAR Alpha Pathway,Wikipathways,2,CDK4;CDK1,26 (26),0.253,1,0,,0 (1),1,1,0.253,1
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,Reactome,3,TAF1;TAF9;GTF2F1,47 (47),0.256,1,0,,0 (0),1,1,0.256,1
Energy Metabolism,Wikipathways,3,HDAC1;MYBBP1A;TFAM,47 (47),0.256,1,0,,0 (1),1,1,0.256,1
nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,BioCarta,1,NCOR2,8 (8),0.262,1,0,,0 (0),1,1,0.262,1
Wnt signaling network,PID,2,LRP5;IGFBP4,28 (29),0.281,1,0,,0 (0),1,1,0.281,1
Reelin signaling pathway,PID,2,MAP1B;LRPAP1,28 (28),0.281,1,0,,0 (0),1,1,0.281,1
multi-step regulation of transcription by pitx2,BioCarta,2,PPP2R5D;HDAC1,28 (28),0.281,1,0,,0 (1),1,1,0.281,1
AndrogenReceptor,NetPath,7,CDC25A;AHR;NONO;NCOR2;RAN;GTF2F1;HDAC1,143 (143),0.286,1,0,,0 (0),1,1,0.286,1
Formation of HIV elongation complex in the absence of HIV Tat,Reactome,3,GTF2F1;SSRP1;NCBP1,50 (52),0.286,1,0,,0 (0),1,1,0.286,1
Supression of HMGB1 mediated inflammation by THBD,Wikipathways,1,HMGB1,9 (9),0.29,1,0,,0 (0),1,1,0.29,1
Activation of PUMA and translocation to mitochondria,Reactome,1,E2F1,9 (9),0.29,1,0,,0 (0),1,1,0.29,1
btg family proteins and cell cycle regulation,BioCarta,1,CHAF1A,9 (9),0.29,1,0,,0 (0),1,1,0.29,1
The role of Nef in HIV-1 replication and disease pathogenesis,Reactome,2,AP2A2;AP2S1,29 (29),0.295,1,0,,0 (0),1,1,0.295,1
Wnt Signaling Pathway,Wikipathways,3,LRP5;CDK6;CTBP1,51 (51),0.297,1,0,,0 (0),1,1,0.297,1
IL2 signaling events mediated by STAT5,PID,2,CCNA2;CDK6,30 (30),0.309,1,0,,0 (0),1,1,0.309,1
Extracellular vesicle-mediated signaling in recipient cells,Wikipathways,2,TGFB1;MET,30 (30),0.309,1,0,,0 (0),1,1,0.309,1
Removal of aminoterminal propeptides from gamma-carboxylated proteins,Reactome,1,F10,10 (10),0.317,1,0,,0 (3),1,1,0.317,1
regulation of splicing through sam68,BioCarta,1,CDK1,10 (10),0.317,1,0,,0 (0),1,1,0.317,1
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,Reactome,1,AURKA,10 (10),0.317,1,0,,0 (0),1,1,0.317,1
Interleukin-27 signaling,Reactome,1,CANX,10 (10),0.317,1,0,,0 (0),1,1,0.317,1
Mammary gland development pathway - Involution (Stage 4 of 4),Wikipathways,1,E2F1,10 (10),0.317,1,0,,0 (1),1,1,0.317,1
Liver X Receptor Pathway,Wikipathways,1,SREBF1,10 (10),0.317,1,0,,0 (1),1,1,0.317,1
Ovarian Infertility Genes,Wikipathways,2,CDK4;MLH1,31 (31),0.323,1,0,,0 (0),1,1,0.323,1
Ribosome biogenesis in eukaryotes - Homo sapiens (human),KEGG,5,NOP56;HEATR1;UTP6;NHP2;RAN,101 (105),0.325,1,0,,0 (0),1,1,0.325,1
Constitutive Androstane Receptor Pathway,Wikipathways,2,SMC1A;ALAS1,32 (32),0.337,1,0,,0 (1),1,1,0.337,1
Initiation of transcription and translation elongation at the HIV-1 LTR,Wikipathways,2,HDAC1;HDAC2,32 (32),0.337,1,0,,0 (0),1,1,0.337,1
Validated transcriptional targets of TAp63 isoforms,PID,3,NOC2L;PLK1;SSRP1,55 (55),0.338,1,0,,0 (0),1,1,0.338,1
Liver steatosis AOP,Wikipathways,5,SREBF1;ACAA2;ALAS1;SMC1A;ACACA,103 (103),0.34,1,0,,0 (0),1,1,0.34,1
Signaling mediated by p38-gamma and p38-delta,PID,1,STMN1,11 (12),0.342,1,0,,0 (0),1,1,0.342,1
Hepatitis C and Hepatocellular Carcinoma,Wikipathways,3,TGFB1;NOS2;BIRC5,56 (56),0.348,1,0,,0 (0),1,1,0.348,1
integrin signaling pathway,BioCarta,2,ACTN4;LRPAP1,33 (33),0.35,1,0,,0 (0),1,1,0.35,1
Signaling of Hepatocyte Growth Factor Receptor,Wikipathways,2,DOCK1;MET,34 (34),0.364,1,0,,0 (0),1,1,0.364,1
Receptor Mediated Mitophagy,Reactome,1,PGAM5,12 (12),0.367,1,0,,0 (0),1,1,0.367,1
Notch,NetPath,3,HDAC1;HDAC2;NCOR2,58 (59),0.369,1,0,,0 (0),1,1,0.369,1
Circadian Clock,Reactome,2,SREBF1;PPP1CC,35 (35),0.378,1,0,,0 (2),1,1,0.378,1
Preimplantation Embryo,Wikipathways,3,KHSRP;SMARCA4;HNRNPAB,59 (59),0.379,1,0,,0 (0),1,1,0.379,1
IL-7 signaling,INOH,8,PLK1;MET;CDK6;CDK1;CDK2;CDK4;CDC7;WEE1,184 (185),0.381,1,0,,0 (0),1,1,0.381,1
Herpes simplex infection - Homo sapiens (human),KEGG,8,IFNGR1;C1QBP;HCFC1;PPP1CC;CDK2;CDK1;GTF2I;SRSF4,185 (185),0.387,1,0,,0 (0),1,1,0.387,1
EPO signaling,INOH,8,PLK1;MET;CDK6;CDK1;CDK2;CDK4;CDC7;WEE1,185 (186),0.387,1,0,,0 (2),1,1,0.387,1
Control of immune tolerance by vasoactive intestinalpeptide,Wikipathways,1,TGFB1,13 (13),0.39,1,0,,0 (0),1,1,0.39,1
DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,Reactome,1,HMGB1,13 (13),0.39,1,0,,0 (3),1,1,0.39,1
b cell survival pathway,BioCarta,1,BIRC5,13 (13),0.39,1,0,,0 (0),1,1,0.39,1
il 6 signaling pathway,BioCarta,1,LRPPRC,13 (13),0.39,1,0,,0 (0),1,1,0.39,1
role of mitochondria in apoptotic signaling,BioCarta,1,AIFM1,13 (13),0.39,1,0,,0 (0),1,1,0.39,1
Osteopontin Signaling,Wikipathways,1,SPP1,13 (13),0.39,1,0,,0 (0),1,1,0.39,1
TFs Regulate miRNAs related to cardiac hypertrophy,Wikipathways,1,TGFB1,13 (13),0.39,1,0,,0 (0),1,1,0.39,1
Mammary gland development pathway - Puberty (Stage 2 of 4),Wikipathways,1,FN1,13 (13),0.39,1,0,,0 (1),1,1,0.39,1
Development of pulmonary dendritic cells and macrophage subsets,Wikipathways,1,IRF8,13 (13),0.39,1,0,,0 (0),1,1,0.39,1
Transcriptional cascade regulating adipogenesis,Wikipathways,1,SREBF1,13 (13),0.39,1,0,,0 (0),1,1,0.39,1
Notch Signaling Pathway,Wikipathways,3,HDAC1;HDAC2;NCOR2,61 (61),0.399,1,0,,0 (0),1,1,0.399,1
IL23-mediated signaling events,PID,2,MPO;NOS2,37 (37),0.404,1,0,,0 (1),1,1,0.404,1
CDT1 association with the CDC6:ORC:origin complex,Reactome,1,CDT1,14 (14),0.413,1,0,,0 (0),1,1,0.413,1
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition,Wikipathways,1,FN1,14 (14),0.413,1,0,,0 (0),1,1,0.413,1
Formation of RNA Pol II elongation complex ,Reactome,3,GTF2F1;SSRP1;NCBP1,63 (65),0.42,1,0,,0 (0),1,1,0.42,1
Androgen receptor signaling pathway,Wikipathways,4,FKBP4;HDAC1;NCOR2;RAN,89 (89),0.426,1,0,,0 (0),1,1,0.426,1
EGFR1,NetPath,18,DOCK1;LDHA;HIPK2;RACGAP1;MET;TAGLN2;CTBP1;ESYT1;ACTN4;AHNAK;HDAC1;STIP1;CDK1;HTT;CDK2;AP2S1;EIF4G1;RPLP0,455 (457),0.434,1,0,,0 (4),1,1,0.434,1
chaperones modulate interferon signaling pathway,BioCarta,1,IFNGR1,15 (15),0.435,1,0,,0 (1),1,1,0.435,1
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,Reactome,1,ATAD2,15 (15),0.435,1,0,,0 (0),1,1,0.435,1
Negative regulation of TCF-dependent signaling by WNT ligand antagonists,Reactome,1,LRP5,15 (15),0.435,1,0,,0 (0),1,1,0.435,1
Mitophagy - animal - Homo sapiens (human),KEGG,3,BCL2L13;E2F1;PGAM5,65 (65),0.44,1,0,,0 (0),1,1,0.44,1
Bladder Cancer,Wikipathways,2,CDK4;E2F1,40 (40),0.443,1,0,,0 (0),1,1,0.443,1
Human Thyroid Stimulating Hormone (TSH) signaling pathway,Wikipathways,3,CDK2;CDK4;E2F1,66 (66),0.449,1,0,,0 (0),1,1,0.449,1
Syndecan-2-mediated signaling events,PID,2,TGFB1;FN1,41 (41),0.456,1,0,,0 (1),1,1,0.456,1
Bladder cancer - Homo sapiens (human),KEGG,2,CDK4;E2F1,41 (41),0.456,1,0,,0 (0),1,1,0.456,1
Common Pathways Underlying Drug Addiction,Wikipathways,2,GRIA3;PPP1CC,41 (41),0.456,1,0,,0 (0),1,1,0.456,1
eukaryotic protein translation,BioCarta,1,EIF4G1,16 (17),0.456,1,0,,0 (0),1,1,0.456,1
Interactome of polycomb repressive complex 2 (PRC2),Wikipathways,1,RBBP4,16 (16),0.456,1,0,,0 (0),1,1,0.456,1
Wnt,NetPath,3,LRP5;CDK6;CTBP1,68 (69),0.469,1,0,,0 (0),1,1,0.469,1
Canonical and Non-Canonical TGF-B signaling,Wikipathways,1,TGFB1,17 (17),0.476,1,0,,0 (0),1,1,0.476,1
KitReceptor,NetPath,3,CDK2;MAD2L1;SPRED1,70 (70),0.488,1,0,,0 (0),1,1,0.488,1
Interleukin-11 Signaling Pathway,Wikipathways,2,TGFB1;BIRC5,44 (44),0.493,1,0,,0 (0),1,1,0.493,1
miRNA targets in ECM and membrane receptors,Wikipathways,2,COL5A1;FN1,44 (44),0.493,1,0,,0 (0),1,1,0.493,1
Beta5 beta6 beta7 and beta8 integrin cell surface interactions,PID,1,FN1,18 (18),0.496,1,0,,0 (2),1,1,0.496,1
er associated degradation (erad) pathway,BioCarta,1,UGGT1,18 (18),0.496,1,0,,0 (0),1,1,0.496,1
SREBF and miR33 in cholesterol and lipid homeostasis,Wikipathways,1,SREBF1,18 (18),0.496,1,0,,0 (0),1,1,0.496,1
Mammary gland development pathway - Embryonic development (Stage 1 of 4),Wikipathways,1,TGFB1,18 (18),0.496,1,0,,0 (1),1,1,0.496,1
Beta defensins,Reactome,2,TLR1;CCR2,45 (51),0.505,1,0,,0 (0),1,1,0.505,1
RAGE,NetPath,2,CDK2;AIFM1,45 (45),0.505,1,0,,0 (0),1,1,0.505,1
Mesodermal Commitment Pathway,Wikipathways,6,WDHD1;C1QBP;TRIM28;NCAPG2;HTT;ACACA,153 (153),0.51,1,0,,0 (0),1,1,0.51,1
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,PID,1,EGLN1,19 (19),0.515,1,0,,0 (0),1,1,0.515,1
prion pathway,BioCarta,1,RPSA,19 (19),0.515,1,0,,0 (0),1,1,0.515,1
Other semaphorin interactions,Reactome,1,PLXND1,19 (19),0.515,1,0,,0 (0),1,1,0.515,1
Apoptosis Modulation by HSP70,Wikipathways,1,AIFM1,19 (19),0.515,1,0,,0 (0),1,1,0.515,1
Aryl Hydrocarbon Receptor Pathway,Wikipathways,2,TGFB1;AHR,46 (46),0.517,1,0,,0 (1),1,1,0.517,1
Neural Crest Differentiation,Wikipathways,4,HDAC2;HDAC1;MYB;HDAC6,101 (101),0.524,1,0,,0 (0),1,1,0.524,1
Validated targets of C-MYC transcriptional repression,PID,3,HDAC1;IRF8;RBL1,74 (74),0.526,1,0,,0 (0),1,1,0.526,1
Bacterial invasion of epithelial cells - Homo sapiens (human),KEGG,3,DOCK1;FN1;MET,74 (74),0.526,1,0,,0 (0),1,1,0.526,1
TGF-beta signaling TAK1,INOH,1,TGFB1,20 (20),0.533,1,0,,0 (0),1,1,0.533,1
SUMOylation of transcription factors,Reactome,1,SUMO3,20 (20),0.533,1,0,,0 (0),1,1,0.533,1
tgf beta signaling pathway,BioCarta,1,TGFB1,20 (20),0.533,1,0,,0 (1),1,1,0.533,1
Syndecan interactions,Reactome,1,TGFB1,20 (20),0.533,1,0,,0 (2),1,1,0.533,1
Olfactory bulb development and olfactory learning,Wikipathways,1,PCNT,20 (20),0.533,1,0,,0 (0),1,1,0.533,1
Exercise-induced Circadian Regulation,Wikipathways,2,SF3A3;SUMO3,48 (48),0.54,1,0,,0 (0),1,1,0.54,1
Regulation of Apoptosis by Parathyroid Hormone-related Protein,Wikipathways,1,BCL2L13,21 (21),0.55,1,0,,0 (0),1,1,0.55,1
Antigen processing and presentation - Homo sapiens (human),KEGG,3,CANX;HSP90AB1;PSME3,77 (77),0.553,1,0,,0 (0),1,1,0.553,1
Epithelial to mesenchymal transition in colorectal cancer,Wikipathways,6,TGFB1;FOXM1;STRAP;RBBP4;LRP5;FN1,160 (160),0.554,1,0,,0 (0),1,1,0.554,1
TGF-beta receptor signaling,PID,2,TGFB1;STRAP,50 (50),0.562,1,0,,0 (0),1,1,0.562,1
Senescence and Autophagy in Cancer,Wikipathways,4,TGFB1;RSL1D1;E2F1;FN1,106 (106),0.562,1,0,,0 (0),1,1,0.562,1
erk1/erk2 mapk signaling pathway,BioCarta,1,PPP2R5D,22 (22),0.567,1,0,,0 (1),1,1,0.567,1
The human immune response to tuberculosis,Wikipathways,1,IFNGR1,22 (22),0.567,1,0,,0 (0),1,1,0.567,1
NRF2-ARE regulation,Wikipathways,1,PGAM5,23 (23),0.583,1,0,,0 (0),1,1,0.583,1
caspase cascade in apoptosis,BioCarta,1,SREBF1,23 (23),0.583,1,0,,0 (0),1,1,0.583,1
Protein export - Homo sapiens (human),KEGG,1,SRP72,23 (23),0.583,1,0,,0 (0),1,1,0.583,1
Metastatic brain tumor,Wikipathways,1,CDK6,23 (23),0.583,1,0,,0 (0),1,1,0.583,1
tumor suppressor arf inhibits ribosomal biogenesis,BioCarta,1,E2F1,24 (24),0.599,1,0,,0 (0),1,1,0.599,1
IL1 and megakaryocytes in obesity,Wikipathways,1,TLR1,24 (24),0.599,1,0,,0 (0),1,1,0.599,1
TGF-beta Receptor Signaling,Wikipathways,2,TGFB1;SPP1,55 (55),0.614,1,0,,0 (0),1,1,0.614,1
Defensins,Reactome,2,TLR1;CCR2,55 (61),0.614,1,0,,0 (2),1,1,0.614,1
VEGFR3 signaling in lymphatic endothelium,PID,1,FN1,25 (25),0.614,1,0,,0 (0),1,1,0.614,1
Hedgehog,NetPath,1,CCNB1,25 (25),0.614,1,0,,0 (0),1,1,0.614,1
Signal Transduction of S1P Receptor,Wikipathways,1,RACGAP1,25 (25),0.614,1,0,,0 (0),1,1,0.614,1
Ectoderm Differentiation,Wikipathways,5,HIST1H2BH;CTBP1;HMGB2;HDAC6;PI4KA,142 (142),0.616,1,0,,0 (0),1,1,0.616,1
TGF-beta signaling pathway - Homo sapiens (human),KEGG,3,TGFB1;E2F4;RBL1,85 (85),0.62,1,0,,0 (0),1,1,0.62,1
BMP2 signaling TGF-beta MV,INOH,2,TGFB1;SMARCA4,56 (56),0.624,1,0,,0 (0),1,1,0.624,1
Other interleukin signaling,Reactome,1,PRTN3,26 (26),0.628,1,0,,0 (2),1,1,0.628,1
IL27-mediated signaling events,PID,1,TGFB1,26 (26),0.628,1,0,,0 (1),1,1,0.628,1
ALK1 signaling events,PID,1,TGFB1,26 (26),0.628,1,0,,0 (0),1,1,0.628,1
Activation of gene expression by SREBF (SREBP),Reactome,1,SREBF1,26 (26),0.628,1,0,,0 (0),1,1,0.628,1
TSH,NetPath,1,CANX,26 (26),0.628,1,0,,0 (1),1,1,0.628,1
Steatosis AOP,Wikipathways,1,SREBF1,26 (26),0.628,1,0,,0 (1),1,1,0.628,1
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,Reactome,1,GTF2F1,27 (27),0.642,1,0,,0 (0),1,1,0.642,1
RNA Pol II CTD phosphorylation and interaction with CE,Reactome,1,GTF2F1,27 (27),0.642,1,0,,0 (0),1,1,0.642,1
alk in cardiac myocytes,BioCarta,1,TGFB1,27 (27),0.642,1,0,,0 (0),1,1,0.642,1
Cytokines and Inflammatory Response,Wikipathways,1,TGFB1,28 (29),0.656,1,0,,0 (0),1,1,0.656,1
IL3-mediated signaling events,PID,1,HDAC1,28 (28),0.656,1,0,,0 (0),1,1,0.656,1
TWEAK,NetPath,1,HDAC1,28 (28),0.656,1,0,,0 (0),1,1,0.656,1
Hippo signaling pathway - multiple species - Homo sapiens (human),KEGG,1,RASSF4,28 (29),0.656,1,0,,0 (0),1,1,0.656,1
RNA Polymerase III Transcription Initiation From Type 1 Promoter,Reactome,1,GTF3A,28 (29),0.656,1,0,,0 (0),1,1,0.656,1
TYROBP Causal Network,Wikipathways,2,SPP1;HLX,60 (60),0.661,1,0,,0 (0),1,1,0.661,1
Phase I - Functionalization of compounds,Wikipathways,0,,0 (0),1,1,1,HMDB00538,144 (195),0.667,1,0.667,1
Corticotropin-releasing hormone signaling pathway,Wikipathways,3,TGFB1;TRIM28;ACACA,92 (92),0.673,1,0,,0 (0),1,1,0.673,1
Budding and maturation of HIV virion,Reactome,1,PPIA,30 (30),0.681,1,0,,0 (0),1,1,0.681,1
Mitophagy,Reactome,1,PGAM5,30 (30),0.681,1,0,,0 (0),1,1,0.681,1
MicroRNAs in cancer - Homo sapiens (human),KEGG,10,CDC25A;CDC25C;MET;CDCA5;ABCC1;E2F1;STMN1;HDAC1;DNMT1;CDK6,299 (299),0.684,1,0,,0 (0),1,1,0.684,1
Vitamin D Receptor Pathway,Wikipathways,6,TGFB1;IRF8;SPP1;LRP5;STEAP4;CDK2,184 (184),0.689,1,0,,0 (1),1,1,0.689,1
Nonalcoholic fatty liver disease,Wikipathways,5,SREBF1;UQCRC1;TGFB1;MLX;CYC1,155 (155),0.692,1,0,,0 (4),1,1,0.692,1
Molecules associated with elastic fibres,Reactome,1,TGFB1,31 (31),0.693,1,0,,0 (0),1,1,0.693,1
Toll-like Receptor Signaling,Wikipathways,1,TLR1,31 (31),0.693,1,0,,0 (0),1,1,0.693,1
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway,Wikipathways,10,SREBF1;SPP1;MET;NOS2;COMP;COL5A1;PPP2R5D;ACACA;HSP90AB1;FN1,302 (302),0.696,1,0,,0 (2),1,1,0.696,1
IL4-mediated signaling events,PID,2,MYB;GTF3A,65 (65),0.704,1,0,,0 (4),1,1,0.704,1
IL12-mediated signaling events,PID,2,NOS2;HLX,65 (65),0.704,1,0,,0 (1),1,1,0.704,1
Inflammatory bowel disease (IBD) - Homo sapiens (human),KEGG,2,TGFB1;IFNGR1,65 (65),0.704,1,0,,0 (0),1,1,0.704,1
IL12 signaling mediated by STAT4,PID,1,TGFB1,32 (32),0.704,1,0,,0 (1),1,1,0.704,1
Development and heterogeneity of the ILC family,Wikipathways,1,AHR,32 (32),0.704,1,0,,0 (0),1,1,0.704,1
LncRNA involvement in canonical Wnt signaling and colorectal cancer,Wikipathways,3,LRP5;CDK6;CTBP1,97 (97),0.707,1,0,,0 (0),1,1,0.707,1
B Cell Receptor Signaling Pathway,Wikipathways,3,ILF2;GTF2I;PIK3AP1,98 (98),0.714,1,0,,0 (0),1,1,0.714,1
BCR,NetPath,4,CDK2;CDK4;CDK6;GTF2I,129 (129),0.715,1,0,,0 (0),1,1,0.715,1
Inflammatory Response Pathway,Wikipathways,1,FN1,33 (33),0.715,1,0,,0 (0),1,1,0.715,1
Apoptosis - multiple species - Homo sapiens (human),KEGG,1,BIRC5,33 (33),0.715,1,0,,0 (0),1,1,0.715,1
BMP signaling Dro,INOH,1,SMARCA4,34 (34),0.726,1,0,,0 (0),1,1,0.726,1
Wnt Signaling Pathway and Pluripotency,Wikipathways,3,LRP5;CTBP1;RACGAP1,101 (101),0.733,1,0,,0 (1),1,1,0.733,1
Class I PI3K signaling events mediated by Akt,PID,1,KPNA1,35 (35),0.736,1,0,,0 (0),1,1,0.736,1
HIF-2-alpha transcription factor network,PID,1,EGLN1,35 (35),0.736,1,0,,0 (2),1,1,0.736,1
Photodynamic therapy-induced NF-kB survival signaling,Wikipathways,1,BIRC5,35 (35),0.736,1,0,,0 (0),1,1,0.736,1
Prolactin,NetPath,2,MYB;PPIA,70 (70),0.742,1,0,,0 (0),1,1,0.742,1
IL1-mediated signaling events,PID,1,ERC1,36 (36),0.746,1,0,,0 (1),1,1,0.746,1
Elastic fibre formation,Reactome,1,TGFB1,36 (36),0.746,1,0,,0 (0),1,1,0.746,1
RNA Polymerase III Transcription Initiation,Reactome,1,GTF3A,36 (37),0.746,1,0,,0 (0),1,1,0.746,1
Alpha6Beta4Integrin,NetPath,2,RPSA;MET,71 (71),0.749,1,0,,0 (0),1,1,0.749,1
Endoderm Differentiation,Wikipathways,2,TGFB1;CAND1,71 (71),0.749,1,0,,0 (0),1,1,0.749,1
Validated transcriptional targets of AP1 family members Fra1 and Fra2,PID,1,CCNA2,37 (37),0.756,1,0,,0 (2),1,1,0.756,1
signal transduction through il1r,BioCarta,1,TGFB1,37 (37),0.756,1,0,,0 (2),1,1,0.756,1
Adherens junction - Homo sapiens (human),KEGG,2,MET;ACTN4,72 (72),0.756,1,0,,0 (0),1,1,0.756,1
G13 Signaling Pathway,Wikipathways,1,CIT,38 (38),0.765,1,0,,0 (0),1,1,0.765,1
Apoptotic cleavage of cellular proteins,Reactome,1,STK26,38 (38),0.765,1,0,,0 (0),1,1,0.765,1
Striated Muscle Contraction Pathway,Wikipathways,1,ACTN4,38 (38),0.765,1,0,,0 (0),1,1,0.765,1
Fibroblast growth factor-1,NetPath,2,RAN;PRKCSH,74 (74),0.769,1,0,,0 (0),1,1,0.769,1
Ghrelin,NetPath,1,ACACA,39 (39),0.774,1,0,,0 (0),1,1,0.774,1
Prolactin Signaling Pathway,Wikipathways,2,NOS2;PPIA,76 (76),0.782,1,0,,0 (0),1,1,0.782,1
IL2,NetPath,2,CDK2;EIF3B,76 (76),0.782,1,0,,0 (0),1,1,0.782,1
IL-5 Signaling Pathway,Wikipathways,1,SPRED1,40 (40),0.782,1,0,,0 (0),1,1,0.782,1
Integrated Lung Cancer Pathway,Wikipathways,1,ERC1,40 (40),0.782,1,0,,0 (0),1,1,0.782,1
Regulation of toll-like receptor signaling pathway,Wikipathways,4,TLR1;SPP1;PLK1;CUEDC2,143 (143),0.786,1,0,,0 (2),1,1,0.786,1
BMP receptor signaling,PID,1,NUP214,41 (41),0.79,1,0,,0 (0),1,1,0.79,1
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway,Wikipathways,1,HDAC1,41 (41),0.79,1,0,,0 (0),1,1,0.79,1
Eukaryotic Transcription Initiation,Wikipathways,1,TAF9,41 (41),0.79,1,0,,0 (0),1,1,0.79,1
Non-integrin membrane-ECM interactions,Reactome,1,TGFB1,42 (42),0.798,1,0,,0 (3),1,1,0.798,1
TGF-Core,Signalink,1,TGFB1,42 (42),0.798,1,0,,0 (0),1,1,0.798,1
LKB1 signaling events,PID,1,STK26,43 (43),0.806,1,0,,0 (0),1,1,0.806,1
IL-6 signaling pathway,Wikipathways,1,HDAC1,43 (43),0.806,1,0,,0 (0),1,1,0.806,1
Collagen chain trimerization,Reactome,1,COL5A1,44 (44),0.813,1,0,,0 (0),1,1,0.813,1
WNT-Core,Signalink,1,LRP5,44 (44),0.813,1,0,,0 (0),1,1,0.813,1
FOXA2 and FOXA3 transcription factor networks,PID,1,ALAS1,45 (45),0.82,1,0,,0 (4),1,1,0.82,1
Peroxisome - Homo sapiens (human),KEGG,2,NOS2;ECI2,83 (83),0.822,1,0,,0 (0),1,1,0.822,1
Hippo signaling pathway - Homo sapiens (human),KEGG,4,TGFB1;LLGL1;BIRC5;PPP1CC,153 (154),0.828,1,0,,0 (0),1,1,0.828,1
ncRNAs involved in Wnt signaling in hepatocellular carcinoma,Wikipathways,2,LRP5;CTBP1,86 (86),0.836,1,0,,0 (0),1,1,0.836,1
Nuclear Receptors Meta-Pathway,Wikipathways,9,TGFB1;SREBF1;GSTM1;AHR;SMC1A;ALAS1;CDK1;CDK4;HSP90AB1,316 (316),0.839,1,0,,0 (0),1,1,0.839,1
Apoptosis,Wikipathways,2,BIRC5;HELLS,87 (87),0.841,1,0,,0 (0),1,1,0.841,1
IL-3 Signaling Pathway,Wikipathways,1,TGFB1,49 (49),0.846,1,0,,0 (0),1,1,0.846,1
Hematopoietic Stem Cell Differentiation,Wikipathways,1,MYB,49 (49),0.846,1,0,,0 (0),1,1,0.846,1
JAK STAT MolecularVariation 2,INOH,1,IFNGR1,50 (50),0.851,1,0,,0 (0),1,1,0.851,1
Chemokine receptors bind chemokines,Reactome,1,CCR2,50 (50),0.851,1,0,,0 (0),1,1,0.851,1
Photodynamic therapy-induced AP-1 survival signaling.,Wikipathways,1,CCNA2,50 (50),0.851,1,0,,0 (0),1,1,0.851,1
EGF-EGFR Signaling Pathway,Wikipathways,4,AP2S1;STMN1;AURKA;E2F1,162 (162),0.86,1,0,,0 (0),1,1,0.86,1
Ebola Virus Pathway on Host,Wikipathways,3,ACTN4;C1QBP;KPNA1,130 (130),0.869,1,0,,0 (0),1,1,0.869,1
IL-4 Signaling Pathway,Wikipathways,1,BIRC5,54 (54),0.872,1,0,,0 (0),1,1,0.872,1
Viral myocarditis - Homo sapiens (human),KEGG,1,EIF4G1,58 (59),0.89,1,0,,0 (0),1,1,0.89,1
TCR,NetPath,6,LDHA;PIK3AP1;RAN;PI4KA;CDK1;HSP90AB1,244 (245),0.897,1,0,,0 (0),1,1,0.897,1
RIG-I-like Receptor Signaling,Wikipathways,1,DDX3Y,60 (60),0.899,1,0,,0 (0),1,1,0.899,1
Toll-like Receptor Signaling Pathway,Wikipathways,2,TLR1;SPP1,102 (102),0.899,1,0,,0 (0),1,1,0.899,1
Angiogenesis overview,Wikipathways,1,PLXND1,61 (61),0.902,1,0,,0 (0),1,1,0.902,1
NRF2 pathway,Wikipathways,3,TGFB1;GSTM1;HSP90AB1,142 (142),0.904,1,0,,0 (1),1,1,0.904,1
Toll-like receptor signaling pathway - Homo sapiens (human),KEGG,2,SPP1;TLR1,104 (104),0.905,1,0,,0 (0),1,1,0.905,1
Oncostatin M Signaling Pathway,Wikipathways,1,CDK2,65 (65),0.916,1,0,,0 (0),1,1,0.916,1
AGE-RAGE pathway,Wikipathways,1,NOS2,66 (66),0.919,1,0,,0 (0),1,1,0.919,1
Metapathway biotransformation Phase I and II,Wikipathways,4,GSTM1;NAA40;GSTO1;GSTCD,186 (186),0.921,1,0,,0 (0),1,1,0.921,1
DNA Damage Response (only ATM dependent),Wikipathways,2,TGFB1;HMGB1,110 (110),0.921,1,0,,0 (0),1,1,0.921,1
IL6,NetPath,1,HDAC1,74 (74),0.941,1,0,,0 (0),1,1,0.941,1
Leptin signaling pathway,Wikipathways,1,ACACA,76 (76),0.945,1,0,,0 (0),1,1,0.945,1
T-Cell antigen Receptor (TCR) Signaling Pathway,Wikipathways,1,TGFB1,92 (92),0.97,1,0,,0 (0),1,1,0.97,1
IL-17 signaling pathway - Homo sapiens (human),KEGG,1,HSP90AB1,93 (93),0.971,1,0,,0 (0),1,1,0.971,1
JAK STAT MolecularVariation 1,INOH,1,IFNGR1,98 (98),0.976,1,0,,0 (3),1,1,0.976,1
Integrin-mediated Cell Adhesion,Wikipathways,1,DOCK1,101 (101),0.979,1,0,,0 (0),1,1,0.979,1
GPCRs_ Other,Wikipathways,1,CELSR1,101 (101),0.979,1,0,,0 (0),1,1,0.979,1
JAK-STAT-Core,Signalink,1,IFNGR1,104 (104),0.981,1,0,,0 (0),1,1,0.981,1
TNF signaling pathway - Homo sapiens (human),KEGG,1,PGAM5,110 (110),0.985,1,0,,0 (0),1,1,0.985,1
VEGFA-VEGFR2 Signaling Pathway,Wikipathways,3,HDAC1;PTPN9;ACACA,236 (236),0.994,1,0,,0 (0),1,1,0.994,1
Cell adhesion molecules (CAMs) - Homo sapiens (human),KEGG,1,VCAN,143 (144),0.996,1,0,,0 (0),1,1,0.996,1
Insulin Signaling,Wikipathways,1,PFKL,160 (160),0.998,1,0,,0 (0),1,1,0.998,1
JAK-STAT signaling pathway - Homo sapiens (human),KEGG,1,IFNGR1,162 (162),0.998,1,0,,0 (0),1,1,0.998,1
Cytokine-cytokine receptor interaction - Homo sapiens (human),KEGG,3,TGFB1;IFNGR1;CCR2,294 (294),0.999,1,0,,0 (0),1,1,0.999,1
Olfactory Signaling Pathway,Reactome,1,REEP4,435 (437),1,1,0,,0 (0),1,1,1,1